"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B2,US 7716585 B2,005-445-762-542-900,2010-05-11,2010,US 65062203 A,2003-08-28,US 65062203 A,2003-08-28,Multi-dimensional graphical display of discovered wireless devices,"A device discovery and presentation system. The architecture facilitates automatically sensing devices, ports, or other wirelessly identifiable entities by detecting such entities, and displaying a 2-D or 3-D representation of the relative location of such entities to a user via a display. The architecture may be controlled to detect such entities in a confined envelope of space for a specified distance.",MICROSOFT CORP,GLASS ANDREW C,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-08-27),https://lens.org/005-445-762-542-900,Granted Patent,yes,24,54,2,2,0,H04W8/14;;H04W48/16;;H04L67/125;;H04M1/72427;;H04L67/75;;H04L67/52;;H04W48/16;;H04W8/14;;H04L67/125;;H04M1/72427;;H04L67/75;;H04L67/52,G06F15/177;;G06F15/16;;H04L29/08;;H04M1/72427;;H04W8/14;;H04W48/16,715/734;;715/736;;715/738;;715/739,6,6,099-315-380-054-201;;021-428-790-406-442;;117-334-089-414-309;;060-761-501-058-52X;;061-872-583-227-398;;007-645-543-149-286,10.1109/mcsa.2000.895378;;10.1109/4236.780963;;10.1145/329124.329153;;10.1109/65.313011;;10.1109/35.649334;;10.1145/844351.844355,"Author: Tim Kindberg, John Barton, Jeff Morgan, Gene Becker, Debbie Caswell, Philippe Debaty, Gita Gopal, Marcos Frid, Venky Krishnan, Howard Morris, John Schettino, Bell Serra. Title: People, Places, Things: Web Presence for the Real Word. Tittle Date: Feb. 2000. Publisher: Hewlett-Packard Company. Pertinent Pages: 18 pages.;;Author: Erik Guttman. Tittle: Service Location Protocol: Automatic Discovery of IP Network Services, IEEE Internet Computing, v.3. Publisher Date: Jul. 1999. Pertinent pages: p. 71-79.;;Author: Petros, Meman Roussopoulos, Ed Swierk Lai, Guido Appenzeller, Xinhau Zhao, Mary Baker. Tittle: The Mobile People Architecture. Tittle Date: Jul. 1999. ACM SIGMOBILE Mobile Computing and Communications Review, v.3 n.3; pp. 36-42.;;Bill N. Schilit, et al., Disseminating Active Map Information to Mobile Hosts, IEEE Network, 1994, pp. 22-32, vol. 8.;;Maarten Van Steen, et al., Locating Objects in Wide-Area Systems, IEEE Commun. Mag., Jan. 1998, 36(1):104-109.;;Vasileios Zeimpekis, et al., A Taxonomy of Indoor and Outdoor Positioning Techniques for Mobile Location Services, ACM SIGecom Exchanges, 2003, pp. 19-27, vol. 3, Issue 4.",ACTIVE
2,US,A1,US 2005/0048987 A1,187-645-388-591-927,2005-03-03,2005,US 65062203 A,2003-08-28,US 65062203 A,2003-08-28,Multi-dimensional graphical display of discovered wireless devices,"A device discovery and presentation system. The architecture facilitates automatically sensing devices, ports, or other wirelessly identifiable entities by detecting such entities, and displaying a 2-D or 3-D representation of the relative location of such entities to a user via a display. The architecture may be controlled to detect such entities in a confined envelope of space for a specified distance.",GLASS ANDREW C.,GLASS ANDREW C,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-08-27),https://lens.org/187-645-388-591-927,Patent Application,yes,24,155,2,2,0,H04W8/14;;H04W48/16;;H04L67/125;;H04M1/72427;;H04L67/75;;H04L67/52;;H04W48/16;;H04W8/14;;H04L67/125;;H04M1/72427;;H04L67/75;;H04L67/52,H04L29/08;;H04M1/72427;;H04W8/14;;H04W48/16,455/456.1,0,0,,,,EXPIRED
3,KR,A,KR 20230002918 A,195-133-257-636-858,2023-01-05,2023,KR 20227040636 A,2021-04-20,GB 202005821 A;;GB 2021050946 W,2020-04-21,방법 및 장치,부하 하에서 셀을 필드 맵핑하는 방법이 제공된다. 본 방법은 셀을 제공하는 단계; 자기장을 측정하기 위한 그래핀 도체를 포함하는 홀 효과 센서를 제공하는 단계; 셀의 페이스에 인접한 제1 위치에 홀 효과 센서를 위치시키는 단계; 부하를 셀에 가하는 단계; 및 홀 효과 센서의 출력을 측정하는 단계를 포함한다.,PARAGRAF LTD,GLASS HUGH;;MATTHEWS ANDREW,,https://lens.org/195-133-257-636-858,Patent Application,no,0,0,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R33/07;;G01R15/20;;G01R31/36;;G01R31/3832;;G01R33/00;;G01R33/028;;G01R33/04,,0,0,,,,PENDING
4,GB,B,GB 2594294 B,041-100-787-480-461,2022-08-10,2022,GB 202005821 A,2020-04-21,GB 202005821 A,2020-04-21,Apparatus,,PARAGRAF LTD,HUGH GLASS;;ANDREW MATTHEWS,,https://lens.org/041-100-787-480-461,Granted Patent,no,0,0,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R31/382;;G01R31/3832;;G01R33/07,,0,0,,,,ACTIVE
5,US,A,US 5797126 A,066-155-810-818-025,1998-08-18,1998,US 60297596 A,1996-02-16,US 60297596 A,1996-02-16,Automatic theater ticket concierge,"A theater-ticket concierge system in which individual kiosks are in wireless communication with a central station so that, based upon programming from the central station, the individual events of interest can be selected by a patron who can view an excerpt or scene and, upon indicating interest, can then view available seating on a seating plan or the like. By selecting an available seat from the seating plan, the patron can be provided with a display of the stage or performance from that seat and, once seat selection is confirmed, the kiosk can, by communication with the central station, charge the patron's credit card and issue an information carrier in the form of a ticket to the event or a coupon which can be redeemed for such ticket.",HELBLING; EDWARD;;GLASS; ANDREW,HELBLING EDWARD;;GLASS ANDREW,INTERACTIVE PATENTS INC (1998-08-07),https://lens.org/066-155-810-818-025,Granted Patent,yes,6,324,1,1,0,G06Q10/02;;G07F9/002;;G06Q10/02;;G07B15/00;;G07B15/00;;G07F9/001;;G07F9/001;;G07F9/002;;G07F17/42;;G07F17/42,G06Q50/00;;G07B15/00;;G07F17/42,705/5,2,0,,,"Cydee Miller, Music marketers hoping to see a Net gain , Marketing News, Jan. 15, 1996, vol. 30, Issue 2, p. 2.;;Larry Stevens, Front line systems , Computerworld, Mar. 2, 1992, vol. 26, Issue 9, pp. 61 63.",EXPIRED
6,DE,T5,DE 112021002426 T5,194-047-006-549-381,2023-02-16,2023,DE 112021002426 T,2021-04-20,GB 202005821 A;;GB 2021050946 W,2020-04-21,VERFAHREN UND VORRICHTUNG,"Es wird ein Verfahren zur Feldabbildung einer Zelle unter Last bereitgestellt. Das Verfahren umfasst die folgenden Schritte: Bereitstellen einer Zelle; Bereitstellen eines Hall-Effekt-Sensors, der einen Graphenleiter zur Messung eines Magnetfeldes umfasst; Positionieren des Hall-Effekt-Sensors an einer ersten Position in der Nähe einer Fläche der Zelle; Anlegen einer Last an die Zelle; und Messen eines Ausgangs des Hall-Effekt-Sensors.",PARAGRAF LTD,GLASS HUGH;;MATTHEWS ANDREW,,https://lens.org/194-047-006-549-381,Patent Application,no,8,0,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R31/382;;G01R33/07,,0,0,,,,PENDING
7,US,A1,US 2023/0176146 A1,181-221-164-150-72X,2023-06-08,2023,US 202117920219 A,2021-04-20,GB 202005821 A;;GB 2021050946 W,2020-04-21,METHOD AND APPARATUS,A method of field mapping a cell under load is provided. The method comprises the steps of: providing a cell; providing a Hall effect sensor comprising a graphene conductor for measuring a magnetic field; positioning the Hall effect sensor at a first position adjacent a face of the cell; applying a load to the cell; and measuring an output of the Hall effect sensor.,PARAGRAF LTD,GLASS HUGH;;MATTHEWS ANDREW,PARAGRAF LIMITED (2022-11-02),https://lens.org/181-221-164-150-72X,Patent Application,yes,0,0,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R33/07;;G01R15/20;;G01R31/36;;G01R31/3828;;G01R33/00,,0,0,,,,PENDING
8,CN,A,CN 115702358 A,198-795-017-589-513,2023-02-14,2023,CN 202180040722 A,2021-04-20,GB 202005821 A;;GB 2021050946 W,2020-04-21,Method and apparatus,A method of field mapping a unit under load is provided. The method comprises the following steps: providing a unit; providing a Hall effect sensor comprising a graphene conductor for measuring a magnetic field; positioning a Hall effect sensor at a first location adjacent a surface of the cell; applying a load to the cell; and measuring the output of the Hall effect sensor.,PARAGRAF LTD,GLASS HUGH;;MATTHEWS ANDREW,,https://lens.org/198-795-017-589-513,Patent Application,no,7,0,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R31/382;;G01R31/3832;;G01R33/07,,0,0,,,,PENDING
9,WO,A1,WO 2021/214449 A1,008-720-938-823-478,2021-10-28,2021,GB 2021050946 W,2021-04-20,GB 202005821 A,2020-04-21,METHOD AND APPARATUS,A method of field mapping a cell under load is provided. The method comprises the steps of: providing a cell; providing a Hall effect sensor comprising a graphene conductor for measuring a magnetic field; positioning the Hall effect sensor at a first position adjacent a face of the cell; applying a load to the cell; and measuring an output of the Hall effect sensor.,PARAGRAF LTD,GLASS HUGH;;MATTHEWS ANDREW,,https://lens.org/008-720-938-823-478,Patent Application,yes,14,1,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R31/382;;G01R31/3832;;G01R33/07,,8,7,094-935-661-798-333;;062-149-458-150-815;;046-985-814-828-914;;118-823-736-252-961;;062-149-458-150-815;;046-985-814-828-914;;011-505-245-313-789,10.1016/j.est.2017.03.014;;23383375;;pmc3563039;;10.1038/srep01207;;10.1109/temc.2008.924391;;10.1016/j.physe.2011.10.007;;23383375;;pmc3563039;;10.1038/srep01207;;10.1109/temc.2008.924391;;10.1038/nmat1849;;17330084,"HARRY T. HARRISON ET AL: ""Magnetic tomography for lead acid batteries"", JOURNAL OF ENERGY STORAGE, vol. 12, 1 August 2017 (2017-08-01), pages 1 - 10, XP055737661, ISSN: 2352-152X, DOI: 10.1016/j.est.2017.03.014;;HUILONG XU ET AL: ""Batch-fabricated high-performance graphene Hall elements"", SCIENTIFIC REPORTS, vol. 3, 4 February 2013 (2013-02-04), XP055355153, DOI: 10.1038/srep01207;;HAAKE K A ET AL: ""A New Type of Robot System for High-Resolution Field Mapping"", IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY, IEEE SERVICE CENTER , NEW YORK , NY, US, vol. 50, no. 3, 1 August 2008 (2008-08-01), pages 747 - 751, XP011232601, ISSN: 0018-9375, DOI: 10.1109/TEMC.2008.924391;;CAYETANO COBALEDA ET AL: ""Quantum hall effect in inhomogeneous trilayer graphene"", PHYSICA E: LOW-DIMENSIONAL SYSTEMS AND NANOSTRUCTURES, ELSEVIER SCIENCE BV, NL, vol. 44, no. 2, 7 October 2011 (2011-10-07), pages 530 - 533, XP028107036, ISSN: 1386-9477, [retrieved on 20111013], DOI: 10.1016/J.PHYSE.2011.10.007;;XU ET AL., BATCH-FABRICATED HIGH-PERFORMANCE GRAPHENE HALL ELEMENTS;;HAAKE ET AL., A NEW TYPE OF ROBOT SYSTEM FOR HIGH-RESOLUTION FIELD MAPPING;;A.K. GEIMK. S. NOVOSELEV: ""The Rise of Graphene"", NATURE MATERIALS, vol. 6, March 2007 (2007-03-01), pages 183 - 191;;MOSSER ET AL., A SPINNING CURRENT CIRCUIT FOR HALL MEASUREMENTS DOWN TO THE NANOTESLA RANGE",PENDING
10,GB,A,GB 2594294 A,194-869-320-341-354,2021-10-27,2021,GB 202005821 A,2020-04-21,GB 202005821 A,2020-04-21,Apparatus,"A method of field mapping a battery cell 10 under load uses at least one Hall effect sensor 20 comprising a graphene conductor positioned adjacent a face of the cell to measure magnetic field when a load is applied to the cell. The Hall effect sensor may be moved to a plurality of locations in an array across the face of the cell. There may also be an array of Hall sensors. A change in magnetic field may indicate cell failure. The Hall sensor may measure input or output current of the cell. Also disclosed is an apparatus comprising a Hall sensor on an actuation system to move the sensor around a cell (figure 2). Further disclosed is an apparatus with a pick-up coil in which a current is generated by the magnetic field of the cell, a measurement coil generating current in response to the pick-up coil, and a magnetic field sensor detecting magnetic field from the measurement coil (figures 3 to 6).",PARAGRAF LTD,HUGH GLASS;;ANDREW MATTHEWS,,https://lens.org/194-869-320-341-354,Patent Application,no,8,2,9,9,0,G01R31/382;;G01R31/3832;;G01R33/0094;;G01R33/028;;G01R33/0082;;G01R33/04;;G01R33/0017;;G01R33/0023;;G01R33/07;;Y02E60/10;;G01R31/382;;G01R31/3832;;G01R33/07;;G01R33/07;;G01R33/0023;;G01R33/0094;;G01R15/202;;G01R33/0052;;G01R31/3648;;G01R31/3832;;G01R33/04;;G01R33/028;;G01R33/0017;;G01R31/3828;;G01R15/202;;G01R31/3648;;G01R33/0094;;G01R33/072,G01R31/382;;G01R31/3832;;G01R33/07,,4,4,094-935-661-798-333;;062-149-458-150-815;;046-985-814-828-914;;011-505-245-313-789,10.1016/j.est.2017.03.014;;23383375;;pmc3563039;;10.1038/srep01207;;10.1109/temc.2008.924391;;10.1038/nmat1849;;17330084,"HARRY T. HARRISON ET AL: ""Magnetic tomography for lead acid batteries"", JOURNAL OF ENERGY STORAGE, vol. 12, 1 August 2017 (2017-08-01), pages 1 - 10, XP055737661, ISSN: 2352-152X, DOI: 10.1016/j.est.2017.03.014;;HUILONG XU ET AL: ""Batch-fabricated high-performance graphene Hall elements"", SCIENTIFIC REPORTS, vol. 3, 4 February 2013 (2013-02-04), XP055355153, DOI: 10.1038/srep01207;;HAAKE K A ET AL: ""A New Type of Robot System for High-Resolution Field Mapping"", IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY, IEEE SERVICE CENTER , NEW YORK , NY, US, vol. 50, no. 3, 1 August 2008 (2008-08-01), pages 747 - 751, XP011232601, ISSN: 0018-9375, DOI: 10.1109/TEMC.2008.924391;;A.K. GEIMK. S. NOVOSELEV: ""The Rise of Graphene"", NATURE MATERIALS, 6 March 2007 (2007-03-06), pages 183 - 191",ACTIVE
11,WO,A1,WO 2016/153789 A1,154-857-070-089-301,2016-09-29,2016,US 2016/0021641 W,2016-03-10,US 201514667663 A,2015-03-24,TEST PATTERNS FOR MOTION-INDUCED CHROMATIC SHIFT,"Display of a test pattern on a liquid crystal display (""LCD"") device or other display device can expose a problem with control logic that causes perceptible shifting in color values away from correct color values. For example, a test pattern evaluation tool determines a test pattern that is based at least in part on a base pattern of pixels. The test pattern evaluation tool successively renders the test pattern for display on a display device. In doing so, the test pattern evaluation tool offsets the base pattern by a number of pixels (e.g., shifting by one pixel horizontally) between successive rendering operations at the native refresh rate of the display device, which facilitates evaluation of whether chromatic shift is induced among at least some sub-pixel display elements of the display device.",MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,,https://lens.org/154-857-070-089-301,Patent Application,yes,0,0,7,7,0,G09G3/006;;G09G2320/0261;;G09G5/02;;G09G3/007;;G09G3/007;;G09G5/02;;G09G2320/0261;;G09G3/006;;G09G3/007;;G09G5/02;;G09G2320/0261;;G02F1/1309;;G09G3/006;;G09G3/3607;;G09G2320/0242;;G09G2320/0295;;G09G2320/0693,G09G5/02;;G09G3/00,,2,2,043-429-039-030-955;;063-436-029-155-632,10.1145/2342896.2342923;;10.1889/1.2785318,"KAZUHISA YANAKA: ""Use of periodic shift and color combinations to enhance illusory motion"", ACM SIGGRAPH 2012 POSTERS - ASSOCIATION FOR COMPUTING MACHINERY-DIGITAL LIBRARY, ACM, NEW YORK, NY, 5 August 2012 (2012-08-05), pages 1, XP058008155, ISBN: 978-1-4503-1682-8, DOI: 10.1145/2342896.2342923;;YUEH-YI LAI ET AL: ""P-57: Color Shift Evaluation in Motion Image"", SID 2007, 2007 SID INTERNATIONAL SYMPOSIUM, SOCIETY FOR INFORMATION DISPLAY, LOS ANGELES, USA, vol. XXXVIII, 20 May 2007 (2007-05-20), pages 403 - 405, XP007013572, ISSN: 0007-966X",PENDING
12,US,A1,US 2016/0284258 A1,171-392-283-586-634,2016-09-29,2016,US 201514667663 A,2015-03-24,US 201514667663 A,2015-03-24,TEST PATTERNS FOR MOTION-INDUCED CHROMATIC SHIFT,"Display of a test pattern on a liquid crystal display (“LCD”) device or other display device can expose a problem with control logic that causes perceptible shifting in color values away from correct color values. For example, a test pattern evaluation tool determines a test pattern that is based at least in part on a base pattern of pixels. The test pattern evaluation tool successively renders the test pattern for display on a display device. In doing so, the test pattern evaluation tool offsets the base pattern by a number of pixels (e.g., shifting by one pixel horizontally) between successive rendering operations at the native refresh rate of the display device, which facilitates evaluation of whether chromatic shift is induced among at least some sub-pixel display elements of the display device.",MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,MICROSOFT TECHNOLOGY LICENSING LLC (2015-03-24),https://lens.org/171-392-283-586-634,Patent Application,yes,19,7,7,7,0,G09G3/006;;G09G3/006;;G09G3/006;;G02F1/1309;;G09G3/007;;G09G3/007;;G09G3/007;;G09G3/3607;;G09G5/02;;G09G5/02;;G09G5/02;;G09G2320/0242;;G09G2320/0261;;G09G2320/0261;;G09G2320/0261;;G09G2320/0295;;G09G2320/0693,G09G3/00;;G02F1/13;;G09G3/36,,0,0,,,,ACTIVE
13,EP,B1,EP 3274982 B1,087-295-532-420-688,2020-05-06,2020,EP 16711939 A,2016-03-10,US 201514667663 A;;US 2016/0021641 W,2015-03-24,TEST PATTERNS FOR MOTION-INDUCED CHROMATIC SHIFT,,MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,,https://lens.org/087-295-532-420-688,Granted Patent,yes,0,0,7,7,0,G09G3/006;;G09G3/006;;G09G3/006;;G02F1/1309;;G09G3/007;;G09G3/007;;G09G3/007;;G09G3/3607;;G09G5/02;;G09G5/02;;G09G5/02;;G09G2320/0242;;G09G2320/0261;;G09G2320/0261;;G09G2320/0261;;G09G2320/0295;;G09G2320/0693,G09G3/00;;G09G5/02,,2,1,021-266-908-595-615,10.1889/1.3499991,"TAEHEE KIM ET AL: ""P-65: Evaluation Method for Moving Picture Color Smear"", S I D INTERNATIONAL SYMPOSIUM. DIGEST OF TECHNICAL PAPERS, vol. 41, no. 1, 1 January 2010 (2010-01-01), US, pages 1494, XP055564022, ISSN: 0097-966X, DOI: 10.1889/1.3499991;;ROHNDE & SCHWARZ: ""Reproducible Quality Analysis of Deinterlacing and Motion Portrayal for Digital TV Displays - Application Note"", 1 December 2008 (2008-12-01), XP055564199, Retrieved from the Internet <URL:https://scdn.rohde-schwarz.com/ur/pws/dl_downloads/dl_application/application_notes/7bm74/7BM74_0E.pdf> [retrieved on 20190304]",ACTIVE
14,CN,A,CN 107408366 A,106-024-921-385-970,2017-11-28,2017,CN 201680018196 A,2016-03-10,US 201514667663 A;;US 2016/0021641 W,2015-03-24,Test patterns for motion-induced chromatic shift,"Display of a test pattern on a liquid crystal display (""LCD"") device or other display device can expose a problem with control logic that causes perceptible shifting in color values away from correct color values. For example, a test pattern evaluation tool determines a test pattern that is based at least in part on a base pattern of pixels. The test pattern evaluation tool successively renders the test pattern for display on a display device. In doing so, the test pattern evaluation tool offsets the base pattern by a number of pixels (e.g., shifting by one pixel horizontally) between successive rendering operations at the native refresh rate of the display device, which facilitates evaluation of whether chromatic shift is induced among at least some sub-pixel display elements of the display device.",MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,,https://lens.org/106-024-921-385-970,Patent Application,no,4,0,7,7,0,G09G3/006;;G09G3/006;;G09G3/006;;G02F1/1309;;G09G3/007;;G09G3/007;;G09G3/007;;G09G3/3607;;G09G5/02;;G09G5/02;;G09G5/02;;G09G2320/0242;;G09G2320/0261;;G09G2320/0261;;G09G2320/0261;;G09G2320/0295;;G09G2320/0693,G09G3/00;;G09G5/02,,0,0,,,,ACTIVE
15,US,B2,US 10043425 B2,144-179-415-353-09X,2018-08-07,2018,US 201514667663 A,2015-03-24,US 201514667663 A,2015-03-24,Test patterns for motion-induced chromatic shift,"Display of a test pattern on a liquid crystal display (“LCD”) device or other display device can expose a problem with control logic that causes perceptible shifting in color values away from correct color values. For example, a test pattern evaluation tool determines a test pattern that is based at least in part on a base pattern of pixels. The test pattern evaluation tool successively renders the test pattern for display on a display device. In doing so, the test pattern evaluation tool offsets the base pattern by a number of pixels (e.g., shifting by one pixel horizontally) between successive rendering operations at the native refresh rate of the display device, which facilitates evaluation of whether chromatic shift is induced among at least some sub-pixel display elements of the display device.",MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,MICROSOFT TECHNOLOGY LICENSING LLC (2015-03-24),https://lens.org/144-179-415-353-09X,Granted Patent,yes,29,3,7,7,0,G09G3/006;;G09G3/006;;G09G3/006;;G02F1/1309;;G09G3/007;;G09G3/007;;G09G3/007;;G09G3/3607;;G09G5/02;;G09G5/02;;G09G5/02;;G09G2320/0242;;G09G2320/0261;;G09G2320/0261;;G09G2320/0261;;G09G2320/0295;;G09G2320/0693,G09G5/02;;G02F1/13;;G09G3/00;;G09G3/36,,20,5,063-436-029-155-632;;043-429-039-030-955;;000-914-474-617-979;;104-084-539-224-801;;071-910-983-486-003,10.1889/1.2785318;;10.1145/2342896.2342923;;10.1889/1.2036473;;10.1109/tce.2012.6414996;;10.1109/tce.2010.5506049,"International Search Report and Written Opinion dated May 6, 2016, from International Patent Application No. PCT/US2016/021641, 13 pp.;;Lai et al., “P-57: Color Shift Evaluation in Motion Image,” SID Int'l Symp., pp. 403-406 (May 2007).;;Written Opinion dated Aug. 4, 2016, from International Patent Application No. PCT/US2016/021641, 6 pp.;;Yanaka, “Use of Periodic Shift and Color Combinations to Enhance Illusory Motion,” ACM SIGGRAPH, 1 p. (Aug. 2012).;;Artamonov, “LCD Panels with Response Time Compensation: 7 Monitors Reviewed,” downloaded from the World Wide Web, 38 pp. (Dec. 2005).;;Binckley, “High Definition Block—Defining High Definition,” downloaded from the World Wide Web on Mar. 24, 2015, 3 pp. (document not dated).;;Blur Busters, “LCD Motion Artifacts: Overdrive,” downloaded from the World Wide Web, 5 pp. (Sep. 2013).;;Eberle, “NEC EA274WMi Monitor Review: Eco-Friendly At 2560×1440,” Tom's Hardware, 28 pp. (May 2014).;;Feng et al., “P-50: Dynamic Gamma: Applications to Improve LCD Temporal Response Using Overdrive,” SID Digest, vol. 36, Issue 1, pp. 462-465 (May 2005).;;Kumar et al., “Image Compression by Moment Preserving Algorithms: A Scrutinization,” Int. J. Comp. Tech Appl, vol. 2, No. 4, pp. 1099-1117 (Jul. 2011).;;Laird, “The Dark Side of Overdrive,” downloaded from the World Wide Web, 10 pp. (Feb. 2009).;;“LCD Monitor Test Images,” downloaded from the World Wide Web on Feb. 24, 2015, 1 p. (document marked May 2008).;;Park et al., “Structural Similarity Based Image Compression for LCD Overdrive,” IEEE Trans. on Consumer Electronics, vol. 58, No. 4, pp. 1276-1284 (Nov. 2012).;;“Response Time—Lagom LCD Test,” downloaded from the World Wide Web on Feb. 24, 2015, 4 pp. (document marked Apr. 2008).;;Simmons, “Factors Affecting PC Monitor Responsiveness,” PC Monitors, 10 pp. (Dec. 2013; document marked: last updated: Jan. 2015).;;Tektronix, “Camera Measurements—Application Note,” downloaded from the World Wide Web on Feb. 23, 2015, 16 pp. (document marked Nov. 2007).;;Wang et al., “A High Compression Ratio Image Coding for Frame Memory Reduction in LCD Overdrive,” Int'l Tech. Conf. on Circuits/Systems, Computers and Communications, pp. 1629-1632 (Jul. 2008).;;Wang et al., “Adaptive Multi-level Block Truncation Coding for Frame Memory Reduction in LCD Overdrive,” IEEE Trans. on Consumer Electronics, vol. 56, No. 2, pp. 1130-1136 (May 2010).;;International Preliminary Report on Patentability dated Dec. 1, 2016, from International Patent Application No. PCT/US2016/021641, 9 pp.;;Communication pursuant to Rules 161(1) and 162 EPC dated Nov. 2, 2017, from European Patent Application No. 16711939.5, 2 pp.",ACTIVE
16,EP,A1,EP 3274982 A1,053-622-535-273-03X,2018-01-31,2018,EP 16711939 A,2016-03-10,US 201514667663 A;;US 2016/0021641 W,2015-03-24,TEST PATTERNS FOR MOTION-INDUCED CHROMATIC SHIFT,,MICROSOFT TECHNOLOGY LICENSING LLC,BRUNNER DANIEL;;ROSEN ANDREW;;GLASS ANDREW,,https://lens.org/053-622-535-273-03X,Patent Application,yes,0,0,7,7,0,G09G3/006;;G09G3/006;;G09G3/006;;G02F1/1309;;G09G3/007;;G09G3/007;;G09G3/007;;G09G3/3607;;G09G5/02;;G09G5/02;;G09G5/02;;G09G2320/0242;;G09G2320/0261;;G09G2320/0261;;G09G2320/0261;;G09G2320/0295;;G09G2320/0693,G09G3/00;;G09G5/02,,1,0,,,See references of WO 2016153789A1,ACTIVE
17,WO,A3,WO 2020/117534 A3,148-497-906-880-504,2020-07-30,2020,US 2019/0063119 W,2019-11-25,US 201816207794 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/148-497-906-880-504,Search Report,yes,18,0,5,5,0,G06F3/04883;;G06F3/04886;;G06F3/03545;;G06F3/03547;;G06F3/04847;;G06F3/04883;;G06F3/04886;;G06F40/279,G06F3/0488,,0,0,,,,PENDING
18,WO,A2,WO 2020/117534 A2,008-295-742-586-314,2020-06-11,2020,US 2019/0063119 W,2019-11-25,US 201816207794 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/008-295-742-586-314,Patent Application,yes,0,1,5,5,0,G06F3/04883;;G06F3/04886;;G06F3/03545;;G06F3/03547;;G06F3/04847;;G06F3/04883;;G06F3/04886;;G06F40/279,G06F3/0488,,0,0,,,,PENDING
19,CN,A,CN 113168285 A,029-091-109-718-526,2021-07-23,2021,CN 201980079731 A,2019-11-25,US 201816207794 A;;US 2019/0063119 W,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/029-091-109-718-526,Patent Application,no,0,0,5,5,0,G06F3/04883;;G06F3/04886;;G06F3/03545;;G06F3/03547;;G06F3/04847;;G06F3/04883;;G06F3/04886;;G06F40/279,G06F3/0488,,0,0,,,,PENDING
20,WO,A1,WO 2019/103858 A1,145-399-462-718-005,2019-05-31,2019,US 2018/0060200 W,2018-11-09,US 201715821488 A,2017-11-22,DYNAMIC DEVICE INTERACTION ADAPTATION BASED ON USER ENGAGEMENT,"The techniques disclosed herein enable dynamic device interaction adaptation based on user engagement. In general, a computer can leverage sensors to determine a user's level of engagement with one or more devices. As the user transitions his or her attention to different devices, the computer can utilize different interaction models to assist the user in interacting with each device that meets a threshold level of engagement with the user. Individual interaction models can configure the computer to direct input gestures received by the computing device to a selected device, and adapt the computer's input modality to provide user interface controls that are optimized for the selected device. When a user is interacting with two or more devices, automatic transitions between different interaction models can help improve the user's interaction with each device.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/145-399-462-718-005,Patent Application,yes,3,0,4,4,0,G06F3/1454;;G06F3/011;;G09G5/14;;G09G2354/00;;G06F3/0481;;G06F3/0482;;G06F2203/04803;;G06F3/04883;;G06F3/013;;G06V40/107;;G06V40/18;;G06F3/04883;;G06F3/013;;G06F9/451;;G09G5/14;;G06F3/1454;;G06F2203/04803;;G09G2354/00;;G06F3/0482;;G06F3/011;;G06F3/0481;;G06V40/18;;G06V40/107,G09G5/14;;G02B27/01;;G06F3/01;;G06F3/14;;G06K9/00;;G06T19/00;;H04W4/02,,1,0,,,"SHUNICHI KASAHARA ET AL: ""Second surface"", 20121128; 20121128 - 20121201, 28 November 2012 (2012-11-28), pages 1 - 4, XP058010277, ISBN: 978-1-4503-1912-6, DOI: 10.1145/2407707.2407727",PENDING
21,US,B2,US 11137905 B2,045-068-590-172-682,2021-10-05,2021,US 201816207794 A,2018-12-03,US 201816207794 A,2018-12-03,Modeless augmentations to a virtual trackpad on a multiple screen computing device,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/045-068-590-172-682,Granted Patent,yes,67,0,5,5,0,G06F3/04883;;G06F3/04886;;G06F3/03545;;G06F3/03547;;G06F3/04847;;G06F3/04883;;G06F3/04886;;G06F40/279,G06F3/0488;;G06F3/0354;;G06F3/0484;;G06F40/279,,20,2,077-922-489-469-298;;037-059-819-778-574,10.1109/mcg.2017.1;;28103543;;10.1109/pacificvis.2015.7156378,"Michelle Annett, Digitally Inking in the 21st Century, Jan. 1, 2017, IEEE computer Society, pp. 92-99 (Year: 2017).;;Bongshin et al., SketchInsight: Natural Data Exploration on Interactive Whiteboards Leveraging Pen and Touch Interaction, Apr. 1, 2015, lEEE Xplore, pp. 199-206 (Year: 2015).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063118”, dated Jan. 31, 2020, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 5, 2020, 28 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Mar. 18, 2020, 15 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Dec. 12, 2019, 14 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,936”, dated Oct. 4, 2019, 10 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Nov. 4, 2019, 13 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063120”, dated Feb. 27, 2020, 12 Pages. (MS# 405535-WO-PCT).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063128”, dated Feb. 27, 2020, 11 Pages. (MS# 405656-WO-PCT).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063125”, dated Apr. 3, 2020, 19 Pages. (MS# 405256-WO-PCT).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Jul. 23, 2020, 33 Pages. (MS# 405256-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jul. 16, 2020, 11 Pages. (MS# 405354-US-NP).;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Oct. 19, 2020, 12 Pages. (MS# 405354-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jan. 25, 2021, 8 Pages. (MS# 405354-US-NP).;;“Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Dec. 24, 2020, 37 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063119”, dated Jun. 24, 2020, 23 Pages. (MS# 405245-WO-PCT).;;“Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Sep. 3, 2020, 20 Pages. (MS# 405535-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 30, 2021, 42 Pages. (MS# 405256-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Jun. 8, 2021, 24 Pages.",ACTIVE
22,CN,A,CN 109791468 A,133-943-082-451-944,2019-05-21,2019,CN 201780060804 A,2017-09-18,US 201615279988 A;;US 2017/0051960 W,2016-09-29,USER INTERFACES FOR BI-MANUAL CONTROL,"Techniques for bi-manual control of an operation may allow gestural input for the operation to be inputted blindly with one hand while a user's attention remains on the other hand. An operation invoked and controlled by the gestural input may automatically associate with an operation controlled by the other hand. The gestural input may facilitate blind control of the operation by being able to beinitially recognized without regard for the scale, orientation, and/or location of the invoking gestural input. Moreover, scale and/or orientation of the operation may be determined by the gestural input. Changes in scale and/or orientation of the gestural input during the blind operation may change the scale and/or orientation of the operation. The operation may manifest by displaying corresponding graphics at a location independent of the gestural input or by associating functionality of the blind operation with an operation performed by the other hand.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW S,,https://lens.org/133-943-082-451-944,Patent Application,no,5,0,5,5,0,G06F3/04883;;G06F3/04883;;G06F3/017;;G06F3/0484;;G06F2203/04808,G06F3/0488;;G06F3/01,,0,0,,,,PENDING
23,WO,A1,WO 2020/117535 A1,125-903-836-916-810,2020-06-11,2020,US 2019/0063120 W,2019-11-26,US 201816207840 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/125-903-836-916-810,Patent Application,yes,2,0,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/0488;;G06F1/16,,0,0,,,,PENDING
24,EP,A1,EP 3519932 A1,141-932-828-955-089,2019-08-07,2019,EP 17780562 A,2017-09-18,US 201615279988 A;;US 2017/0051960 W,2016-09-29,USER INTERFACES FOR BI-MANUAL CONTROL,,MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW S,,https://lens.org/141-932-828-955-089,Patent Application,yes,0,0,5,5,0,G06F3/04883;;G06F3/04883;;G06F3/017;;G06F3/0484;;G06F2203/04808,G06F3/0488;;G06F3/01,,1,0,,,See references of WO 2018063836A1,DISCONTINUED
25,US,B2,US 11314409 B2,006-649-342-402-742,2022-04-26,2022,US 201816207840 A,2018-12-03,US 201816207840 A,2018-12-03,Modeless augmentations to a virtual trackpad on a multiple screen computing device,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/006-649-342-402-742,Granted Patent,yes,67,5,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/04883;;G06F3/0354;;G06F3/04886,,21,2,077-922-489-469-298;;037-059-819-778-574,10.1109/mcg.2017.1;;28103543;;10.1109/pacificvis.2015.7156378,"“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063125”, dated Apr. 3, 2020, 12 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063120”, dated Feb. 27, 2020, 12 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063128”, dated Feb. 27, 2020, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Dec. 19, 2019, 24 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,936”, dated Oct. 4, 2019, 10 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Nov. 4, 2019, 13 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063118”, dated Jan. 31, 2020, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 5, 2020, 28 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Mar. 18, 2020, 15 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Jul. 1, 2020, 26 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Oct. 19, 2020, 12 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Jul. 23, 2020, 33 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jul. 16, 2020, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jan. 25, 2021, 8 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 30, 2021, 42 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063119”, dated Jun. 24, 2020, 23 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Dec. 24, 2020, 37 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Aug. 27, 2021, 37 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,794”, dated Jun. 7, 2021, 17 Pages.;;Annett, Michelle, “(Digitally) Inking in the 21st Century”, In Journal of IEEE Computer Graphics and Applications, vol. 37, Issue 1, Jan. 2017, pp. 92-99.;;Lee, et al., “Sketchlnsight: Natural Data Exploration on Interactive Whiteboards Leveraging Pen and Touch Interaction”, In Journal of IEEE Pacific Visualization Symposium, Apr. 14, 2015, pp. 199-206.",ACTIVE
26,US,A1,US 2018/0088792 A1,102-209-240-934-458,2018-03-29,2018,US 201615279988 A,2016-09-29,US 201615279988 A,2016-09-29,USER INTERFACES FOR BI-MANUAL CONTROL,"Techniques for bi-manual control of an operation may allow gestural input for the operation to be inputted blindly with one hand while a user's attention remains on the other hand. An operation invoked and controlled by the gestural input may automatically associate with an operation controlled by the other hand. The gestural input may facilitate blind control of the operation by being able to be initially recognized without regard for the scale, orientation, and/or location of the invoking gestural input. Moreover, scale and/or orientation of the operation may be determined by the gestural input. Changes in scale and/or orientation of the gestural input during the blind operation may change the scale and/or orientation of the operation. The operation may manifest by displaying corresponding graphics at a location independent of the gestural input or by associating functionality of the blind operation with an operation performed by the other hand.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW S,MICROSOFT TECHNOLOGY LICENSING LLC (2016-09-24),https://lens.org/102-209-240-934-458,Patent Application,yes,6,17,5,5,0,G06F3/04883;;G06F3/04883;;G06F3/017;;G06F3/0484;;G06F2203/04808,G06F3/0488,,0,0,,,,ACTIVE
27,US,A1,US 2022/0382447 A1,135-506-406-333-061,2022-12-01,2022,US 202217659285 A,2022-04-14,US 202217659285 A;;US 201816207840 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/135-506-406-333-061,Patent Application,yes,3,1,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/04883;;G06F3/0354;;G06F3/04886,,0,0,,,,ACTIVE
28,US,B2,US 10732826 B2,178-199-210-336-677,2020-08-04,2020,US 201715821488 A,2017-11-22,US 201715821488 A,2017-11-22,Dynamic device interaction adaptation based on user engagement,"The techniques disclosed herein enable dynamic device interaction adaptation based on user engagement. In general, a computer can leverage sensors to determine a user's level of engagement with one or more devices. As the user transitions his or her attention to different devices, the computer can utilize different interaction models to assist the user in interacting with each device that meets a threshold level of engagement with the user. Individual interaction models can configure the computer to direct input gestures received by the computing device to a selected device, and adapt the computer's input modality to provide user interface controls that are optimized for the selected device. When a user is interacting with two or more devices, automatic transitions between different interaction models can help improve the user's interaction with each device.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-11-21),https://lens.org/178-199-210-336-677,Granted Patent,yes,75,4,4,4,0,G06F3/1454;;G06F3/011;;G09G5/14;;G09G2354/00;;G06F3/0481;;G06F3/0482;;G06F2203/04803;;G06F3/04883;;G06F3/013;;G06V40/107;;G06V40/18;;G06F3/04883;;G06F3/013;;G06F9/451;;G09G5/14;;G06F3/1454;;G06F2203/04803;;G09G2354/00;;G06F3/0482;;G06F3/011;;G06F3/0481;;G06V40/18;;G06V40/107,G06F3/0482;;G06F3/01;;G06F3/0481;;G06F3/0488;;G06F3/14;;G06F9/451;;G06K9/00;;G09G5/14,,2,1,094-235-924-054-620,10.1145/2407707.2407727,"Kasahara, et al., “Second Surface: Multi-User Spatial Collaboration System Based on Augmented Reality”, In the Proceedings of SIGGRAPH Asia 2012 Emerging Technologies, Article No. 20, Nov. 28, 2012, 4 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2018/060200”, dated Apr. 9, 2019, 26 Pages.",ACTIVE
29,WO,A1,WO 2018/063836 A1,171-580-555-434-342,2018-04-05,2018,US 2017/0051960 W,2017-09-18,US 201615279988 A,2016-09-29,USER INTERFACES FOR BI-MANUAL CONTROL,"Techniques for bi-manual control of an operation may allow gestural input for the operation to be inputted blindly with one hand while a user's attention remains on the other hand. An operation invoked and controlled by the gestural input may automatically associate with an operation controlled by the other hand. The gestural input may facilitate blind control of the operation by being able to be initially recognized without regard for the scale, orientation, and/or location of the invoking gestural input. Moreover, scale and/or orientation of the operation may be determined by the gestural input. Changes in scale and/or orientation of the gestural input during the blind operation may change the scale and/or orientation of the operation. The operation may manifest by displaying corresponding graphics at a location independent of the gestural input or by associating functionality of the blind operation with an operation performed by the other hand.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW S,,https://lens.org/171-580-555-434-342,Patent Application,yes,2,0,5,5,0,G06F3/017;;G06F3/04883;;G06F3/04883;;G06F2203/04808;;G06F3/0484,G06F3/0488;;G06F3/01,,0,0,,,,PENDING
30,US,A1,US 2020/0174653 A1,190-340-359-845-650,2020-06-04,2020,US 201816207840 A,2018-12-03,US 201816207840 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",KLEIN CHRISTIAN;;GLASS ANDREW STUART,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/190-340-359-845-650,Patent Application,yes,4,17,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/0488;;G06F3/0354,,0,0,,,,ACTIVE
31,CN,A,CN 113168284 A,006-877-194-638-167,2021-07-23,2021,CN 201980079558 A,2019-11-26,US 201816207840 A;;US 2019/0063120 W,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/006-877-194-638-167,Patent Application,no,0,0,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/0488;;G06F1/16,,0,0,,,,PENDING
32,US,A1,US 2019/0155495 A1,036-250-179-811-151,2019-05-23,2019,US 201715821488 A,2017-11-22,US 201715821488 A,2017-11-22,DYNAMIC DEVICE INTERACTION ADAPTATION BASED ON USER ENGAGEMENT,"The techniques disclosed herein enable dynamic device interaction adaptation based on user engagement. In general, a computer can leverage sensors to determine a user's level of engagement with one or more devices. As the user transitions his or her attention to different devices, the computer can utilize different interaction models to assist the user in interacting with each device that meets a threshold level of engagement with the user. Individual interaction models can configure the computer to direct input gestures received by the computing device to a selected device, and adapt the computer's input modality to provide user interface controls that are optimized for the selected device. When a user is interacting with two or more devices, automatic transitions between different interaction models can help improve the user's interaction with each device.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-11-21),https://lens.org/036-250-179-811-151,Patent Application,yes,72,14,4,4,0,G06F3/1454;;G06F3/011;;G09G5/14;;G09G2354/00;;G06F3/0481;;G06F3/0482;;G06F2203/04803;;G06F3/04883;;G06F3/013;;G06V40/107;;G06V40/18;;G06F3/04883;;G06F3/013;;G06F9/451;;G09G5/14;;G06F3/1454;;G06F2203/04803;;G09G2354/00;;G06F3/0482;;G06F3/011;;G06F3/0481;;G06V40/18;;G06V40/107,G06F3/0488;;G06F3/01;;G06F9/44,,0,0,,,,ACTIVE
33,US,A1,US 2020/0174660 A1,062-186-797-262-187,2020-06-04,2020,US 201816207794 A,2018-12-03,US 201816207794 A,2018-12-03,MODELESS AUGMENTATIONS TO A VIRTUAL TRACKPAD ON A MULTIPLE SCREEN COMPUTING DEVICE,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",KLEIN CHRISTIAN;;GLASS ANDREW STUART,KLEIN CHRISTIAN;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/062-186-797-262-187,Patent Application,yes,12,52,5,5,0,G06F3/04883;;G06F3/04886;;G06F3/03545;;G06F3/03547;;G06F3/04847;;G06F3/04883;;G06F3/04886;;G06F40/279,G06F3/0488;;G06F3/0354;;G06F3/0484,,0,0,,,,ACTIVE
34,US,B2,US 11809702 B2,123-009-491-205-992,2023-11-07,2023,US 202217659285 A,2022-04-14,US 202217659285 A;;US 201816207840 A,2018-12-03,Modeless augmentations to a virtual trackpad on a multiple screen computing device,"The disclosed technologies address various technical and user experience problems by augmenting the functionality provided by virtual on-screen trackpads without requiring users to switch between modes. In this way, users can access extended functionality without interfering with expected traditional trackpad functionality (e.g. moving a cursor, clicking, and scrolling). In particular, technologies are disclosed for modeless digital pen input to a virtual trackpad, modeless gestures for summoning user interfaces, modeless gestures utilizing position relative to adjacent user interfaces, and modeless cursor control and interaction with virtual touch targets.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/123-009-491-205-992,Granted Patent,yes,6,0,6,6,0,G06F3/04886;;G06F3/04883;;G06F1/1692;;G06F3/03545;;G06F3/03547;;G06F3/04883;;G06F3/04886;;G06F2203/04808,G06F3/04883;;G06F3/0354;;G06F3/04886,,3,0,,,"“Notice of Allowance Issued in U.S. Appl. No. 17/696,136”, dated Feb. 16, 2023, 12 Pages.;;“Office Action Issued in Indian Patent Application No. 202147024276”, dated Jan. 9, 2023, 8 Pages.;;“Office Action Issued in Indian Patent Application No. 202147024277”, dated Dec. 30, 2022, 9 Pages.",ACTIVE
35,EP,A1,EP 3695401 A1,133-491-945-536-157,2020-08-19,2020,EP 18815842 A,2018-11-09,US 201715821488 A;;US 2018/0060200 W,2017-11-22,DYNAMIC DEVICE INTERACTION ADAPTATION BASED ON USER ENGAGEMENT,,MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART,,https://lens.org/133-491-945-536-157,Patent Application,yes,0,0,4,4,0,G06F3/1454;;G06F3/011;;G09G5/14;;G09G2354/00;;G06F3/0481;;G06F3/0482;;G06F2203/04803;;G06F3/04883;;G06F3/013;;G06V40/107;;G06V40/18;;G06F3/04883;;G06F3/013;;G06F9/451;;G09G5/14;;G06F3/1454;;G06F2203/04803;;G09G2354/00;;G06F3/0482;;G06F3/011;;G06F3/0481;;G06V40/18;;G06V40/107,G09G5/14;;G02B27/01;;G06F3/01;;G06F3/14;;G06K9/00;;G06T19/00;;H04W4/02,,0,0,,,,DISCONTINUED
36,US,B2,US 11073980 B2,181-187-023-316-742,2021-07-27,2021,US 201615279988 A,2016-09-29,US 201615279988 A,2016-09-29,User interfaces for bi-manual control,"Techniques for bi-manual control of an operation may allow gestural input for the operation to be inputted blindly with one hand while a user's attention remains on the other hand. An operation invoked and controlled by the gestural input may automatically associate with an operation controlled by the other hand. The gestural input may facilitate blind control of the operation by being able to be initially recognized without regard for the scale, orientation, and/or location of the invoking gestural input. Moreover, scale and/or orientation of the operation may be determined by the gestural input. Changes in scale and/or orientation of the gestural input during the blind operation may change the scale and/or orientation of the operation. The operation may manifest by displaying corresponding graphics at a location independent of the gestural input or by associating functionality of the blind operation with an operation performed by the other hand.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW S,MICROSOFT TECHNOLOGY LICENSING LLC (2016-09-24),https://lens.org/181-187-023-316-742,Granted Patent,yes,23,0,5,5,0,G06F3/04883;;G06F3/04883;;G06F3/017;;G06F3/0484;;G06F2203/04808,G06F3/0488;;G06F3/01;;G06F3/0484,,2,1,059-278-493-809-059,10.1145/2909132.2909285,"Palleis, et al., “Exploring Two-handed Indirect Multi-touch Input for a Docking Task”, In Proceedings of the International Working Conference on Advanced Visual Interfaces, Jun. 7, 2016, pp. 36-39.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2017/051960”, dated Jan. 22, 2018, 14 Pages.",ACTIVE
37,WO,A8,WO 2002/102992 A8,053-801-933-614-817,2004-07-22,2004,US 0219528 W,2002-06-19,US 29938501 P,2001-06-19,"NOVEL NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF MAKING, AND USES THEREOF",,REGENERON PHARMA;;MURPHY ANDREW J;;GLASS DAVID J,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/053-801-933-614-817,Patent Application,no,0,0,6,6,0,A61K38/00;;C07K14/723;;C07K14/705,A61K38/00;;C07K14/705;;C07K14/72,,0,0,,,,PENDING
38,US,B2,US 8097067 B2,043-168-202-686-194,2012-01-17,2012,US 43618009 A,2009-05-06,US 43618009 A,2009-05-06,Runtime sensor for small forced air handling units,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",FOX ANDREW R;;GLASS DENNIS M;;3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,3M INNOVATIVE PROPERTIES COMPANY (2009-05-05),https://lens.org/043-168-202-686-194,Granted Patent,yes,36,21,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,B01D46/30,95/25;;95/1;;95/26;;X 55DIG 34;;96/417;;96/423;;96/424;;96/397;;73/24.01;;73/570,1,0,,,"International Search Report PCT/US2010/033506 3 pages, Dec. 8, 2010.",INACTIVE
39,WO,A3,WO 2010/129523 A3,104-509-478-675-377,2011-02-03,2011,US 2010/0033506 W,2010-05-04,US 43618009 A,2009-05-06,RUNTIME SENSOR FOR SMALL FORCED AIR HANDLING UNITS,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,,https://lens.org/104-509-478-675-377,Search Report,no,5,0,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,F24F11/02;;F04D25/08;;F24F11/00;;F24F13/28,,0,0,,,,PENDING
40,WO,A3,WO 2007/095050 A3,136-920-371-923-212,2007-11-15,2007,US 2007/0003364 W,2007-02-08,US 77191406 P,2006-02-09,"N-HYDROXYGUANIDINES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods for the treatment of IDO-associated diseases.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M,COMBS ANDREW P;;GLASS BRIAN M,,https://lens.org/136-920-371-923-212,Search Report,yes,5,0,3,3,0,C07C279/18;;C07C279/18;;C07D213/38;;C07D213/38;;C07D213/64;;C07D213/64;;C07D213/74;;C07D213/74;;C07D231/12;;C07D231/12;;C07D231/38;;C07D231/38;;C07D231/40;;C07D231/40;;C07D263/32;;C07D263/32;;C07D277/28;;C07D277/28;;C07D285/06;;C07D285/06;;C07D295/13;;C07D295/13;;C07D295/215;;C07D295/215,C07C279/18;;A61K31/155;;C07D213/75;;C07D231/40;;C07D263/32;;C07D285/06,,2,1,063-737-191-858-685,16930024;;10.1021/jo060793t,"A. R. KATRITZKY ET AL: ""Synthesis of mono and symmetrical di-N-hydroxy- and N-aminoguanidines"", JOURNAL OF ORGANIC CHEMISTRY., vol. 71, no. 18, 2006, USAMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., pages 6753 - 6758, XP002449759;;DATABASE WPI Week 199249, Derwent World Patents Index; AN 1992-401782, XP002449761",PENDING
41,US,A1,US 2010/0282076 A1,143-892-415-788-277,2010-11-11,2010,US 43618009 A,2009-05-06,US 43618009 A,2009-05-06,RUNTIME SENSOR FOR SMALL FORCED AIR HANDLING UNITS,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,3M INNOVATIVE PROPERTIES COMPANY (2009-05-05),https://lens.org/143-892-415-788-277,Patent Application,yes,32,23,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,B01D45/08,95/25,0,0,,,,INACTIVE
42,WO,A2,WO 2007/095050 A2,004-464-011-661-420,2007-08-23,2007,US 2007/0003364 W,2007-02-08,US 77191406 P,2006-02-09,"N-HYDROXYGUANIDINES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods for the treatment of IDO-associated diseases.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M,COMBS ANDREW P;;GLASS BRIAN M,,https://lens.org/004-464-011-661-420,Patent Application,yes,0,20,3,3,0,C07C279/18;;C07C279/18;;C07D213/38;;C07D213/38;;C07D213/64;;C07D213/64;;C07D213/74;;C07D213/74;;C07D231/12;;C07D231/12;;C07D231/38;;C07D231/38;;C07D231/40;;C07D231/40;;C07D263/32;;C07D263/32;;C07D277/28;;C07D277/28;;C07D285/06;;C07D285/06;;C07D295/13;;C07D295/13;;C07D295/215;;C07D295/215,,,0,0,,,,PENDING
43,AU,A1,AU 2002/345718 A1,017-268-723-401-735,2003-01-02,2003,AU 2002/345718 A,2002-06-19,US 29938501 P;;US 0219528 W,2001-06-19,"Novel nucleic acids, polypeptides, methods of making, and uses thereof",,REGENERON PHARMA,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/017-268-723-401-735,Patent Application,no,0,0,6,6,0,A61K38/00;;C07K14/723;;C07K14/705,A61K38/00;;C07K14/705;;C07K14/72,,0,0,,,,DISCONTINUED
44,CA,A1,CA 2451058 A1,164-046-934-435-907,2002-12-27,2002,CA 2451058 A,2002-06-19,US 29938501 P;;US 0219528 W,2001-06-19,"NOVEL NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF MAKING, AND USES THEREOF","HUMAN LGR9 GPCR polypeptides and related nucleic acids are provided. Include d are natural HUMAN LGR9 GPCR homologs from several species and polypeptides comprising a HUMAN LGR9 GPCR domain having specific activity. The polypeptid es may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are 10 isolated hybridization probes and oligonucleotide primers capable of specifically hybridizing with the disclos ed genes, specific binding agents and methods of making and using the subject compositions, including high throughput screens.",REGENERON PHARMA,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/164-046-934-435-907,Patent Application,no,0,0,6,6,11,A61K38/00;;C07K14/723;;C07K14/705,A61K38/00;;C07K14/705;;C07K14/72,,0,0,,,,DISCONTINUED
45,US,A1,US 2007/0203140 A1,140-651-250-773-395,2007-08-30,2007,US 70396107 A,2007-02-08,US 70396107 A;;US 77191406 P,2006-02-09,"N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase","The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods for the treatment of IDO-associated diseases.",COMBS ANDREW P;;GLASS BRIAN M,COMBS ANDREW P;;GLASS BRIAN M,INCYTE CORPORATION (2007-04-02),https://lens.org/140-651-250-773-395,Patent Application,yes,7,36,3,3,0,C07C279/18;;C07C279/18;;C07D213/38;;C07D213/38;;C07D213/64;;C07D213/64;;C07D213/74;;C07D213/74;;C07D231/12;;C07D231/12;;C07D231/38;;C07D231/38;;C07D231/40;;C07D231/40;;C07D263/32;;C07D263/32;;C07D277/28;;C07D277/28;;C07D285/06;;C07D285/06;;C07D295/13;;C07D295/13;;C07D295/215;;C07D295/215,A61K31/5375;;A61K31/4172;;A61K31/496,514/237.8;;514/374;;514/424;;514/317;;514/357;;514/253.01;;514/633;;544/159;;544/360;;546/332;;564/229,0,0,,,,DISCONTINUED
46,EP,A4,EP 1458847 A4,074-437-545-126-786,2005-10-26,2005,EP 02744474 A,2002-06-19,US 0219528 W;;US 29938501 P,2001-06-19,"NOVEL NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF MAKING, AND USES THEREOF",,REGENERON PHARMA,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/074-437-545-126-786,Search Report,no,4,0,6,6,0,A61K38/00;;C07K14/705;;C07K14/723,A61K38/00;;C07K14/705;;C07K14/72,,2,1,040-917-718-777-261,11353515;;10.1002/gene.1029,"OVERBEEK PAUL A ET AL: ""A transgenic insertion causing cryptorchidism in mice"", GENESIS: THE JOURNAL OF GENETICS AND DEVELOPMENT, WILEY-LISS, NEW YORK, NY,, US, vol. 30, no. 1, May 2001 (2001-05-01), pages 26 - 35, XP002196450, ISSN: 1526-954X;;AGOULNIK A I ET AL: ""CLONING GREAT - G PROTEIN-COUPLED RECEPTOR AFFECTING TESTICULAR DESCENT"", AMERICAN JOURNAL OF HUMAN GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL, US, vol. SUPPL. 4, no. 69, 2001, pages 218,AN216, XP001073497, ISSN: 0002-9297",DISCONTINUED
47,EP,A1,EP 1458847 A1,196-664-068-093-662,2004-09-22,2004,EP 02744474 A,2002-06-19,US 0219528 W;;US 29938501 P,2001-06-19,"NOVEL NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF MAKING, AND USES THEREOF",,REGENERON PHARMA,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/196-664-068-093-662,Patent Application,yes,0,0,6,6,11,A61K38/00;;C07K14/723;;C07K14/705,A61K38/00;;C07K14/705;;C07K14/72,,0,0,,,,DISCONTINUED
48,US,B1,US 6324546 B1,020-751-402-866-783,2001-11-27,2001,US 17210398 A,1998-10-12,US 17210398 A,1998-10-12,Automatic logging of application program launches,"Computer systems typically include many application programs which enable uses to perform a wide range of tasks. The application programs are generally stored on high-capacity memory devices, such as hard drives. Many of these high-capacity memory devices are slow relative to other components of computer system and thus noticeably reduce the overall performance, particularly during start of application programs. One way of improving performance is to organize application programs in memory devices so that often-used application programs are stored in areas that are faster to access or otherwise have less effect on computer performance. Unfortunately, there is no convenient way of keeping track of how often each application program is used. Accordingly, the inventors devised an operating system that logs, or records, certain information every time an application program is started. The log ultimately provides a convenient measure of how frequently application programs are used. Another facet of the invention includes using the log to reorganize how application programs are stored in a memory device.",MICROSOFT CORP,KA CHONG I;;GLASS ANDREW C,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (1998-12-04),https://lens.org/020-751-402-866-783,Granted Patent,yes,17,74,1,1,0,G06F11/3476;;G06F2201/88;;G06F2201/865;;G06F11/3476;;G06F2201/88;;Y10S707/99953;;Y10S707/99954;;G06F2201/865,G06F11/34;;G06F17/30,707/203;;707/202;;707/204;;707/511,2,1,040-420-063-437-376,10.1016/b978-0-12-701750-1.50009-6,"Bach, M.J., ""Process Control"", In: The Design of the Unix Operating System, Prentice Hall, Englewood Cliffs, NJ, pp. 191-246, (1986).;;Tsichritzis, D.C., et al., ""Processor Allocation"", In: Operating Systems, Academic Press, New York, pp. 52-68, (1974).",EXPIRED
49,CA,C,CA 2760617 C,102-982-803-522-149,2017-03-28,2017,CA 2760617 A,2010-05-04,US 43618009 A;;US 2010/0033506 W,2009-05-06,RUNTIME SENSOR FOR SMALL FORCED AIR HANDLING UNITS,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,,https://lens.org/102-982-803-522-149,Granted Patent,no,0,0,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,F24F11/02;;F04D25/08;;F24F11/00;;F24F13/28,,0,0,,,,INACTIVE
50,CA,A1,CA 2760617 A1,123-068-598-772-516,2010-11-11,2010,CA 2760617 A,2010-05-04,US 43618009 A;;US 2010/0033506 W,2009-05-06,RUNTIME SENSOR FOR SMALL FORCED AIR HANDLING UNITS,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,,https://lens.org/123-068-598-772-516,Patent Application,no,0,0,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,F24F11/02;;F04D25/08;;F24F11/00;;F24F13/28,,0,0,,,,INACTIVE
51,WO,A2,WO 2002/102992 A2,117-085-214-682-392,2002-12-27,2002,US 0219528 W,2002-06-19,US 29938501 P,2001-06-19,"NOVEL NUCLEIC ACIDS, POLYPEPTIDES, METHODS OF MAKING, AND USES THEREOF","HUMAN LGR9 GPCR polypeptides and related nucleic acids are provided. Included are natural HUMAN LGR9 GPCR homologs from several species and polypeptides comprising a HUMAN LGR9 GPCR domain having specific activity. The polypeptides may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are 10 isolated hybridization probes and oligonucleotide primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions, including high throughput screens.",REGENERON PHARMA;;MURPHY ANDREW J;;GLASS DAVID J,MURPHY ANDREW J;;GLASS DAVID J,,https://lens.org/117-085-214-682-392,Patent Application,yes,0,0,6,6,0,A61K38/00;;C07K14/723;;C07K14/705,A61K38/00;;C07K14/705;;C07K14/72,,1,0,,,See references of EP 1458847A4,PENDING
52,WO,A2,WO 2010/129523 A2,161-888-092-135-941,2010-11-11,2010,US 2010/0033506 W,2010-05-04,US 43618009 A,2009-05-06,RUNTIME SENSOR FOR SMALL FORCED AIR HANDLING UNITS,"Herein are disclosed devices and methods that can be used to provide an indication of the need to change a filter in a small forced air handling unit, based on the actual operating time (runtime) of the unit. The methods rely on the use of at least one vibration sensor that is placed in contact with a surface of an exterior component of the air handling unit and that can determine whether the unit is operating by sensing vibrations of the surface caused by operation of the unit.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;GLASS DENNIS M,,https://lens.org/161-888-092-135-941,Patent Application,yes,0,1,6,6,0,B01D46/0086;;F24F3/0442;;Y10S55/34;;F24F11/39;;F24F3/0442;;B01D46/0086;;Y10S55/34;;F24F11/39,F24F11/02;;F04D25/08;;F24F11/00;;F24F13/28,,0,0,,,,PENDING
53,GB,A,GB 2577152 A,168-495-326-653-969,2020-03-18,2020,GB 201908226 A,2019-06-10,GB 201814746 A,2018-09-11,Improved transport equipment,"A method of manufacturing an item of traffic equipment 20, comprises moulding a main body from an elastomeric material at an elevated temperature; removing the main body from the mould, the main body is at an intermediate temperature between the elevated moulding temperature and ambient temperature; placing a pre-formed piece of a thermoplastic paint sheet material in contact with a surface of the main body and applying heat to an outward surface of the sheet material to cause bonding between the contacting surfaces of the pre-formed piece of sheet material and the main body. An item of traffic equipment, including a main body having a relief pattern on its outer surface defining at least one recess 26 is also provided. The thermoplastic paint sheet material may include reflective beads integrated therein. The step of applying heat may include using a heat gun. The item may be a speed ramp, traffic cone, road traffic barrier, or railway sleeper.",JSP LTD,ANDREW GLASS;;ANDREW WINDLEY;;STEPHEN FRANCIS SANDERS;;CLIVE JOHNSTONE,,https://lens.org/168-495-326-653-969,Patent Application,no,6,0,6,6,0,B29C65/028;;B29C43/02;;B29C65/022;;B29C65/028;;B29C65/10;;B29C65/565;;B29C65/58;;B29C65/72;;B29C66/006;;B29C66/1122;;B29C66/5326;;B29C66/543;;B29C66/71;;B29C66/712;;B29C66/73341;;B29C66/7392;;B29C66/91413;;B29C66/919;;B29C66/91921;;B29C66/949;;B29C69/00;;B29K2027/06;;B29K2105/26;;E01F9/529;;E01F9/50;;E01F9/529;;E01F9/553,B29C65/02;;E01F9/50;;E01F9/529;;E01F9/553,,1,0,,,https://www.hilltop-products.co.uk/news/hot-air-plastic-welding-guide,ACTIVE
54,IE,B1,IE 87229 B1,096-850-261-517-950,2021-05-26,2021,IE 20190151 A,2019-09-03,GB 201814746 A;;GB 201908226 A,2018-09-11,Improved transport equipment,"A method of manufacturing an item of traffic equipment , comprises moulding a main body from an elastomeric material in a mould at an elevated temperature; removing the main body from the mould wherein the main body is at an intermediate temperature between the elevated moulding temperature and ambient temperature; placing a pre-formed piece of a thermoplastic paint sheet material in contact with a surface of the main body at the intermediate temperature; and applying heat to an outward facing surface of the preformed piece of thermoplastic paint sheet material so as to cause bonding between the contacting surfaces of the pre-formed piece of thermoplastic paint sheet material and the main body. An item of traffic equipment, comprises a main body formed from a moulded elastomeric material having a relief pattern on its outer surface defining at least one recess; and a pre-formed piece of thermoplastic paint sheet material of substantially the same shape and size as the at least one recess fitted within the at least one recess; wherein the a pre-formed piece of thermoplastic paint sheet material is directly bonded to the main body. <Figure 2>",JSP LTD,ANDREW GLASS;;ANDREW WINDLEY;;STEPHEN FRANCIS SANDERS;;CLIVE JOHNSTONE,,https://lens.org/096-850-261-517-950,Granted Patent,no,0,0,6,6,0,B29C65/028;;B29C43/02;;B29C65/022;;B29C65/028;;B29C65/10;;B29C65/565;;B29C65/58;;B29C65/72;;B29C66/006;;B29C66/1122;;B29C66/5326;;B29C66/543;;B29C66/71;;B29C66/712;;B29C66/73341;;B29C66/7392;;B29C66/91413;;B29C66/919;;B29C66/91921;;B29C66/949;;B29C69/00;;B29K2027/06;;B29K2105/26;;E01F9/529;;E01F9/50;;E01F9/529;;E01F9/553,B29C65/00;;E01F9/00,,0,0,,,,ACTIVE
55,IE,A1,IE 20190151 A1,125-861-124-824-392,2020-07-08,2020,IE 20190151 A,2019-09-03,GB 201814746 A;;GB 201908226 A,2018-09-11,Improved transport equipment,"A method of manufacturing an item of traffic equipment , comprises moulding a main body from an elastomeric material in a mould at an elevated temperature; removing the main body from the mould wherein the main body is at an intermediate temperature between the elevated moulding temperature and ambient temperature; placing a pre-formed piece of a thermoplastic paint sheet material in contact with a surface of the main body at the intermediate temperature; and applying heat to an outward facing surface of the preformed piece of thermoplastic paint sheet material so as to cause bonding between the contacting surfaces of the pre-formed piece of thermoplastic paint sheet material and the main body. An item of traffic equipment, comprises a main body formed from a moulded elastomeric material having a relief pattern on its outer surface defining at least one recess; and a pre-formed piece of thermoplastic paint sheet material of substantially the same shape and size as the at least one recess fitted within the at least one recess; wherein the a pre-formed piece of thermoplastic paint sheet material is directly bonded to the main body.",JSP LTD,ANDREW GLASS;;ANDREW WINDLEY;;STEPHEN FRANCIS SANDERS;;CLIVE JOHNSTONE,,https://lens.org/125-861-124-824-392,Patent Application,no,0,0,6,6,0,B29C65/028;;B29C43/02;;B29C65/022;;B29C65/028;;B29C65/10;;B29C65/565;;B29C65/58;;B29C65/72;;B29C66/006;;B29C66/1122;;B29C66/5326;;B29C66/543;;B29C66/71;;B29C66/712;;B29C66/73341;;B29C66/7392;;B29C66/91413;;B29C66/919;;B29C66/91921;;B29C66/949;;B29C69/00;;B29K2027/06;;B29K2105/26;;E01F9/529;;E01F9/50;;E01F9/529;;E01F9/553,B29C65/00;;E01F9/00,,0,0,,,,ACTIVE
56,GB,B,GB 2577152 B,118-644-097-209-030,2020-09-09,2020,GB 201908226 A,2019-06-10,GB 201814746 A,2018-09-11,Improved transport equipment,,JSP LTD,ANDREW GLASS;;ANDREW WINDLEY;;STEPHEN FRANCIS SANDERS;;CLIVE JOHNSTONE,,https://lens.org/118-644-097-209-030,Granted Patent,no,6,0,6,6,0,B29C65/028;;B29C43/02;;B29C65/022;;B29C65/028;;B29C65/10;;B29C65/565;;B29C65/58;;B29C65/72;;B29C66/006;;B29C66/1122;;B29C66/5326;;B29C66/543;;B29C66/71;;B29C66/712;;B29C66/73341;;B29C66/7392;;B29C66/91413;;B29C66/919;;B29C66/91921;;B29C66/949;;B29C69/00;;B29K2027/06;;B29K2105/26;;E01F9/529;;E01F9/50;;E01F9/529;;E01F9/553,B29C65/02;;E01F9/50;;E01F9/529;;E01F9/553,,1,0,,,https://www.hilltop-products.co.uk/news/hot-air-plastic-welding-guide,ACTIVE
57,CL,A1,CL 2007002650 A1,028-521-644-758-061,2008-02-08,2008,CL 2007002650 A,2007-09-12,US 84571106 P,2006-09-19,"COMPUESTOS DERIVADOS DE HETEROCICLO N-HIDROXIAMINO; COMPOSICION FARMACEUTICA, UTIL PARA TRATAR CANCER, INFECCIONES VIRALES Y DESORDENES NEURODEGENERATIVOS ENTRE OTRAS.",,INCYTE CORP,COMBS ANDREW P GLASS BRIAN M S,,https://lens.org/028-521-644-758-061,Patent Application,no,0,0,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,A61K31/42;;A61P25/28;;A61P31/12;;A61P35/00;;C07D261/18,,0,0,,,,PENDING
58,EP,A1,EP 0278058 A1,026-379-912-623-60X,1988-08-17,1988,EP 87115650 A,1987-10-24,CH 24787 A,1987-01-23,Apparatus for checking the authenticity of documents.,"Es wird eine Echtheitserkennungseinrichtung für Dokumente (1) beschrieben, bei denen in einem Merkmalteil deterministische Merkmale (12) unter stochastischen Merkmalen (15) verborgen liegen. Dazu werden Bildflächen (24) benutzt, die in oder in der Umgebung der reellen Bildebene des zur Abbildung des Merkmalteils benutzten optischen Systems (22) liegen. Durch den Einfluss des stochastischen Merkmals (15) entstehen unscharfe Abbildungen, die nur mit Hilfsmitteln ausgewertet werden können. Als Auswertmethoden werden beispielsweise die Intensitätsvergleichsmethode oder, bei periodischem deterministischem Merkmal (12), die Fourier-Analysenmethode benutzt, um die Echtheit des deterministischen Merkmals (12) festzustellen. Diese Methoden können durch die Tiefenschärfemethode ergänzt werden, mittels der festgestellt wird, ob die mittlere Korngrösse des stochastischen Merkmals (15) der im echten Dokument zu erwartenden entspricht. Nachdem festgestellt ist, dass das Dokument (1) echt ist, werden die Funktionen der angschlossenen Anlage (35) freigegeben.  ",LANDIS & GYR AG,HUISER ANDRE MARTINUS JAN;;GLASS ANDREW STUART,,https://lens.org/026-379-912-623-60X,Patent Application,yes,4,7,2,2,0,G06K19/16;;G07F7/086;;G06V20/80;;G06V10/42;;G06V10/88;;G06K19/16;;G06V10/88;;G06V10/42;;G06V20/80,G06K19/16;;G06V10/42;;G06V10/88;;G07D7/20;;G07F7/08,,0,0,,,,DISCONTINUED
59,CH,A5,CH 671299 A5,073-205-443-791-321,1989-08-15,1989,CH 24787 A,1987-01-23,CH 24787 A,1987-01-23,CH 671299 A5,,LANDIS & GYR AG,HUISER ANDRE MARTINUS JAN;;GLASS ANDREW STUART,,https://lens.org/073-205-443-791-321,Granted Patent,no,0,1,2,2,0,G06K19/16;;G07F7/086;;G06V20/80;;G06V10/42;;G06V10/88;;G06K19/16;;G06V10/88;;G06V10/42;;G06V20/80,G06K19/16;;G06V10/42;;G06V10/88;;G07D7/20;;G07F7/08,,0,0,,,,EXPIRED
60,US,B2,US 11294463 B2,171-463-826-342-19X,2022-04-05,2022,US 201816207892 A,2018-12-03,US 201816207892 A,2018-12-03,Augmenting the functionality of user input devices using a digital glove,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/171-463-826-342-19X,Granted Patent,yes,67,0,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354;;G06F3/0484;;G06F3/04847;;G06F3/0488;;G06F3/04883,,19,2,077-922-489-469-298;;037-059-819-778-574,10.1109/mcg.2017.1;;28103543;;10.1109/pacificvis.2015.7156378,"“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Nov. 4, 2019, 13 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Dec. 19, 2019, 24 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Dec. 12, 2019, 14 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,936”, dated Oct. 4, 2019, 10 Pages.;;International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063125, dated Apr. 3, 2020, 19 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063118”, dated Jan. 31, 2020, 11 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Mar. 18, 2020, 15 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063120”, dated Feb. 27, 2020, 12 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063128”, dated Feb. 27, 2020, 11 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Jul. 1, 2020, 26 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063119”, dated Jun. 24, 2020, 23 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jul. 16, 2020, 11 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Oct. 19, 2020, 12 Pages.;;“Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Sep. 3, 2020, 20 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Jan. 25, 2021, 8 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,794”, dated Jun. 7, 2021, 17 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Jun. 8, 2021, 24 Pages.;;Annett, Michelle, “(Digitally) Inking in the 21st Century”, In Journal of IEEE Computer Graphics and Applications, vol. 37, Issue 1, Jan. 2017, pp. 92-99.;;Lee, et al., “SketchInsight: Natural Data Exploration on Interactive Whiteboards Leveraging Pen and Touch Interaction”, In Journal of IEEE Pacific Visualization Symposium, Apr. 14, 2015, pp. 199-206.",ACTIVE
61,US,A1,US 2022/0309242 A1,000-106-915-050-803,2022-09-29,2022,US 202217839330 A,2022-06-13,US 202217839330 A;;US 202017024428 A,2020-09-17,LANGUAGE AUTODETECTION FROM NON-CHARACTER SUB-TOKEN SIGNALS,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2020-09-17),https://lens.org/000-106-915-050-803,Patent Application,yes,1,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,0,0,,,,ACTIVE
62,WO,A3,WO 2007/109050 A3,021-079-421-179-595,2008-10-23,2008,US 2007/0006439 W,2007-03-15,US 74348906 P,2006-03-15,SYSTEM AND METHOD FOR CONTROLLING THE PRESENTATION OF MATERIAL AND OPERATION OF EXTERNAL DEVICES,"By performing a comparison of words spoken by a speaker and defined material which is presented to the speaker, information can be determined which allows for the convenient control of the presentation of material and external devices. A comparison of a speaker's words with defined material can be beneficially used as an input for controlling the operation of an exercise apparatus, video games, material presented to an audience, and the presentation of the material itself. Similar feedback loops can also be used with measurement and stimulation of neurophysiologic states, to make the activity of reading more enjoyable and convenient, or for other purposes.",GLASS ANDREW B;;VAN STYN HENRY;;KANE COLEMAN,GLASS ANDREW B;;VAN STYN HENRY;;KANE COLEMAN,,https://lens.org/021-079-421-179-595,Search Report,yes,2,0,3,5,0,G09B5/04;;G09B5/04;;G09B7/00;;G09B7/00;;G09B17/003;;G09B17/003,A63B71/00,,0,0,,,,PENDING
63,US,B2,US 11199901 B2,190-777-483-166-796,2021-12-14,2021,US 201816207973 A,2018-12-03,US 201816207973 A,2018-12-03,Augmenting the functionality of non-digital objects using a digital glove,"The disclosed technologies address technical problems, including improving human-computer interaction, by augmenting the functionality provided by non-digital objects using a digital glove. To provide this functionality, a machine learning model is trained using sensor data generated by sensors in a digital glove and data generated by a user input device while the digital glove is utilized to manipulate an object like a user input device. Once trained, the machine learning model can take sensor data generated by a digital glove while manipulating a non-digital object and generate virtual user input device data that can be utilized to control a host computer. A digital glove can also be utilized to perform selection operations using non-digital objects when pressure data generated by one or more of the pressure sensors in the digital glove indicates that pressure was exerted at a finger of the digital glove in excess of a threshold value.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/190-777-483-166-796,Granted Patent,yes,67,0,3,3,0,G06F3/014;;G06N20/10;;G06N3/08;;G06N5/01;;G06N7/01;;G06N20/00;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847,G06F3/01;;G06F3/0354;;G06F3/0484;;G06N20/00,,19,2,077-922-489-469-298;;037-059-819-778-574,10.1109/mcg.2017.1;;28103543;;10.1109/pacificvis.2015.7156378,"“Non Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Dec. 19, 2019, 24 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Dec. 12, 2019, 14 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,936”, dated Oct. 4, 2019, 10 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063120”, dated Feb. 27, 2020, 12 Pages. (MS# 405535-WO-PCT).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063128”, dated Feb. 27, 2020, 11 Pages. (MS# 405656-WO-PCT).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063118”, dated Jan. 31, 2020, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 5, 2020, 28 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US19/063125”, dated Apr. 3, 2020, 19 Pages. (MS# 405256-WO-PCT).;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2019/063119”, dated Jun. 24, 2020, 23 Pages. (MS# 405245-WO-PCT).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Jul. 23, 2020, 33 Pages. (MS# 405256-US-NP).;;“Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Sep. 3, 2020, 20 Pages. (MS# 405535-US-NP).;;“Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Dec. 24, 2020, 37 Pages. (MS# 405256-US-NP).;;“Notice of Allowance Issued in U.S. Appl. No. 16/207,794”, dated Jun. 7, 2021, 17 Pages. (MS# 405245-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Jun. 8, 2021, 24 Pages. (MS# 405535-US-NP).;;Annett, Michelle, “(Digitally) Inking in the 21st Century”, In Journal of IEEE Computer Graphics and Applications, vol. 37, Issue 1, Jan. 2017, pp. 92-99.;;Lee, et al., “SketchInsight: Natural Data Exploration on Interactive Whiteboards Leveraging Pen and Touch Interaction”, In Journal of IEEE Pacific Visualization Symposium, Apr. 14, 2015, pp. 199-206.;;“Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Jul. 1, 2020, 26 Pages. (MS# 405245-US-NP).;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Mar. 30, 2021, 42 Pages. (MS# 405256-US-NP).;;“Final Office Action Issued in U.S. Appl. No. 16/207,892”, dated Aug. 27, 2021, 37 Pages.",ACTIVE
64,US,A,US 4537504 A,113-582-900-002-344,1985-08-27,1985,US 34206582 A,1982-01-25,CH 72081 A;;CH 255981 A;;CH 612681 A,1981-02-03,"Security blank with enhanced authenticating features, and a method and an apparatus for determining the genuineness of the security blank","A security blank is formed with a light-redirecting spatial structure including a deterministic component establishing at least one authenticating feature, and a stochastic component superimposed on the deterministic component, and sufficiently obscuring the deterministic component so as largely to frustrate recognition of the function of the authenticating feature by intensity measurement of light reflected therefrom. Recognition of the function of the authenticating feature is made possible by a method and an apparatus measuring the degree of coherence of two narrow bundles of light rays obtained from light reflected from the spatial structure upon its illumination by light of a selected wavelength.",LANDIS & GYR AG,BALTES HEINRICH P;;GLASS ANDREW S;;JAUCH KARL,LGZ LANDIS & GYR ZUG AG (1982-01-15),https://lens.org/113-582-900-002-344,Granted Patent,yes,6,99,5,8,0,G06K7/14;;G06K19/16;;G07F7/086;;G07F7/086;;G06K7/14;;G06K19/16,G06K7/14;;G06K19/16;;G07F7/08,356/71;;283/85;;356/354,2,1,112-340-552-556-640,20168541;;10.1364/ao.16.000558,"Inverse Problems and Coherence Ferwerda et al., International U.R.S.I. Symposium 1980 on Electromagnetic Waves, Munich, Aug. 26 29, 1980, pp. 315C/1 and 315C/2.;;Meaurement of Second Order Coherence in a Light Beam Using a Microscope & a Grating Carter, Applied Optics, vol. 16, 3, Mar. 1977, pp. 558 563.",EXPIRED
65,US,A1,US 2022/0317772 A1,042-915-483-016-217,2022-10-06,2022,US 202217696136 A,2022-03-16,US 202217696136 A;;US 201816207892 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF USER INPUT DEVICES USING A DIGITAL GLOVE,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/042-915-483-016-217,Patent Application,yes,3,1,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354;;G06F3/04847;;G06F3/04883,,0,0,,,,ACTIVE
66,US,A1,US 2010/0041000 A1,144-043-658-649-984,2010-02-18,2010,US 38878509 A,2009-02-19,US 38878509 A;;US 68660907 A;;US 3150808 P;;US 74348906 P,2006-03-15,System and Method for Controlling the Presentation of Material and Operation of External Devices,"By performing a comparison of words spoken by a speaker and defined material which is presented to the speaker, information can be determined which allows for the convenient control of the presentation of material and external devices. A comparison of a speaker's words with defined material can be beneficially used as an input for controlling the operation of an exercise apparatus, video games, material presented to an audience, and the presentation of the material itself. Similar feedback loops can also be used with measurement and stimulation of neurophysiologic states, to make the activity of reading more enjoyable and convenient, or for other purposes.",GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,,https://lens.org/144-043-658-649-984,Patent Application,yes,88,38,2,5,0,G09B5/02;;G09B5/02,G09B19/04;;G09B17/04,434/179;;434/185,0,0,,,,DISCONTINUED
67,US,A1,US 2007/0218432 A1,044-506-532-645-761,2007-09-20,2007,US 68660907 A,2007-03-15,US 68660907 A;;US 74348906 P,2006-03-15,System and Method for Controlling the Presentation of Material and Operation of External Devices,"By performing a comparison of words spoken by a speaker and defined material which is presented to the speaker, information can be determined which allows for the convenient control of the presentation of material and external devices. A comparison of a speaker's words with defined material can be beneficially used as an input for controlling the operation of an exercise apparatus, video games, material presented to an audience, and the presentation of the material itself. Similar feedback loops can also be used with measurement and stimulation of neurophysiologic states, to make the activity of reading more enjoyable and convenient, or for other purposes.",GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,READ ALOUD TECHNOLOGY LLC (2007-07-18),https://lens.org/044-506-532-645-761,Patent Application,yes,75,46,3,5,0,G09B5/04;;G09B5/04;;G09B7/00;;G09B7/00;;G09B17/003;;G09B17/003,G09B19/00,434/156,0,0,,,,DISCONTINUED
68,US,B2,US 11361158 B2,076-169-457-758-85X,2022-06-14,2022,US 202017024428 A,2020-09-17,US 202017024428 A,2020-09-17,Language autodetection from non-character sub-token signals,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2020-09-17),https://lens.org/076-169-457-758-85X,Granted Patent,yes,2,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,2,0,,,"Jauhiainen, et al., “Automatic Language Identification in Texts: A Survey”, In Repository of arXiv:1804.08186, Apr. 22, 2018, 97 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2021/035563”, dated Sep. 23, 2021, 10 Pages.",ACTIVE
69,WO,A1,WO 2019/067528 A1,112-159-080-648-945,2019-04-04,2019,US 2018/0052839 W,2018-09-26,US 201762563148 P,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY;;WINKLER JEFFREY;;GLASS ANDREW,,https://lens.org/112-159-080-648-945,Patent Application,yes,2,7,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61P25/28;;A61K31/498;;C07D241/44,,3,2,127-959-283-812-039;;070-629-306-038-763,pmc5505514;;10.1038/nature22405;;28562591;;10.1007/s00702-017-1737-4;;28550509,"MEWS ET AL.: ""Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory"", NATURE, vol. 546, 15 June 2017 (2017-06-15), pages 381 - 386, XP055586593;;RIBEIRO ET AL.: ""Possible involvement of ACSS2 gene in alcoholism"", J. NEURAL. TRANSM., 26 May 2017 (2017-05-26), XP036302290;;See also references of EP 3687628A4",PENDING
70,WO,A1,WO 2022/060439 A1,028-033-871-210-722,2022-03-24,2022,US 2021/0035563 W,2021-06-03,US 202017024428 A,2020-09-17,LANGUAGE AUTODETECTION FROM NON-CHARACTER SUB-TOKEN SIGNALS,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND,,https://lens.org/028-033-871-210-722,Patent Application,yes,2,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,1,0,,,"TOMMI JAUHIAINEN ET AL: ""Automatic Language Identification in Texts: A Survey"", ARXIV.ORG, CORNELL UNIVERSITY LIBRARY, 201 OLIN LIBRARY CORNELL UNIVERSITY ITHACA, NY 14853, 23 April 2018 (2018-04-23), XP081425274",PENDING
71,WO,A1,WO 2020/117537 A1,066-668-230-740-464,2020-06-11,2020,US 2019/0063125 W,2019-11-26,US 201816207892 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF USER INPUT DEVICES USING A DIGITAL GLOVE,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,,https://lens.org/066-668-230-740-464,Patent Application,yes,3,0,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354,,0,0,,,,PENDING
72,DE,D1,DE 69631373 D1,135-724-608-787-403,2004-02-26,2004,DE 69631373 T,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,ABRECHNUNGSVERWALTUNG FÜR TELEKOMMUNIKATIONSBENUTZUNG,,BRITISH TELECOMM,ALLISON STEPHEN;;HAWTHORNE MARTIN;;MAIRS ANDREW;;GLASS GEORGE,,https://lens.org/135-724-608-787-403,Granted Patent,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
73,US,B2,US 11630951 B2,058-453-707-310-077,2023-04-18,2023,US 202217839330 A,2022-06-13,US 202217839330 A;;US 202017024428 A,2020-09-17,Language autodetection from non-character sub-token signals,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2020-09-17),https://lens.org/058-453-707-310-077,Granted Patent,yes,1,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,0,0,,,,ACTIVE
74,DE,T2,DE 69631373 T2,119-708-145-477-213,2004-11-11,2004,DE 69631373 T,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,ABRECHNUNGSVERWALTUNG FÜR TELEKOMMUNIKATIONSBENUTZUNG,,BRITISH TELECOMM,ALLISON STEPHEN;;HAWTHORNE MARTIN;;MAIRS ANDREW;;GLASS GEORGE,,https://lens.org/119-708-145-477-213,Granted Patent,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
75,US,A1,US 2020/0174566 A1,188-277-722-762-884,2020-06-04,2020,US 201816207892 A,2018-12-03,US 201816207892 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF USER INPUT DEVICES USING A DIGITAL GLOVE,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/188-277-722-762-884,Patent Application,yes,7,6,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354;;G06F3/0484;;G06F3/0488,,0,0,,,,ACTIVE
76,US,A9,US 2012/0237906 A9,012-992-578-533-699,2012-09-20,2012,US 38878509 A,2009-02-19,US 38878509 A;;US 68660907 A;;US 3150808 P;;US 74348906 P,2006-03-15,System and Method for Controlling the Presentation of Material and Operation of External Devices,"By performing a comparison of words spoken by a speaker and defined material which is presented to the speaker, information can be determined which allows for the convenient control of the presentation of material and external devices. A comparison of a speaker's words with defined material can be beneficially used as an input for controlling the operation of an exercise apparatus, video games, material presented to an audience, and the presentation of the material itself. Similar feedback loops can also be used with measurement and stimulation of neurophysiologic states, to make the activity of reading more enjoyable and convenient, or for other purposes.",GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,GLASS ANDREW B;;STYN HENRY VAN;;KANE COLEMAN,READ ALOUD TECHNOLOGY LLC (2009-02-19),https://lens.org/012-992-578-533-699,Amended Application,yes,0,11,2,5,0,G09B5/02;;G09B5/02,G09B17/04;;G09B19/04,434/179;;434/185,0,0,,,,DISCONTINUED
77,US,A1,US 2020/0174567 A1,046-953-016-666-483,2020-06-04,2020,US 201816207973 A,2018-12-03,US 201816207973 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF NON-DIGITAL OBJECTS USING A DIGITAL GLOVE,"The disclosed technologies address technical problems, including improving human-computer interaction, by augmenting the functionality provided by non-digital objects using a digital glove. To provide this functionality, a machine learning model is trained using sensor data generated by sensors in a digital glove and data generated by a user input device while the digital glove is utilized to manipulate an object like a user input device. Once trained, the machine learning model can take sensor data generated by a digital glove while manipulating a non-digital object and generate virtual user input device data that can be utilized to control a host computer. A digital glove can also be utilized to perform selection operations using non-digital objects when pressure data generated by one or more of the pressure sensors in the digital glove indicates that pressure was exerted at a finger of the digital glove in excess of a threshold value.",KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/046-953-016-666-483,Patent Application,yes,4,5,3,3,0,G06F3/014;;G06N20/10;;G06N3/08;;G06N5/01;;G06N7/01;;G06N20/00;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847,G06F3/01;;G06F3/0354;;G06F3/0484;;G06N20/00,,0,0,,,,ACTIVE
78,WO,A1,WO 2020/117533 A1,133-263-274-828-516,2020-06-11,2020,US 2019/0063118 W,2019-11-25,US 201816207973 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF NON-DIGITAL OBJECTS USING A DIGITAL GLOVE,"The disclosed technologies address technical problems, including improving human-computer interaction, by augmenting the functionality provided by non-digital objects using a digital glove. To provide this functionality, a machine learning model is trained using sensor data generated by sensors in a digital glove and data generated by a user input device while the digital glove is utilized to manipulate an object like a user input device. Once trained, the machine learning model can take sensor data generated by a digital glove while manipulating a non-digital object and generate virtual user input device data that can be utilized to control a host computer. A digital glove can also be utilized to perform selection operations using non-digital objects when pressure data generated by one or more of the pressure sensors in the digital glove indicates that pressure was exerted at a finger of the digital glove in excess of a threshold value.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,,https://lens.org/133-263-274-828-516,Patent Application,yes,1,0,3,3,0,G06F3/014;;G06N20/10;;G06N3/08;;G06N5/01;;G06N7/01;;G06N20/00;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847,G06F3/01;;G06N20/00,,0,0,,,,PENDING
79,US,A1,US 2023/0252235 A1,030-961-488-809-162,2023-08-10,2023,US 202318301341 A,2023-04-17,US 202318301341 A;;US 202217839330 A;;US 202017024428 A,2020-09-17,TRAINING A LANGUAGE DETECTION MODEL FOR LANGUAGE AUTODETECTION FROM NON-CHARACTER SUB-TOKEN SIGNALS,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2020-09-17),https://lens.org/030-961-488-809-162,Patent Application,yes,1,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,0,0,,,,PENDING
80,US,A1,US 2023/0134764 A1,146-732-141-859-854,2023-05-04,2023,US 202218148306 A,2022-12-29,US 202218148306 A;;US 202217696136 A;;US 201816207892 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF USER INPUT DEVICES USING A DIGITAL GLOVE,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/146-732-141-859-854,Patent Application,yes,2,1,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354;;G06F3/04847;;G06F3/04883,,0,0,,,,PENDING
81,US,A1,US 2022/0083734 A1,188-805-752-643-196,2022-03-17,2022,US 202017024428 A,2020-09-17,US 202017024428 A,2020-09-17,LANGUAGE AUTODETECTION FROM NON-CHARACTER SUB-TOKEN SIGNALS,"In non-limiting examples of the present disclosure, systems, methods and devices for determining a language of a text string are presented. A language detection model may be maintained. The language detection model may comprise identities and weights for initial and final consonants, identities and weights for prefixes and suffixes, and identities and weights for vowel sequences, where each identity is derived from a training corpus. The weights may correspond to a frequency of a text unit in the corpus. A text string may be received and a match score between the text string and the language of the language detection model may be determined. The match score may be based on initial and final consonant scores, prefix and suffix scores, and/or vowel sequence scores for each word in the text string. If the match score meets a threshold value a follow-up action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADKE ROLAND,MICROSOFT TECHNOLOGY LICENSING LLC (2020-09-17),https://lens.org/188-805-752-643-196,Patent Application,yes,0,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,0,0,,,,ACTIVE
82,AU,A4,AU 2021/107070 A4,009-827-559-640-213,2021-12-02,2021,AU 2021/107070 A,2021-08-24,AU 2020/904745 A,2020-12-18,"Support apparatus, system and method","A support apparatus (10) includes a base component (14) with apertures (58) to allow fluid to pass though the base component. Also provided is at least one sidewall (16) and a base connector (18) to releasably connect the base component to the sidewall to maintain the sidewall in an upwardly extending position when an upper side (14.1) of the base component is horizontal. Also disclosed is a corner connector (19) for releasably interconnecting two adjacent sidewalls of the apparatus, and a juxtaposing connector (20) for releasably interconnecting two adjacent sidewalls of two such apparatuses. A central connector (22) can interconnect the base components of two such apparatuses. The invention also extends to a support system having a plurality of such apparatuses, to a method of installing such an apparatus or system, and to a method of establishing an irrigatable mass on a substrate using such an apparatus or system. FIG. 1 16.1 16.1 lo",GLASS PETER,GLASS PETER;;SIMPSON ANDREW;;KO EDWARD;;LECHNER TYRAN,,https://lens.org/009-827-559-640-213,Limited Patent,no,0,0,1,1,0,A01G9/02;;A01G9/025;;A01G9/033;;A01G9/28;;Y02A30/254;;Y02B80/32,A01G9/02;;A01G9/033;;A01G9/28,,0,0,,,,ACTIVE
83,WO,A2,WO 2007/109050 A2,113-674-597-429-166,2007-09-27,2007,US 2007/0006439 W,2007-03-15,US 74348906 P,2006-03-15,SYSTEM AND METHOD FOR CONTROLLING THE PRESENTATION OF MATERIAL AND OPERATION OF EXTERNAL DEVICES,"By performing a comparison of words spoken by a speaker and defined material which is presented to the speaker, information can be determined which allows for the convenient control of the presentation of material and external devices. A comparison of a speaker's words with defined material can be beneficially used as an input for controlling the operation of an exercise apparatus, video games, material presented to an audience, and the presentation of the material itself. Similar feedback loops can also be used with measurement and stimulation of neurophysiologic states, to make the activity of reading more enjoyable and convenient, or for other purposes.",GLASS ANDREW B;;VAN STYN HENRY;;KANE COLEMAN,GLASS ANDREW B;;VAN STYN HENRY;;KANE COLEMAN,,https://lens.org/113-674-597-429-166,Patent Application,yes,0,0,3,5,0,G09B5/04;;G09B5/04;;G09B7/00;;G09B7/00;;G09B17/003;;G09B17/003,G09B19/00,,0,0,,,,PENDING
84,CN,A,CN 116194925 A,017-706-168-710-762,2023-05-30,2023,CN 202180063398 A,2021-06-03,US 202017024428 A;;US 2021/0035563 W,2020-09-17,Automatic detection of languages from non-character sub-tag signals,"In non-limiting examples of the present disclosure, systems, methods, and devices are presented for determining a language of a text string. A language detection model may be maintained. The language detection model may include identities and weights for initial and tail consonants, identities and weights for prefixes and suffixes, and identities and weights for a sequence of vowels, where each identity is derived from a training corpus. The weights may correspond to frequencies of the text units in the corpus. A text string may be received, and a match score between the text string and a language of a language detection model may be determined. The matching score may be based on a word head consonant score and a word tail consonant score, a prefix score and a suffix score, and/or a vowel sequence score for each word in the text string. If the match score satisfies a threshold, a subsequent action associated with the language may be performed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MICHAEL H;;RADKE ROLAND,,https://lens.org/017-706-168-710-762,Patent Application,no,0,0,7,7,0,G06F40/263;;G06F40/263,G06F40/263,,0,0,,,,PENDING
85,US,B2,US 11669164 B2,141-396-923-258-576,2023-06-06,2023,US 202217696136 A,2022-03-16,US 202217696136 A;;US 201816207892 A,2018-12-03,Augmenting the functionality of user input devices using a digital glove,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-27),https://lens.org/141-396-923-258-576,Granted Patent,yes,8,0,6,6,0,G06F3/014;;G06F3/016;;G06F3/03545;;G06F3/013;;G06F3/014;;G06F3/017;;G06F3/03545;;G06F3/04847;;G06F3/04883,G06F3/01;;G06F3/0354;;G06F3/04847;;G06F3/04883,,3,0,,,"“Non Final Office Action Issued in U.S. Appl. No. 17/659,285”, dated Nov. 25, 2022, 30 Pages.;;“Office Action Issued in Indian Patent Application No. 202147024276”, dated Jan. 9, 2023, 8 Pages.;;“Office Action Issued in Indian Patent Application No. 202147024277”, dated Dec. 30, 2022, 9 Pages.",ACTIVE
86,GB,A,GB 2509411 A,030-117-747-492-531,2014-07-02,2014,GB 201402744 A,2012-10-02,GB 2012052431 W;;US 201113309732 A,2011-12-02,Register mapping with multiple instruction sets,A processor core supports execution of program instruction from both a first instruction set and a second instruction set. An architectural register file (18) containing architectural registers is shared by the two instruction sets. The two instruction sets employ logical register specifiers which for at least some values of those logical registers specifiers correspond to different architectural registers within the architectural register file (18). A first decoder (4) for the first instruction set and a second decoder (6) for the second instruction set serve to decode the logical register specifiers to a common register addressing format. This common register addressing format is used to supply register specifiers to renaming circuitry for supporting register renaming in conjunction with a physical register file (16) and an (10) architectural register file (18).,ADVANCED RISC MACH LTD,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER,,https://lens.org/030-117-747-492-531,Patent Application,no,4,0,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/30;;G06F9/38,,0,0,,,,ACTIVE
87,AT,T1,AT E9851 T1,111-725-578-342-65X,1984-10-15,1984,AT 81109503 T,1981-11-04,CH 72081 A;;CH 255981 A;;CH 612681 A;;EP 81109503 A,1981-02-03,VERFAHREN ZUR VERHINDERUNG ERFOLGREICHER FAELSCHUNGEN VON DOKUMENTEN UND ANORDNUNG ZUR DURCHFUEHRUNG DES VERFAHRENS.,,LGZ LANDIS & GYR ZUG AG,"BALTES, HEINRICH PETER;;GLASS, ANDREW STUART;;JAUCH, KARL M.",,https://lens.org/111-725-578-342-65X,Granted Patent,no,0,0,1,8,0,,G06K1/12;;G06K7/14;;G06K19/08,,0,0,,,,DISCONTINUED
88,GB,B,GB 2509411 B,036-323-198-975-404,2020-10-07,2020,GB 201402744 A,2012-10-02,GB 2012052431 W;;US 201113309732 A,2011-12-02,Register mapping with multiple instruction sets,,ADVANCED RISC MACH LTD,GLEN ANDREW HARRIS;;JAMES NOLAN HARDAGE;;MARK CARPENTER GLASS,,https://lens.org/036-323-198-975-404,Granted Patent,no,4,0,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/30,,0,0,,,,ACTIVE
89,EP,A3,EP 0057271 A3,157-956-525-112-030,1982-09-01,1982,EP 81109503 A,1981-11-04,CH 72081 A;;CH 255981 A;;CH 612681 A,1981-02-03,METHOD FOR PREVENTING THE SUCESSFUL FORGERY OF DOCUMENTS AND DEVICE THEREFOR,"Auf dem Dokument (1) wird ein Echtheitsmerkmal in Form einer räumlichen Struktur (2) aufgezeichnet. In einem Prüfgerät werden aus dem an der Struktur (2) gestreuten Licht einer Lichtquelle (6) zwei enge Lichtbündel (10; 11) ausgesondert. Zur Echtheitsprüfung des Dokumentes (1) wird mittels mindestens eines Lichtfühlers (18) und eines Signalverarbeitungsgliedes (19) der Kohärenzgrad oder die Intensitätskorrelation der beiden Lichtbündel (10; 11) gemessen und mittels eines Entscheidungsgliedes (20) ein Ja-Signal bzw. Nein-Signal erzeugt. Die Erkennung des Echtheitsmerkmals durch Intensitätsmessungen wird erschwert oder verunmöglicht, indem die Struktur (2) durch Überlagerung einer deterministischen Komponente und einer stochastischen, diffus streuenden Komponente gebildet wird.",LGZ LANDIS & GYR ZUG AG,"BALTES, HEINRICH PETER;;GLASS, ANDREW STUART;;JAUCH, KARL M.",OFFERTA DI LICENZA AL PUBBLICO (1987-06-05),https://lens.org/157-956-525-112-030,Search Report,yes,10,0,5,8,0,G06K7/14;;G06K19/16;;G07F7/086;;G07F7/086;;G06K7/14;;G06K19/16,G06K7/14;;G06K19/16;;G07F7/08,,0,0,,,,EXPIRED
90,US,A1,US 2017/0300675 A1,172-166-469-746-211,2017-10-19,2017,US 201715584022 A,2017-05-02,US 201715584022 A;;US 201213485683 A,2012-05-31,LOGIN INTERFACE SELECTION FOR COMPUTING ENVIRONMENT USER LOGIN,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART;;MICROSOFT CORP,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-05-16),https://lens.org/172-166-469-746-211,Patent Application,yes,1,20,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,G06F21/31;;H04W12/06;;H04W88/02,,0,0,,,,ACTIVE
91,US,B2,US 8972701 B2,161-411-325-023-425,2015-03-03,2015,US 201113312131 A,2011-12-06,US 201113312131 A,2011-12-06,Setting zero bits in architectural register for storing destination operand of smaller size based on corresponding zero flag attached to renamed physical register,"A data processing system is provided in which destination operands to be stored within architectural registers are constrained to have zero values added as prefixes in order that the architectural register value has a fixed bit width irrespective of the bit width of the destination operand being written thereto. Instead of adding these zero values everywhere in the data path, they are instead represented by zero flags in at least the physical registers utilized for register renaming operations and in the result queue prior to results being written to the architectural register file. This saves circuitry resources and reduces energy consumption.",HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER,ARM LIMITED (2012-01-06),https://lens.org/161-411-325-023-425,Granted Patent,yes,4,0,2,2,0,G06F9/30014;;G06F9/30189;;G06F9/384;;G06F9/30189;;G06F9/384;;G06F9/30014;;G06F1/3234;;G06F9/30003;;G06F9/30112,G06F9/30;;G06F1/32,712/217;;712/210;;X712 E9023;;713/320,0,0,,,,ACTIVE
92,US,S,US D0321226 S,046-214-195-707-420,1991-10-29,1991,US 36109989 F,1989-06-05,US 36109989 F,1989-06-05,Seat for a rowing exercise machine,,LUMEX,SOLOW HOWARD J;;GLASS ANDREW B;;STERLACCI GEORGE M,CYBEX INTERNATIONAL INC (1989-06-01),https://lens.org/046-214-195-707-420,Design Right,yes,5,2,1,1,0,,,D21/191,1,0,,,"Noting Beats the Pulling Power of Liferower, Marketing Brochure-Dated 1987.",EXPIRED
93,WO,A1,WO 2017/087515 A1,085-451-790-418-387,2017-05-26,2017,US 2016/0062266 W,2016-11-16,US 201514943008 A,2015-11-16,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where at least one rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, communications, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS ENERGIES INC;;VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,,https://lens.org/085-451-790-418-387,Patent Application,yes,5,0,2,9,0,B64B1/50;;B64F3/00;;G05D1/0866,G05D1/08;;B64B1/50;;B64F3/00,,0,0,,,,PENDING
94,US,A1,US 2013/0145126 A1,144-140-058-093-446,2013-06-06,2013,US 201113309732 A,2011-12-02,US 201113309732 A,2011-12-02,REGISTER MAPPING WITH MULTIPLE INSTRUCTION SETS,A processor core supports execution of program instruction from both a first instruction set and a second instruction set. An architectural register file 18 containing architectural registers is shared by the two instruction sets. The two instruction sets employ logical register specifiers which for at least some values of those logical registers specifiers correspond to different architectural registers within the architectural register file 18. A first decoder 4 for the first instruction set and a second decoder 6 for the second instruction set serve to decode the logical register specifiers to a common register addressing format. This common register addressing format is used to supply register specifiers to renaming circuitry 10 for supporting register renaming in conjunction with a physical register file 16 and an architectural register file 18.,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER,ARM LIMITED (2012-01-06),https://lens.org/144-140-058-093-446,Patent Application,yes,3,4,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/38;;G06F9/312,712/212;;X712E09028;;X712E09045;;X712E09027;;X712E09033,0,0,,,,ACTIVE
95,US,A1,US 2013/0326605 A1,003-778-703-760-310,2013-12-05,2013,US 201213485683 A,2012-05-31,US 201213485683 A,2012-05-31,LOGIN INTERFACE SELECTION FOR COMPUTING ENVIRONMENT USER LOGIN,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART;;MICROSOFT CORP,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-05-31),https://lens.org/003-778-703-760-310,Patent Application,yes,5,30,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,H04L9/32;;G06F15/16;;G06F21/00,726/7,0,0,,,,ACTIVE
96,US,A1,US 2019/0258784 A1,074-145-016-747-822,2019-08-22,2019,US 201916403742 A,2019-05-06,US 201916403742 A;;US 201715584022 A;;US 201213485683 A,2012-05-31,LOGIN INTERFACE SELECTION FOR COMPUTING ENVIRONMENT USER LOGIN,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",MICROSOFT TECHNOLOGY LICENSING LLC,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-05-16),https://lens.org/074-145-016-747-822,Patent Application,yes,0,3,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,G06F21/31;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
97,US,A1,US 2012/0124301 A1,188-503-799-723-27X,2012-05-17,2012,US 92641510 A,2010-11-16,US 92641510 A,2010-11-16,Buffer store with a main store and an auxiliary store,A loop buffer is provided with a main store 26 and an auxiliary store 28 . The main store 26 stores micro-operation instructions. The auxiliary store 28 has fewer entries than the main store 26 and stores target addresses for predicted taken branch instructions stored within the main store 26 . Read control circuitry serves to control reading from the main store and from an auxiliary store such that target addresses are read from the auxiliary store in association with the predicted taken branch instructions read from the main store.,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER,ARM LIMITED (2010-12-07),https://lens.org/188-503-799-723-27X,Patent Application,yes,6,4,2,2,0,G06F9/3806;;G06F9/3806;;G06F5/065;;G06F5/065;;G06F9/381;;G06F9/381,G06F12/00,711/154;;X711E12001,0,0,,,,ACTIVE
98,US,B2,US 11230391 B2,082-222-382-114-802,2022-01-25,2022,US 201615776552 A,2016-11-16,US 201615776552 A;;US 201514943008 A;;US 2016/0062266 W,2015-11-16,Systems and methods for attitude control of tethered aerostats,"A control system for a tethered aerostat is provided, where at least one rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, communications, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS ENERGIES INC,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,ALTAEROS ENERGIES INC (2018-10-23),https://lens.org/082-222-382-114-802,Granted Patent,yes,108,0,2,9,0,B64B1/50;;B64C19/00;;B64F3/00;;B64U10/60;;B64B1/50;;B64F3/00,B64F3/00;;B64B1/50,,11,0,,,"International Search Report and Written Opinion dated Mar. 18, 2013 for corresponding International Application No. PCT/US2012/055898.;;International Preliminary Report on Patentability dated Apr. 3, 2014 for corresponding International Application No. PCT/US2012/055898.;;International Search Report and Written Opinion dated Feb. 28, 2017 for corresponding International Application No. PCT/US2016/062266.;;International Preliminary Report on Patentability dated May 31, 2018 for corresponding International Application No. PCT/US2016/062266.;;International Search Report and Written Opinion dated May 13, 2013 for correspondng International Application No. PCT/US2013/021837.;;International Preliminary Report on Patentability dated Jul. 31, 2014 for corresponding International Application No. PCT/US2013/021837.;;Extended European Search Report dated Sep. 28, 2015 for corresponding European Application No. 13738570.4.;;Invitation to Pay Additional Fees dated Dec. 26, 2017 in connection with International Application No. PCT/2017/057177.;;International Search report and Written Opinion dated Feb. 22, 2018 in connection with International Application No. PCT/US2017/057177.;;International Preliminary Report on Patentability dated May 2, 2019 in connection with International Application No. PCT/US2017/057177.;;Extended European Search Report dated May 7, 2020 in connection with European Application No. 17862190.0.",ACTIVE
99,US,A1,US 2013/0145127 A1,115-431-526-501-534,2013-06-06,2013,US 201113312131 A,2011-12-06,US 201113312131 A,2011-12-06,ZERO VALUE PREFIXES FOR OPERANDS OF DIFFERING BIT-WIDTHS,"A data processing system is provided in which destination operands to be stored within architectural registers are constrained to have zero values added as prefixes in order that the architectural register value has a fixed bit width irrespective of the bit width of the destination operand being written thereto. Instead of adding these zero values everywhere in the data path, they are instead represented by zero flags in at least the physical registers utilised for register renaming operations and in the result queue prior to results being written to the architectural register file. This saves circuitry resources and reduces energy consumption.",HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER,ARM LIMITED (2012-01-06),https://lens.org/115-431-526-501-534,Patent Application,yes,3,10,2,2,0,G06F9/30014;;G06F9/30189;;G06F9/384;;G06F9/30189;;G06F9/384;;G06F9/30014;;G06F1/3234;;G06F9/30003;;G06F9/30112,G06F9/30;;G06F9/312,712/214;;712/217;;X712E09023;;X712E09033;;X712E09016,0,0,,,,ACTIVE
100,US,B2,US 8914615 B2,153-244-405-258-683,2014-12-16,2014,US 201113309732 A,2011-12-02,US 201113309732 A,2011-12-02,Mapping same logical register specifier for different instruction sets with divergent association to architectural register file using common address format,A processor core supports execution of program instruction from both a first instruction set and a second instruction set. An architectural register file 18 containing architectural registers is shared by the two instruction sets. The two instruction sets employ logical register specifiers which for at least some values of those logical registers specifiers correspond to different architectural registers within the architectural register file 18 . A first decoder 4 for the first instruction set and a second decoder 6 for the second instruction set serve to decode the logical register specifiers to a common register addressing format. This common register addressing format is used to supply register specifiers to renaming circuitry 10 for supporting register renaming in conjunction with a physical register file 16 and an architectural register file 18.,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER,ARM LIMITED (2012-01-06),https://lens.org/153-244-405-258-683,Granted Patent,yes,60,1,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/34;;G06F9/30;;G06F9/38,712/208;;712/210;;712/217;;X712 E9027;;X712 E9038,1,0,,,"International Search Report and Written Opinion of the International Searching Authority mailed Dec. 14, 2012 in PCT/GB2012/052431.",ACTIVE
101,WO,A8,WO 2017/087515 A8,083-566-217-906-529,2017-08-17,2017,US 2016/0062266 W,2016-11-16,US 201514943008 A,2015-11-16,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where at least one rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, communications, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS ENERGIES INC;;VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,,https://lens.org/083-566-217-906-529,Amended Application,yes,0,0,2,9,0,B64B1/50;;B64F3/00;;G05D1/0866,G05D1/08;;B64B1/50;;B64F3/00,,0,0,,,,PENDING
102,US,B2,US 10614200 B2,077-167-025-194-445,2020-04-07,2020,US 201916403742 A,2019-05-06,US 201916403742 A;;US 201715584022 A;;US 201213485683 A,2012-05-31,Login interface selection for computing environment user login,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",MICROSOFT TECHNOLOGY LICENSING LLC,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-05-16),https://lens.org/077-167-025-194-445,Granted Patent,yes,1,8,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,G06F21/00;;G06F21/31;;H04W12/06;;H04W12/08;;H04W88/02,,0,0,,,,ACTIVE
103,US,S,US D0321225 S,162-189-287-934-739,1991-10-29,1991,US 36109589 F,1989-06-05,US 36109589 F,1989-06-05,Seat for an upper body exercise machine,,LUMEX,SOLOW HOWARD J;;GLASS ANDREW B;;SNOW DAVID W,LUMEX INC. 100 SPENCE STREET BAY SHORE NEW YORK 11706 A CORP. OF NY (1989-06-01);;CYBEX INTERNATIONAL INC (1996-08-07),https://lens.org/162-189-287-934-739,Design Right,yes,6,1,1,1,0,,,D21/191,0,0,,,,EXPIRED
104,US,B2,US 9946545 B2,010-750-835-632-176,2018-04-17,2018,US 92641510 A,2010-11-16,US 92641510 A,2010-11-16,Buffer store with a main store and and auxiliary store,A loop buffer is provided with a main store 26 and an auxiliary store 28 . The main store 26 stores micro-operation instructions. The auxiliary store 28 has fewer entries than the main store 26 and stores target addresses for predicted taken branch instructions stored within the main store 26 . Read control circuitry serves to control reading from the main store and from an auxiliary store such that target addresses are read from the auxiliary store in association with the predicted taken branch instructions read from the main store.,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER;;ADVANCED RISC MACH LTD,HARDAGE JAMES NOLAN;;HARRIS GLEN ANDREW;;GLASS MARK CARPENTER,ARM LIMITED (2010-12-07),https://lens.org/010-750-835-632-176,Granted Patent,yes,6,0,2,2,0,G06F9/3806;;G06F9/3806;;G06F5/065;;G06F5/065;;G06F9/381;;G06F9/381,G06F15/00;;G06F5/06;;G06F9/00;;G06F9/38;;G06F9/44,,2,1,041-496-518-340-173,10.1109/tc.2005.92,"Jayapala et al., “Clustered Loop Buffer Organization for Low Energy VLIW Embedded Processors”, IEEE Computer Society, vol. 54, No. 6, Jun. 2005, pp. 672-683.;;Lee et al., “Instruction Fetch Energy Reduction Using Loop Caches for Embedded Applications with Small Tight Loops”, No Date, pp. 267-269.",ACTIVE
105,EP,A2,EP 0057271 A2,093-981-229-118-643,1982-08-11,1982,EP 81109503 A,1981-11-04,CH 72081 A;;CH 255981 A;;CH 612681 A,1981-02-03,Method for preventing the sucessful forgery of documents and device therefor.,"Auf dem Dokument (1) wird ein Echtheitsmerkmal in Form einer räumlichen Struktur (2) aufgezeichnet. In einem Prüfgerät werden aus dem an der Struktur (2) gestreuten Licht einer Lichtquelle (6) zwei enge Lichtbündel (10; 11) ausgesondert. Zur Echtheitsprüfung des Dokumentes (1) wird mittels mindestens eines Lichtfühlers (18) und eines Signalverarbeitungsgliedes (19) der Kohärenzgrad oder die Intensitätskorrelation der beiden Lichtbündel (10; 11) gemessen und mittels eines Entscheidungsgliedes (20) ein Ja-Signal bzw. Nein-Signal erzeugt. Die Erkennung des Echtheitsmerkmals durch Intensitätsmessungen wird erschwert oder verunmöglicht, indem die Struktur (2) durch Überlagerung einer deterministischen Komponente und einer stochastischen, diffus streuenden Komponente gebildet wird.",LANDIS & GYR AG,BALTES HEINRICH PETER;;GLASS ANDREW STUART;;JAUCH KARL M,OFFERTA DI LICENZA AL PUBBLICO (1987-06-05),https://lens.org/093-981-229-118-643,Patent Application,yes,0,7,5,8,0,G06K7/14;;G06K19/16;;G07F7/086;;G07F7/086;;G06K7/14;;G06K19/16,G06K7/14;;G06K19/16;;G07F7/08,,0,0,,,,EXPIRED
106,US,A1,US 2016/0139601 A1,142-012-357-255-469,2016-05-19,2016,US 201514943008 A,2015-11-16,US 201514943008 A;;US 201213621537 A;;US 201161537102 P,2011-09-21,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where at least one rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, communications, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS EN INC,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,,https://lens.org/142-012-357-255-469,Patent Application,yes,1,11,1,9,0,B64B1/50;;B64F3/00;;G05D1/0816;;B64B1/50;;B64F3/00;;B64B2201/00,G05D1/08;;B64B1/50;;B64F3/00,,0,0,,,,DISCONTINUED
107,US,A1,US 2015/0082007 A1,086-730-052-656-912,2015-03-19,2015,US 201414548800 A,2014-11-20,US 201414548800 A;;US 201113309732 A,2011-12-02,REGISTER MAPPING WITH MULTIPLE INSTRUCTION SETS,A processor core supports execution of program instruction from both a first instruction set and a second instruction set. An architectural register file 18 containing architectural registers is shared by the two instruction sets. The two instruction sets employ logical register specifiers which for at least some values of those logical registers specifiers correspond to different architectural registers within the architectural register file 18. A first decoder 4 for the first instruction set and a second decoder 6 for the second instruction set serve to decode the logical register specifiers to a common register addressing format. This common register addressing format is used to supply register specifiers to renaming circuitry 10 for supporting register renaming in conjunction with a physical register file 16 and an architectural register file 18.,ADVANCED RISC MACH LTD,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER,ARM LIMITED (2015-03-04),https://lens.org/086-730-052-656-912,Patent Application,yes,3,1,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/30,712/208,0,0,,,,DISCONTINUED
108,WO,A3,WO 2013/043586 A3,139-602-422-631-400,2013-05-16,2013,US 2012/0055898 W,2012-09-18,US 201213621537 A;;US 201161537102 P,2011-09-21,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where up to two rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS EN INC;;VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,,https://lens.org/139-602-422-631-400,Search Report,yes,5,0,4,9,0,B64B1/50;;B64B1/00;;B64B1/50,B64B1/50;;B64B1/52;;G05D1/10,,0,0,,,,PENDING
109,WO,A1,WO 2013/079910 A1,035-614-003-841-62X,2013-06-06,2013,GB 2012052431 W,2012-10-02,US 201113309732 A,2011-12-02,REGISTER MAPPING WITH MULTIPLE INSTRUCTION SETS,A processor core supports execution of program instruction from both a first instruction set and a second instruction set. An architectural register file (18) containing architectural registers is shared by the two instruction sets. The two instruction sets employ logical register specifiers which for at least some values of those logical registers specifiers correspond to different architectural registers within the architectural register file (18). A first decoder (4) for the first instruction set and a second decoder (6) for the second instruction set serve to decode the logical register specifiers to a common register addressing format. This common register addressing format is used to supply register specifiers to renaming circuitry for supporting register renaming in conjunction with a physical register file (16) and an (10) architectural register file (18).,ADVANCED RISC MACH LTD,HARRIS GLEN ANDREW;;HARDAGE JAMES NOLAN;;GLASS MARK CARPENTER,,https://lens.org/035-614-003-841-62X,Patent Application,yes,4,1,7,7,0,G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/30112;;G06F9/3012;;G06F9/30174;;G06F9/384;;G06F9/3012;;G06F9/30174;;G06F9/30112;;G06F9/384;;G06F9/34;;G06F9/3824;;G06F9/30098;;G06F9/30145,G06F9/30,,0,0,,,,PENDING
110,US,A1,US 2013/0075523 A1,022-714-755-206-377,2013-03-28,2013,US 201213621537 A,2012-09-17,US 201213621537 A;;US 201161537102 P,2011-09-21,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where up to two rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS EN INC;;ALTAEROS EN INC,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,ALTAEROS ENERGIES INC (2012-09-17),https://lens.org/022-714-755-206-377,Patent Application,yes,13,15,4,9,0,B64B1/50;;B64B1/00;;B64B1/50,B64B1/00,244/96,0,0,,,,ACTIVE
111,DE,D1,DE 3166630 D1,107-717-910-619-389,1984-11-15,1984,DE 3166630 T,1981-11-04,CH 72081 A;;CH 255981 A;;CH 612681 A,1981-02-03,METHOD FOR PREVENTING THE SUCESSFUL FORGERY OF DOCUMENTS AND DEVICE THEREFOR,,LANDIS & GYR AG,BALTES HEINRICH PETER;;GLASS ANDREW STUART;;JAUCH KARL M,,https://lens.org/107-717-910-619-389,Granted Patent,no,0,0,5,8,0,G06K7/14;;G06K19/16;;G07F7/086;;G07F7/086;;G06K7/14;;G06K19/16,G06K7/14;;G06K19/16;;G07F7/08,,0,0,,,,EXPIRED
112,WO,A2,WO 2013/043586 A2,146-488-180-985-464,2013-03-28,2013,US 2012/0055898 W,2012-09-18,US 201213621537 A;;US 201161537102 P,2011-09-21,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where up to two rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS EN INC;;VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,,https://lens.org/146-488-180-985-464,Patent Application,yes,0,4,4,9,0,B64B1/50;;B64B1/00;;B64B1/50,B64B1/50;;B64B1/52;;G05D1/10,,0,0,,,,PENDING
113,EP,B1,EP 0057271 B1,053-382-267-921-917,1984-10-10,1984,EP 81109503 A,1981-11-04,CH 72081 A;;CH 255981 A;;CH 612681 A,1981-02-03,METHOD FOR PREVENTING THE SUCESSFUL FORGERY OF DOCUMENTS AND DEVICE THEREFOR,,LGZ LANDIS & GYR ZUG AG,"BALTES, HEINRICH PETER;;GLASS, ANDREW STUART;;JAUCH, KARL M.",OFFERTA DI LICENZA AL PUBBLICO (1987-06-05),https://lens.org/053-382-267-921-917,Granted Patent,yes,0,0,5,8,0,G06K7/14;;G06K19/16;;G07F7/086;;G07F7/086;;G06K7/14;;G06K19/16,G06K7/14;;G06K19/16;;G07F7/08,,0,0,,,,EXPIRED
114,US,B2,US 10282529 B2,086-660-061-594-345,2019-05-07,2019,US 201715584022 A,2017-05-02,US 201715584022 A;;US 201213485683 A,2012-05-31,Login interface selection for computing environment user login,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",MICROSOFT TECHNOLOGY LICENSING LLC,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2017-05-16),https://lens.org/086-660-061-594-345,Granted Patent,yes,65,0,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,H04L29/06;;G06F21/31;;H04W12/06;;H04W88/02,,41,0,,,"“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Aug. 7, 2014 ,10 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Apr. 1, 2015, 12 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Feb. 26, 2016, 13 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Oct. 30, 2015, 21 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Dec. 19, 2014, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Apr. 16, 2014, 15 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 13/485,683”, dated Oct. 13, 2016, 23 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 13/485,683”, dated Dec. 16, 2016, 15 Pages.;;“First Chinese Office Action and Search Report Issued in Chinese Patent Application No. 201310213093.1”, dated Sep. 1, 2015, 6 Pages.;;“Second Office Action Issued in Chinese Patent Application No. 201310213093.1”, dated Jun. 1, 2016, 8 Pages.;;“Reply to Second Office Action Issued in Chinese Application No. 201310213093.1”, dated Jul. 19, 2016, 4 Pages.;;“Third Office Action Issued in Chinese Patent Application No. 201310213093.1”, dated Oct. 28, 2016, 6 Pages.;;“Notice of Allowance Issued in Chinese Patent Application No. 201310213093.1”, dated Mar. 28, 2017, 4 Pages.;;“Reply Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Jul. 16, 2014, 17 Pages.;;“Reply Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Nov. 7, 2014 , 15 Pages.;;Reply Non Final Office Action Issued in U.S. Appl. No. 13/485,683, daed Mar. 19, 2014, 17 Pages.;;“Notice of Appeal Issued in U.S. Appl. No. 13/485,683”, dated Oct. 1, 2015, 9 Pages.;;“Reply Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Feb. 1, 2016, 17 Pages.;;“Notice of Appeal Issued in U.S. Appl. No. 13/485,683”, dated Jun. 27, 2016, 8 Pages.;;“Appeal Brief Issued in U.S. Appl. No. 13/485,683”, dated Aug. 29, 2016, 44 Pages.;;“User Interface Language Management”, Retrieved From: https://docs.microsoft.com/en-gb/windows/desktop/Intl/user-interface-language-management :, May 23, 2012, 4 Pages.;;“Using Multilingual User Interface on Windows Embedded Standard 2009”, Retrieved From: https://docs.microsoft.com/en-us/previous-versions/windows/embedded/ee428798(v=msdn.10), Jul. 2009, 13 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,829”, dated: Mar. 24, 2015, 21 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,829”, dated: Mar. 11, 2016, 19 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,829”, dated: Jun. 16, 2017, 26 pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,829”, dated: Nov. 18, 2016, 23 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,829”, dated: Jul. 30, 2015, 23 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,917”, dated: Jun. 24, 2016, 27 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,917”, dated: May 4, 2017, 33 Pages.;;“First Office Action and Search Report Issued in Chinese Patent Application No. 201310211732.0”, dated: Oct. 26, 2015, 17 Pages.;;“Third Office Action Issued in Chinese Application No. 201310211732.0”, dated: Aug. 30, 2016, 7 Pages.;;“First Office Action and Search Report Issued in Chinese Patent Application No. 201310212039.5”, dated: Dec. 25, 2015, 17 Pages.;;“Office Action Issued in Chinese Patent Application No. 201310212039.5”, dated: Oct. 31, 2016, 9 Pages.;;“Second Office Action Issued in Chinese Patent Application No. 201310212039.5”, dated: May 31, 2016, 22 Pages.;;“Third Office Action Issued in Chinese Patent Application No. 201310212039.5”, dated: May 2, 2017, 16 Pages.;;Wang, Wan-Jun, “A Method of Multi-attribute Connection Number Decision Making Based on Fuzzy Linguistic”, in Journal of Mathematics in Practice and Theory 21, Nov. 30, 2008, 3 Pages.;;Xiao, et al., “Model for Performance Appraisal With Uncertain Linguistic Information”, In Journal of Chongqing University of Arts and Sciences (Natural Science Edition), Jan. 31, 2010, 5 Pages.;;Yan, et al., “Group Decision-Making Based on Multi-Granularity Linguistic Term and Unknown Attribute Weight”, In Journal of Hefei University of Technology (Natural Science), Jul. 31, 2010, 2 Pages.;;Yao, et al., “Method for Uncertain Linguistic Multiple Attribute Group Decision Making with Incomplete Attribute Weights”, In Journal of Northeastern University (Natural Science), No. 4, Apr. 30, 2010, 4 Pages.;;Yichi, et al., “Two-Tuple Linguistic Multiple Attribute Group Decision Making With Incomplete Attribute Weight Information”, In Journal of Wuhan University of Technology, Jun. 2008, 2 Pages.;;“Second Office Action Issued In Chinese Patent Application No. 201310211732.0”, dated: Jun. 1, 2016, 21 Pages.",ACTIVE
115,US,B2,US 9639676 B2,035-686-925-687-828,2017-05-02,2017,US 201213485683 A,2012-05-31,US 201213485683 A,2012-05-31,Login interface selection for computing environment user login,"A device may provide a login process to authenticate users prior to admittance to a computing environment. The device may also enable users to adjust various the computing environment, e.g., the language selected for communicating with the user and the user interfaces to be presented to the user, and may store such adjustments in a secured user account. However, if the user account is inaccessible to the device during the login process, the device is unable to adapt the login process to apply the user's adjustments. Instead, the device may be configured to store users' adjustments (including language selection) outside of the user accounts, and to, upon identifying the user during the login process, present login interfaces specified in the user account. Additionally, users may select different login interfaces during login, and the device may retrieve these login interfaces for selection during future login processes for the same user.",BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART;;MICROSOFT TECHNOLOGY LICENSING LLC,BETZ ADAM JAMES;;CURTISS WADE H;;GLASS ANDREW STUART,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-05-31),https://lens.org/035-686-925-687-828,Granted Patent,yes,14,11,8,8,0,G06F2221/2149;;H04W12/06;;H04W88/02;;G06F21/31;;H04W12/086;;H04W12/06;;H04W88/02;;G06F2221/2149;;H04W12/086;;G06F21/31,H04L29/06;;G06F21/31;;H04W12/06;;H04W88/02,,4,0,,,"First Chinese Office Action/Search Report cited in Chinese Application No. 201310213093.1 dated Sep. 1, 2015, 6 pgs.;;“Second Office Action Issued in Chinese Patent Application No. 201310213093.1”, Mailed Date: Jun. 1, 2016, 8 Pages.;;Reply second Chinese Office Action cited in Chinese Application No. 201310213093.1 dated Jul. 19, 2016, 4 pgs.;;“Third Office Action Issued in Chinese Patent Application No. 201310213093.1”, Mailed Date: Oct. 28, 2016, 6 Pages. (w/o English Translation).",ACTIVE
116,US,B2,US 9187165 B2,044-174-317-078-014,2015-11-17,2015,US 201213621537 A,2012-09-17,US 201213621537 A;;US 201161537102 P,2011-09-21,Systems and methods for attitude control of tethered aerostats,"A control system for a tethered aerostat is provided, where up to two rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D;;ALTAEROS EN INC,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN W;;GOESSLING ANDREW D,ALTAEROS ENERGIES INC (2012-09-17),https://lens.org/044-174-317-078-014,Granted Patent,yes,37,6,4,9,0,B64B1/50;;B64B1/00;;B64B1/50,B64B1/50;;B64B1/00,,0,0,,,,ACTIVE
117,US,A1,US 2020/0024000 A1,093-013-360-963-764,2020-01-23,2020,US 201615776552 A,2016-11-16,US 201615776552 A;;US 201514943008 A;;US 2016/0062266 W,2015-11-16,SYSTEMS AND METHODS FOR ATTITUDE CONTROL OF TETHERED AEROSTATS,"A control system for a tethered aerostat is provided, where at least one rotational and at least one translational degree of freedom are controlled to setpoints through the variation of tether lengths by an actuator system. The term tether includes a single tether, a tether group or a sub section of tether controlled by an individual actuator. Accurate rotational and translational control is essential for the successful operation of an aerostat under several applications, including surveillance, weather monitoring, communications, and power generation. For a given use case, the controller can be constructed and arranged to manage the tradeoff between several key performance characteristics, such as transient performance, steady-state pointing accuracy, tether tension regulation, and power generation.",ALTAEROS ENERGIES INC,VERMILLION CHRISTOPHER R;;GLASS BENJAMIN WILLIAM;;GOESSLING ANDREW D,ALTAEROS ENERGIES INC (2018-10-23),https://lens.org/093-013-360-963-764,Patent Application,yes,0,2,2,9,0,B64B1/50;;B64C19/00;;B64F3/00;;B64U10/60;;B64B1/50;;B64F3/00,B64F3/00;;B64B1/50,,0,0,,,,ACTIVE
118,GB,A,GB 2437461 A,096-239-496-325-818,2007-10-24,2007,GB 0714625 A,2006-01-04,US 2006/0000372 W;;US 2974005 A,2005-01-04,cmos transistor junction region formed by a cvd etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFERY,,https://lens.org/096-239-496-325-818,Patent Application,no,0,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336;;H01L21/205;;H01L21/8238,,0,0,,,,ACTIVE
119,WO,A1,WO 2020/069093 A1,001-611-034-099-088,2020-04-02,2020,US 2019/0053108 W,2019-09-26,US 201962824092 P;;US 201862736638 P,2018-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,BERGER SHELLEY;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/001-611-034-099-088,Patent Application,yes,4,1,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61P25/28;;C07D241/44,,3,1,020-641-509-764-763,10.1016/j.ejmech.2014.10.067;;25462259,"DATABASE Pubmed U.S. National Library of Medicine; 26 October 2006 (2006-10-26), ""2E)-3-Oxo-2-[(quinoxalin-6- ylamino)methylidene]butanenitrile"", Database accession no. 11514217;;DOUARON ET AL.: ""Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 89, 23 October 2014 (2014-10-23), pages 467 - 479, XP055699287;;See also references of EP 3856184A4",PENDING
120,CN,A,CN 107667349 A,160-763-440-214-051,2018-02-06,2018,CN 201580080667 A,2015-06-04,US 2015/0034127 W,2015-06-04,METHOD AND SYSTEM FOR CLUSTERING ENGINEERING DATA IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The preferred embodiments described below include methods, systems and computer readable media for clustering engineering data in a multidisciplinary engineering system. Engineering data in a multidisciplinary engineering system is grouped into clusters (601) of data that can be used to represent an engineering purpose in the multidisciplinary engineering system. The engineering data can be grouped for any engineering purpose, such as a group of devices included in a safety area of an automated facility, a group of devices included in an automation system or a group of devices that are assigned to a specific bus controller. Workstations (305) can access, view and modify the clusters (601) of engineering data from engineering discipline specific engineering applications (307).",SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN,,https://lens.org/160-763-440-214-051,Patent Application,no,5,2,4,4,0,G06F9/465;;G06Q10/06;;G06Q10/06;;G06F16/285;;G06F16/2246;;G06F16/285;;G06F16/2246;;G06Q10/06;;G05B19/058,G06F9/46;;G06Q10/06,,1,0,,,"SIEMENS: ""SIMATIC WinCC Process visualization with Plant Intelligence"", 《HTTPS://WWW.AUTOMATION.SIEMENS.COM/SALESMATERIAL-AS/BROCHURE/EN/BROCHURE_SIMATIC-WINCC_EN.PDF》",DISCONTINUED
121,GB,B,GB 2437461 B,016-149-568-492-842,2010-11-24,2010,GB 0714625 A,2006-01-04,US 2006/0000372 W;;US 2974005 A,2005-01-04,cmos transistor junction region formed by a cvd etching and deposition sequence,,INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFERY,,https://lens.org/016-149-568-492-842,Granted Patent,no,0,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336;;H01L21/205;;H01L21/8238,,0,0,,,,ACTIVE
122,US,A1,US 2018/0157735 A1,104-189-373-122-565,2018-06-07,2018,US 201515577927 A,2015-06-04,US 2015/0034127 W,2015-06-04,METHOD AND SYSTEM FOR CLUSTERING ENGINEERING DATA IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The preferred embodiments described below include methods, systems and computer readable media for clustering engineering data in a multidisciplinary engineering system. Engineering data in a multidisciplinary engineering system is grouped into clusters ( 601 ) of data that can be used to represent an engineering purpose in the multidisciplinary engineering system. The engineering data can be grouped for any engineering purpose, such as a group of devices included in a safety area of an automated facility, a group of devices included in an automation system or a group of devices that are assigned to a specific bus controller. Workstations ( 305 ) can access, view and modify the clusters ( 601 ) of engineering data from engineering discipline specific engineering applications ( 307 ).",SIEMENS AG,NOETZELMANN OSWIN;;DYLLA ANDREW;;LABAS ATTILA;;DUREL MARINE;;GLASS MICHAEL,SIEMENS AKTIENGESELLSCHAFT (2017-12-21);;SIEMENS CORPORATION (2018-01-01);;SIEMENS PRODUCT LIFECYCLE MANAGEMENT SOFTWARE INC (2017-12-15),https://lens.org/104-189-373-122-565,Patent Application,yes,0,3,4,4,0,G06F9/465;;G06Q10/06;;G06Q10/06;;G06F16/285;;G06F16/2246;;G06F16/285;;G06F16/2246;;G06Q10/06;;G05B19/058,G06F17/30,,0,0,,,,DISCONTINUED
123,WO,A2,WO 2006/104529 A2,190-917-005-921-947,2006-10-05,2006,US 2006/0000372 W,2006-01-04,US 2974005 A,2005-01-04,CMOS TRANSISTOR JUNCTION REGIONS FORMED BY A CVD ETCHING AND DEPOSITION SEQUENCE,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP;;MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/190-917-005-921-947,Patent Application,yes,0,18,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336,,0,0,,,,PENDING
124,DE,T5,DE 112006000151 T5,181-128-067-142-246,2008-04-24,2008,DE 112006000151 T,2006-01-04,US 2974005 A;;US 2006/0000372 W,2005-01-04,"CMOS Transistsorübergangsbereiche, die durch ein CVD Ätzen gebildet sind und Ablagerungsabfolge",,INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/181-128-067-142-246,Patent Application,no,0,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336,,0,0,,,,ACTIVE
125,DE,B4,DE 112006000151 B4,083-691-654-109-539,2010-01-21,2010,DE 112006000151 T,2006-01-04,US 2974005 A;;US 2006/0000372 W,2005-01-04,"Herstellungsverfahren für CMOS Transistsorübergangsbereiche, die durch ein CVD Ätzen gebildet sind und eine Ablagerungsabfolge in ein und derselben Kammer",,INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/083-691-654-109-539,Granted Patent,no,2,2,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336;;H01L21/8238;;H01L29/78,,0,0,,,,ACTIVE
126,JP,A,JP 2012199557 A,146-583-757-733-532,2012-10-18,2012,JP 2012102383 A,2012-04-27,US 2974005 A,2005-01-04,CMOS TRANSISTOR JUNCTION REGIONS FORMED BY CVD ETCHING AND DEPOSITION SEQUENCE,"PROBLEM TO BE SOLVED: To provide a source-drain replacement technique of a CMOS transistor, to etch a recess in a substrate material using one equipment set and then perform deposition of different materials having stresses, specifically to provide a method of etching and subsequent deposition without atmospheric exposure.SOLUTION: A method of forming junction regions of a CMOS transistor by etching and deposition comprises the steps of: removing a first portion of a substrate 120 next to a gate electrode 190 to form a first junction region 270, and a second portion of the substrate 120 located opposite the first portion via the gate electrode 190 to form a second junction region 280 on the substrate 120; and forming a layer having epitaxial thickness of a crystalline material in the first junction region 270 and the second junction region 280. The removing step and the forming step are performed in the same chamber without breaking a seal of the chamber.",INTEL CORP,ANAND MURTHY;;GLENN GLASS;;ANDREW WESTMEYER;;MICHAEL HATTENDORF;;JEFFREY WANK,,https://lens.org/146-583-757-733-532,Patent Application,no,5,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/8238;;C23C16/42;;H01L21/205;;H01L21/336;;H01L27/092;;H01L29/78,,2,0,,,"JPN6013041429; Ｋａｈ Ｗｅｅ Ａｎｇ ｅｔ ａｌ．: 'Ｅｎｈａｎｃｅｄ ｐｅｒｆｏｒｍａｎｃｅ ｉｎ ５０ ｎｍ Ｎ-ＭＯＳＦＥＴｓ ｗｉｔｈ ｓｉｌｉｃｏｎ-ｃａｒｂｏｎ ｓｏｕｒｃｅ／ｄｒａｉｎ ｒｅｇｉｏｎｓ' ＩＥＤＭ ＴＥＣＨＮＩＣＡＬ ＤＩＧＥＳＴ , 20041213, ｐｐ． １０６９-１０７１, ＩＥＥＥ;;JPN6013041428; Ｒｏｇｅｒ Ｌｏｏ ｅｔ ａｌ．: 'Ａ ｎｅｗ ｔｅｃｈｎｉｑｕｅ ｔｏ ｆａｂｒｉｃａｔｅ ｕｌｔｒａ-ｓｈａｌｌｏｗ-ｊｕｎｃｔｉｏｎｓ， ｃｏｍｂｉｎｉｎｇ ｉｎ ｓｉｔｕ ｖａｐｏｕｒ ＨＣｌ ｅｔｃｈｉｎｇ ａｎｄ ｉｎ ｓｉ' ＡＰＰＬＩＥＤ ＳＵＲＦＡＣＥ ＳＣＩＥＮＣＥ ｖｏｌ． ２２４， ｎｏ． １-４, 20040315, ＰＰ． ６３-６７, ＥＬＳＥＶＩＥＲ",ACTIVE
127,TW,B,TW I297927 B,146-488-814-387-512,2008-06-11,2008,TW 95100343 A,2006-01-04,US 2974005 A,2005-01-04,Cmos transistor junction regions formed by a cvd etching and deposition sequence,,INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/146-488-814-387-512,Granted Patent,no,0,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,,,0,0,,,,ACTIVE
128,WO,A1,WO 2023/278798 A1,007-740-173-001-772,2023-01-05,2023,US 2022/0035859 W,2022-06-30,US 202163217672 P,2021-07-01,UNIVERSAL ASSAY CARTRIDGE AND METHODS OF USE,"Sample cartridge, valve assembly and processing methods for providing mechanical lysis, chemical lysis or both for a given fluid sample are provided herein. Such systems can include a sample processing cartridge having a valve assembly configured for transport of the processing of fluid sample within the sample cartridge. The valve assembly can include a valve body and cap that secure a filter therebetween and facilitate inflow of mechanical or chemical lysing agents as needed for a fluid sample. Assay workflows for performing both mechanical and chemical lysis of a fluid sample within the same workflow of a single universal sample cartridge are also provided.",CEPHEID;;NANDURI HARIKA;;WEITSMAN ANDREW;;GLASS JENNIFER;;WEI MICHELLE;;NOYES TINA,NANDURI HARIKA;;WEITSMAN ANDREW;;GLASS JENNIFER;;WEI MICHELLE;;NOYES TINA,,https://lens.org/007-740-173-001-772,Patent Application,yes,6,0,4,4,0,B01L3/502761;;B01L3/502715;;B01L3/502738;;B01L3/563;;B01L2200/0647;;B01L2200/10;;B01L2300/0681;;B01L2400/0644;;B01L2400/06;;B01L3/502761;;B01L2200/04;;B01L2200/0647;;B01L2200/16;;B01L2300/0654;;B01L2300/0681;;B01L2300/0864;;B01L2400/0487;;B01L2400/0644;;C12Q1/6844,B01L3/00,,0,0,,,,PENDING
129,WO,A1,WO 2016/195688 A1,017-568-452-946-606,2016-12-08,2016,US 2015/0034127 W,2015-06-04,US 2015/0034127 W,2015-06-04,METHOD AND SYSTEM FOR CLUSTERING ENGINEERING DATA IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The preferred embodiments described below include methods, systems and computer readable media for clustering engineering data in a multidisciplinary engineering system. Engineering data in a multidisciplinary engineering system is grouped into clusters (601) of data that can be used to represent an engineering purpose in the multidisciplinary engineering system. The engineering data can be grouped for any engineering purpose, such as a group of devices included in a safety area of an automated facility, a group of devices included in an automation system or a group of devices that are assigned to a specific bus controller. Workstations (305) can access, view and modify the clusters (601) of engineering data from engineering discipline specific engineering applications (307).",SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN,,https://lens.org/017-568-452-946-606,Patent Application,yes,6,1,4,4,0,G06F9/465;;G06Q10/06;;G06Q10/06;;G06F16/285;;G06F16/2246;;G06F16/285;;G06F16/2246;;G06Q10/06;;G05B19/058,G06F9/46;;G06Q10/00,,3,0,,,". ET AL: ""SIMATIC WinCC Process visualization with Plant Intelligence SIMATIC HMI Answers for industry"", 30 April 2012 (2012-04-30), XP055220903, Retrieved from the Internet <URL:https://www.automation.siemens.com/salesmaterial-as/brochure/en/brochure_simatic-wincc_en.pdf> [retrieved on 20151014];;31 December 2005 (2005-12-31), XP055220919, Retrieved from the Internet <URL:https://cache.industry.siemens.com/dl/files/430/21401430/att_36978/v1/CFC_For_S7_e.pdf> [retrieved on 20151014];;See also references of EP 3304297A1",PENDING
130,EP,A1,EP 3304297 A1,033-641-912-239-813,2018-04-11,2018,EP 15731163 A,2015-06-04,US 2015/0034127 W,2015-06-04,METHOD AND SYSTEM FOR CLUSTERING ENGINEERING DATA IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,,SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN,SIEMENS AKTIENGESELLSCHAFT (2020-01-08);;SIEMENS INDUSTRY SOFTWARE INC. (2020-01-08),https://lens.org/033-641-912-239-813,Patent Application,yes,3,0,4,4,0,G06F9/465;;G06Q10/06;;G06Q10/06;;G06F16/285;;G06F16/2246;;G06F16/285;;G06F16/2246;;G06Q10/06;;G05B19/058,G06F9/46;;G06Q10/00,,1,0,,,See also references of WO 2016195688A1,DISCONTINUED
131,TW,A,TW 200634987 A,179-408-573-238-325,2006-10-01,2006,TW 95100343 A,2006-01-04,US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/179-408-573-238-325,Patent of Addition,no,0,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/8238;;H01L21/336;;H01L29/78,,0,0,,,,ACTIVE
132,KR,A,KR 20070100787 A,195-635-427-322-617,2007-10-11,2007,KR 20077018012 A,2007-08-03,US 2974005 A,2005-01-04,CMOS TRANSISTOR JUNCTION REGIONS FORMED BY A CVD ETCHING AND DEPOSITION SEQUENCE,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/195-635-427-322-617,Patent Application,no,0,4,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336;;H01L21/205;;H01L21/3065;;H01L29/78,,0,0,,,,DISCONTINUED
133,WO,A3,WO 2006/104529 A3,115-048-702-070-605,2010-09-02,2010,US 2006/0000372 W,2006-01-04,US 2974005 A,2005-01-04,CMOS TRANSISTOR JUNCTION REGIONS FORMED BY A CVD ETCHING AND DEPOSITION SEQUENCE,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP;;MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,MURTHY ANAND;;GLASS GLENN;;WESTMEYER ANDREW;;HATTENDORF MICHAEL;;WANK JEFFREY,,https://lens.org/115-048-702-070-605,Search Report,yes,6,0,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/336,,5,4,064-219-662-969-477;;016-026-113-467-931;;088-935-428-975-009;;064-093-298-723-743,10.1109/.2005.1469197;;10.1016/j.apsusc.2003.08.030;;10.1109/iedm.2004.1419383;;10.1109/essder.2004.1356549,"UENO T ET AL: ""Dramatically enhanced performance of recessed SiGe source-drain pmos by in-situ etch and regrowth technique (InSERT)"", VLSI TECHNOLOGY 2005. DIGEST OF TECHNICAL PAPERS. 2005 SYMPOSIUM ON KYOTO, JAPAN, JUNE 14-16, 2005, 14 June 2005 (2005-06-14), PISCATAWAY, NJ, USA, IEEE, pages 24 - 25, XP010818157, ISBN: 4-900784-00-1;;LOO R ET AL: ""A new technique to fabricate ultra-shallow-junctions, combining in situ vapour HCl etching and in situ doped epitaxial SiGe re-growth"", APPLIED SURFACE SCIENCE, vol. 224, no. 1-4, 15 March 2004 (2004-03-15), ELSEVIER, NETHERLANDS, pages 63 - 67, XP002381356, ISSN: 0169-4332;;KAH WEE ANG ET AL: ""Enhanced performance in 50 nm N-MOSFETs with silicon-carbon source/drain regions"", IEEE INTERNATIONAL ELECTRON DEVICES MEETING, 2004. IEDM TECHNICAL DIGEST. SAN FRANCISCO, CA, USA, DEC. 13-15, 2004, 13 December 2004 (2004-12-13), PISCATAWAY, NJ, USA, IEEE, pages 1069 - 1071, XP010789001, ISBN: 0-7803-8684-1;;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 04 31 May 1995 (1995-05-31);;ZHIKUAN ZHANG ET AL: ""Self-aligned recessed source/drain ultra-thin body SOI MOSFET technology"", PROCEEDING OF THE 34TH EUROPEAN SOLID-STATE DEVICE RESEARCH CONFERENCE, 2004. ESSDERC 2004. LEUVEN, BELGIUM 21-23 SEPT. 2004, 21 September 2004 (2004-09-21), PISCATAWAY, NJ, USA, IEEE, pages 301 - 304, XP010738436, ISBN: 0-7803-8478-4",PENDING
134,AU,B2,AU 713964 B2,003-552-233-509-751,1999-12-16,1999,AU 1996/066244 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,Billing for communications usage,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/003-552-233-509-751,Granted Patent,no,2,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
135,KR,A,KR 20210066866 A,110-495-285-833-378,2021-06-07,2021,KR 20217012357 A,2019-09-26,US 201862736638 P;;US 201962824092 P;;US 2019/0053108 W,2018-09-26,ACSS2를 억제하기 위한 조성물 및 방법,본 발명은 히스톤 아세틸화를 조절하기 위해 ACSS2를 억제하기 위한 또는 신경학적 질환 또는 장애를 치료 또는 예방하기 위한 조성물 및 방법을 제공한다.,UNIV PENNSYLVANIA,BERGER SHELLEY L;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/110-495-285-833-378,Patent Application,no,0,0,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D241/42;;C07D403/12;;C07D409/14,,0,0,,,,PENDING
136,CA,A1,CA 3111627 A1,098-753-955-284-512,2020-04-02,2020,CA 3111627 A,2019-09-26,US 201862736638 P;;US 201962824092 P;;US 2019/0053108 W,2018-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,BERGER SHELLEY L;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/098-753-955-284-512,Patent Application,no,0,0,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61P25/28;;C07D241/44,,0,0,,,,PENDING
137,WO,A1,WO 2014/004227 A1,147-923-685-805-06X,2014-01-03,2014,US 2013/0046673 W,2013-06-20,US 201213533997 A,2012-06-27,INTEGRATING DIAGNOSTIC INFORMATION IN DEVELOPMENT ENVIRONMENT,"Aspects of the subject matter described herein relate to assisting software development. In aspects, a software development environment may display code and information about the code on a user interface. In one example, the information includes diagnostic information about the code. The information may be represented by actionable tags that allow the software developer to drill-down and obtain more detailed information about the code. The information may be automatically obtained by the software development environment in a way that does not interfere with the development activities of the software developer. The actionable tags are displayed in close proximity to code with which they are associated.",MICROSOFT CORP,BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS,,https://lens.org/147-923-685-805-06X,Patent Application,yes,6,0,6,6,0,G06F11/3664;;G06F11/3664,G06F11/36,,0,0,,,,PENDING
138,EP,B1,EP 0840977 B1,176-031-055-766-13X,2004-01-21,2004,EP 96925879 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,BILLING FOR COMMUNICATIONS USAGE,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/176-031-055-766-13X,Granted Patent,yes,2,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,2,0,,,"NOMS 90. IEEE1990 NETWORK OPERATIONS & MANAGEMENT SYMPOSIUM, 11 February 1990 - 1914, SAN DIEGO, CA US, page 1-10 XP000534180 R.L.AVEYARD ET AL.: ""New Billing System Development"";;TENCON '89, 22 - 24 November 1989, BOMBAY, INDIA, pages 593-599, XP000203943 I. BENYACAR ET AL.: ""Concepts in recording of services""",EXPIRED
139,CA,A1,CA 3034840 A1,162-019-742-031-864,2018-03-01,2018,CA 3034840 A,2017-08-22,US 201662379772 P;;US 2017/0048019 W,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,"The present disclosure relates generally to improved room air purifiers and filtration media for use in room air purifiers. In some embodiments, the room air purifiers and media exhibit excellent filtration of cigarette smoke and/or formaldehyde. Some embodiments include a multilayer filtration media, comprising: a fluorinated electret layer; a sorbent layer adjacent to the fluorinated electret layer; and an optional backing layer having a Gurley stiffness of at least about 200 mg; where the backing layer is not present, at least one of the fluorinated electret layer, the sorbent layer, or the combination of the two layers has a Gurley stiffness of at least about 200 mg. In some embodiments, the filtration media is pleated.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/162-019-742-031-864,Patent Application,no,0,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D46/52;;B01D39/16;;B01J20/28;;B32B5/24,,0,0,,,,DISCONTINUED
140,US,A1,US 2023/0044516 A1,162-517-731-560-893,2023-02-09,2023,US 202217855578 A,2022-06-30,US 202217855578 A;;US 202163217672 P,2021-07-01,UNIVERSAL ASSAY CARTRIDGE AND METHODS OF USE,"Sample cartridge, valve assembly and processing methods for providing mechanical lysis, chemical lysis or both for a given fluid sample are provided herein. Such systems can include a sample processing cartridge having a valve assembly configured for transport of the processing of fluid sample within the sample cartridge. The valve assembly can include a valve body and cap that secure a filter therebetween and facilitate inflow of mechanical or chemical lysing agents as needed for a fluid sample. Assay workflows for performing both mechanical and chemical lysis of a fluid sample within the same workflow of a single universal sample cartridge are also provided.",CEPHEID,NANDURI HARIKA;;WEITSMAN ANDREW;;GLASS JENNIFER LYNN;;WEI MICHELLE;;NOYES TINA,CEPHEID (2022-07-21),https://lens.org/162-517-731-560-893,Patent Application,yes,0,1,4,4,0,B01L3/502761;;B01L3/502715;;B01L3/502738;;B01L3/563;;B01L2200/0647;;B01L2200/10;;B01L2300/0681;;B01L2400/0644;;B01L2400/06;;B01L3/502761;;B01L2200/04;;B01L2200/0647;;B01L2200/16;;B01L2300/0654;;B01L2300/0681;;B01L2300/0864;;B01L2400/0487;;B01L2400/0644;;C12Q1/6844,B01L3/00;;C12Q1/6844,,0,0,,,,PENDING
141,CN,A,CN 109641170 A,153-688-913-183-814,2019-04-16,2019,CN 201780052268 A,2017-08-22,US 201662379772 P;;US 2017/0048019 W,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,"The present disclosure relates generally to improved room air purifiers and filtration media for use in room air purifiers. In some embodiments, the room air purifiers and media exhibit excellent filtration of cigarette smoke and/or formaldehyde. Some embodiments include a multilayer filtration media, comprising: a fluorinated electret layer; a sorbent layer adjacent to the fluorinated electret layer; and an optional backing layer having a Gurley stiffness of at least about 200 mg; where the backing layer is not present, at least one of the fluorinated electret layer, the sorbent layer, or thecombination of the two layers has a Gurley stiffness of at least about 200 mg. In some embodiments, the filtration media is pleated.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/153-688-913-183-814,Patent Application,no,5,1,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D46/52;;B01D39/16;;B01J20/28;;B32B5/24,,0,0,,,,ACTIVE
142,US,A1,US 2019/0209954 A1,012-603-659-501-929,2019-07-11,2019,US 201716328401 A,2017-08-22,US 201716328401 A;;US 201662379772 P;;US 2017/0048019 W,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,"The present disclosure relates generally to improved room air purifiers and filtration media for use in room air purifiers. In some embodiments, the room air purifiers and media exhibit excellent filtration of cigarette smoke and/or formaldehyde. Some embodiments include a multilayer filtration media, comprising: a fluorinated electret layer; a sorbent layer adjacent to the fluorinated electret layer; and an optional backing layer having a Gurley stiffness of at least about 200 mg; where the backing layer is not present, at least one of the fluorinated electret layer, the sorbent layer, or the combination of the two layers has a Gurley stiffness of at least about 200 mg. In some embodiments, the filtration media is pleated.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,3M INNOVATIVE PROPERTIES COMPANY (2019-02-18),https://lens.org/012-603-659-501-929,Patent Application,yes,0,3,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D39/16;;B01D46/00;;B01D46/52;;B01D53/04;;B01J20/20;;B01J20/28;;B32B5/02;;B32B5/16;;B32B5/26;;B32B5/30,,0,0,,,,DISCONTINUED
143,AU,A1,AU 2022/300992 A1,035-300-548-697-558,2024-01-18,2024,AU 2022/300992 A,2022-06-30,US 202163217672 P;;US 2022/0035859 W,2021-07-01,UNIVERSAL ASSAY CARTRIDGE AND METHODS OF USE,"Sample cartridge, valve assembly and processing methods for providing mechanical lysis, chemical lysis or both for a given fluid sample are provided herein. Such systems can include a sample processing cartridge having a valve assembly configured for transport of the processing of fluid sample within the sample cartridge. The valve assembly can include a valve body and cap that secure a filter therebetween and facilitate inflow of mechanical or chemical lysing agents as needed for a fluid sample. Assay workflows for performing both mechanical and chemical lysis of a fluid sample within the same workflow of a single universal sample cartridge are also provided.",CEPHEID,NANDURI HARIKA;;WEITSMAN ANDREW;;GLASS JENNIFER;;IBANEZ MICHELLE WEI;;NOYES TINA,,https://lens.org/035-300-548-697-558,Patent Application,no,0,0,4,4,0,B01L3/502761;;B01L3/502715;;B01L3/502738;;B01L3/563;;B01L2200/0647;;B01L2200/10;;B01L2300/0681;;B01L2400/0644;;B01L2400/06;;B01L3/502761;;B01L2200/04;;B01L2200/0647;;B01L2200/16;;B01L2300/0654;;B01L2300/0681;;B01L2300/0864;;B01L2400/0487;;B01L2400/0644;;C12Q1/6844,B01L3/00,,0,0,,,,PENDING
144,EP,A1,EP 0840977 A1,058-420-818-045-033,1998-05-13,1998,EP 96925879 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,BILLING FOR COMMUNICATIONS USAGE,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/058-420-818-045-033,Patent Application,yes,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
145,BR,A,BR 9610027 A,071-484-043-050-630,1999-07-06,1999,BR 9610027 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,Método e aparelho para processar dados para produzir uma conta pelo uso de uma rede de comunicações,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;GLASS WILLIAM GEORGE;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW,,https://lens.org/071-484-043-050-630,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,PENDING
146,US,A,US 5781797 A,069-982-728-780-601,1998-07-14,1998,US 95492092 A,1992-09-30,US 95492092 A,1992-09-30,Method and system for configuring device driver by selecting a plurality of component drivers to be included in the device driver,"A method and system for configuring and executing device drivers in a computer system is provided. In a preferred embodiment, the device drivers comprise a plurality of component drivers. Each component driver performs a function (e.g., disk caching) that may be used in accessing a device. The component drivers of a device driver are ordered from a top layer to a bottom layer. When accessing a device, the top layer component driver of the device driver is first invoked. Each component driver performs its function and invokes the next lower layer component driver. The bottom layer component driver interacts directly with the device. An operating system, preferably, dynamically configures the device drivers at computer system startup. The operating system has a plurality of component drivers that are available to be configured into a device driver. To configure a device driver, the operating system invokes each component driver to determine whether the component driver should be included as a layer in the device drive. If a component driver should be included, the component driver stores a reference to the component driver in a call-down table for the device driver. The call-down table stores the ordering of the component driver layers. When accessing the device, the operating system first invokes the component driver referenced by the top reference in the call-down table. Each component driver in turn invokes the component driver referenced by the next lower reference in the call-down table.",MICROSOFT CORP,CRICK ANDREW P R;;GLASS MIKE;;SHEA THOMAS J;;SHAH SHISHIR,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;ADAPTEC INC (1993-04-01);;MICROSOFT CORPORATION (1998-04-16),https://lens.org/069-982-728-780-601,Granted Patent,yes,32,38,1,1,0,G06F13/102;;G06F13/102,G06F13/10,395/830,7,1,028-769-847-826-465,10.1147/sj.272.0170,"OS/2 help , by EXE, VS, n11, p. 6(1), May 1991.;;Understanding device drivers in operating system/2 , by Mizell, A.M., IBM Systems Journal, vol. 27, No. 2, pp.170 184, 1988.;;Data Compression algorithm for system initialisation Rd 333008, Jan. 1992.;;Granting requests for sample device drivers and descriptions , by Puckett, Dale L., Rainbow, v5, n7, p. 236(14), Feb. 1986.;;Typesetting language standard search heats up , by Bridges Linda, PC Week, v3, n36, p. 158 (2), Sep. 9, 1986.;;New Framework for device support in Berkeley Univ . . . by Torek, C., 1990.;;Microsoft OS/2 Laddr Complaint Device Driver Specification of Version 1.0 for the OS/2 Laddr Device Driver Development Kit; Copyright 1990 1991; pp. 1 105.",EXPIRED
147,CA,C,CA 2227914 C,024-308-513-185-170,2001-03-20,2001,CA 2227914 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,BILLING FOR COMMUNICATIONS USAGE,"Aspects of the invention provide a method and apparatus for producing a bill for usage of a telecommunications network. The method comprises the steps of : obtaining from the telecommunications network a set of events on the network ; providing a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network; selecting from the set of schemas, schemas applicable to the products used by the user ; and applying the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM,ALLISON DAVID STEPHEN;;GLASS WILLIAM GEORGE;;MAIRS ANDREW;;HAWTHORNE DAVID MARTIN,,https://lens.org/024-308-513-185-170,Granted Patent,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
148,MX,A,MX 9800742 A,072-164-231-784-547,1998-11-29,1998,MX 9800742 A,1998-01-26,EP 95305312 A,1995-07-27,BILLING FOR COMMUNICATIONS USAGE.,"Aspects of the invention provide a method and apparatus for producing a bill for usage of a telecommunications network. The method comprises the steps of: obtaining from the telecommunications network a set of events on the network; providing a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network; selecting from the set of schemas, schemas applicable to the products used by the user; and applying the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM;;COMPANY,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/072-164-231-784-547,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,PENDING
149,US,B1,US 10564719 B1,109-896-650-090-755,2020-02-18,2020,US 201816207936 A,2018-12-03,US 201816207936 A,2018-12-03,Augmenting the functionality of user input devices using a digital glove,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO;;BERGER ROY H,MICROSOFT TECHNOLOGY LICENSING LLC (2018-11-30),https://lens.org/109-896-650-090-755,Granted Patent,yes,26,4,2,2,0,G06F3/014;;G06F3/014;;G06F3/013;;G06F3/013;;G06F3/016;;G06F3/017;;G06F3/04847,G06F3/01;;G06F3/0484,,3,0,,,"“Non Final Office Action Issued in U.S. Appl. No. 16/207,973”, dated Nov. 4, 2019, 13 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,794”, dated Dec. 19, 2019, 24 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 16/207,840”, dated Dec. 12, 2019, 14 Pages.",ACTIVE
150,NZ,A,NZ 313717 A,093-665-272-914-245,1999-11-29,1999,NZ 31371796 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,Billing for communications usage,"Aspects of the application provide a method and apparatus for producing a bill for usage of a telecommunications network. The method comprises the steps of: obtaining from the telecommunications network a set of events on the network; providing a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network; selecting from the set of schemas, schemas applicable to the products used by the user; and applying the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/093-665-272-914-245,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,PENDING
151,EP,A4,EP 3503992 A4,005-300-293-563-372,2020-01-22,2020,EP 17844282 A,2017-08-22,US 201662379772 P;;US 2017/0048019 W,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,,3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/005-300-293-563-372,Search Report,no,2,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D46/52;;B01D39/16;;B01J20/28;;B32B5/24,,1,0,,,See also references of WO 2018039231A1,DISCONTINUED
152,US,A1,US 2022/0117958 A1,081-723-992-672-923,2022-04-21,2022,US 201917277759 A,2019-09-26,US 201917277759 A;;US 201862736638 P;;US 201962824092 P;;US 2019/0053108 W,2018-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,BERGER SHELLEY L;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/081-723-992-672-923,Patent Application,yes,0,0,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61P25/30,,0,0,,,,PENDING
153,WO,A1,WO 2020/117539 A1,112-913-096-597-515,2020-06-11,2020,US 2019/0063128 W,2019-11-26,US 201816207936 A,2018-12-03,AUGMENTING THE FUNCTIONALITY OF USER INPUT DEVICES USING A DIGITAL GLOVE,"The disclosed technologies address various technical problems, including improving human-computer interaction, by augmenting the functionality provided by user input devices using a digital glove. For example, a digital glove can be utilized to provide pressure sensitivity for non-pressure sensitive touchscreen devices, attribute input made with a digital pen to a user wearing the digital glove, augment the functionality provided by mice and other types of handheld user input devices, augment the functionality provided gaze tracking systems, improve camera-based motion tracking systems, and to augment the functionality provided by speech recognition systems.",MICROSOFT TECHNOLOGY LICENSING LLC,KLEIN CHRISTIAN;;GLASS ANDREW STUART;;YOON SANG HO;;BERGER ROY H,,https://lens.org/112-913-096-597-515,Patent Application,yes,2,0,2,2,0,G06F3/014;;G06F3/014;;G06F3/013;;G06F3/013;;G06F3/016;;G06F3/017;;G06F3/04847,G06F3/01;;G06F3/041,,0,0,,,,PENDING
154,EP,A4,EP 3856184 A4,124-795-371-049-013,2022-07-20,2022,EP 19864249 A,2019-09-26,US 201862736638 P;;US 201962824092 P;;US 2019/0053108 W,2018-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,,UNIV PENNSYLVANIA,BERGER SHELLEY L;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/124-795-371-049-013,Search Report,no,0,0,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/30;;A61P25/32;;A61P25/36;;C07D241/42;;C07D241/44;;C07D403/12;;C07D409/04;;C07D409/14,,9,8,127-959-283-812-039;;045-305-629-051-076;;070-629-306-038-763;;066-876-586-426-376;;051-638-279-657-360;;011-804-423-418-066;;054-769-772-071-784;;126-904-001-744-791,pmc5505514;;10.1038/nature22405;;28562591;;10.1111/acer.13748;;10.1007/s00702-017-1737-4;;28550509;;10.1007/s10571-017-0464-6;;28097489;;10.1371/journal.pone.0181892;;pmc5513537;;28715509;;10.1007/s12031-014-0317-4;;24829091;;pmc3063321;;21376584;;10.1016/j.bmcl.2011.02.055;;pmc3303926;;10.1016/j.bmc.2012.02.022;;22386982,"PHILIPP MEWS ET AL: ""Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory"", NATURE, vol. 546, no. 7658, 31 May 2017 (2017-05-31), London, pages 381 - 386, XP055586593, ISSN: 0028-0836, DOI: 10.1038/nature22405;;""Abstracts-Speakers"", ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 42, 31 May 2018 (2018-05-31), pages 271A - 340A, XP071479719, ISSN: 0145-6008, DOI: 10.1111/ACER.13748;;RIBEIRO ANDREA FROZINO ET AL: ""Possible involvement of ACSS2 gene in alcoholism"", JOURNAL OF NEURAL TRANSMISSION, SPRINGER VIENNA, VIENNA, vol. 124, no. 9, 26 May 2017 (2017-05-26), pages 1151 - 1158, XP036302290, ISSN: 0300-9564, [retrieved on 20170526], DOI: 10.1007/S00702-017-1737-4;;SIDDIQUI SARFRAJ AHMAD ET AL: ""Enhanced Histone Acetylation in the Infralimbic Prefrontal Cortex is Associated with Fear Extinction"", CELLULAR AND MOLECULAR NEUROBIOLOGY, SPRINGER NEW YORK, US, vol. 37, no. 7, 17 January 2017 (2017-01-17), pages 1287 - 1301, XP036313574, ISSN: 0272-4340, [retrieved on 20170117], DOI: 10.1007/S10571-017-0464-6;;STEPHANIE A. MADDOX ET AL: ""A Naturally-Occurring Histone Acetyltransferase Inhibitor Derived from Garcinia indica Impairs Newly Acquired and Reactivated Fear Memories"", PLOS ONE, vol. 8, no. 1, 21 January 2013 (2013-01-21), pages e54463, XP055227382, DOI: 10.1371/journal.pone.0054463;;WANG YUNPENG ET AL: ""Inhibition of Histone Deacetylase in the Basolateral Amygdala Facilitates Morphine Context-Associated Memory Formation in Rats"", JOURNAL OF MOLECULAR NEUROSCIENCE, BIRKHAEUSER, CAMBRIDGE, MA, US, vol. 55, no. 1, 15 May 2014 (2014-05-15), pages 269 - 278, XP035425956, ISSN: 0895-8696, [retrieved on 20140515], DOI: 10.1007/S12031-014-0317-4;;QIANYI CHEN ET AL: ""2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: A structureactivity relationship study"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 7, 14 February 2011 (2011-02-14), pages 1929 - 1932, XP028162307, ISSN: 0960-894X, [retrieved on 20110217], DOI: 10.1016/J.BMCL.2011.02.055;;RAJKUMAR RAJULE ET AL: ""Perturbing pro-survival proteins using quinoxaline derivatives: A structure–activity relationship study"", BIOORGANIC, vol. 20, no. 7, 1 April 2012 (2012-04-01), AMSTERDAM, NL, pages 2227 - 2234, XP055616084, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2012.02.022;;See also references of WO 2020069093A1",PENDING
155,CA,A1,CA 3224143 A1,152-911-575-298-901,2023-01-05,2023,CA 3224143 A,2022-06-30,US 202163217672 P;;US 2022/0035859 W,2021-07-01,UNIVERSAL ASSAY CARTRIDGE AND METHODS OF USE,"Sample cartridge, valve assembly and processing methods for providing mechanical lysis, chemical lysis or both for a given fluid sample are provided herein. Such systems can include a sample processing cartridge having a valve assembly configured for transport of the processing of fluid sample within the sample cartridge. The valve assembly can include a valve body and cap that secure a filter therebetween and facilitate inflow of mechanical or chemical lysing agents as needed for a fluid sample. Assay workflows for performing both mechanical and chemical lysis of a fluid sample within the same workflow of a single universal sample cartridge are also provided.",CEPHEID,NANDURI HARIKA;;WEITSMAN ANDREW;;GLASS JENNIFER;;IBANEZ MICHELLE WEI;;NOYES TINA,,https://lens.org/152-911-575-298-901,Patent Application,no,0,0,4,4,0,B01L3/502761;;B01L3/502715;;B01L3/502738;;B01L3/563;;B01L2200/0647;;B01L2200/10;;B01L2300/0681;;B01L2400/0644;;B01L2400/06;;B01L3/502761;;B01L2200/04;;B01L2200/0647;;B01L2200/16;;B01L2300/0654;;B01L2300/0681;;B01L2300/0864;;B01L2400/0487;;B01L2400/0644;;C12Q1/6844,,,0,0,,,,PENDING
156,US,A1,US 2014/0007049 A1,179-208-357-023-518,2014-01-02,2014,US 201213533997 A,2012-06-27,US 201213533997 A,2012-06-27,INTEGRATING DIAGNOSTIC INFORMATION IN DEVELOPMENT ENVIRONMENT,"Aspects of the subject matter described herein relate to assisting software development. In aspects, a software development environment may display code and information about the code on a user interface. In one example, the information includes diagnostic information about the code. The information may be represented by actionable tags that allow the software developer to drill-down and obtain more detailed information about the code. The information may be automatically obtained by the software development environment in a way that does not interfere with the development activities of the software developer. The actionable tags are displayed in close proximity to code with which they are associated.",BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS;;MICROSOFT CORP,BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-22),https://lens.org/179-208-357-023-518,Patent Application,yes,26,1,6,6,0,G06F11/3664;;G06F11/3664,G06F9/44,717/113,0,0,,,,ACTIVE
157,EP,A1,EP 2867775 A1,016-736-266-677-477,2015-05-06,2015,EP 13734579 A,2013-06-20,US 201213533997 A;;US 2013/0046673 W,2012-06-27,INTEGRATING DIAGNOSTIC INFORMATION IN DEVELOPMENT ENVIRONMENT,,MICROSOFT TECHNOLOGY LICENSING LLC,BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS,,https://lens.org/016-736-266-677-477,Patent Application,yes,0,0,6,6,0,G06F11/3664;;G06F11/3664,G06F11/36,,0,0,,,,DISCONTINUED
158,EP,A1,EP 3503992 A1,057-932-813-646-203,2019-07-03,2019,EP 17844282 A,2017-08-22,US 201662379772 P;;US 2017/0048019 W,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,,3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/057-932-813-646-203,Patent Application,yes,0,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D46/52;;B01D39/16;;B01J20/28;;B32B5/24,,0,0,,,,DISCONTINUED
159,CN,A,CN 104428757 A,035-065-275-266-893,2015-03-18,2015,CN 201380034213 A,2013-06-20,US 2013/0046673 W;;US 201213533997 A,2012-06-27,Integrating diagnostic information in development environment,"Aspects of the subject matter described herein relate to assisting software development. In aspects, a software development environment may display code and information about the code on a user interface. In one example, the information includes diagnostic information about the code. The information may be represented by actionable tags that allow the software developer to drill-down and obtain more detailed information about the code. The information may be automatically obtained by the software development environment in a way that does not interfere with the development activities of the software developer. The actionable tags are displayed in close proximity to code with which they are associated.",MICROSOFT CORP,BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS,,https://lens.org/035-065-275-266-893,Patent Application,no,7,0,6,6,0,G06F11/3664;;G06F11/3664,G06F11/36,,1,0,,,"TAKESHI NISHIDA: ""“vim-scripts/AutoComplPop”"", 《HTTPS://GITHUB.COM/VIM-SCRIPTS/AUTOCOMPLPOP》",ACTIVE
160,NO,D0,NO 980329 D0,083-400-808-153-08X,1998-01-26,1998,NO 980329 A,1998-01-26,EP 95305312 A;;GB 9601836 W,1995-07-27,Debitering av kommunikasjonsbruk,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/083-400-808-153-08X,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,PENDING
161,EP,A1,EP 3856184 A1,144-508-705-251-109,2021-08-04,2021,EP 19864249 A,2019-09-26,US 201862736638 P;;US 201962824092 P;;US 2019/0053108 W,2018-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,,UNIV PENNSYLVANIA,BERGER SHELLEY L;;MEWS PHILIPP;;WINKLER JEFFREY;;GLASS ANDREW;;EGERVARI GABOR,,https://lens.org/144-508-705-251-109,Patent Application,yes,0,0,6,6,0,A61K31/498;;A61P25/28;;C07D409/04;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/00;;A61P25/22;;A61P25/24;;A61P25/30;;A61P25/32;;A61P25/36;;A61K31/498;;A61K31/5377;;A61P25/00;;A61P25/28;;A61P25/32;;A61P25/36;;C07D409/14;;C07D241/42;;C07D403/12;;A61P25/30;;A61K31/498,A61K31/498;;A61P25/28;;C07D241/44,,0,0,,,,PENDING
162,AU,A,AU 1996/066244 A,169-391-605-678-923,1997-02-26,1997,AU 1996/066244 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,Billing for communications usage,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/169-391-605-678-923,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
163,KR,A,KR 20190040275 A,177-174-413-743-339,2019-04-17,2019,KR 20197007891 A,2017-08-22,US 201662379772 P;;US 2017/0048019 W,2016-08-26,개선된 실내 공기 청정기 및 여과 매체,"본 발명은 일반적으로 개선된 실내 공기 청정기 및 실내 공기 청정기에 사용하기 위한 여과 매체에 관한 것이다. 몇몇 실시예에서, 실내 공기 청정기 및 매체는 담배 연기 및/또는 포름알데히드의 우수한 여과를 나타낸다. 몇몇 실시예는 다층 여과 매체를 포함하며, 이 다층 여과 매체는 플루오르화 일렉트릿 층; 플루오르화 일렉트릿 층에 인접한 수착제 층; 및 약 200 mg 이상의 걸리 강성(Gurley stiffness)을 갖는 선택적인 배킹 층을 포함하며; 배킹 층이 존재하지 않는 경우에, 플루오르화 일렉트릿 층, 수착제 층 또는 이들 2개의 층의 조합 중 적어도 하나가 약 200 mg 이상의 걸리 강성을 갖는다. 몇몇 실시예에서, 여과 매체는 주름형성된다.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/177-174-413-743-339,Patent Application,no,0,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D39/16;;B01J20/20;;B01J20/28;;B32B5/24;;F24F3/16,,0,0,,,,PENDING
164,WO,A1,WO 1997/005734 A1,027-995-232-792-923,1997-02-13,1997,GB 9601836 W,1996-07-29,EP 95305312 A,1995-07-27,BILLING FOR COMMUNICATIONS USAGE,"Aspects of the invention provide a method and apparatus for producing a bill for usage of a telecommunications network. The method comprises the steps of: obtaining from the telecommunications network a set of events on the network; providing a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network; selecting from the set of schemas, schemas applicable to the products used by the user; and applying the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM;;ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/027-995-232-792-923,Patent Application,yes,2,6,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,2,0,,,"R.L.AVEYARD ET AL.: ""New Billing System Development"", NOMS 90. IEEE1990 NETWORK OPERATIONS & MANAGEMENT SYMPOSIUM, 11 February 1990 (1990-02-11) - 1914, SAN DIEGO, CA US, pages 1-10, XP000534180;;I. BENYACAR ET AL.: ""Concepts in recording of services"", TENCON '89, 22 November 1989 (1989-11-22) - 24 November 1989 (1989-11-24), BOMBAY, INDIA, pages 593 - 599, XP000203943",PATENTED
165,US,A,US 6052450 A,071-237-997-180-016,2000-04-18,2000,US 27198 A,1998-01-27,EP 95305312 A;;GB 9601836 W,1995-07-27,Billing for communications usage,"A method and apparatus produce a bill for usage of a telecommunications network. The system obtains from the telecommunications network a set of events on the network; provides a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network, selects from the set of schemas, schemas applicable to the products used by the user; and applies the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY (1998-01-07),https://lens.org/071-237-997-180-016,Granted Patent,yes,4,40,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,379/127;;379/112,2,0,,,"NOMS 90. IEEE 1990 Network Operations & Management Symposium, Feb. 11, 1990 1914, San Diego, CA US., p. 1 10 XP000534180 R.L.Aveyard et al.: New Billing System Development see p. 9 p. 10.;;Tencon 89 Nov. 22 24, 1989, Bombay, India, pp. 593 599, XP000203943 I. Benyacar et al.: Concepts in recording of services see the whole document.",EXPIRED
166,TW,A,TW 201811416 A,091-294-693-341-753,2018-04-01,2018,TW 106128969 A,2017-08-25,US 201662379772 P,2016-08-26,Improved room air purifiers and filtration media,"The present disclosure relates generally to improved room air purifiers and filtration media for use in room air purifiers. In some embodiments, the room air purifiers and media exhibit excellent filtration of cigarette smoke and/or formaldehyde. Some embodiments include a multilayer filtration media, comprising: a fluorinated electret layer; a sorbent layer adjacent to the fluorinated electret layer; and an optional backing layer having a Gurley stiffness of at least about 200 mg; where the backing layer is not present, at least one of the fluorinated electret layer, the sorbent layer, or the combination of the two layers has a Gurley stiffness of at least about 200 mg. In some embodiments, the filtration media is pleated.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW ROBERT;;GERHARDT BRYAN LEE;;JASUJA HIMANSHU;;GLASS DENNIS MICHAEL,,https://lens.org/091-294-693-341-753,Patent of Addition,no,0,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D39/08;;B03C3/34,,0,0,,,,ACTIVE
167,NO,L,NO 980329 L,101-035-210-289-060,1998-03-26,1998,NO 980329 A,1998-01-26,EP 95305312 A;;GB 9601836 W,1995-07-27,Debitering av kommunikasjonsbruk,,BRITISH TELECOMM,ALLISON DAVID STEPHEN;;HAWTHORNE DAVID MARTIN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/101-035-210-289-060,Abstract,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,PENDING
168,TW,B,TW I781955 B,138-673-277-581-68X,2022-11-01,2022,TW 106128969 A,2017-08-25,US 201662379772 P,2016-08-26,Improved room air purifiers and filtration media,,3M INNOVATIVE PROPERTIES COMPANY,FOX ANDREW ROBERT;;GERHARDT BRYAN LEE;;JASUJA HIMANSHU;;GLASS DENNIS MICHAEL,,https://lens.org/138-673-277-581-68X,Granted Patent,no,11,0,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,,,0,0,,,,ACTIVE
169,US,B2,US 9069899 B2,142-156-209-876-362,2015-06-30,2015,US 201213533997 A,2012-06-27,US 201213533997 A,2012-06-27,Integrating diagnostic information in development environment,"Aspects of the subject matter described herein relate to assisting software development. In aspects, a software development environment may display code and information about the code on a user interface. In one example, the information includes diagnostic information about the code. The information may be represented by actionable tags that allow the software developer to drill-down and obtain more detailed information about the code. The information may be automatically obtained by the software development environment in a way that does not interfere with the development activities of the software developer. The actionable tags are displayed in close proximity to code with which they are associated.",BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS;;MICROSOFT TECHNOLOGY LICENSING LLC,BRAGDON ANDREW C;;JONES GARETH;;GROVES MARK A;;TREWIN TRACEY GLASS,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-22),https://lens.org/142-156-209-876-362,Granted Patent,yes,36,2,6,6,0,G06F11/3664;;G06F11/3664,G06F15/177;;G06F3/00;;G06F3/048;;G06F9/44;;G06F9/45;;G06F9/46;;G06F11/36;;G06F17/00;;G06F17/24,,5,1,047-424-374-776-191,10.1145/1240624.1240823,"""NDepend-Analysis Report"", Retrieved at >, Feb. 1, 2012, pp. 1-3.;;""Coverity Static Analysis"", Retrieved at >, Retrieved Date: Apr. 12, 2012, pp. 1-3.;;Biehl, et al., ""FASTDash: A Visual Dashboard for Fostering Awareness in Software Teams"", Retrieved at >, Proceedings of the SIGCHI conference on Human factors in computing systems, Apr. 28, 2007, pp. 1313-1322.;;D'Souza, et al., ""Tool Evaluation Report: Fortify"", Retrieved at >, Apr. 24, 2007, pp. 1-10.;;PCT International Search Report and Written Opinion for Application No. PCT/US2013/046673, European Patent Office, P.B. 5818 Patentlaan 2, NL-2280 HV Rijswijk, Mailed: Oct. 16, 2013, 10 pages.",ACTIVE
170,WO,A1,WO 2018/039231 A1,122-584-573-706-090,2018-03-01,2018,US 2017/0048019 W,2017-08-22,US 201662379772 P,2016-08-26,IMPROVED ROOM AIR PURIFIERS AND FILTRATION MEDIA,"The present disclosure relates generally to improved room air purifiers and filtration media for use in room air purifiers. In some embodiments, the room air purifiers and media exhibit excellent filtration of cigarette smoke and/or formaldehyde. Some embodiments include a multilayer filtration media, comprising: a fluorinated electret layer; a sorbent layer adjacent to the fluorinated electret layer; and an optional backing layer having a Gurley stiffness of at least about 200 mg; where the backing layer is not present, at least one of the fluorinated electret layer, the sorbent layer, or the combination of the two layers has a Gurley stiffness of at least about 200 mg. In some embodiments, the filtration media is pleated.",3M INNOVATIVE PROPERTIES CO,FOX ANDREW R;;JASUJA HIMANSHU;;GERHARDT BRYAN L;;GLASS DENNIS M,,https://lens.org/122-584-573-706-090,Patent Application,yes,3,4,10,10,0,B32B5/24;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D39/1623;;B01D2239/0407;;B01D2239/0435;;B01D2239/065;;B01D2239/0654;;B01J20/28016;;B01J20/2803;;B01D39/163;;B01D2239/0622;;B01J20/20;;B01J20/28035;;B01J20/28052;;B32B5/24;;B01D2239/0435;;F24F8/10;;B01D39/163;;B01J20/28016;;B01J20/2803;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B32B5/022;;B32B5/16;;B32B5/30;;B01D2239/0654;;B01D2239/0407;;B01D2239/0622;;B01D2239/0464;;B01D2239/0618;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724;;B01J20/20;;B01J20/28035;;B01J20/28052;;B01D2239/0407;;B01D2239/0435;;B01D2239/0654;;B32B5/24;;B01D39/1623;;B01D2239/065;;B01D39/163;;B01D46/0032;;B01D46/0036;;B01D46/521;;B01D53/04;;B01D2239/0464;;B01D2239/0618;;B01D2239/0622;;B01D2239/0627;;B01D2239/1216;;B01D2239/1258;;B01D2239/1275;;B01D2253/102;;B01D2257/708;;B01D2259/4508;;B01D2275/10;;B01D2279/50;;B01J20/28016;;B01J20/2803;;B32B5/022;;B32B5/16;;B32B5/26;;B32B5/30;;B32B2250/03;;B32B2260/025;;B32B2262/0215;;B32B2262/0253;;B32B2264/108;;B32B2307/724,B01D46/52;;B01D39/16;;B01J20/28;;B32B5/24,,1,0,,,See also references of EP 3503992A4,PENDING
171,CA,A1,CA 2227914 A1,174-212-340-394-283,1997-02-13,1997,CA 2227914 A,1996-07-29,EP 95305312 A;;GB 9601836 W,1995-07-27,BILLING FOR COMMUNICATIONS USAGE,"Aspects of the invention provide a method and apparatus for producing a bill for usage of a telecommunications network. The method comprises the steps of: obtaining from the telecommunications network a set of events on the network; providing a set of schema applicable to a set of products available to the user, the schema for processing events retrieved from the network; selecting from the set of schemas, schemas applicable to the products used by the user; and applying the selected schemas to the set of events to process the events into a form ready for bill production.",BRITISH TELECOMM,HAWTHORNE DAVID MARTIN;;ALLISON DAVID STEPHEN;;MAIRS ANDREW;;GLASS WILLIAM GEORGE,,https://lens.org/174-212-340-394-283,Patent Application,no,0,0,18,18,0,H04M15/00;;H04M15/41;;H04M15/44;;H04M2215/0104;;H04M2215/0164;;H04Q3/0029;;H04Q2213/1313;;H04M15/00;;H04M15/44;;H04M15/41;;H04Q3/0029;;H04M15/00;;H04M2215/0104;;H04M2215/0164;;H04Q2213/1313,H04M15/00;;H04Q3/00,,0,0,,,,EXPIRED
172,WO,A2,WO 2008/036653 A2,004-290-878-637-944,2008-03-27,2008,US 2007/0078759 W,2007-09-18,US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/004-290-878-637-944,Patent Application,yes,3,175,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,1,0,,,"EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 17, no. 6, 1982, pages 577 - 580",PENDING
173,TW,A,TW 200819445 A,158-868-356-756-105,2008-05-01,2008,TW 96135025 A,2007-09-19,US 84571106 P,2006-09-19,"N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/158-868-356-756-105,Patent of Addition,no,0,0,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,C07D413/02;;A61K31/42;;A61K31/496;;A61K31/5377;;A61P37/06;;C07D261/12,,0,0,,,,PENDING
174,EP,A2,EP 2064207 A2,039-014-305-734-527,2009-06-03,2009,EP 07814905 A,2007-09-18,US 2007/0078745 W;;US 84570006 P,2006-09-19,"N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase",,INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,"INCYTE HOLDINGS CORPORATION (2018-01-16);;INCYTE HOLDINGS CORPORATION, US (2016-09-27);;INCYTE HOLDINGS CORPORATION, WILMINGTON, US (2016-02-24)",https://lens.org/039-014-305-734-527,Patent Application,yes,0,0,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,0,0,,,,ACTIVE
175,AU,A1,AU 2020/250026 A1,117-560-861-692-378,2021-09-23,2021,AU 2020/250026 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/117-560-861-692-378,Patent Application,no,0,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,0,0,,,,ACTIVE
176,ES,T3,ES 2444574 T3,132-222-051-689-419,2014-02-25,2014,ES 07814905 T,2007-09-18,US 84570006 P;;US 2007/0078745 W,2006-09-19,"N-hidroxiamidinoheterociclos como moduladores de la indolamina 2,3-dioxigenasa","Compuesto de Fórmula III: **Fórmula** o sal del mismo farmacéuticamente aceptable, en la que: Q es fenilo opcionalmente sustituido por 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, CN, NO2, ORa4, SRa4, C(O)Rb4, C(O)NRc4Rd4, C(O)ORa4, OC(O)Rb4, OC(O)NRc4Rd4, NRc4Rd4, NRc4C(O)Rb4, NRc4C(O)NRc4Rd4, NRc4C(O)ORa4, S(O)Rb4, S(O)NRc4Rd4, S(O)2Rb4, NRc4S(O)2Rb4 y S(O)2NRc4Rd4; o Q es alquilo C1-6 sustituido por fenilo, en el que dicho fenilo está sustituido por alquilo C1-4; R2 es halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, pentahalosulfanilo, Cy3, CN, NO2, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(>=NRi3)NRc3Rd3, NRc3C(>=NRi3)NRc3Rd3, P(Rf3)2, P(ORe3)2, P(O)Re3Rf3, P(O)ORe3ORf3, S(O)Rb3, S(O)NRc3Rd3, S(O)2R23, NRc3S(O)2Rb3 o S(O)2NRc3Rd3; en la que dicho alquilo C1-10, alquenilo C2-10 o alquinilo C2-10 está opcionalmente sustituido con 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-10, hidroxialquilo C1-10, cianoalquilo C1-10, pentahalosulfanilo, Cy3, CN, NO2, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(>=NRi3)NRc3Rd3, NRc3C(>=NRi3)NRc3Rd3, P(Rf3)2, P(ORe3)2, P(O)Re3Rf3, P(O)ORe3ORf3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3 y S(O)2NRc3Rd3; R3 está seleccionado de entre H, halo, alquilo C1-4, alquenilo C2-6 y alquinilo C2-6; R5 es H; Ra3 y Ra4 están seleccionados independientemente de entre H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-(alquilo C1-6)-, en los que dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(>=NRi5)NRc5Rd5, NRc5C(>=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5; R63 y Rb4 están seleccionados independientemente de entre H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-(alquilo C1-6)-, en los que dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(>=NRi5)NRc5Rd5, NRc5C(>=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5; Rc3 y Rc4 están seleccionados independientemente de entre H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-(alquilo C1-6)-, en los que dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(>=NRi5)NRc5Rd5, NRc5C(>=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re4Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5; Rd3 y Rd4 están seleccionados independientemente de entre H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-(alquilo C1-6)-, en los que dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6, está opcionalmente sustituido con 1, 2, 3, 4 ó 5 sustituyentes seleccionados independientemente de entre halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(>=NRi)NRc5Rd5, NRc5C(>=NRi)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/132-222-051-689-419,Granted Patent,no,0,0,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,0,0,,,,ACTIVE
177,CN,A,CN 113614090 A,154-258-394-430-25X,2021-11-05,2021,CN 202080022154 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/154-258-394-430-25X,Patent Application,no,0,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,0,0,,,,PENDING
178,EP,A1,EP 3947392 A1,154-987-970-509-733,2022-02-09,2022,EP 20717312 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF",,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/154-987-970-509-733,Patent Application,yes,0,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,0,0,,,,ACTIVE
179,ES,T3,ES 2704641 T3,167-501-602-730-943,2019-03-19,2019,ES 07842681 T,2007-09-18,US 84571106 P;;US 2007/0078759 W,2006-09-19,"Compuestos N-hidroxiamidinoheterocíclicos como moduladores de la indoleamina 2,3-dioxigenasa","Un compuesto de Fórmula III: **Fórmula** o una sal farmacéuticamente aceptable del mismo, en el que: Q es arilo opcionalmente sustituido por 1, 2, 3, 4, o 5 sustituyentes seleccionados independientemente de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, y4, - (alquilo C1-4 )-Cy4, CN, N02, ORa4, -(alquilo C1-4 )-ORa4, SRa4, -(alquilo C1-4 )-SRa4, C(O)Rb4, -(alquilo C1-4 )- C(O)Rb4, C(O)NRc4Rd4, -(alquilo C1-4 )-C(O)NRc4Rd4, C(O)ORa4, -( alquilo C1-4 )-C(O)ORa4, OC(O)Rb4, -(alquilo C1-4 )-OC(O)Rb4, OC(O)NRc4Rd4, -(alquilo C1-4 )-OC(O)NRc4Rd4, NRc4Rd4, NRc4C(O)Rb4, -(alquilo C1-4 )- NRc4CORb4, NRc4C(O)NRc4Rd4, -(alquilo C1-4 )-NRc4C(O)NRc4Rd4, NRc4C(O)ORa4, -(alquilo C1-4 )- NRc4C(O)ORa4, C(=NRi4)NRc4Rd4, NRc4C(=NRi4)NRc4Rd4, P(Rf4)2, S(O)Rb4, -(alquilo C1-4)-S(O)Rb4, S(O)NRc4Rd4, -(alquilo C1-4 )-S(O)NRc4Rd4, S(O)2Rb4, -(alquilo C1-4 )-S(O)2Rb4, NRc4S(O)2Rb4, -(alquilo C1-4 )- NRc4S(O)2Rb4, S(O)2NRc4Rd4, and -( alquilo C1-4 )-S(O)2NRc4Rd4; o Q es alquilo C1-6 opcionalmente sustituido por 1, 2, 3, 4, o 5 sustituyentes seleccionados independientemente de halo, 6alquilo C1-, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, pentahalosulfanilo, Cy4, -(alquilo C1-4 )-Cy4, CN, N02, ORa4, -(alquilo C1-4 )-ORa4, SRa4,-(alquilo C1-4)-SRa4, C(O)kb4, -(alquilo C1-4 )-C(O)Rb4, C(O)NRc4Rd4, -(alquilo C1-4 )-C(O)NRc4Rd4, C(O)ORa4, -(alquilo C1-4 )- C(O)ORa4, OC(O)Rb4, -(alquilo C1-4)-OC(O)Rb4, OC(O)NRc4Rd4, -(alquilo C1-4 )-OC(O)NRc4Rd4, NRc4Rd4, NRc4C(O)Rb4, -(alquilo C1-4 )-NRc4CORb4, NRc4C(O)NRc4Rd4,-(C1-4alquilo)-NRc4C(O)NRc4Rd4, NRc4C(O)ORa4, - (alquilo C1-4 )-NRc4C(O)ORa4, C(=NRi4)NRc4Rd4, NRc4C(=NRi4)NRc4Rd4, P(Rf4)2, S(O)Rb4, -(C1-4alquilo)- S(O)Rb4, S(O)NRc4Rd4, -(alquilo C1-4 )-S(O)NRc4Rd4, S(O)2Rb4, -(alquilo C1-4)-S(O)2Rb4, NRc4S(O)2Rb4, -(alquilo C1-4 )-NRc4S(O)2Rb4, S(O)2NRc4Rd4, and -(alquilo C1-4 )-S(O)2NRc4Rd4; R2 es halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, pentahalosulfanilo, Cy3, CN, NO2, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(=NRi3)NRc3Rd3, NRc3C(=NRi3)NRc3Rd3, P(Rf3)2, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3, o S(O)2NRc3Rd3; en donde dicho alquilo C1-10, alquenilo C2-10, o alquinilo C2-10, está opcionalmente sustituido por 1, 2, 3, 4, o 5 sustituyentes seleccionados independientemente de halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-10, hidroxialquilo C1-10, cianoalquilo C1-10, pentahalosulfanilo, Cy3, CN, N02, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(=NRi3)NRc3Rd3, NRc3C(=NRi3)NRc3Rd3, P(Rf3)2, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3, y S(O)2NRc3Rd3; R4 se selecciona de H, halo, alquilo C1-4, alquenilo C2-6 y 6alquinilo C2-; R5 es H, C(O)R6, C(O)OR7 o C(O)NR8NR9; R6 y R7 se seleccionan independientemente de H, alquilo C1-8, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, arilalquilo, heteroarilalquilo, cicloalquilalquilo y heterocicloalquilalquilo, cada uno opcionalmente sustituido por 1, 2, 3 sustituyentes seleccionados independientemente de halo, CN, NO2, OH, alcoxi C1-4, haloalcoxi C1-4, amino, alquilamino C1-4, dialquilamino C2-8, alquilo C1-6, alquenilo C2-6 y alquinilo C2-6; R8 y R9 se seleccionan independientemente de H, alquilo C1-8, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, arilalquilo, heteroarilalquilo, cicloalquilalquilo y heterocicloalquilalquilo, cada uno opcionalmente sustituido por 1, 2, o 3 sustituyentes seleccionados independientemente de halo, CN, NO2, OH, alcoxi C1-4, haloalcoxi C1-4, amino, alquilamino C1-4, dialquilamino C2-8, alquilo C1-6, alquenilo C2-6 y alquinilo C2-6; o R2 y R4 junto con los átomos a los que están unidos forman un arilo, cicloalquilo, heteroarilo o anillo de heterocicloalquilo de 4-20 miembros, en donde dicho arilo, cicloalquilo, heteroarilo o anillo de heterocicloalquilo de 4-20 miembros está opcionalmente sustituido por 1, 2, 3, 4, o 5 sustituyentes seleccionados independientemente de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy2, CN, N02, ORa2, SRa2, C(O)Rb2, C(O)NRc2Rd2, C(O)ORa2, OC(O)Rb2, OC(O)NRc2Rd2, NRc2Rd2, NRc2C(O)Rb2, NRc2C(O)NRc2Rc2, NRc2C(O)ORa2, C(=NRi2)NRc2Rd2, NRc2C(=NRi2)NRc2Rd2, P(Rf2)2, P(ORe2)2, P(O)Re2Rf2, P(O)ORe2ORf2, S(O)Rb2, S(O)NRc2Rc2, S(O)2Rb2, NRc2S(O)2Rb2, y S(O)2NRc2Rd2, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6, está opcionalmente sustituido por 1, 2 o 3 sustituyentes seleccionados independientemente de Cy2, CN, N02, ORa2, SRa2, C(O)Rb2, C(O)NRc2Rc2, C(O)ORa2, OC(O)Rb2, OC(O)NRc2Rd2, NRc2Rd2, NRc2C(O)Rb2, NRc2C(O)NRc2Rd2, NRc2C(O)ORa2, C(=NRi2)NRc2Rd2, NRc2C(=NRi2)NRc2Rd2, P(Rf2)2, P(ORe2)2, P(O)Re2Rf2, P(O)ORe2ORf2, S(O)Rb2, S(O)NRc2Rd2, S(O)2Rb2, NRc2S(O)2Rb2, and S(O)2NRc2Rc2; Ra3 y Ra4 se seleccionan independientemente de H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-(alquilo C1-6)-, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido por 1, 2, 3, 4 o 5 sustituyentes seleccionados independientemente de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(=NRi5)NRc5Rd5, NRc5C(=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5, y S(O)2NRc5Rd5;",INCYTE HOLDINGS CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/167-501-602-730-943,Granted Patent,no,0,0,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,0,0,,,,ACTIVE
180,WO,A3,WO 2008/036653 A3,192-292-885-083-480,2008-07-31,2008,US 2007/0078759 W,2007-09-18,US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/192-292-885-083-480,Search Report,yes,7,0,15,15,0,C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,2,0,,,"RIFFAUD J-P ET AL: ""SUR LES PROPRIETES ANALGESIQUES ET ANTIINFLAMMATOIRES DES BENZOFURYL-2 AMIDOXIMES"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 17, no. 6, 1982, pages 577 - 580, XP002036825, ISSN: 0223-5234;;DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YOUNGDALE, GILBERT A. ET AL: ""Synthesis and antifertility activity of 5-(phenoxymethyl)-2- oxazolidinethiones"", XP002467245, retrieved from STN Database accession no. 1966:35829",PENDING
181,CA,A1,CA 2662773 A1,140-577-451-951-431,2008-03-27,2008,CA 2662773 A,2007-09-18,US 84571106 P;;US 2007/0078759 W,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions an d pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;YUE EDDY WAI;;SPARKS RICHARD B;;GLASS BRIAN M,,https://lens.org/140-577-451-951-431,Patent Application,no,0,0,15,15,3,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,0,0,,,,ACTIVE
182,US,A1,US 2016/0357411 A1,149-278-273-298-667,2016-12-08,2016,US 201514733850 A,2015-06-08,US 201514733850 A,2015-06-08,MODIFYING A USER-INTERACTIVE DISPLAY WITH ONE OR MORE ROWS OF KEYS,"Examples of the disclosure enable a user-interactive display presented on a touch-sensitive input panel to be modified. In some examples, a request to modify an arrangement of a plurality of keys presented on the touch-sensitive input panel is generated. The keys are arranged in a first quantity of rows and are associated with a first set of characters including a first plurality of characters and a second plurality of characters. A first key is associated with the first plurality of characters, and a second key is associated with the second plurality of characters. Based on the generated request, the keys are arranged in a second quantity of rows different from the first quantity of rows. Aspects of the disclosure enable a mobile device to be customized such that a user may provide input (e.g., via typing) in a user-friendly manner.",MICROSOFT TECHNOLOGY LICENSING LLC,MENDONCA ROUELLA JOAN;;GLASS ANDREW STUART;;PAEK TIMOTHY S;;AVILA GYANCARLO GARCIA,MICROSOFT TECHNOLOGY LICENSING LLC (2015-05-29),https://lens.org/149-278-273-298-667,Patent Application,yes,21,0,4,4,0,G06F3/04886;;G06F3/04886;;G06F3/04845;;G06F3/0482;;G06F3/0488;;G06F3/04886,G06F3/0484;;G06F3/0482;;G06F3/0488,,0,0,,,,DISCONTINUED
183,US,B2,US 9021084 B2,050-205-402-498-685,2015-04-28,2015,US 60380509 A,2009-10-22,US 60380509 A,2009-10-22,Network device discovery,"A system and method enable a local area network connected mobile device to discover, via an ancillary wireless communication channel, a local area network connected device and install the appropriate driver and network configuration information when the mobile device and network connected device are brought into physical close proximity with each other.",CHAPIN DAVID M;;EDMONDS JONATHAN ALLEN;;STUTZMAN ANDREW T;;GLASS BRIAN ROBERT;;XEROX CORP,CHAPIN DAVID M;;EDMONDS JONATHAN ALLEN;;STUTZMAN ANDREW T;;GLASS BRIAN ROBERT,XEROX CORPORATION (2009-11-02),https://lens.org/050-205-402-498-685,Granted Patent,yes,18,2,2,2,0,H04L41/12;;H04L41/12,G06F15/177;;G06F15/173;;H04L12/24,709/224;;709/220,0,0,,,,ACTIVE
184,CA,C,CA 2662773 C,102-419-292-913-38X,2015-11-24,2015,CA 2662773 A,2007-09-18,US 84571106 P;;US 2007/0078759 W,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/102-419-292-913-38X,Granted Patent,no,0,0,15,15,3,C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70,C07D261/18;;A61K31/341;;A61K31/381;;A61K31/42;;A61K31/423;;A61P37/04;;C07D261/20;;C07D307/68;;C07D333/70,,0,0,,,,ACTIVE
185,WO,A2,WO 2008/036642 A2,027-932-216-443-549,2008-03-27,2008,US 2007/0078745 W,2007-09-18,US 84570006 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/027-932-216-443-549,Patent Application,yes,0,171,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,A61K31/415;;C07D413/04;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,0,0,,,,PENDING
186,US,A1,US 2011/0099264 A1,058-043-734-416-975,2011-04-28,2011,US 60380509 A,2009-10-22,US 60380509 A,2009-10-22,NETWORK DEVICE DISCOVERY,"A system and method enable a local area network connected mobile device to discover, via an ancillary wireless communication channel, a local area network connected device and install the appropriate driver and network configuration information when the mobile device and network connected device are brought into physical close proximity with each other.",XEROX CORP,CHAPIN DAVID M;;EDMONDS JONATHAN ALLEN;;STUTZMAN ANDREW T;;GLASS BRIAN ROBERT,XEROX CORPORATION (2009-11-02),https://lens.org/058-043-734-416-975,Patent Application,yes,19,29,2,2,0,H04L41/12;;H04L41/12,G06F15/173,709/224,0,0,,,,ACTIVE
187,EP,A1,EP 3304271 A1,092-466-273-489-334,2018-04-11,2018,EP 16731709 A,2016-06-06,US 201514733850 A;;US 2016/0035943 W,2015-06-08,MODIFYING A USER-INTERACTIVE DISPLAY WITH ONE OR MORE ROWS OF KEYS,,MICROSOFT TECHNOLOGY LICENSING LLC,MENDONCA ROUELLA JOAN;;GLASS ANDREW STUART;;PAEK TIMOTHY S;;AVILA GYANCARLO GARCIA,,https://lens.org/092-466-273-489-334,Patent Application,yes,0,0,4,4,0,G06F3/04886;;G06F3/04886;;G06F3/04845;;G06F3/0482;;G06F3/0488;;G06F3/04886,G06F3/0488,,0,0,,,,DISCONTINUED
188,US,B1,US 6631519 B1,032-783-170-755-030,2003-10-07,2003,US 53925100 A,2000-03-30,US 53925100 A,2000-03-30,Automated schema and interface generation,"
    Automated generation of schema and interface methods is described. The system receives a schema definition file, which in one aspect of the system is an XML file. The system parses the schema definition file into an internal representation comprising collection classes. A SQL generator traverses the collection classes and generates SQL statements that define tables, views and stored procedures. A component generator traverses the collection classes and generates computer program source code implementing components that access properties defined in the schema definition data, and methods that provide for persistent storage of the objects in a database. 
",MICROSOFT CORP,NICHOLSON ANDREW L;;GLASS MICHAEL J;;KOSBIE DAVID S;;VAUGHAN THOMAS A,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2000-03-29),https://lens.org/032-783-170-755-030,Granted Patent,yes,8,311,1,1,0,G06F16/211;;G06F16/211;;Y10S707/99943,G06F9/44;;G06F17/30,717/169;;717/169;;717/170;;707/102,0,0,,,,EXPIRED
189,WO,A1,WO 2016/200707 A1,171-338-324-082-313,2016-12-15,2016,US 2016/0035943 W,2016-06-06,US 201514733850 A,2015-06-08,MODIFYING A USER-INTERACTIVE DISPLAY WITH ONE OR MORE ROWS OF KEYS,"Examples of the disclosure enable a user-interactive display presented on a touch-sensitive input panel to be modified. In some examples, a request to modify an arrangement of a plurality of keys presented on the touch-sensitive input panel is generated. The keys are arranged in a first quantity of rows and are associated with a first set of characters including a first plurality of characters and a second plurality of characters. A first key is associated with the first plurality of characters, and a second key is associated with the second plurality of characters. Based on the generated request, the keys are arranged in a second quantity of rows different from the first quantity of rows. Aspects of the disclosure enable a mobile device to be customized such that a user may provide input (e.g., via typing) in a user-friendly manner.",MICROSOFT TECHNOLOGY LICENSING LLC,MENDONCA ROUELLA JOAN;;GLASS ANDREW STUART;;PAEK TIMOTHY S;;AVILA GYANCARLO GARCIA,,https://lens.org/171-338-324-082-313,Patent Application,yes,5,0,4,4,0,G06F3/04886;;G06F3/04886;;G06F3/04845;;G06F3/0482;;G06F3/0488;;G06F3/04886,G06F3/0488,,0,0,,,,PENDING
190,DE,D1,DE 69229474 D1,146-508-007-099-907,1999-07-29,1999,DE 69229474 T,1992-12-03,US 80187791 A;;US 9210380 W,1991-12-03,INTERAKTIVES VIDEOSYSTEM ZUR BEOBACHTUNG UND ZUM TRAINING DER LEISTUNGSFÄHIGKEIT EINER PERSON,,FRENCH SPORTECH CORP,FRENCH BARRY;;FERGUSON KEVIN;;MCDONALD HALLEY;;GLASS ANDREW;;MOHANSINGH TIMOTHY;;BORGES GREGORY,,https://lens.org/146-508-007-099-907,Granted Patent,no,0,0,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,0,0,,,,EXPIRED
191,CN,A,CN 107710138 A,016-866-495-192-890,2018-02-16,2018,CN 201680033558 A,2016-06-06,US 201514733850 A;;US 2016/0035943 W,2015-06-08,MODIFYING A USER-INTERACTIVE DISPLAY WITH ONE OR MORE ROWS OF KEYS,"Examples of the disclosure enable a user-interactive display presented on a touch-sensitive input panel to be modified. In some examples, a request to modify an arrangement of a plurality of keys presented on the touch-sensitive input panel is generated. The keys are arranged in a first quantity of rows and are associated with a first set of characters including a first plurality of characters anda second plurality of characters. A first key is associated with the first plurality of characters, and a second key is associated with the second plurality of characters. Based on the generated request, the keys are arranged in a second quantity of rows different from the first quantity of rows. Aspects of the disclosure enable a mobile device to be customized such that a user may provide input(e.g., via typing) in a user-friendly manner.",MICROSOFT TECHNOLOGY LICENSING LLC,MENDONCA ROUELLA JOAN;;GLASS ANDREW STUART;;PAEK TIMOTHY S;;AVILA GYANCARLO GARCIA,,https://lens.org/016-866-495-192-890,Patent Application,no,0,0,4,4,0,G06F3/04886;;G06F3/04886;;G06F3/04845;;G06F3/0482;;G06F3/0488;;G06F3/04886,G06F3/0488,,0,0,,,,DISCONTINUED
192,DE,T2,DE 69229474 T2,143-905-709-089-869,2000-03-02,2000,DE 69229474 T,1992-12-03,US 80187791 A;;US 9210380 W,1991-12-03,INTERAKTIVES VIDEOSYSTEM ZUR BEOBACHTUNG UND ZUM TRAINING DER LEISTUNGSFÄHIGKEIT EINER PERSON,,FRENCH SPORTECH CORP,FRENCH BARRY;;FERGUSON KEVIN;;MCDONALD HALLEY;;GLASS ANDREW;;MOHANSINGH TIMOTHY;;BORGES GREGORY,,https://lens.org/143-905-709-089-869,Granted Patent,no,0,0,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,0,0,,,,EXPIRED
193,US,A1,US 2022/0202787 A1,150-814-667-749-637,2022-06-30,2022,US 202017442733 A,2020-03-25,US 202017442733 A;;US 201962824190 P;;IB 2020052825 W,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/150-814-667-749-637,Patent Application,yes,0,0,11,11,2,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,A61K31/439;;A61K45/06;;C07D498/18,,0,0,,,,PENDING
194,CA,A1,CA 2663057 A1,132-974-821-126-99X,2008-03-27,2008,CA 2663057 A,2007-09-18,US 84570006 P;;US 2007/0078745 W,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions an d pharmaceutical methods thereof.",INCYTE CORP,GLASS BRIAN M;;SPARKS RICHARD B;;COMBS ANDREW P;;YUE EDDY WAI,,https://lens.org/132-974-821-126-99X,Patent Application,no,0,0,12,12,3,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,0,0,,,,ACTIVE
195,EP,B1,EP 3947392 B1,179-411-529-512-005,2024-02-28,2024,EP 20717312 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF",,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/179-411-529-512-005,Granted Patent,yes,3,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,1,0,,,"LUENGO J I ET AL: ""MANIPULATION OF THE RAPAMYCIN EFFECTOR DOMAIN. SELECTIVE NUCLEOPHILIC SUBSTITUTION OF THE C7 METHOXY GROUP"", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 59, no. 22, 4 November 1994 (1994-11-04), XP000651276, ISSN: 0022-3263, DOI: 10.1021/JO00101A006",ACTIVE
196,MX,A,MX 2021011376 A,178-541-019-851-882,2021-10-13,2021,MX 2021011376 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF.","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,CONNOLLY MICHAEL;;BONAZZI SIMONE;;SHAVLAKADZE TEA;;GLASS DAVID J;;PATTERSON ANDREW W,,https://lens.org/178-541-019-851-882,Patent Application,no,0,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00;;C07D498/18,,0,0,,,,PENDING
197,WO,A1,WO 2020/194209 A1,140-869-073-426-334,2020-10-01,2020,IB 2020052825 W,2020-03-25,US 201962824190 P,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/140-869-073-426-334,Patent Application,yes,7,2,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,39,25,021-697-234-144-141;;012-781-922-366-608;;018-027-023-098-56X;;040-692-130-168-76X;;084-509-210-795-657;;183-143-678-156-514;;091-762-167-328-721;;028-386-403-141-053;;101-936-623-204-924;;002-719-485-917-319;;063-987-941-336-125;;005-910-694-042-592;;028-237-981-802-053;;048-760-044-102-310;;119-089-342-392-18X;;089-958-577-650-361;;052-775-030-455-023;;128-753-285-752-087;;060-221-367-896-647;;009-432-951-795-221;;035-899-612-116-37X;;026-469-333-215-440;;069-150-416-650-646;;018-027-023-098-56X;;034-391-483-835-138,10.1021/jo00101a006;;pmc3331679;;22500797;;10.1016/j.cell.2012.03.017;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;10.1016/j.ekir.2017.07.016;;29340326;;pmc5762943;;10.7164/antibiotics.44.688;;1712766;;10.1021/ja00019a057;;10.1126/science.1115535;;16293764;;pmc2754830;;15186745;;10.1016/j.cub.2004.03.059;;pmc4954603;;19797661;;10.1126/science.1177221;;10.1038/426620b;;14668850;;14668851;;10.1038/426620a;;10.1111/acel.12194;;24341993;;pmc4032600;;10.1038/nature08221;;pmc2786175;;19587680;;24233701;;10.1126/science.342.6160.789;;10.1126/scitranslmed.3009892;;25540326;;pmc2727061;;10.1523/jneurosci.0066-09.2009;;19474323;;10.1016/0040-4020(77)80264-0;;10.1016/j.jacc.2009.08.031;;20082935;;10.4161/auto.6.2.11135;;20104016;;25453134;;10.1111/liv.12416;;10.15252/emmm.201505079;;pmc4693502;;26612854;;26951622;;pmc4818752;;10.15252/emmm.201506131;;10.1016/j.gde.2016.03.005;;pmc5055853;;27065468;;10.1002/hlca.19910740513;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;16968213;;10.1146/annurev.pharmtox.47.120505.105359,"LUENGO J I ET AL: ""MANIPULATION OF THE RAPAMYCIN EFFECTOR DOMAIN. SELECTIVE NUCLEOPHILIC SUBSTITUTION OF THE C7 METHOXY GROUP"", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 59, no. 22, 4 November 1994 (1994-11-04), XP000651276, ISSN: 0022-3263, DOI: 10.1021/JO00101A006;;LAPLANTE M. ET AL., CELL, vol. 149, no. 2, 2012, pages 274 - 93;;MARZ A.M. ET AL., MOL CELL BIOL., vol. 33, no. 7, 2013, pages 1357 - 1367;;ROYCE M.E. ET AL., BREAST CANCER, vol. 9, 2015, pages 73 - 79;;PLENICEANU O. ET AL., KIDNEY INT REP., vol. 3, no. 1, 2018, pages 155 - 159;;MCALPINE, J.B. ET AL., J. ANTIBIOTICS, vol. 44, 1991, pages 688;;SCHREIBER, S.L. ET AL., J. AM. CHEM. SOC., vol. 113, 1991, pages 7433;;KAEBERLEIN ET AL., SCIENCE, vol. 310, 2005, pages 1193 - 1196;;KAPAHI ET AL., CURR BIOL, vol. 14, 2004, pages 885 - 890;;SELMAN ET AL., SCIENCE, vol. 326, 2009, pages 140 - 144;;VELLAI ET AL., NATURE, vol. 426, 2003, pages 620;;R. A. MILLER ET AL., AGING CELL, vol. 13, no. 3, 2014, pages 468 - 477;;HARRISON ET AL., NATURE, vol. 460, no. 7253, 2009, pages 392 - 395;;M. LESLIE, SCIENCE, vol. 342, 2013;;J. MANNICK ET AL., SCI TRANSL MED., vol. 6, no. 268, 2014, pages 268ra179;;ZENG ET AL.: ""The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy"", J. NEUROSCI., 2009, pages 6964 - 6972;;CELL METABOLISM, vol. 26, 1 August 2017 (2017-08-01), pages 419 - 428;;THOMAS SORRELL: ""Handbook of Chemistry and Physics"", 1999, UNIVERSITY SCIENCE BOOKS;;SMITHMARCH: ""March's Advanced Organic Chemistry"", 2001, JOHN WILEY & SONS, INC.;;LAROCK: ""Comprehensive Organic Transformations"", 1989, VCH PUBLISHERS, INC.;;CARRUTHERS: ""Some Modern Methods of Organic Synthesis"", 1987, CAMBRIDGE UNIVERSITY PRESS;;JACQUES ET AL.: ""Enantiomers, Racemates and Resolutions"", 1981, WILEY INTERSCIENCE;;WILEN ET AL., TETRAHEDRON, vol. 33, 1977, pages 2725;;ELIEL, E.L.: ""Stereochemistry of Carbon Compounds"", 1962, MCGRAW-HILL;;WILEN: ""S.H. Tables of Resolving Agents and Optical Resolutions"", 1972, UNIV. OF NOTRE DAME PRESS, pages: 268;;BUSS, S.J. ET AL.: ""Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction"", J AM COLL CARDIOL., vol. 54, no. 25, 2009, pages 2435 - 46, XP026807861;;BUSS, S.J. ET AL.: ""Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters"", AUTOPHAGY, vol. 6, no. 2, 2010, pages 304 - 6;;VILLAMIL, F.G. ET AL.: ""Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomized study of RAD001 vs. calcineurin inhibitors"", LIVER INT., vol. 34, no. 10, 2014, pages 1513 - 21;;CHINNERY, P.F., EMBO MOL. MED., vol. 7, 2015, pages 1503 - 1512;;KOOPMAN, W.J. ET AL., EMBO MOL. MED., vol. 8, 2016, pages 311 - 327;;YOUNG, M.J.YOUNDCOPELAND, W.C., CURR. OPIN. GENET. DEV., vol. 38, 2016, pages 52 - 62;;TL, vol. 43, 1995, pages 7823;;TL, vol. 37, 1994, pages 6835;;JOC, vol. 59, 1994, pages 6512;;THE JOURNAL OF ANTIBIOTICS, vol. 44, no. 6, 1991, pages 688 - 90;;TETRAHEDRON LETTERS, vol. 33, no. 33, 1992, pages 4139 - 4142;;MIERKE, D. F.SCHMIEDER, P.KARUSO, P.KESSLER, H.: ""Conformational Analysis of the cis- and trans-Isomers of FK506 by NMR and Molecular Dynamics"", HELVETICA CHIMICA ACTA, vol. 74, 1991, pages 1027 - 1047;;MOL. CELL BIOL., vol. 33, 2013, pages 1357 - 1367;;LEE, C. H.INOKI, K.GUAN, K. L.: ""mTOR pathway as a target in tissue hypertrophy"", ANNU. REV. PHARMACOL. TOXICOL., vol. 47, 2007, pages 443 - 467",PENDING
198,CA,A1,CA 3134653 A1,001-809-102-018-440,2020-10-01,2020,CA 3134653 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/001-809-102-018-440,Patent Application,no,0,0,11,11,2,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,0,0,,,,PENDING
199,WO,A3,WO 2008/036642 A3,060-749-974-530-773,2008-08-07,2008,US 2007/0078745 W,2007-09-18,US 84570006 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/060-749-974-530-773,Search Report,yes,4,0,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,4,0,,,"DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; NISHIMURA, HARUKI ET AL.: ""Amidoxime derivatives"", XP002467961, retrieved from STN Database accession no. 1975:606233;;DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SYCHEVA, T. P. ET AL: ""Compounds with potential antitubercular activity. VI. Amidoximes, amide hydrazones, and S-oxides of thioamides of some heterocyclic acids"", XP002467962, retrieved from STN Database accession no. 1963:73272;;DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BELIK, A. V. ET AL: ""Descriptor .nu.'cp-aided study of the rearrangement of 1-oxa-2-azoles"", XP002467963, retrieved from STN Database accession no. 1995:326366;;DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ANDRIANOV, V. G. ET AL: ""Rearrangements of 1-oxa-2-azoles. 4. Synthesis and rearrangement of amidoximes of isoxazole- and 4,5-dihydroisoxazole-3-carboxylic acids"", XP002467964, retrieved from STN Database accession no. 1992:6493",PENDING
200,EP,B1,EP 2064194 B1,143-080-970-745-686,2018-11-07,2018,EP 07842681 A,2007-09-18,US 2007/0078759 W;;US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLIC COMPOUNDS AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE",,INCYTE HOLDINGS CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,INCYTE HOLDINGS CORPORATION (2015-12-09);;INCYTE CORPORATION (2015-03-11),https://lens.org/143-080-970-745-686,Granted Patent,yes,7,0,15,15,0,C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/20;;C07D307/68;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,2,0,,,"RIFFAUD J-P ET AL: ""SUR LES PROPRIETES ANALGESIQUES ET ANTIINFLAMMATOIRES DES BENZOFURYL-2 AMIDOXIMES"" EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 17, no. 6, 1982, pages 577-580, XP002036825 ISSN: 0223-5234;;DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YOUNGDALE, GILBERT A. ET AL: ""Synthesis and antifertility activity of 5-(phenoxymethyl)-2- oxazolidinethiones"" XP002467245 retrieved from STN Database accession no. 1966:35829 & JOURNAL OF MEDICINAL CHEMISTRY , 9(1), 155-7 CODEN: JMCMAR; ISSN: 0022-2623, 1966,",ACTIVE
201,US,A1,US 2022/0414334 A1,031-164-457-289-947,2022-12-29,2022,US 202117358932 A,2021-06-25,US 202117358932 A,2021-06-25,POST-MODEL FILTERING OF PREDICTIVE TEXT,"In non-limiting examples of the present disclosure, systems, methods and devices for filtering predictive text surfacing candidates are provided. A predictive text filtering model may be maintained. The predictive text filtering model may comprise a plurality of terms that are associated in the predictive text filtering model with a precarious classification, and a range of a number of words for filtering cooccurrences of precarious and other precarious or blocklist terms from the plurality of terms. A text input may be processed with a predictive text model. A plurality of surfacing candidates may be determined based on the processing of the text input with the predictive text model. The predictive text filtering model may be applied to a surfacing candidate of the plurality of candidates. The surfacing candidate may be filtered from further processing. At least one non-filtered surfacing candidate may be displayed.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;MAGNUS MARGARET HOPE;;RADTKE ROLAND;;MANNBY CLAES-FREDRIK URBAN,MICROSOFT TECHNOLOGY LICENSING LLC (2021-06-24),https://lens.org/031-164-457-289-947,Patent Application,yes,12,0,1,1,0,G06F40/279;;G06F40/253;;G06N3/09;;G06N3/045;;G06N3/0475;;G06N3/0442;;G06F40/295;;G06N3/02;;G06F40/253,G06F40/295;;G06F40/253;;G06N3/02,,0,0,,,,PENDING
202,EP,B1,EP 2064207 B1,050-731-389-101-187,2013-11-06,2013,EP 07814905 A,2007-09-18,US 2007/0078745 W;;US 84570006 P,2006-09-19,"N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase",,INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,"INCYTE HOLDINGS CORPORATION (2018-01-16);;INCYTE HOLDINGS CORPORATION, US (2016-09-27);;INCYTE HOLDINGS CORPORATION, WILMINGTON, US (2016-02-24)",https://lens.org/050-731-389-101-187,Granted Patent,yes,4,0,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,4,0,,,"DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; NISHIMURA, HARUKI ET AL.: ""Amidoxime derivatives"" XP002467961 retrieved from STN Database accession no. 1975:606233 & JP 50 050369 A (DAINIPPON PHARMACEUTICAL CO., LTD) 5 September 1973 (1973-09-05);;DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SYCHEVA, T. P. ET AL: ""Compounds with potential antitubercular activity. VI. Amidoximes, amide hydrazones, and S-oxides of thioamides of some heterocyclic acids"" XP002467962 retrieved from STN Database accession no. 1963:73272 & ZHURNAL OBSHCHEI KHIMII , 32, 3669-74 CODEN: ZOKHA4; ISSN: 0044-460X, 1962,;;DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BELIK, A. V. ET AL: ""Descriptor .nu.'cp-aided study of the rearrangement of 1-oxa-2-azoles"" XP002467963 retrieved from STN Database accession no. 1995:326366 & ZHURNAL ORGANICHESKOI KHIMII , 30(5), 757-9 CODEN: ZORKAE; ISSN: 0514-7492, 1994,;;DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ANDRIANOV, V. G. ET AL: ""Rearrangements of 1-oxa-2-azoles. 4. Synthesis and rearrangement of amidoximes of isoxazole- and 4,5-dihydroisoxazole-3-carboxylic acids"" XP002467964 retrieved from STN Database accession no. 1992:6493 & KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII , (6), 827-32 CODEN: KGSSAQ; ISSN: 0453-8234, 1991,",ACTIVE
203,AR,A1,AR 062881 A1,068-359-300-017-612,2008-12-10,2008,AR P070104118 A,2007-09-18,US 84571106 P,2006-09-19,"N-HIDROXIAMIDINOHETEROCICLOS COMO MODULADORES DE INDOLAMINA-2,3-DIOXIGENASA","Composiciones y métodos farmacéuticos. Moduladores de indolamina-2,3-dioxigenasa (IDO), para tratar cáncer, infecciones virales, depresion, trastorno neurodegenerativo, trauma, cataratas, rechazo de trasplantes, enfermedad autoinmune. Reivindicacion 1: Un compuesto de la formula 1: o una de sus sales farmacéuticamente aceptables, caracterizado porque: W es O, S o NR1; U es N o CR3: X es N o CR4; Q es H, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, arilo, heteroarilo, cicloalquilo o heterocicloalquilo, en donde dicho alquilo C1-6, alquenilo C2-6, alquinilo C2-6, arilo, heteroarilo, cicloalquilo o heterocicloalquilo está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, pentahalosulfanilo, Cy4, -alquil C1-4-Cy4, CN, NO2, ORa4, -alquil C1-4-ORa4, SRa4, -alquil C1-4-SRa4, C(O)Rb4, -alquil C1- 4-C(O)Rb4, C(O)NRc4Rd4, -alquil C1-4-C(O)NRc4Rd4, C(O)ORa4, -alquil C1-4-C(O)ORa4, OC(O)Rb4, -alquil C1-4-OC(O)Rb4, OC(O)NRc4Rd4, -alquil C1-4-OC(O)NRc4Rd4, NRc4Rd4, NRc4C(O)Rb4, -alquil C1-4-NRc4CORb4, NRc4C(O)NRc4Rd4 -alquil C1-4-NRc4C(O)NRc4Rd4, NRc4C(O)ORa4, -alquil C1-4-NRc4C(O)ORa4, C(=NRi4)NRc4Rd4, NRc4C(=NRi4)NRc4Rd4, P(Rf4)2, P(ORe4)2, P(O)Re4Rf4, P(O)ORe4ORf4, S(O)Rb4, -(alquil C1-4-S(O)Rb4, S(O)NRc4Rd4, -alquil C1-4-S(O)NRc4Rd4, S(O)2Rb4, -alquil C1-4-S(O)2Rb4, NRc4S(O)2Rb4, -alquil C1-4-NRc4S(O)2Rb4, S(O)2NRc4Rd4 y -alquil C1-4-S(O)2NRc4Rd4; R1 es H, alquilo C1-10, alquenilo C2-6 o alquinilo C2-6; R2 es halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, pentahalosulfanilo, Cy3, CN, NO2, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(=NRi3)NRc3Rd3, NRc3C(=NRi3)NRc3Rd3, P(Rf3)2, P(ORe3)2, P(O)Re3Rf3, P(O)ORe3ORf3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3 o S(O)2NRc3Rd3 en donde dicho alquilo C1-10, alquenilo C2-10, o alquinilo C2-10, está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, haloalquilo C1-10, hidroxialquilo C1-10, cianoalquilo C1-10, pentahalosulfanilo, Cy3, CN, NO2, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(=NRi3)NRc3Rd3, NRc3C(=NRi3)NRc3Rd3, P(Rf3)2, P(ORe3)2, P(O)Re3Rf3, P(O)ORe3ORf3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3 y S(O)2NRc3Rd3; R3 y R4 están seleccionados, de modo independiente, de H, halo, alquilo C1-4, alquenilo C2-6 y alquinilo C2-6; R5 es H, C(O)R6, C(O)OR7 o C(O)NR8NR9; R6 y R7 están seleccionados, de modo independiente, de H, alquilo C1-8, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, arilalquilo, heteroarilalquilo, cicloalquilalquilo y heterocicloalquilalquilo, cada uno opcionalmente sustituido con 1, 2, 3 sustituyentes seleccionados, de modo independiente, de halo, CN, NO2, OH, alcoxi C1-4, haloalcoxi C1-4, amino, alquil C1-4-amino, dialquil C2-8-amino, alquilo C1-6, alquenilo C2-6 y alquinilo C2-6; R8 y R9 están seleccionados, de modo independiente, de H, alquilo C1-8, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, arilalquilo, heteroarilalquilo, cicloalquilalquilo y heterocicloalquilalquilo, cada uno opcionalmente sustituido con 1, 2 o 3 sustituyentes seleccionados, de modo independiente, de halo, CN, NO2, OH, alcoxi C1-4, haloalcoxi C1-4, amino, alquil C1-4-amino, dialquil C2-8-amino, alquilo C1-6, alquenilo C2-6 y alquinilo C2-6; o R1 y R3 junto con los átomos a los que están unidos forman un heteroarilo o un anillo heterocicloalquilo de 4-20 miembros, en donde dicho heteroarilo o anillo heterocicloalquilo de 4-20 miembros está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy, CN, NO2, ORa, SRa, C(O)Rb, C(O)NRcRd, C(O)ORa, OC(O)Rb, OC(O)NRcRd, NRcRd, NRcC(O)Rb, NRcC(O)NRcRd, NRcC(O)ORa, C(=NRi)NRcRd, NRcC(=NRi)NRcRd, P(Rf)2, P(ORe)2, P(O)ReRf, P(O)OReORf, S(O)Rb, S(O)NRcRd, S(O)2Rb, NRcS(O)2Rb y S(O)2NRcRd, en donde dicho alquilo C1-6, alquenilo C2-6, o alquinilo C2-6, está sustituido con 1, 2, o 3 sustituyentes seleccionados, de modo independiente, de Cy, CN, NO2, ORa, SRa, C(O)Rb, C(O)NRcRd, C(O)ORa, OC(O)Rb, OC(O)NRcRd, NRcRd, NRcC(O)Rb, NRcC(O)NRcRd, NRcC(O)ORa, C(=NRi)NRcRd, NRcC(=NRi)NRcRd, P(Rf)2, P(ORe)2, P(O)ReRf, P(O)OReORf, S(O)Rb, S(O)NRcRd, S(O)2Rb, NRcS(O)2Rb y S(O)2NRcRd; o R2 y R3 junto con los átomos a los que están unidos forman un arilo, cicloalquilo, heteroarilo o anillo heterocicloalquilo de 4-20 miembros, en donde dicho arilo, cicloalquilo, heteroarilo o anillo heterocicloalquilo de 4-20 miembros está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy1, CN, NO2, ORa1, SRa1, C(O)Rb1, C(O)NRc1Rd1, C(O)ORa1, OC(O)Rb1, OC(O)NRc1Rd1, NRc1Rd1, NRc1C(O)Rb1, NRc1C(O)NRc1Rd1, NRc1C(O)ORa1, C(=NRi1)NRc1Rd1, NRc1C(=NRi1)NRc1Rd1, P(Rf1)2, P(ORe1)2, P(O)Re1Rf1, P(O)ORe1ORf1, S(O)Rb1, S(O)NRc1Rd1, S(O)2Rb1, NRc1S(O)2Rb1 y S(O)2NRc1Rd1, en donde dicho alquilo C1-6, alquenilo C2-6, alquinilo C2-6, está opcionalmente sustituido con 1, 2, o 3 sustituyentes seleccionados, de modo independiente, Cy1, CN, NO2, ORa1, SRa1, C(O)Rb1, C(O)NRc1Rd1, C(O)ORa1, OC(O)Rb1, OC(O)NRc1Rd1, NRc1Rd1, NRc1C(O)Rb1, NRc1C(O)NRc1Rd1, NRc1C(O)ORa1, C(=NRi1)NRc1Rd1, NRc1C(=NRi1)NRc1Rd1, P(Rf1)2, P(ORe1)2, P(O)Re1Rf1, P(O)ORe1ORf1, S(O)Rb1, S(O)NRc1Rd1, S(O)2Rb1, NRc1S(O)2Rb1 y S(O)2NRc1Rd1, o R2 y R4 junto con los átomos a los que están unidos forman un arilo, cicloalquilo, heteroarilo o anillo heterocicloalquilo de 4-20 miembros, en donde dicho arilo, cicloalquilo, heteroarilo o anillo heterocicloalquilo de 4-20 miembros está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy2, CN, NO2, ORa2, SRa2, C(O)Rb2, C(O)NRc2Rd2, C(O)ORa2, OC(O)Rb2, OC(O)NRc2Rd2, NRc2Rd2, NRc2C(O)Rb2, NRc2C(O)NRc2Rd2, NRc2C(O)ORa2, C(=NRi2)NRc2Rd2, NRc2C(=NRi2)NRc2Rd2, P(Rf2)2, P(ORe2)2, P(O)Re2Rf2, P(O)ORe2ORf2, S(O)Rb2, S(O)NRc2Rd2, S(O)2Rb2, NRc2S(O)2Rb2 y S(O)2NRc2Rd2, en donde dicho alquilo C1-6, alquenilo C2-6, alquinilo C2-6, está opcionalmente sustituido con 1, 2, o 3 sustituyentes seleccionados, de modo independiente, Cy2, CN, NO2, ORa2, SRa2, C(O)Rb2, C(O)NRc2Rd2, C(O)ORa2, OC(O)Rb2, OC(O)NRc2Rd2, NRc2Rd2, NRc2C(O)Rb2, NRc2C(O)NRc2Rd2, NRc2C(O)ORa2, C(=NRi2)NRc2Rd2, NRc2C(=NRi2)NRc2Rd2, P(Rf2)2, P(ORe2)2, P(O)Re2Rf2, P(O)ORe2ORf2, S(O)Rb2, S(O)NRc2Rd2, S(O)2Rb2, NRc2S(O)2Rb2 y S(O)2NRc2Rd2, Ra3 y Ra4 están seleccionados, de modo independiente, de H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2- 6, Cy5 y Cy-alquilo C1-6-, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5 SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(=NRi5)NRc5Rd5, NRc5C(=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5, Rb3 y Rb4 están seleccionados, de modo independiente de H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, Cy5 y Cy5-alquilo C1-6-, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(=NRi5)NRc5Rd5, NRc5C(=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5, Rc3 y Rc4 están seleccionados, de modo independiente, de H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, C(O)Rb5, C(O)NRc5Rd5, C(=NRi5)NRc5Rd5, Cy5 y Cy5-alquilo C1-6-, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(=NRi5)NRc5Rd5, NRc5C(=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5, Rd3 y Rd4 están seleccionados, de modo independiente, de H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, C(O)Rb5, C(O)NRc5Rd5, C(=NRi5)NRc5Rd5, Cy5 y Cy5-alquilo C1-6-, en donde dicho alquilo C1-6, alquenilo C2-6 o alquinilo C2-6 está opcionalmente sustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados, de modo independiente, de halo, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, hidroxialquilo C1-6, cianoalquilo C1-6, Cy5, CN, NO2, ORa5, SRa5, C(O)Rb5, C(O)NRc5Rd5, C(O)ORa5, OC(O)Rb5, OC(O)NRc5Rd5, NRc5Rd5, NRc5C(O)Rb5, NRc5C(O)NRc5Rd5, NRc5C(O)ORa5, C(=NRi5)NRc5Rd5, NRc5C(=NRi5)NRc5Rd5, P(Rf5)2, P(ORe5)2, P(O)Re5Rf5, P(O)ORe5ORf5, S(O)Rb5, S(O)NRc5Rd5, S(O)2Rb5, NRc5S(O)2Rb5 y S(O)2NRc5Rd5, o Rc3 y Rd3 junto con el átomo de N al que están unidos forman un grupo heteroarilo o heterocicloalquilo de 4, 5, 6 o",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,,https://lens.org/068-359-300-017-612,Patent Application,no,0,0,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,,,0,0,,,,PENDING
204,EP,A2,EP 2064194 A2,110-523-707-416-677,2009-06-03,2009,EP 07842681 A,2007-09-18,US 2007/0078759 W;;US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLIC COMPOUNDS AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE",,INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI,INCYTE HOLDINGS CORPORATION (2015-12-09);;INCYTE CORPORATION (2015-03-11),https://lens.org/110-523-707-416-677,Patent Application,yes,0,0,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,C07D261/18;;A61K31/34;;A61K31/381;;A61K31/415;;A61P25/00;;A61P29/00;;A61P31/12;;A61P35/00;;C07D261/20;;C07D307/68;;C07D333/70,,1,0,,,See references of WO 2008036653A2,ACTIVE
205,AU,B2,AU 2020/250026 B2,111-829-723-517-986,2023-08-10,2023,AU 2020/250026 A,2020-03-25,US 201962824190 P;;IB 2020052825 W,2019-03-26,"Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof","Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;PATTERSON ANDREW W;;SHAVLAKADZE TEA,,https://lens.org/111-829-723-517-986,Granted Patent,no,3,0,11,11,0,C07D498/18;;A61K31/436;;A61P19/00;;A61P3/04;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P19/10;;A61P37/00;;A61P13/12;;A61P25/02;;A61P19/02;;A61P9/12;;A61K45/06;;C07D498/18;;A61K31/436;;A61K45/06;;A61P1/16;;A61P13/12;;A61P35/00;;A61K2300/00;;A61K31/439;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P3/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P35/00;;A61P37/00,,1,1,021-697-234-144-141,10.1021/jo00101a006,"Luengo, J.I. et al., “Manipulation of the Rapamycin Effector Domain. Selective Nucleophilic Substitution of the C-7 Methoxy Group”, J. Org. Chem. 1994, 59, 22, 6512–6513; Pub: November 1, 1994; https://doi.org/10.1021/jo00101a006",ACTIVE
206,WO,A3,WO 2004/095297 A3,177-035-573-488-621,2004-12-09,2004,US 2004/0004219 W,2004-02-11,US 39607103 A,2003-03-25,A HIGH PERFORMANCE SERIAL BUS TESTING METHODOLOGY,"According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits.",INTEL CORP,NEJEDLO JAY;;WIZNEROWICZ MICHAEL;;ELLIS DAVID;;GLASS RICHARD S;;MARTWICK ANDREW;;SCHOENBORN THEODORE,,https://lens.org/177-035-573-488-621,Search Report,yes,3,0,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,PENDING
207,US,A1,US 2017/0083174 A1,100-146-718-468-292,2017-03-23,2017,US 201514884721 A,2015-10-15,US 201514884721 A;;US 201562221592 P,2015-09-21,Facilitating Selection of Attribute Values for Graphical Elements,"A computer-implemented technique is described herein for facilitating a user's interaction with graphical elements, such as emoji characters. The technique entails: presenting a collection of graphical elements on a display surface of a user interface mechanism; presenting a selector mechanism on the display surface that provides a plurality of attribute value options (such as skin tone options); receiving a selection by the user of one of the attribute value options, to provide a selected attribute value; globally modifying at least a subset of the graphical elements in the collection based on the selected attribute value, and displaying those modified graphical elements. In one approach, the technique presents the collection of graphical elements in an array that is capable of being panned along at least a first axis of movement. The technique reveals the selector mechanism when the user pans the array along a second axis of movement.",MICROSOFT TECHNOLOGY LICENSING LLC,TOBENS III JOSEPH BERNARD;;AVILLA GYANCARLO GARCÍA;;GLASS ANDREW STUART;;LOMAN COREY JOSEPH,MICROSOFT TECHNOLOGY LICENSING LLC (2015-10-12),https://lens.org/100-146-718-468-292,Patent Application,yes,0,51,6,6,0,G06F3/0482;;G06F3/0482;;G06F3/0237;;G06F3/0237;;G06F3/04817;;G06F3/04842;;G06F3/04845;;G06F3/04847;;G06F3/04847;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;G06F3/04883,G06F3/0482;;G06F3/0484;;G06F3/0485;;G06F3/0488,,0,0,,,,ACTIVE
208,US,A1,US 2018/0094496 A1,095-249-128-671-787,2018-04-05,2018,US 201715719672 A,2017-09-29,US 201715719672 A;;US 201662403054 P,2016-09-30,DOWNHOLE MILLING CUTTING STRUCTURES,"Systems, tools, and methods include using a milling assembly with a mill having multiple, different types of cutting element inserts. A gage region of the mill includes a first type of cutting element insert, and a shoulder region of the mill includes a second type of cutting element insert. One cutting element insert may include chip-breaking features, and the other may be a shear or gouging cutting element.",SCHLUMBERGER TECHNOLOGY CORP,SU ZHENBI;;PALANI VIJAYAKUMAR;;CHELLAPPA SUDARSANAM;;HU JIANBING;;GLASS CHRISTOPHER;;BURDETT TIMOTHY ANDREW,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-06-27);;WELLBORE INTEGRITY SOLUTIONS LLC (2019-12-31),https://lens.org/095-249-128-671-787,Patent Application,yes,12,13,3,3,0,E21B29/06;;E21B7/061;;E21B29/06;;E21B29/002;;E21B7/061;;E21B29/06,E21B29/00;;E21B7/06;;E21B10/26;;E21B29/06,,0,0,,,,ACTIVE
209,US,B2,US 10203843 B2,143-748-182-629-26X,2019-02-12,2019,US 201514884721 A,2015-10-15,US 201514884721 A;;US 201562221592 P,2015-09-21,Facilitating selection of attribute values for graphical elements,"A computer-implemented technique is described herein for facilitating a user's interaction with graphical elements, such as emoji characters. The technique entails: presenting a collection of graphical elements on a display surface of a user interface mechanism; presenting a selector mechanism on the display surface that provides a plurality of attribute value options (such as skin tone options); receiving a selection by the user of one of the attribute value options, to provide a selected attribute value; globally modifying at least a subset of the graphical elements in the collection based on the selected attribute value, and displaying those modified graphical elements. In one approach, the technique presents the collection of graphical elements in an array that is capable of being panned along at least a first axis of movement. The technique reveals the selector mechanism when the user pans the array along a second axis of movement.",MICROSOFT TECHNOLOGY LICENSING LLC,TOBENS III JOSEPH BERNARD;;AVILLA GYANCARLO GARCÍA;;GLASS ANDREW STUART;;LOMAN COREY JOSEPH,MICROSOFT TECHNOLOGY LICENSING LLC (2015-10-12),https://lens.org/143-748-182-629-26X,Granted Patent,yes,10,7,6,6,0,G06F3/0482;;G06F3/0482;;G06F3/0237;;G06F3/0237;;G06F3/04817;;G06F3/04842;;G06F3/04845;;G06F3/04847;;G06F3/04847;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;G06F3/04883,G06F3/0484;;G06F3/023;;G06F3/0481;;G06F3/0482;;G06F3/0485;;G06F3/0488,,17,0,,,"Emoji++ for iOS 8 Is the Best Alternative to Emoji Keyboard for iPhone (Oct. 3, 2014) http://cupertinotimes.com/emoji-ios-8-best-alternative-emoji-keyboard-iphone/.;;Search Report and Written Opinion for PCT/US2016/048812, dated Nov. 9, 2016, 11 pages.;;Horowitz, Paul, “Lose the Cartoon Yellow People Emoji! How to Access Diverse Emoji Icons in iOS,” available at <<http://osxdaily.com/2015/04/11/how-access-diverse-emoji-icons-ios/>>, OSXDaily, published on Apr. 11, 2015, 8 pages.;;“How to Use New Emojis on iOS 8.3,” available at <<https://www.youtube.com/watch?v=eEAXWu404vE>>, by Saint Huang TV, YouTube, three screen shots, published on Apr. 9, 2015, 4 pages.;;Walmsley, Will, “Mini Mode Mods, Speed Improvements, A *New Emoji* and More!,” available at <<http://minuum.com/category/ios/>>, Minuum, published on May 19, 2015, 22 pages.;;El Khoury, Rita, “[Live Long and Prosper] Whatsapp Adds Skin Tone Emojis and Spock Vulcan Salute on Android,” available at <<http://www.androidpolice.com/2015/06/30/live-long-and-prosper-whatsapp-adds-skin-tone-emojis-and-spock-vulcan-salute-on-android/>>, Android Police, published on Jun. 30, 2015, 4 pages.;;Clover, Juli, “OS X 10.10.3 and iOS 8.3 Beta 2 Updates Introduce New Emoji, Skin Tone Modifiers,” available at <<http://www.macrumors.com/2015/02/23/10-10-3-new emoji/>>, MacRumors, published on Feb. 23, 2015, 9 pages.;;Calore, Michael, “Use the New Emoji in Windows 10,” available at <<http://www.wired.com/2015/07/new-emoji-in-windows-10/>>, Wired, published on Jul. 29, 2015, 16 pages.;;Calimlim, Aldrin, “6 emoji keyboard apps for iOS to help you say more,” available at <<http://appadvice.com/appnn/2015/07/6-emoji-keyboard-apps-for-ios-to-help-you-say-more>>, AppAdvice, published on Jul. 17, 2015, 20 pages.;;“Settings + personalization,” available at <<http://www.windowsphone.com/en-us/how-to/wp8/settings-and-personalization/typing-shortcuts>>, Windows Phone, Microsoft Corporation, retrieved on Sep. 22, 2015, 3 pages.;;“RainbowKey Keyboard—color keyboard with HD background themes, fancy fonts and fun emoji,” available at <<https://itunes.apple.com/us/app/rainbowkey-keyboard-color/id915637540?mt=8>>, by Keyboard+, iTunes Preview, retrieved on Sep. 22, 2015, 3 pages.;;“Change Android Emoji Characters without Root,” available at <<https://www.youtube.com/watch?v=ha8zJe2aFEU&feature=youtu.be>>, by Fonts Free, YouTube, three screen shots, published on Mar. 22, 2015, 5 pages.;;Cantisano, Tim, “Diverse emojis arrive on Windows 10 build 10547,” available at <<http://www.neowin.net/news/diverse-emojis-arrive-on-windows-10-build-10547>>, Neowin LLC, retrieved on Sep. 22, 2015, 3 pages.;;Weir, Andy, “Windows 10 Mobile Insider Preview build 10547 is now being tested,” available at <<http://www.neowin.net/news/windows-10-mobile-insider-preview-build-10547-is-now-being-tested>>, Neowin LLC, retrieved on Sep. 22, 2015, 2 pages.;;Smith, David, “Emoji++ 1.2 with the new emoji skin tones is now available. Options at bottom of main list,” available at <<https://mobile.twitter.com/_davidsmith/status/618065629631877120>>, Twitter, Inc., Jul. 6, 2015, 2 pages.;;“Second Written Opinion Issued in PCT Application No. PCT/US2016/048812”, dated Aug. 25, 2017, 7 Pages.;;“International Preliminary Report on Patentability Issued in PCT Application No. PCT/US2016/048812”, dated Dec. 7, 2017, 8 Pages.",ACTIVE
210,EP,A2,EP 1606713 A2,159-904-199-984-906,2005-12-21,2005,EP 04710277 A,2004-02-11,US 2004/0004219 W;;US 39607103 A,2003-03-25,A HIGH PERFORMANCE SERIAL BUS TESTING METHODOLOGY,,INTEL CORP,NEJEDLO JAY;;WIZNEROWICZ MICHAEL;;ELLIS DAVID;;GLASS RICHARD S;;MARTWICK ANDREW;;SCHOENBORN THEODORE,,https://lens.org/159-904-199-984-906,Patent Application,yes,0,0,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,DISCONTINUED
211,US,A1,US 2011/0165188 A1,009-678-099-691-215,2011-07-07,2011,US 201113050143 A,2011-03-17,US 201113050143 A;;US 85698207 A;;US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP A DELAWARE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAY TSUN,INCYTE CORPORATION (2008-02-18);;INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION (2015-01-07),https://lens.org/009-678-099-691-215,Patent Application,yes,0,25,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,A61K39/12;;A61K31/341;;A61K31/381;;A61K31/42;;A61K31/423;;A61K31/496;;A61K31/5377;;A61K39/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/04;;A61P37/06;;C07D261/14;;C07D261/20;;C07D307/52;;C07D333/70;;C07D413/04;;C07D413/12;;C12N9/99,424/204.1;;548/246;;514/380;;424/277.1;;549/58;;514/443;;549/491;;514/461;;544/367;;514/254.04;;544/137;;514/236.8;;548/241;;514/379;;435/184;;424/184.1,5,4,054-269-121-291-520;;096-665-121-074-620;;025-212-543-652-454;;045-797-583-191-826,10.1038/nrd1031;;12612646;;10.1016/j.drudis.2008.03.026;;18954804;;19269363;;pmc2894612;;10.1016/j.cell.2009.02.024;;19461669;;10.1038/nrc2639,"Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205;;Schafer et al. Drug discovery Today 2008, 13 (21/22), 913-916.;;Horig et al. Journal of Translation Medicine 2004, 2(44); p. 1-8;;. Luo et al. Cel 136, March 6, 2009; 823-837;;Lob et al. Nature Reviews: Cancer, 9:445-452 (2009)",ACTIVE
212,WO,A2,WO 2004/095297 A2,168-470-418-232-933,2004-11-04,2004,US 2004/0004219 W,2004-02-11,US 39607103 A,2003-03-25,A HIGH PERFORMANCE SERIAL BUS TESTING METHODOLOGY,"According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits.",INTEL CORP,NEJEDLO JAY;;WIZNEROWICZ MICHAEL;;ELLIS DAVID;;GLASS RICHARD S;;MARTWICK ANDREW;;SCHOENBORN THEODORE,,https://lens.org/168-470-418-232-933,Patent Application,yes,0,3,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,PENDING
213,WO,A1,WO 2017/052986 A1,032-179-809-932-894,2017-03-30,2017,US 2016/0048812 W,2016-08-26,US 201562221592 P;;US 201514884721 A,2015-09-21,FACILITATING SELECTION OF ATTRIBUTE VALUES FOR GRAPHICAL ELEMENTS,"A computer-implemented technique is described herein for facilitating a user's interaction with graphical elements, such as emoji characters. The technique entails: presenting a collection of graphical elements on a display surface of a user interface mechanism; presenting a selector mechanism on the display surface that provides a plurality of attribute value options (such as skin tone options); receiving a selection by the user of one of the attribute value options, to provide a selected attribute value; globally modifying at least a subset of the graphical elements in the collection based on the selected attribute value, and displaying those modified graphical elements. In one approach, the technique presents the collection of graphical elements in an array that is capable of being panned along at least a first axis of movement. The technique reveals the selector mechanism when the user pans the array along a second axis of movement.",MICROSOFT TECHNOLOGY LICENSING LLC,TOBENS JOSEPH BERNARD III;;AVILLA GYANCARLO GARCIA;;GLASS ANDREW STUART;;LOMAN COREY JOSEPH,,https://lens.org/032-179-809-932-894,Patent Application,yes,2,0,6,6,0,G06F3/0488;;G06F3/0237;;G06F3/04847;;G06F3/0482;;G06F3/0485;;G06F3/0482;;G06F3/04883;;G06F3/0485;;G06F3/04842;;G06F3/04845;;G06F3/04817;;G06F3/0488;;G06F3/0237;;G06F3/04847,G06F3/0488;;G06F3/023;;G06F3/0482;;G06F3/0484;;G06F3/0485,,0,0,,,,PENDING
214,WO,A1,WO 2019/070774 A1,163-719-449-705-624,2019-04-11,2019,US 2018/0054049 W,2018-10-03,US 201715727442 A,2017-10-06,MULTIFINGER TOUCH KEYBOARD,"Implementations described herein provide a multifinger keyboard that is generated based on detected input. Each key of the multifinger keyboard includes multiple input zones, which are positioned and dimensioned to correlate with a present orientation of a user's fingers. The multifinger keyboard is automatically regenerated to account for drift and other changes in position of a user's hand relative to the keyboard, thereby providing reliable targeting without requiring physical homing indicators. Each input zone may be associated with different output values, such that applying different input types to a single input zone results in different outputs. Potential outputs are determined based on concurrent inputs received at the multifinger keyboard, from which a final output is generated.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;ESPINOZA REYES RICARDO ARTURO;;QUAN RAYMOND;;KHUT SOPHORS;;KLEIN CHRISTIAN,,https://lens.org/163-719-449-705-624,Patent Application,yes,1,0,2,2,0,G06F2203/04808;;G06F3/04886;;G06F3/04166;;G06F2203/04808;;G06F3/04166;;G06F3/0412;;G06F3/0426;;G06F3/04883;;G06F3/04886;;G06F2203/04104,G06F3/0488,,0,0,,,,PENDING
215,US,B2,US 10648266 B2,171-758-578-894-558,2020-05-12,2020,US 201715719672 A,2017-09-29,US 201715719672 A;;US 201662403054 P,2016-09-30,Downhole milling cutting structures,"Systems, tools, and methods include using a milling assembly with a mill having multiple, different types of cutting element inserts. A gage region of the mill includes a first type of cutting element insert, and a shoulder region of the mill includes a second type of cutting element insert. One cutting element insert may include chip-breaking features, and the other may be a shear or gouging cutting element.",WELLBORE INTEGRITY SOLUTIONS LLC,SU ZHENBI;;PALANI VIJAYAKUMAR;;CHELLAPPA SUDARSANAM;;HU JIANBING;;GLASS CHRISTOPHER;;BURDETT TIMOTHY ANDREW,SCHLUMBERGER TECHNOLOGY CORPORATION (2019-06-27);;WELLBORE INTEGRITY SOLUTIONS LLC (2019-12-31),https://lens.org/171-758-578-894-558,Granted Patent,yes,17,1,3,3,0,E21B29/06;;E21B7/061;;E21B29/06;;E21B29/002;;E21B7/061;;E21B29/06,E21B29/06;;E21B7/06;;E21B10/26;;E21B10/43;;E21B29/00,,0,0,,,,ACTIVE
216,CN,A,CN 108027708 A,076-744-164-086-410,2018-05-11,2018,CN 201680054896 A,2016-08-26,US 201562221592 P;;US 201514884721 A;;US 2016/0048812 W,2015-09-21,FACILITATING SELECTION OF ATTRIBUTE VALUES FOR GRAPHICAL ELEMENTS,"A computer-implemented technique is described herein for facilitating a user's interaction with graphical elements, such as emoji characters. The technique entails: presenting a collection of graphical elements on a display surface of a user interface mechanism; presenting a selector mechanism on the display surface that provides a plurality of attribute value options (such as skin tone options);receiving a selection by the user of one of the attribute value options, to provide a selected attribute value; globally modifying at least a subset of the graphical elements in the collection based on the selected attribute value, and displaying those modified graphical elements. In one approach, the technique presents the collection of graphical elements in an array that is capable of being panned along at least a first axis of movement. The technique reveals the selector mechanism when the user pans the array along a second axis of movement.",MICROSOFT TECHNOLOGY LICENSING LLC,TOBENS JOSEPH BERNARD III;;AVILLA GYANCARLO GARCIA;;GLASS ANDREW STUART;;LOMAN COREY JOSEPH,,https://lens.org/076-744-164-086-410,Patent Application,no,9,0,6,6,0,G06F3/0482;;G06F3/0482;;G06F3/0237;;G06F3/0237;;G06F3/04817;;G06F3/04842;;G06F3/04845;;G06F3/04847;;G06F3/04847;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;G06F3/04883,G06F3/0488;;G06F3/023;;G06F3/0482;;G06F3/0484;;G06F3/0485,,0,0,,,,ACTIVE
217,US,A1,US 2008/0125470 A1,049-572-945-936-724,2008-05-29,2008,US 85696707 A,2007-09-18,US 85696707 A;;US 84570006 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,INCYTE CORPORATION (2007-11-14),https://lens.org/049-572-945-936-724,Patent Application,yes,23,38,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,A61K31/426;;A61K31/41;;A61K31/42;;A61P35/00;;C07D249/04;;C07D261/06;;C07D277/20,514/365;;548/247;;514/378;;548/205;;514/359;;548/255,0,0,,,,DISCONTINUED
218,CA,C,CA 2663057 C,191-452-541-374-472,2015-12-08,2015,CA 2663057 A,2007-09-18,US 84570006 P;;US 2007/0078745 W,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxy-genase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,,https://lens.org/191-452-541-374-472,Granted Patent,no,0,0,12,12,3,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,C07D413/04;;A61K31/415;;A61K31/4155;;A61K31/416;;A61K31/426;;A61P11/06;;A61P25/00;;A61P31/18;;A61P35/00;;A61P37/00;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04,,0,0,,,,ACTIVE
219,US,B2,US 8507541 B2,051-313-511-556-383,2013-08-13,2013,US 201113050143 A,2011-03-17,US 201113050143 A;;US 85698207 A;;US 84571106 P,2006-09-19,"N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;TSUN YUE EDDY WAI;;INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;TSUN YUE EDDY WAI,INCYTE CORPORATION (2008-02-18);;INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION (2015-01-07),https://lens.org/051-313-511-556-383,Granted Patent,yes,93,19,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,A61K31/42;;C07D261/04;;C07D261/06;;C07D261/14,514/378;;514/380;;548/246;;548/247,110,59,054-269-121-291-520;;096-665-121-074-620;;025-212-543-652-454;;045-797-583-191-826;;063-737-191-858-685;;019-144-908-782-085;;013-795-773-731-248;;150-844-364-749-880;;001-981-252-196-562;;119-988-487-690-208;;041-260-008-634-373;;060-816-653-258-219;;018-422-129-096-212;;007-364-858-655-289;;026-270-626-648-305;;075-322-609-792-62X;;100-742-147-618-920;;009-541-274-056-984;;087-879-787-031-413;;106-638-472-601-725;;061-374-522-112-878;;071-965-807-311-691;;027-669-605-545-017;;040-157-485-027-187;;061-110-170-968-832;;086-128-066-686-790;;002-816-771-338-232;;127-248-406-139-331;;096-471-577-709-81X;;009-330-869-368-477;;028-331-912-923-91X;;063-541-481-824-649;;161-405-813-595-448;;140-525-380-092-494;;000-520-585-022-212;;092-741-017-671-560;;025-627-873-839-996;;114-933-881-301-004;;015-744-840-542-520;;069-000-610-116-224;;042-407-807-346-693;;095-857-079-995-273;;028-209-249-873-397;;086-952-678-103-889;;039-435-249-119-479;;083-988-154-360-900;;100-929-438-538-20X;;101-928-902-806-784;;177-592-739-522-677;;135-595-543-209-072;;004-004-562-734-326;;068-152-976-614-195;;047-947-610-785-552;;078-857-123-705-83X;;017-659-115-243-161;;036-456-403-198-974;;004-616-072-707-912;;112-371-958-795-838;;048-538-161-726-58X,10.1038/nrd1031;;12612646;;10.1016/j.drudis.2008.03.026;;18954804;;19269363;;pmc2894612;;10.1016/j.cell.2009.02.024;;19461669;;10.1038/nrc2639;;16930024;;10.1021/jo060793t;;10.1021/ol026483o;;12182612;;10.1007/bf01165710;;10.1007/bf01169945;;10.1007/bf00475617;;10.1007/bf02253172;;10.1007/bf00476969;;10.1007/bf01169844;;10.3987/com-03-9833;;10.1002/jps.2600660104;;833720;;1722946;;10.1007/978-1-4684-5952-4_39;;10.1158/1535-7163.mct-08-0149;;19139110;;pmc3418602;;10721095;;10.1007/978-1-4615-4709-9_64;;10.1135/cccc19900728;;8097319;;pmc46336;;10.1073/pnas.90.8.3539;;12209992;;10.1002/ijc.10645;;925862;;10.1248/yakushi1947.97.6_689;;10.1248/cpb.39.301;;10.1248/cpb.22.2211;;10.1248/cpb.19.1731;;10.3987/com-93-s33;;12738417;;10.1016/s1471-4906(03)00072-3;;10.4049/jimmunol.164.7.3596;;10725715;;10.1248/cpb.23.2643;;10.1248/cpb.44.967;;10.1248/cpb.45.832;;16034082;;10.4049/jimmunol.175.3.1456;;20124451;;10.1158/1535-7163.mct-09-0628;;10.3987/s-1981-01-0293;;10.3987/r-1982-02-0339;;10.1007/bf00809014;;10.1080/00397918808078813;;10.2174/156800909790192374;;20025603;;10.1046/j.1365-2567.2002.01390.x;;pmc1782674;;11985668;;10.1080/00304940409458679;;10.1021/ci700018y;;17910431;;15711557;;10.1038/nm1196;;10.1126/science.281.5380.1191;;9712583;;10.1126/science.1073514;;12228717;;15254595;;10.1172/jci21583;;pmc449750;;10.1172/jci200421583;;10.1002/chin.200049106;;10.1002/prep.19950200103;;11937550;;10.4049/jimmunol.168.8.3941;;15961516;;pmc1895260;;10.1182/blood-2005-04-1403;;10.1016/j.mencom.2008.05.017;;10.1023/a:1021668216426;;10.1023/b:rucb.0000035644.16331.f0;;10.1007/bf00807600;;7354029;;10.1016/s0021-9258(19)86035-0;;10.1016/s0021-9258(19)77982-4;;3123485;;10.1096/fasebj.5.11.1907934;;1907934;;pmc2196057;;10.1084/jem.20020052;;12186837;;10.1038/nm934;;14502282;;10.1002/jlac.19294750106;;19177477;;10.1002/chem.200802160,"Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.;;Schafer et al. Drug discovery Today 2008, 13 (21/22), 913-916.;;Horig et al. Journal of Translation Medicine 2004, 2(44); p. 1-8.;;Luo et al. Cel 136, Mar. 6, 2009; 823-837.;;Lob et al. Nature Reviews: Cancer, 9:445-452 (2009).;;Corbett et al. In vivo methods for screening and preclinical testing. Cancer Drug Discovery and Development: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, 2nd Ed. Teicher, B.A. and Andrews, P.A., Gumana Press Inc., Totowa, NJ, 2004*.;;Current Protocols in Immunology, vol. 4, Coligan, J.E., et al; Immunotherapy of Cancer, Human Press, 2006, Disis, M.L.*.;;Greene, et al., Protective Groups in Organic Synthesis, 2d. Ed., Wiley & Sons, 1991*.;;Higuchi et al., ""Pro-drugs as Novel Delivery Systems,"" vol. 14 of the A.C.S. Symposium Series Bioreversible Carriers in Drug Design, ed. Edward B. Roche, American Pharmaceutical Association and Pergamon Press, 1987*.;;Roche, Edward B., Bioreversible Carriers in Drug Design, ed., American Pharmaceutical Association and Pergamon Press, 1987*.;;Sambrook, J, Russel, D. Molecular Cloning: A laboratory Manual (3rd edition). Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY, USA. 2001*.;;A.R. Katritzky et al., ""Synthesis of mono and symmetrical di-N-hydroxy- and N-aminoguanidines"", Journal of Organic Chemistry, 71(18):6753-8 (2006).;;Ait-Mohand, Samia. and Dolbier, Jr. William R., ""New and Convenient Method for Incorporation of pentafluorosulfanyl (SF5) Substituents Into Aliphatic Organic Compounds"", Organic Letters, 4(17), 3013-3015, 2002.;;Andrianov et al. ""Degenerate Rearrangement of 3-amino-1,2,5-oxadiazole-4-carboxamidoxime"", Khimiya Geterotsiklicheskikh Soedinenii, (1988), (12), 1701 (and abstract Database Hcaplus, on STN, 1989:515108, No. 111:115108).;;Andrianov et al., ""Acid halides of 4-aminofurazan-3-carbohydroxamic acids"", Chemistry of Heterocyclic Compounds, Latvian Institute of Organic Chemistry, vol. 30, 3:370-371 (1994) (English translation of Khimiya Geterotsiklicheskikh Soedinenii, (1994), (3), 420-21) and abstract Database Hcaplus STN File CA, 1995:376582; 123:198702.;;Andrianov et al., ""Ring formation reactions of 4-aminofurazan-3-carboxyamidoximes"", Chemistry of Heterocyclic Compounds, 30(4):470-474 (1993) (English translation of Andrianov et al., ""4-aminofurazan-3-carboxamidoxime cyclization"", Khimiya Geterotsiklicheskikh Soedinenii (4):534-8 (1994) (and abstract Database Caplus No. 1995:393128; 122:290788).;;Andrianov et al., ""4-aminofurazan-3-hydroximic halides"", Institute of Organic Synthesis, 5:581-585 (1992) translation of ""Acid halides of 4-aminofurazan-3-carbohydroximic acid"", Khimiya Geterotsiklicheskikh Soedinenii, (1992), (5), 687-91 and abstract Database Hcaplus, on STN, 1993:212973, No. 118:212973.;;Andrianov et al., ""Rearrangements of 1-oxa-2-azoles. 2. Structure and isomerization of pentamethyleneamidoximes of 4-aminofurazan-3-carboxylic acid"", Khimiya Geterotsiklicheskikh Soedinenii, (1991), (1), 122-3 (and abstract Database Hcaplus, STN, 1991:449555, No. 115:49555).;;Andrianov et al., ""Rearrangements of 5-trifluoromethyl-1,2,4-oxadiazoles by action of ammonia and amines"", Institute of Organic Synthesis, Academy of Sciences of the Latvian SSR, p. 707 translation of ""Ammonia- and amine-induced rearrangements of 5-(trifluoromethyl)-1,2,4-oxadiazoles"", Khimiya Geterotsiklicheskikh Soedinenii, (1988), (6), 856-7 and abstract Database Hcaplus, on STN, 1989:212695, No, 110:212695).;;Andrianov et al., ""Synthesis and properties of derivatives of 4-aminofuroxan-3-carboxylic acid"", Chemistry of Heterocyclic Compounds, 33(8), 973-976 (1997), translation of Khimiya Geterotsiklicheskikh Soedinenii, (1997) No. 8, pp. 1115-1119 and abstract Database Hcaplus, on STN, 1998:221958, No. 128:308445.;;Andrianov et al., ""Synthesis of furazans by rearrangement of 3-acyl-1-oxa-2-azole oximes"", UDC 547.793.07(047) 2611(90):1199-1213 (1991), Institute of Organic Synthesis, Academy of Science of the Latvian SSR, (Translation of Khimiya Geterotsiklicheskikh Soedinenii, (1990) No. 11, pp. 1443-1459).;;Andrianov et al., ""Synthesis, structure, and rearrangement of 4-aminofurazan-3-carboxamide oximes"", UDC 547.793.2, 29(5):877-880 (1994), (translation of Zhurnal Organicheskoi Khimii, (1993), 29(5), 1062-6) and abstract Database Hcaplus, on STN, 1994:270259, No. 120:270259.;;Andrianov, et al., ""Synthesis and properties of 4-amino-3-cyanofurazan"", Chemistry of Heterocyclic Compounds, vol. 30, No. 5, pp. 608-611 (1994), translation of Khimiya Geterotsiklicheskikh Soedinenii, (5), 693-6 (1994) with abstract Database Hcaplus, on STN 1995:374071, No. 123:198701.;;Areschka et al., ""Studies on the benzofuran series. LXI. 3-Benzofuranylacetamidoximes with antihypertenstive potential"", European Journal of Medicinal Chemistry, (1977), 12(1), 87-91 (with English abstract).;;Beaudegnies et al., ""Synthesis of furazan conjugated new heterocycles"", Heterocycles, (2003), 60(11), 2417-2424 and abstract Database Hcaplus, on STN, 2003:865834, No. 140:59538.;;Belik et al., ""Descriptor v'cp-aided study of the rearrangement of 1-oxa-2-azoles"", Zhurnal Organicheskoi Khimii, 30(5), 757-9 (1994) with abstract STN File CA, 122:238877; 1995:326366.;;Belik, et al., ""Theoretical investigation of rearrangements of 1-oxa-2-azole-3-carboxamidoximes"", Russian Journal of Organic Chemistry, 34(4), 543-548 (1998) (Translation of Zhurnal Organicheskoi Khimii 34(4), 577-582) (with abstract STN File CA, 130:209340; 1999:79495).;;Berge, et al., ""Pharmaceutical Salts"", J. of Pharmaceutical Science, vol. 66 No. 1, pp. 1-19 (1977).;;Brown, et al., ""Implications of Interferon-induced Tryptophan Catabolism in Cancer, Auto-immune Diseases and Aids"", Adv. Exp. Med. Biol., 294: 425-35 (1991).;;Burger et al., ""Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo,"" Mol. Cancer Ther 2009;8(1) Jan. 2009, 26-35.;;Chauhan et al., ""Antifilarial profile of substituted pyrazoles: a new class of antifilarial agents,"" Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1993), 32B(8), 858-61 (with abstract Database Hcaplus STN File CA, 120:244819; 1994:244819).;;Database CAPLUS, on STN, 1963: 73272, No. 83, 12528c-e, see RN 90585-88-9 CAPLUS, XP-002467962 dated May 2, 2008, (abstract of Sycheva, et al. ""Compaunds with Potential Antitubercular Activity. VI. Amidoximes, amide Hydrazones, and S-Oxides of Thioamides of some Heterocyclic acids"", (1962) 32, 3669-74) (1page).;;Database CAPLUS, on STN, 1966: 35828, No. 64, 6633a-d, see RN 4698-75-3 CAPLUS, XP-002467245 dated May 2, 2008 (abstract of Sycheva, et al., ""Compaunds with Potential Antitubercular Activity. X. Derivatives of Benzoxazole-2-carboxylic acid"", (1965) 46-51 (1 page).;;Database CAPLUS, on STN, 1975:606233, No. 83: 32463a, 32466a, see RN 5 5942-51-3 CAPLUS, XP-002467961 dated May 2, 2008 (abstract of Nishimura, Haruki et al., JP Patent No. 50050369, issued May 6, 1975 ""Amidoxime Derivatives"",) (1 page).;;Database CAPLUS, on STN, 1992: 6493, No. 116, 6493, XP-002467964, RN 137890-17-6 dated Jun. 2, 2008, (abstract of Andrianov, et al., ""Rearrangements of 1-oxa-2-azoles. 4. synthesis and rearrangement of Amidoximes of soxazole-and 4,5-dihydrosoxazole-3-carboxylic acid"", (1991) (6), 827-32) (1 page).;;Daubener, et al., ""IFN-gamma Activated Indoleamine 2,3-Dioxygenase Activity in Human Cells Is an Antiparasitic and an Antibacterial Effector Mechanism"", Adv. Exp. Med. Biol., 467: 517-24 (1999).;;Deeb et al., ""Heterocyclic synthesis from 3-amino-4-cyanopyrazole,"" Collection of Czechoslovak Chemical Communications (1990), 55(3), 728-33 (with abstract Database Hcaplus STN File CA, 113:97502; 1990:497502).;;Dranoff et al., ""Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity,"" Proc. Natl. Acad. Sci, USA. 90:3539-3543 (1993).;;El-Mobayed et al., ""Synthesis of heterocyclic compounds containing nitrogen and sulfur from 3-amino-4-cyanopyrazole,"" Journal of the Chemical Society of Pakistan (1989), 11(4), 287-90 (with abstract Database Hcaplus STN File CA, 113:231330; 1990:631330).;;Friberg, M., Jennings, R., et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer: 101:151-155, 2002.;;Fujii, et al., ""Antitumor activities of some fifty compounds related to adenine derivatives,"" Yakugaku Zasshi (1977), 97(6), 689-91(with abstract Database Hcaplus STN File CA, 87:111278; 1977:511278).;;Fujii et al., ""Purines. XLVIII. Syntheses and proton nuclear magnetic resonance study of 2-deuterioadenines substituted or unsubstituted at the 9-position and of their N-oxygenated derivatives,"" Chemical & Pharmaceutical Bulletin (1991), 39(2), 301-8 (with abstract Database Hcaplus STN File CA, 114:247645; 1991:247645).;;Fujii et al., ""Purines. XV. Conversion of N,9-dimethyladenine into the 1,9-dimethyl isomer. Reverse operation of the dimroth rearrangement,"" Chemical & Pharmaceutical Bulletin (1974), 22(10), 2211-16 (with abstract Database Hcaplus STN File CA, Abstract 82:43349; 1975:43349).;;Fujii et al., ""Purines. V. Dimroth rearrangement of 1-alkoxyadenines. Synthesis of N-alkoxyadenines,"" Chemical & Pharmaceutical Bulletin (1971), 19(8), 1731-4 (with abstract Database Hcaplus STN File CA, Abstract 75:110279; 1971:510279).;;Fujii et al., ""Purines. III. Rearrangement of 1-alkoxy-9-alkyladenines to 6-alkoxyamino-9-alkylpurines through isolatable N'-alkoxy-l-alkyl-5-formamidoimidazole-4-carboxamidines,"" Tetrahedron (1971), 27(12), 2415-23 (with abstract Database Hcaplus STN File CA, Abstract 75:76739; 1971:476739).;;Fujii et al., ""Oxidation of N6-benzyladenine with m-chloroperoxybenzoic acid: formation of the N(1)-oxide,"" Heterocycles (1994), 37(1), 219-22 (with abstract Database Hcaplus STN File CA, 121:35143; 1994:435143).;;Grohmann, et al., ""Tolerance, DCs and tryptophan: much ado about IDO"", Trends Immunol., 24: 242-8 (2003).;;Hwu P, et al., ""Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation"", J. Immunol. 164(7):3596-9, (2000).;;Ichikawa, T. et al., ""A new synthesis of adenine and 4-aminoimidazole-5-carboxamide"", Central Research Laboratories, Ajinomoto Co., Inc., pp. 253-255 (1965).;;Itaya et al., ""Purines. XVIII. Kinetic studies of the Dimroth rearrangement of 1-alkoxy-9-methyladenines and 1-benzyloxyadenosine. Effect of 1-benzyloxy and 9-beta-D-ribofuranosyl groups on the rates of the ring opening and the reclosure,"" Chemical & Pharmaceutical Bulletin (1975), 23(11), 2643-53 (with abstract Database Hcaplus STN File CA, Abstract 84:44592; 1976:44592).;;Itaya et al., ""Purines. LXXII. Oxidation of N6-alkyladenines with m-chloroperoxybenzoic acid leading to N6-alkyladenine 1-oxides,"" Chemical & Pharmaceutical Bulletin (1996), 44(5), 967-971, (with abstract Database Hcaplus STN File CA, 125:86583; 1996:325165; CAS RN 155720-89-1).;;Itaya et al., ""Purines. LXXV. Dimroth rearrangement, hydrolytic deamination, and pyrimidine-ring breakdown of 7-alkylated 1-alkoxyadenines: N(1)-C(2) versus N(1)-C(6) bond fission,"" Chemical & Pharmaceutical Bulletin (1997), 45(5), 832-841(with abstract Database Hcaplus STN File CA, 127:65632, 1997:349657).;;Ji, et al., ""Provision of Granulocyte-Macrophage Colony-Stimulating Factor Converts an Autoimmune Response to a Self-Antigen into an Antitumor Response"", J. Immunol, 2005, 175:1456-63.;;Koblish, et al., ""Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors"", Molecular Cancer Therapeutics, 9(2):489-498 (Published Online Feb. 2, 2010 at 10.1158/11535-7163.MCT-09-0628).;;Koblish, et al., ""Potent, Orally Active Hydroxylamidine Inhibitors of Indoleamine-2,3-dioxygenase Suppress Growth of IDO1-expressing Tumors through Systemic Inhibition of Tryptophan Catabolism"", 24th Annual Meeting of the International Society for the Biological Therapy of Cancer (ISBTC) in National Harbor MD/Washington DC (Oct. 30, 2009) (poster-1 page) and abstract J. Immunother. vol. 32, No. 9 (2009) p. 1005.;;Kocevar et al., ""Some new synthetic approaches for the preparation of pteridine 3-oxides and pteridines,"" Heterocycles (1981), 15(1), 293-6 (with abstract Database Hcaplus STN File CA, 94:121470; 1981:121470).;;Kocevar et al., ""New synthetic approach for pyrazolo[3,4-b] pyrazines and isoxazolo[4,5-b] pyrazines,"" Heterocycles (1982), 19(2), 339-42 (with abstract Database Hcaplus STN File CA, 96:162655; 1982:162655).;;Kocevar et al., ""Neighboring group participation in formation of condensed azines. Formation of pyrazolo[3,4-b]pyrazines, isoxazolo[4,5-b]pyrazines and isothiazolo[5,4-b]pyridine. Heterocycles, CCX,"" Monatshefte fuer Chemie (1982), 113(6-7), 731-44 (with abstract Database Hcaplus STN File CA, 97:182276; 1982:582276).;;Kocevar et al., ""Simple Procedure for the Synthesis of Pyridinecarbohydroximoyl Chlorides and Bromides"", Synth. Commun., 18(12), 1427-1432 (1988).;;Liu et al., ""Estimation and prediction on heats of formation for nitro furazan series compounds with new molecular subgraph"", Huaxue Wuli Xuebao, (2002), 15(5), 351-356 and abstract Database Hcaplus, on STN, 2002:880171, No. 138:204550.;;Liu, et al., ""INCB024360, a Potent and Selective Inhibitor of Indoleamine 2,3-dioxygenase (IDO1) as a Novel Cancer Immunotherapeutic Agent"", Mol Cancer Ther, 8(12 Suppl):Poster #C106 (2009).;;Liu, et al., ""Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy"", Current Cancer Drug Targets, 9:938-952 (2009).;;Logan, et al., ""HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity"", Immunology, 105: 478-87 (2002).;;Longo, G., ""Dioximes. LXXVIII"", Gazzetta Chimica Italiana, (1931), 61, 575-83 (and abstract Database Hcaplus, on STN, 1932:6117, No. 26:6117).;;Medawar, ""Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates"", Symp. Soc. Exp. Biol. 7: 320-38 (1953).;;Meyer, Kevin G., ""Improved synthesis of 3-aminofurazan-4-carboxylic acid"", Organic Preparations and Procedures INt. 36(4):361-362 (2004).;;Milletti et al,, ""New and Original pKa Prediction Method Using Grid Molecular Interaction Fields"", Journal of Chemical Information and Modeling, 2007, 47(6), 2172-2181 and abstract Database Hcaplus, on STN, 2007:1104249, No. 148:33199.;;Mishnev et al., ""Crystal and molecular structure of isomers of the oxime of 3-aminofurazanoyl piperidine"", Institute of Organic Synthesis, Latvian Academy of Sciences, pp. 349-352 translation of Zhurnal Strukturnoi Khimii, 32(3):45-48 (1991).;;Muller et al., ""Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy"", Nature Med., 11:312-9 (2005).;;Munn et al., ""Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism"", Science 281: 1191-3 (1998).;;Munn et al., ""Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase"", Science 297: 1867-70 (2002).;;Munn et al., ""Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes"", J. Clin. Invest., 114(2): 280-90 (2004).;;Nekrasov et al., ""Effect of particular structural features of aminooximes on formation of final products in reactions with 5-aryl-2,3-dihydrofuran-2,3-diones"", Russian Journal of Organic Chemistry, (2000), 36(2), 263-268, (Translation of Zhurnal Organicheskoi Khimii,vol. 36, No. 2 (2000) pp. 285-90) and abstract Database Hcaplus, on STN, 2000:643842, No. 133:321845.;;Peterson et al., Evaluation of Functionalized Tryptophan Derivatives and related Compounds as Competitive Inhibitors of Indoleamine 2,3-Dioxygenase Med. Chem. Res. 3, 531-544, (1994).;;Physicians' Desk Reference (PDR, e.g., 1996 edition, Medical Economics Company, Montvale, NJ) Zh. Org. Chim. (1993), 29, 1062-1066.;;Pivina et al., ""Comparative characteristic of energy content calculating methods for the furazan series as an example of energetic materials"", Propellants, Explosives, Pyrotechnics, (1995), 20(1) 5-10 and abstract Database Hcaplus, on STN, 1995:464236, No. 122:217824.;;Poluektova et al., ""Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis"", J. Immunol., 168(8):3941-9 (2002).;;Potula et al., ""Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis"", Blood, 106:2382-90 (2005).;;Rakitin et al., ""Reaction of furoxannitrolic acids with nitrogen tetroxide"", Khimiya Geterotsiklicheskikh Soedinenii, (1993), (9), 1283-7 (with abstract Database Hcaplus, on STN, 1994:244883, No. 120:244883).;;Rakitin et al., ""Synthesis of Furaxanenitrolic acids"", N. D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences, 117913 Moscow pp. 952-954 (1994), Translated from Khimiya Geterotsiklicheskikh Soedinenii,(1993), (8), 1117-19 (with abstract Database Hcaplus, on STN, 1994:164073, No. 120:164073).;;Ravin, Louis J., ""Preformulation"", Remington's Pharmaceutical Sciences, 17th ed., Mack Publishing Company, Easton, PA., Chapter 76, pp. 1409-1423 (1985).;;Riffaud, et al., ""Sur les propriétiés analqésiques at antiinflammatoires des benzofuryl-2 amidoximes"", European Journal of Medicinal Chemistry, Editions Scientifique Elsevier, Paris, Fr., vol. 1796, pp. 577-580, (1982) (please see ISRPCTUS2007078759 regarding the relevance of this reference).;;Robev et al., ""Pharmacological study of newly synthesized 2-phenyl-4-anilinopyrimidine-5-amidoxime,"" Doklady Bolgarskoi Akademii Nauk (1982), 35(10), 1451-4 (with abstract Database Hcaplus STN File CA, 98:191493; 1983:191493).;;Romanova et al., ""Synthesis and reactivity of azidomes: III 1-Azido (4-amino-1, 2, 5-oxadiazol-3-yl) aldoxime in the Cycloaddtion Reaction,"" Russian I of Org. Chem., 39(4), 574-578 (translation of Zhurnal Organicheskoi Khimii, vol. 39 No. 4, pp. 610-615 (2003)).;;Rozhov et al., ""Synthesis of 1,2,4-oxadiazole-, pyrrole- and 1,2,3-triazole-substituted (1,2,3-triazol-1-yl)furazans"", Mendeleev Communications, 2008, 18(3), 161-163 and abstract Database Hcaplus, on STN, 2008:880463, No. 150:352019.;;Sako, ""Product class 19: pyridopyrimidines,"" Science of Synthesis (2004), 16, 1155-1267 (and abstract Database Hcaplus STN File CA, 142:197902; 2004:205975).;;Scherle, P., ""Characterization of Novel and Potent Inhibitors of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase (IDO) for Use as Cancer Therapy"" presented on Mar. 5, 2009 at the Translational Research Cancer Center Consortium annual meeting in Philadelphia, PA.;;Search Run STN International ""11641284"" dated Jan. 16, 2009 (93 pages).;;Search Run Jul. 13, 2010/Scifinder, 10 pages.;;Search Run Jul. 28, 2009 / HCAPLUS, 95 pgs.;;Search Run Jul. 28, 2009/Registry File Compounds, 107 pgs.;;Shaposhnikov et al., ""New Heterocycles with a 3-Aminofurazanyl Substituent"", Russian Journal of Organic Chemistry, (2002), 38(9), 1351-1355, (Translation of Zhurnal Organicheskoi Khimii, (2002), 38(9), 1405-8, and abstract Database Hcaplus, on STN, 2002:953422, No. 138:368816.;;Sheremetev et al., ""Hydroxylammonium salts of Furazan family"", International Annual Conference of ICT (2003), 34th, 101/1-101/10 and abstract Database Hcaplus, on STN, 2003:641413, No. 139:383553.;;Sheremetev et al., ""Synthesis of secondary and tertiary aminofurazans"", Russian Chemical Bulletin 53(3), 596-614 (2004), translation from Izvestiya Akademii Nauk, Seriya Khimicheskaya, 53(3), pp. 569-586 (Mar. 2004) (and abstract Database Caplus No. 2004:589877; 142:219211).;;Sherif et al., ""Syntheses with heterocyclic beta-enaminonitriles. An expeditious synthetic approach to polyfunctionally substituted 5-phenyl-sulfonylthiophenes and their fused derivatives,"" Monatshefie fuer Chemie (1997), 128(6/7), 687-696 (with abstract Database Hcaplus STN File CA, 127:331458; 1997:619483).;;Sinditskii et al., ""Study on combustion of new energetic furazans"", 29th International Annual Conference of ICT (Jun. 30-Jul. 3, 1998) (Energetic Materials), 170.1-170.11 and abstract Database Hcaplus, on STN, 1998:498929, No. 129:163569.;;Sono, et al., ""Indoleamine 2,3-Dioxygenase"", J. Biol. Chem. 255(4), 1339-1345 (1980).;;Spasova et al., ""Certain derivatives of pyrazole as potential antimetabolites of 4(5)-amino-imidazole-5(4)-carboxamide,"" Progress in Chemotherapy, (Antibacterial, Antiviral, Antineoplast.), Proceedings of the 8th International Congress of Chemotherapy Athens 1973, vol. 3, 841-4 (with abstract Database Hcaplus STN File CA, 84:54765; 1976:54765).;;Spasova et al., ""Inhibition of the growth of L. casei by some pyrazole analogues of 5(4)-aminoimidazole-4(5)-carboxamide,"" Doklady Bolgarskoi Akademii Nauk (1975), 28(11), 1517-20 (with abstract Database Hcaplus STN File CA, Abstract 84:99208; 1976:99208).;;STN File CA, Abstract 145:457146 (abstract of Wang et al, ""Experimental study on synthesis of 3-amino-4-chloroximinofurazan"" Hanneng Cailiao (2005), 13 (Suppl.), 1-3) (1 page).;;Takikawa et al., ""Mechanism of Interferon-gammaAction,"" J. Biol. Chem. 263(4):2041-8 (1988).;;Taylor, et al., ""Relationship between Interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism"", FASEB J., 5:2516-22 (1991).;;Terness, P. et al., ""Inhibition of Allogenieic T cell Proliferation by Indoleamine 3,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites"", J.Exp. med., 196,(4),447-457, (2002).;;Tselinskii et al., ""Synthesis and reactivity of carbohydroximoyl azides: II. 4-substituted 1,2,5-oxadiazole-3-carbohydroximoylazides and 1-hydroxy-5-(4-R-1,2,5-oxadiazol-3-yl)tetrazoles"", Russian Journal of Organic Chemistry, (2001), 37(11), 1638-1642, translation of Zhurnal Organicheskoi Khimii (2001), 37(11), 1708-1712 (with abstract Database Hcaplus, on STN, 2002:200728, No. 137:20337).;;Uyttenhove, et al., ""Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase"", Nat. Med., 9(10):1269-1274, (2003).;;Wieland et al, ""Zur Konstitution der polymeren Knallsauren. Pericyanilsaure, Epicyanilsaure und Metacyanilsaure"", Eingelaufen am 25 pp. 54-78 (1929).;;Wieland et al., ""Zur Konstitution der polymeren Knallsauren. X"", Aus dem Chem. Laboratorium der Bayr. Akademie der Wissenschaften zu Munchen, Eingelaufen am 23, pp. 43-53 (1929).;;Wang et al., ""Synthesis of 3-amino-4-aminoximidofurazan and its crystal structure"", Hecheng Huaxue, (2006), 14(3), 234-239 (with abstract Database Hcaplus, on STN, 2006:616681, No. 146:206250.;;Wang et al., ""Furazan-functionalized tetrazolate-based salts: a new family of insensitive energetic materials"", Chemistry-A European Journal, 2009, 15(11), 2625-2634 and abstract Database Hcaplus, on STN, 2009:347940, No. 150:518273.;;Wang et al., ""Crystal structure of 3-amino-4-acylaminoximinofurazan"", Chinese Journal of Energetic Materials, translation of Hanneng Cailiao, 14(6), 441-445 (2006) with abstract Database Hcaplus, on STN, 2007:380035, No. 148:382415.",ACTIVE
220,US,A1,US 2019/0107944 A1,070-401-339-200-295,2019-04-11,2019,US 201715727442 A,2017-10-06,US 201715727442 A,2017-10-06,Multifinger Touch Keyboard,"Implementations described herein provide a multifinger keyboard that is generated based on detected input. Each key of the multifinger keyboard includes multiple input zones, which are positioned and dimensioned to correlate with a present orientation of a user's fingers. The multifinger keyboard is automatically regenerated to account for drift and other changes in position of a user's hand relative to the keyboard, thereby providing reliable targeting without requiring physical homing indicators. Each input zone may be associated with different output values, such that applying different input types to a single input zone results in different outputs. Potential outputs are determined based on concurrent inputs received at the multifinger keyboard, from which a final output is generated.",MICROSOFT TECHNOLOGY LICENSING LLC,GLASS ANDREW STUART;;ESPINOZA REYES RICARDO ARTURO;;QUAN RAYMOND;;KHUT SOPHORS;;KLEIN CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-04),https://lens.org/070-401-339-200-295,Patent Application,yes,19,36,2,2,0,G06F3/04886;;G06F3/04886;;G06F3/0412;;G06F3/04166;;G06F3/04166;;G06F3/0426;;G06F3/04883;;G06F2203/04104;;G06F2203/04808;;G06F2203/04808,G06F3/0488;;G06F3/041;;G06F3/042,,0,0,,,,DISCONTINUED
221,CN,A,CN 108019173 A,147-257-995-862-746,2018-05-11,2018,CN 201710932312 A,2017-09-29,US 201662403054 P,2016-09-30,DOWNHOLE MILLING CUTTING STRUCTURES,"Systems, tools, and methods include using a milling assembly with a mill having multiple, different types of cutting element inserts. A gage region of the mill includes a first type of cutting elementinsert, and a shoulder region of the mill includes a second type of cutting element insert. One cutting element insert may include chip-breaking features, and the other may be a shear or gouging cutting element.",SCHLUMBERGER TECHNOLOGY CORP,ZHENBI SU;;VIJAYAKUMAR PALANI;;SUDARSANAM CHELLAPPA;;JIANBING HU;;CHRISTOPHER GLASS;;TIMOTHY ANDREW BURDETT,,https://lens.org/147-257-995-862-746,Patent Application,no,9,0,3,3,0,E21B29/06;;E21B7/061;;E21B29/06;;E21B29/002;;E21B7/061;;E21B29/06,E21B29/06,,0,0,,,,DISCONTINUED
222,US,A1,US 2008/0214546 A1,128-150-083-294-29X,2008-09-04,2008,US 85698207 A,2007-09-18,US 85698207 A;;US 84571106 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,INCYTE CORPORATION (2008-02-15),https://lens.org/128-150-083-294-29X,Patent Application,yes,23,36,15,15,0,A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P29/00;;A61P31/12;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/02;;A61P37/04;;A61P37/06;;A61P43/00;;C07D261/18;;C07D261/18;;C07D261/20;;C07D261/20;;C07D307/68;;C07D307/68;;C07D333/70;;C07D333/70,A61K31/5377;;A61K31/42;;A61P31/12;;A61P35/00;;A61P37/00;;C07D261/12;;C07D413/04;;C12N9/04;;C12N9/99,514/236.8;;548/243;;514/380;;544/137;;435/190;;435/184,0,0,,,,DISCONTINUED
223,US,B2,US 8377976 B2,029-090-459-280-312,2013-02-19,2013,US 201113070069 A,2011-03-23,US 201113070069 A;;US 85696707 A;;US 84570006 P,2006-09-19,"N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP;;COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,INCYTE CORPORATION (2007-11-19);;INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION (2015-01-07),https://lens.org/029-090-459-280-312,Granted Patent,yes,86,23,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,A61K31/42;;A61K31/425,514/365;;514/378,109,65,088-873-608-648-063;;007-523-125-016-055;;021-561-810-011-572;;041-060-106-526-986;;013-114-749-285-747;;049-931-470-454-861;;045-797-583-191-826;;016-921-796-437-459;;019-144-908-782-085;;013-795-773-731-248;;150-844-364-749-880;;001-981-252-196-562;;119-988-487-690-208;;041-260-008-634-373;;060-816-653-258-219;;037-966-732-902-965;;018-422-129-096-212;;007-364-858-655-289;;117-847-230-405-422;;026-270-626-648-305;;075-322-609-792-62X;;100-742-147-618-920;;009-541-274-056-984;;087-879-787-031-413;;106-638-472-601-725;;061-374-522-112-878;;071-965-807-311-691;;027-669-605-545-017;;040-157-485-027-187;;061-110-170-968-832;;106-638-472-601-725;;086-128-066-686-790;;022-797-334-329-279;;088-873-608-648-063;;025-155-187-898-58X;;002-816-771-338-232;;007-924-674-083-389;;127-248-406-139-331;;096-471-577-709-81X;;009-330-869-368-477;;028-331-912-923-91X;;063-737-191-858-685;;063-541-481-824-649;;161-405-813-595-448;;140-525-380-092-494;;000-520-585-022-212;;092-741-017-671-560;;025-627-873-839-996;;114-933-881-301-004;;015-744-840-542-520;;069-000-610-116-224;;020-435-634-003-86X;;042-407-807-346-693;;095-857-079-995-273;;028-209-249-873-397;;026-091-081-004-054;;086-952-678-103-889;;039-435-249-119-479;;029-479-318-767-560;;083-988-154-360-900;;100-929-438-538-20X;;101-928-902-806-784;;006-610-750-633-787;;177-592-739-522-677;;096-665-121-074-620,10.1186/1479-5876-2-44;;15610560;;pmc544857;;18847306;;10.1517/14712598.8.11.1705;;18676626;;10.1167/iovs.08-2374;;pmc2610264;;15718917;;20663292;;pmc2956440;;10.1179/174329210x12650506623645;;17430116;;10.2174/138920007780362572;;19461669;;10.1038/nrc2639;;19534572;;10.1517/14728220903018940;;10.1021/ol026483o;;12182612;;10.1007/bf01165710;;10.1007/bf01169945;;10.1007/bf00475617;;10.1007/bf02253172;;10.1007/bf00476969;;10.1007/bf01169844;;15967116;;10.1593/neo.04658;;pmc1501151;;10.3987/com-03-9833;;10.1002/jps.2600660104;;833720;;16489067;;10.1158/1078-0432.ccr-05-1966;;1722946;;10.1007/978-1-4684-5952-4_39;;10.1158/1535-7163.mct-08-0149;;19139110;;pmc3418602;;10721095;;10.1007/978-1-4615-4709-9_64;;10.1135/cccc19900728;;8097319;;pmc46336;;10.1073/pnas.90.8.3539;;12209992;;10.1002/ijc.10645;;925862;;10.1248/yakushi1947.97.6_689;;10.1248/cpb.39.301;;10.1248/cpb.22.2211;;10.1248/cpb.19.1731;;10.3987/com-93-s33;;12209992;;10.1002/ijc.10645;;12738417;;10.1016/s1471-4906(03)00072-3;;10.1002/3527607889.ch8;;10.1186/1479-5876-2-44;;15610560;;pmc544857;;10.1158/0008-5472.can-06-2925;;17234791;;10.4049/jimmunol.164.7.3596;;10725715;;10.1038/sj.bjc.6603477;;17117179;;pmc2360726;;10.1248/cpb.23.2643;;10.1248/cpb.44.967;;10.1248/cpb.45.832;;16034082;;10.4049/jimmunol.175.3.1456;;16930024;;10.1021/jo060793t;;20124451;;10.1158/1535-7163.mct-09-0628;;10.3987/s-1981-01-0293;;10.3987/r-1982-02-0339;;10.1007/bf00809014;;10.1080/00397918808078813;;10.2174/156800909790192374;;20025603;;10.1046/j.1365-2567.2002.01390.x;;pmc1782674;;11985668;;10.1080/00304940409458679;;10.1021/ci700018y;;17910431;;10.1016/j.addr.2003.10.020;;14962582;;15711557;;10.1038/nm1196;;10.1126/science.281.5380.1191;;9712583;;10.1126/science.1073514;;12228717;;10.1172/jci31178;;17476344;;pmc1857253;;15254595;;10.1172/jci21583;;pmc449750;;10.1172/jci200421583;;10.1002/chin.200049106;;10.1158/1078-0432.ccr-04-2671;;16115948;;10.1002/prep.19950200103;;11937550;;10.4049/jimmunol.168.8.3941;;15961516;;pmc1895260;;10.1182/blood-2005-04-1403;;14962581;;10.1016/j.addr.2003.10.005;;10.1016/j.mencom.2008.05.017;;10.1016/j.drudis.2008.03.026;;18954804,"Belik, et al., Russian J. Org. Chem. 34:543 (1998).;;Hörig et al., J. Translational Med. 2:44 (2004).;;Quan, et al., Expert Opin. Biol. Ther., 8:1705 at 1714 (2008).;;Mailankot, et al., IOVS, 49:5466 at 5474 (2008).;;Pellegrin, et al., Shock, 23:209 (2005).;;Bonda, et al., Redox Rep., 15:161 (2010).;;Kohl, et al., Curr. Drug Metab., 8:283 (2007).;;Lob, et al., Nature Reviews: Cancer, 9:445 (2009).;;Tan, et al., Expert Opin. Ther. Targets, 13:987 (2009).;;Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp. 1-16 (2005).;;Ait-Mohand, Samia. And Dolbier, Jr. William R., ""New and Convenient Method for Incorporation of pentafluorosulfanyl (SF5) Substituents Into Aliphatic Organic Compounds"", Organic Letters, 4(17), 3013-3015, 2002.;;Andrianov et al. ""Degenerate Rearrangement of 3-amino-1,2,5-oxadiazole-4-carboxamidoxime"", Khimiya Geterotsiklicheskikh Soedinenii, (1988), (12), 1701 (and abstract Database Hcaplus, on STN, 1989:515108, No. 111:115108).;;Andrianov et al., ""Acid halides of 4-aminofurazan-3-carbohydroxamic acids "", Chemistry of Heterocyclic Compounds, Latvian Institute of Organic Chemistry, vol. 30, 3:370-371 (1994) (English translation of Khimiya Geterotsiklicheskikh Soedinenii, (3), 420-21) and abstract Database Hcaplus STN File CA, 1995:376582; 123:198702.;;Andrianov et al., ""Ring formation reactions of 4-aminofurazan-3-carboxyamidoximes"", Chemistry of Heterocyclic Compounds, 30(4):470-474 (1993) (English translation of Andrianov et al., ""4-aminofurazan-3-carboxamidoxime cyclization"", Khimiya Geterotsiklicheskikh Soedinenii (4):534-8 (1994) (and abstract Database Caplus No. 1995:393128; 122:290788); XP002526509 (1994).;;Andrianov et al., ""4-aminofurazan-3-hydroximic halides"", Institute of Organic Synthesis, 5:581-585 (1992) translation of ""Acid halides of 4-aminofurazan-3-carbohydroximic acid"", Khimiya Geterotsiklicheskikh Soedinenii, (1992), (5), 687-91 and abstract Database Hcaplus, on STN, 1993:212973, No. 118:212973.;;Andrianov et al., ""Rearrangements of 1-oxa-2-azoles. 2. Structure and isomerization of pentamethyleneamidoximes of 4-aminofurazan-3-carboxylic acid"", Khimiya Geterotsiklicheskikh Soedinenii, (1991), (1), 122-3 (and abstract Database Hcaplus, STN, 1991:449555, No. 115:49555).;;Andrianov et al., ""Rearrangements of 5-trifluoromethy1-1,2,4-oxadiazoles by action of ammonia and amines"", Institute of Organic Synthesis, Academy of Sciences of the Latvian SSR, p. 707 translation of ""Ammonia- and amine-induced rearrangements of 5-(trifluoromethyl)-1,2,4-oxadiazoles"", Khimiya Geterotsiklicheskikh Soedinenii, (1988), (6), 856-7 and abstract Database Hcaplus, on STN, 1989:212695, No. 110:212695).;;Andrianov et al., ""Synthesis and properties of derivatives of 4-aminofuroxan-3-carboxylic acid"", Chemistry of Heterocyclic Compounds, 33(8), 973-976 (1997), translation of Khimiya Geterotsiklicheskikh Soedinenii, (1997) No. 8, pp. 1115-1119 and abstract Database Hcaplus, on STN, 1998:221958, No. 128:308445.;;Andrianov et al., ""Synthesis of furazans by rearrangement of 3-acyl-1-oxa-2-azole oximes"", UDC 547.793.07(047) 2611(90):1199-1213 (1991), Institute of Organic Synthesis, Academy of Science of the Latvian SSR, (Translation of Khimiya Geterotsiklicheskikh Soedinenii, (1990) No. 11, pp. 1443-1459).;;Andrianov et al., ""Synthesis, structure, and rearrangement of 4-aminofurazan-3-carboxamide oximes"", UDC 547.793.2, 29(5):877-880 (1994), (translation of Zhurnal Organicheskoi Khimii, (1993), 29(5), 1062-6) and abstract Database Hcaplus, on STN, 1994:270259, No. 120:270259; XP002526508 (1993).;;Andrianov et al., ""Synthesis and properties of 4-amino-3-cyanofurazan"", Chemistry of Heterocyclic Compounds, vol. 30, No. 5, pp. 608-611 (1994), translation of Khimiya Geterotsiklicheskikh Soedinenii, (5), 693-6 (1994) with abstract Database Hcaplus, on STN 1995:374071, No. 123:198701.;;Areschka et al., ""Studies on the benzofuran series. LXI. 3-Benzofuranylacetamidoximes with antihypertenstive potential"", European Journal of Medicinal Chemistry, (1977), 12(1), 87-91 (with English abstract).;;Astigiano, et al., Neoplasia, 7(4):390-396 (2005).;;Bagdasarov et al., ""Extraction-photometric determination of copper and cobalt with oxime derivatives of benzimidazole"", Zavodskaya Laboratoriya (1976), 42(2), 143-144 (Non-English Reference), U.S. Appl. No. 11/856,982 in Jan. 29, 2010 Office Action-copy provided with reference) (15 pgs.).;;Beaudegnies et al., ""Synthesis of furazan conjugated new heterocycles"", Heterocycles, (2003), 60(11), 2417-2424 and abstract Database Hcaplus, on STN, 2003:865834, No. 140:59538.;;Belik et al., ""Descriptor v'cp-aided study of the rearrangement of 1-oxa-2-azoles"", Zhurnal Organicheskoi Khimii, 30(5), 757-9 (1994) with abstract STN File CA, 122:238877; 1995:326366.;;Belik et al., ""Theoretical investigation of rearrangements of 1-oxa-2-azole-3-carboxamidoximes"", Russian Journal of Organic Chemistry, 34(4), 543-548 (1998) (Translation of Zhurnal Organicheskoi Khimii 34(4), 577-582) (with abstract STN File CA, 130:209340; 1999:79495).;;Berge et al., ""Pharmaceutical Salts"", J. of Pharmaceutical Science, vol. 66 No. 1, pp. 1-19 (1977).;;Brandacher, et al., Clin. Cancer Res., 12(4):1144-1151 (2006) (abstract).;;Brown et al., ""Implications of Interferon-induced Tryptophan Catabolism in Cancer, Auto-immune Diseases and Aids"", Adv. Exp. Med. Biol., 294: 425-35 (1991).;;Burger et al., ""Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo,"" Mol. Cancer Ther 2009;8(1), 2009, 26-35.;;Chauhan et al., ""Antifilarial profile of substituted pyrazoles: a new class of antifilarial agents,"" Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1993), 32B(8), 858-61 (with abstract Database Hcaplus STN File CA, 120:244819; 1994:244819).;;Corbett et al. ""In vivo methods for screening and preclinical testing."" Cancer Drug Discovery and Development: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, 2nd Ed. Teicher, B.A. and Andrews, P.A., Gumana Press Inc., Totowa, NJ, 2004.;;Current Protocols in Immunology, vol. 4, Coligan, J.E., et al; Immunotherapy of Cancer, Human Press, 2006, Disis, M.L.;;Database CAPLUS, on STN, 1963: 73272, No. 83, 12528c-e, see RN 90585-88-9 CAPLUS, XP-002467962 dated May 2, 2008, (abstract of Sycheva, et al. ""Compounds with Potential Antitubercular Activity. VI. Amidoximes, amide Hydrazones, and S-Oxides of Thioamides of some Heterocyclic acids"", (1962) 32, 3669-74) (1page).;;Database CAPLUS, on STN, 1966: 35828, No. 64, 6633a-d, see RN 4698-75-3 CAPLUS, XP-002467245 dated May 2, 2008 (abstract of Sycheva, et al., ""Compounds with Potential Antitubercular Activity. X. Derivatives of Benzoxazole-2-carboxylic acid"", (1965) 46-51 (1 page).;;Database CAPLUS, on STN, 1975:606233, No. 83: 32463a, 32466a, see RN 55942-51-3 CAPLUS, XP-002467961 dated May 2, 2008 (abstract of Nishimura, Haruki et al., JP Patent No. 50050369, issued May 6, 1975 ""Amidoxime Derivatives"",) (1 page).;;Database CAPLUS, on STN, 1992:6493, No. 116, 6493, XP-002467964, RN 137890-17-6 dated Jun. 2, 2008, (abstract of Andrianov, et al., ""Rearrangements of 1-oxa-2-azoles. 4. synthesis and rearrangement of Amidoximes of soxazole-and 4,5-dihydrosoxazole-3-carboxylic acid"", (1991) (6), 827-32) (1 page).;;Daubener et al., ""IFN-gamma Activated Indoleamine 2,3-Dioxygenase Activity in Human Cells Is an Antiparasitic and an Antibacterial Effector Mechanism"", Adv. Exp. Med. Biol., 467: 517-24 (1999).;;Deeb et al., ""Heterocyclic synthesis from 3-amino-4-cyanopyrazole,"" Collection of Czechoslovak Chemical Communications (1990), 55(3), 728-33 (with abstract Database Hcaplus STN File CA, 113:97502; 1990:497502).;;Dranoff et al., ""Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity,"" Proc. Natl. Acad. Sci, USA. 90:3539-3543 (1993).;;El-Mobayed et al., ""Synthesis of heterocyclic compounds containing nitrogen and sulfur from 3-amino-4-cyanopyrazole,"" Journal of the Chemical Society of Pakistan (1989), 11(4), 287-90 (with abstract Database Hcaplus STN File CA, 113:231330; 1990:631330).;;Friberg et al. ""Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection."" Int. J. Cancer: 101:151-155, 2002.;;Fujii et al., ""Antitumor activities of some fifty compounds related to adenine derivatives,"" Yakugaku Zasshi (1977), 97(6), 689-91(with abstract Database Hcaplus STN File CA, 87:111278; 1977:511278).;;Fujii et al., ""Purines. XLVIII. Syntheses and proton nuclear magnetic resonance study of 2-deuterioadenines substituted or unsubstituted at the 9-position and of their N-oxygenated derivatives,"" Chemical & Pharmaceutical Bulletin (1991), 39(2), 301-8 (with abstract Database Hcaplus STN File CA, 114:247645; 1991:247645).;;Fujii et al., ""Purines. XV. Conversion of N,9-dimethyladenine into the 1,9-dimethyl isomer. Reverse operation of the dimroth rearrangement,"" Chemical & Pharmaceutical Bulletin (1974), 22(10), 2211-16 (with abstract Database Hcaplus STN File CA, Abstract 82:43349; 1975:43349).;;Fujii et al., ""Purines. V. Dimroth rearrangement of 1-alkoxyadenines. Synthesis of N-alkoxyadenines,"" Chemical & Pharmaceutical Bulletin (1971), 19(8), 1731-4 (with abstract Database Hcaplus STN File CA, Abstract 75:110279; 1971:510279).;;Fujii et al., ""Purines. III. Rearrangement of 1-alkoxy-9-alkyladenines to 6-alkoxyamino-9-alkylpurines through isolatable N'-alkoxy-l-alkyl-5-formamidoimidazole-4-carboxamidines ,"" Tetrahedron (1971), 27(12), 2415-23 (with abstract Database Hcaplus STN File CA, Abstract 75:76739; 1971:476739).;;Fujii et al., ""Oxidation of N6-benzyladenine with m-chloroperoxybenzoic acid: formation of the N(1)-oxide,"" Heterocycles (1994), 37(1), 219-22 (with abstract Database Hcaplus STN File CA, 121:35143; 1994:435143).;;Friberg, Int. J. Cancer, 101:151-155 (2002).;;Giron, D. J., ""Investigations of Polymorphism and Pseudo-Polymorphism in Pharmaceuticals by Combined Thermoanalytical Techniques,"" J. Therm. Anal. Cal. (2001), 64, pp. 37-60.;;Giron, D. J., ""Ápplications of Thermal Analysis and Coupled Techniques in Pharmaceutical Industry,"" J. Therm. Anal. Cal. (2002), 68, pp. 335-357.;;Greene et al., Protective Groups in Organic Synthesis, 2d. Ed., Wiley & Sons, 1991.;;Grohmann et al., ""Tolerance, DCs and tryptophan: much ado about IDO"", Trends Immunol., 24: 242-8 (2003).;;Griesser, ""The Importance of Solvates"" in Polymorphism in the Pharmaceutical Industry, 211-233 (Rolf Hilfiker, ed., 2006).;;Guillory, K., ""Generation of Polymorphs, Hydrates, Solvates, and Amorphous Solids"", in Polymorphism in Pharmaceutical Solids, 183-226 (Harry G. Britain, ed., 1999).;;Higuchi et al., ""Pro-drugs as Novel Delivery Systems,"" vol. 14 of the A.C.S. Symposium Series Bioreversible Carriers in Drug Design, ed. Edward B. Roche, American Pharmaceutical Association and Pergamon Press, 1987.;;Honig et al., ""From bench to clinic and back: perspective on the 1st IQPC Translational Research Conference"", Journal of Translational Medicine, 2:44 (2004) pp. 1-8.;;Hou, et al., Cancer Res 67(2):792-801 (2007).;;Hwu et al., ""Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation"", J. Immunol. 164(7):3596-9, (2000).;;Ichikawa et al., ""A new synthesis of adenine and 4-aminoimidazole-5-carboxamide"", J. Heterocycl. Chem., vol. 2 No. 3, pp. 253-255 (1965) (with STN File CA, abstract 68:78253).;;Ino, et al., British Journal of Cancer, 95:1555-1561 (2006).;;Itaya et al., ""Purines. XVIII. Kinetic studies of the Dimroth rearrangement of 1-alkoxy-9-methyladenines and 1-benzyloxyadenosine. Effect of 1-benzyloxy and 9-beta-D-ribofuranosyl groups on the rates of the ring opening and the reclosure,"" Chemical & Pharmaceutical Bulletin (1975), 23(11), 2643-53 (with abstract Database Hcaplus STN File CA, Abstract 84:44592; 1976:44592).;;Itaya et al., ""Purines. LXXII. Oxidation of N6-alkyladenines with m-chloroperoxybenzoic acid leading to N6-alkyladenine 1-oxides,"" Chemical & Pharmaceutical Bulletin (1996), 44(5), 967-971, (with abstract Database Hcaplus STN File CA, 125:86583; 1996:325165; CAS RN 155720-89-1).;;Itaya et al., ""Purines. LXXV. Dimroth rearrangement, hydrolytic deamination, and pyrimidine-ring breakdown of 7-alkylated 1-alkoxyadenines: N(1)-C(2) versus N(1)-C(6) bond fission,"" Chemical & Pharmaceutical Bulletin (1997), 45(5), 832-841(with abstract Database Hcaplus STN File CA, 127:65632, 1997:349657).;;Ji et al., ""Provision of Granulocyte-Macrophage Colony-Stimulating Factor Converts an Autoimmune Response to a Self-Antigen into an Antitumor Response,"" J. Immunol, 2005, 175:1456-63.;;Katritzky et al., ""Synthesis of mono and symmetrical di-N-hydroxy- and N-aminoguanidines,"" Journal of Organic Chemistry, 71(18):6753-8 (2006).;;Koblish et al., ""Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors"", Molecular Cancer Therapeutics, 9(2):489-498 (Published Online Feb. 2, 2010 at 10.1158/11535-7163.MCT-09-0628).;;Koblish et al., ""Potent, Orally Active Hydroxylamidine Inhibitors of Indoleamine-2,3-dioxygenase Suppress Growth of IDO1-expressing Tumors through Systemic Inhibition of Tryptophan Catabolism,"" 24th Annual Meeting of the International Society for the Biological Therapy of Cancer (ISBTC) in National Harbor MD/Washington DC (Oct. 30, 2009) (poster-1 page) and abstract J. Immunother. vol. 32, No. 9 (2009) p. 1005.;;Kocevar et al., ""Some new synthetic approaches for the preparation of pteridine 3-oxides and pteridines,"" Heterocycles (1981), 15(1), 293-6 (with abstract Database Hcaplus STN File CA, 94:121470; 1981:121470).;;Kocevar et al., ""New synthetic approach for pyrazolo[3,4-b] pyrazines and isoxazolo[4,5-b] pyrazines,"" Heterocycles (1982), 19(2), 339-42 (with abstract Database Hcaplus STN File CA, 96:162655; 1982:162655).;;Kocevar et al., ""Neighboring group participation in formation of condensed azines. Formation of pyrazolo[3,4-b]pyrazines, isoxazolo[4,5-b]pyrazines and isothiazolo[5,4-b]pyridine. Heterocycles. CCX,"" Monatshefte fuer Chemie (1982), 113(6-7), 731-44 (with abstract Database Hcaplus STN File CA, 97:182276; 1982:582276).;;Kocevar et al., ""Simple Procedure for the Synthesis of Pyridinecarbohydroximoyl Chlorides and Bromides"", Synth. Commun., 18(12), 1427-1432 (1988).;;Liu et al., ""Estimation and prediction on heats of formation for nitro furazan series compounds with new molecular subgraph"", Huaxue Wuli Xuebao, (2002), 15(5), 351-356 and abstract Database Hcaplus, on STN, 2002:880171, No. 138:204550.;;Liu et al., ""INCB024360, a Potent and Selective Inhibitor of Indoleamine 2,3-dioxygenase (IDO1) as a Novel Cancer Immunotherapeutic Agent,"" Mol Cancer Ther, 8(12 Suppl):Poster #C106 (2009).;;Liu et al., ""Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy,"" Current Cancer Drug Targets, 9:938-952 (2009).;;Logan et al., ""HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity,"" Immunology, 105: 478-87 (2002).;;Longo G., ""Dioximes. LXXVIII"", Gazzetta Chimica Italiana, (1931), 61, 575-83 (and abstract Database Hcaplus, on STN, 1932:6117, No. 26:6117).;;Medawar, ""Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates,"" Symp. Soc. Exp. Biol. 7: 320-38 (1953).;;Meyer, K. G., ""Improved synthesis of 3-aminofurazan-4-carboxylic acid,"" Organic Preparations and Procedures INt. 36(4):361-362 (2004).;;Milletti et al., ""New and Original pKa Prediction Method Using Grid Molecular Interaction Fields,"" Journal of Chemical Information and Modeling, 2007, 47(6), 2172-2181 and abstract Database Hcaplus, on STN, 2007:1104249, No. 148:33199.;;Mishnev et al., ""Crystal and molecular structure of isomers of the oxime of 3-aminofurazanoyl piperidine,"" Institute of Organic Synthesis, Latvian Academy of Sciences, pp. 349-352 translation of Zhurnal Strukturnoi Khimii, 32(3):45-48 (1991).;;Morissette et al., ""High-Throughput Crystallization: Polymorphs, Salts, Co-Crystals and Solvates,"" Adv. Drug Delivery Rev., 56:275-300 (2004).;;Muller et al , ""Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy,"" Nature Med., 11:312-9 (2005).;;Munn et al., ""Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism,"" Science 281:1191-3 (1998).;;Munn et al., ""Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase,"" Science 297:1867-70 (2002).;;Munn, et al., Journal of Clinical Investigation, 117(5):1147-1154 (2007).;;Munn et al., ""Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes,"" J. Clin. Invest., 114(2):280-90 (2004).;;Nekrasov et al., ""Effect of particular structural features of aminooximes on formation of final products in reactions with 5-aryl-2,3-dihydrofuran-2,3-diones"", Russian Journal of Organic Chemistry, (2000), 36(2), 263-268, (Translation of Zhurnal Organicheskoi Khimii,vol. 36, No. 2 (2000) pp. 285-290) and abstract Database Hcaplus, on STN, 2000:643842, No. 133:321845.;;Okamoto, et al., Clin Cancer Res 11(16):6030-6039, at 6037-6038 (2005).;;Peterson et al., ""Evaluation of Functionalized Tryptophan Derivatives and related Compounds as Competitive Inhibitors of Indoleamine 2,3-Dioxygenase,"" Med. Chem. Res. 3, 531-544, (1994).;;Physicians' Desk Reference (PDR, e.g., 1996 edition, Medical Economics Company, Montvale, NJ) Zh. Org. Chim. (1993), 29, 1062-1066.;;Pivina et al., ""Comparative characteristic of energy content calculating methods for the furazan series as an example of energetic materials,"" Propellants, Explosives, Pyrotechnics, (1995), 20(1) 5-10 and abstract Database Hcaplus, on STN, 1995:464236, No. 122:217824.;;Poluektova et al., ""Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis,"" J. Immunol., 168(8):3941-9 (2002).;;Potula et al , ""Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis,"" Blood, 106:2382-90 (2005).;;Rakitin et al., ""Reaction of furoxannitrolic acids with nitrogen tetroxide,"" Khimiya Geterotsiklicheskikh Soedinenii, (1993), (9), 1283-7 (with abstract Database Hcaplus, on STN, 1994:244883, No. 120:244883).;;Rakitin et al., ""Synthesis of Furaxanenitrolic acids,"" N. D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences, 117913 Moscow pp. 952-954 (1994), Translated from Khimiya Geterotsiklicheskikh Soedinenii,(1993), (8), 117-19 (with abstract Database Hcaplus, on STN, 1994:164073, No. 120:164073).;;Ravin, L. J., ""Preformulation,"" Remington's Pharmaceutical Sciences, 17th ed., Mack Publishing Company, Easton, PA., Chapter 76, pp. 1409-1423 (1985).;;Riffaud et al., ""Sur les propriétiés analgésiques at antiinflammatoires des benzofuryl-2 amidoximes"", European Journal of Medicinal Chemistry, Editions Scientifique Elsevier, Paris, Fr., vol. 1796, pp. 577-580, (1982) (please see the International Search Report of International Appln. No. PCT/US2007/078759 regarding the relevance of this reference).;;Robev et al., ""Pharmacological study of newly synthesized 2-pheny1-4-anilinopyrimidine-5-amidoxime,"" Doklady Bolgarskoi Akademii Nauk (1982), 35(10), 1451-4 (with abstract Database Hcaplus STN File CA, 98:191493; 1983:191493).;;Roche, E. B., Bioreversible Carriers in Drug Design, ed., American Pharmaceutical Association and Pergamon Press, 1987.;;Rodriguez-Spong et al., ""General principles of pharmaceutical solid polymorphism: a supramolecular perspective,"" Advanced Drug Delivery Review, (2004), 56, pp. 241-274.;;Romanova et al., ""Synthesis and reactivity of azidomes: III 1-Azido (4-amino-1, 2, 5-oxadiazol-3-y1) aldoxime in the Cycloaddtion Reaction,"" Russian J. of Org. Chem., 39(4), 574-578 (translation of Zhurnal Organicheskoi Khimii, vol. 39 No. 4, pp. 610-615 (2002)).;;Rozhov et al., ""Synthesis of 1,2,4-oxadiazole-, pyrrole- and 1,2,3-triazole-substituted (1,2,3-triazol-1-yl)furazans,"" Mendeleev Communications, 2008, 18(3), 161-163 and abstract Database Hcaplus, on STN, 2008:880463, No. 150:352019.;;Sako, ""Product class 19: pyridopyrimidines,"" Science of Synthesis (2004), 16, 1155-1267 (and abstract Database Hcaplus STN File CA, 142:197902; 2004:205975).;;Sambrook, J. and Russel, D., ""Molecular Cloning: A Laboratory Manual (3rd edition)."" Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY, USA. 2001.;;Schafer et al., ""Failure is an option: learning from unsuccessful proof of concept trials,"" Drug Discovery Today, vol. 13, Nos. 21/22, pp. 913-916 (2008).;;Scherle, P., ""Characterization of Novel and Potent Inhibitors of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase (IDO) for Use as Cancer Therapy,"" presented on Mar. 5, 2009 at the Translational Research Cancer Center Consortium annual meeting in Philadelphia, PA.;;Search Run STN International ""11641284"" dated Jan. 16, 2009 (93 pages).",ACTIVE
224,KR,A,KR 20050120661 A,127-742-525-462-370,2005-12-22,2005,KR 20057017931 A,2005-09-23,US 39607103 A,2003-03-25,A HIGH PERFORMANCE SERIAL BUS TESTING METHODOLOGY,"According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits.",INTEL CORP,NEJEDLO JAY;;WIZNEROWICZ MICHAEL;;ELLIS DAVID;;GLASS RICHARD S;;MARTWICK ANDREW;;SCHOENBORN THEODORE,,https://lens.org/127-742-525-462-370,Patent Application,no,0,2,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,INACTIVE
225,EP,A1,EP 3353641 A1,133-034-485-751-96X,2018-08-01,2018,EP 16763137 A,2016-08-26,US 201562221592 P;;US 201514884721 A;;US 2016/0048812 W,2015-09-21,FACILITATING SELECTION OF ATTRIBUTE VALUES FOR GRAPHICAL ELEMENTS,,MICROSOFT TECHNOLOGY LICENSING LLC,TOBENS JOSEPH BERNARD III;;AVILLA GYANCARLO GARCIA;;GLASS ANDREW STUART;;LOMAN COREY JOSEPH,,https://lens.org/133-034-485-751-96X,Patent Application,yes,0,0,6,6,0,G06F3/0482;;G06F3/0482;;G06F3/0237;;G06F3/0237;;G06F3/04817;;G06F3/04842;;G06F3/04845;;G06F3/04847;;G06F3/04847;;G06F3/0485;;G06F3/0485;;G06F3/0488;;G06F3/0488;;G06F3/04883,G06F3/0488;;G06F3/023;;G06F3/0482;;G06F3/0484;;G06F3/0485,,1,0,,,See references of WO 2017052986A1,DISCONTINUED
226,US,A1,US 2011/0172279 A1,183-296-703-285-690,2011-07-14,2011,US 201113070069 A,2011-03-23,US 201113070069 A;;US 85696707 A;;US 84570006 P,2006-09-19,"N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE","The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.",INCYTE CORP A DELAWARE CORP,COMBS ANDREW P;;GLASS BRIAN M;;SPARKS RICHARD B;;YUE EDDY WAI TSUN,INCYTE CORPORATION (2007-11-19);;INCYTE HOLDINGS CORPORATION AND INCYTE CORPORATION (2015-01-07),https://lens.org/183-296-703-285-690,Patent Application,yes,29,20,12,12,0,C07D261/18;;C07D261/20;;C07D277/56;;C07D413/04;;C07D417/04;;A61P11/06;;A61P17/02;;A61P25/00;;A61P25/24;;A61P25/28;;A61P27/12;;A61P31/12;;A61P31/18;;A61P35/00;;A61P35/02;;A61P37/00;;A61P37/06;;A61P43/00;;C07D413/04;;C07D261/20;;C07D277/56;;C07D417/04;;C07D261/18,A61K31/427;;A61K31/42;;A61K31/423;;A61K31/426;;A61P27/12;;A61P35/00;;A61P35/02;;A61P37/06;;C07D261/18;;C07D261/20;;C07D277/56;;C07D417/04;;C12N9/99,514/370;;548/197;;435/184;;548/247;;514/378;;548/198;;514/365;;548/241;;514/379,10,8,088-873-608-648-063;;007-523-125-016-055;;021-561-810-011-572;;041-060-106-526-986;;013-114-749-285-747;;049-931-470-454-861;;045-797-583-191-826;;016-921-796-437-459,10.1186/1479-5876-2-44;;15610560;;pmc544857;;18847306;;10.1517/14712598.8.11.1705;;18676626;;10.1167/iovs.08-2374;;pmc2610264;;15718917;;20663292;;pmc2956440;;10.1179/174329210x12650506623645;;17430116;;10.2174/138920007780362572;;19461669;;10.1038/nrc2639;;19534572;;10.1517/14728220903018940,"Belik, et al., Russian J. Org. Chem. 34:543 (1998).;;Hörig et al., J. Translational Med. 2:44 (2004).;;Quan, et al., Expert Opin. Biol. Ther., 8:1705 at 1714 (2008).;;Mailankot, et al., IOVS, 49:5466 at 5474 (2008);;Pellegrin, et al., Shock, 23:209 (2005).;;Bonda, et al., Redox Rep., 15:161 (2010).;;Kohl, et al., Curr. Drug Metab., 8:283 (2007).;;Lob, et al., Nature Reviews: Cancer, 9:445 (2009).;;Tan, et al., Expert Opin. Ther. Targets, 13:987 (2009).;;Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp. 1-16 (2005).",ACTIVE
227,US,B2,US 7812394 B2,061-185-018-135-330,2010-10-12,2010,US 25019108 A,2008-10-13,US 25019108 A;;US 64352306 A;;US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03),https://lens.org/061-185-018-135-330,Granted Patent,yes,12,5,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L31/119,257/337;;257/338;;257/344;;257/345;;X257E21106,4,4,016-026-113-467-931;;088-935-428-975-009;;064-219-662-969-477;;064-093-298-723-743,10.1016/j.apsusc.2003.08.030;;10.1109/iedm.2004.1419383;;10.1109/.2005.1469197;;10.1109/essder.2004.1356549,"Loo, R. et al., ""A new technique to fabricate ultra-shallow-junctions, combining in situ vapour HCI etching and in situ doped epitaxial SiGe re-growth"", Applied Surface Science, vol. 224., No. 1-4, Mar. 15, 2004, pp. 63-67.;;Kah Wee Ang et al., ""Enhanced performance in 50nm N-MOSFETS with silicon-carbon source/drain regions"", IEEE International Electron Devices Meeting, 2004. IEDM Technical Digest, San Francisco, CA, Dec. 13-15, 2004, pp. 1069-1071.;;Ueno, T. et al., ""Dramatically enhanced performance of recessed SiGe source-drain pmos by in-situ etch and regrowth technique (InSERT)"", VLSI Technology 2005, Digest of Technical Papers, 2005 Symposium on Kyoto, Japan, Jun. 14-16, 2005.;;Zhikuan Zhang et al., ""Self-aligned recessed source/drain ultra-thin body SOI MOSFET technology"", Proceeding of the 34th European Solid-State Device Research Conference, 2004. ESSDERC 2004, Leuven, Belgium, Sep. 21-23, 2004, pp. 301-304.",ACTIVE
228,US,B2,US 7479432 B2,119-327-288-571-056,2009-01-20,2009,US 64352306 A,2006-12-21,US 64352306 A;;US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03),https://lens.org/119-327-288-571-056,Granted Patent,yes,11,29,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L27/108,438/300;;438/299;;438/303;;X438E29277;;X438E21106,4,4,016-026-113-467-931;;088-935-428-975-009;;064-219-662-969-477;;064-093-298-723-743,10.1016/j.apsusc.2003.08.030;;10.1109/iedm.2004.1419383;;10.1109/.2005.1469197;;10.1109/essder.2004.1356549,"Loo, R. et al., ""A new technique to fabricate ultra-shallow-junctions, combining in situ vapour HCI etching and in situ doped epitaxial SiGe re-growth"", Applied Surface Science, vol. 224., No. 1-4, Mar. 15, 2004, pp. 63-67.;;Kah Wee Ang et al., ""Enhanced performance in 50nm N-MOSFETS with silicon-carbon source/drain regions"", IEEE International Electron Devices Meeting, 2004. IEDM Technical Digest, San Francisco, CA, Dec. 13-15, 2004, pp. 1069-1071.;;Ueno, T. et al., ""Dramatically enhanced performance of recessed SiGe source-drain pmos by in-situ etch and regrowth technique (InSERT)"", VLSI Technology 2005, Digest of Technical Papers, 2005 Symposium on Kyoto, Japan, Jun. 14-16 2005.;;Zhikuan Zhang et al., ""Self-aligned recessed source/drain ultra-thin body SOI MOSFET technology"", Proceeding of the 34th European Solid-State Device Research Conference, 2004. ESSDERC 2004, Leuven, Belgium, Sep. 21-23, 2004, pp. 301-304.",ACTIVE
229,EP,B1,EP 2863308 B1,133-746-861-985-467,2018-08-08,2018,EP 14197207 A,2013-06-19,EP 14197207 A;;EP 13786749 A;;IB 2013001931 W,2013-06-19,Decentralized distributed computing system,,HITACHI LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,"HITACHI, LTD. (2016-11-02)",https://lens.org/133-746-861-985-467,Granted Patent,yes,0,0,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50;;G06F9/48;;H04L12/18,,3,0,,,"DHRUBA BORTHAKUR: ""The Hadoop Distributed File System: Architecture and Design"", 1 January 2007 (2007-01-01), XP055125023, Retrieved from the Internet <URL:http://hadoop.apache.org/docs/r0.18.0/hdfs_design.pdf> [retrieved on 20140624];;T. WHITE: ""Hadoop: The Definitive Guide, Third Edition"", part Chapter 3 May 2012, O'REILLY, ISBN: 978-1-449-31152-0, pages: 45 - 82;;T. WHITE: ""Hadoop: The Definitive Guide, Third Edition"", part Chapter 9 May 2012, O'REILLY, ISBN: 978-1-449-31152-0, pages: 295 - 336",ACTIVE
230,WO,A1,WO 2014/203023 A1,127-116-730-770-753,2014-12-24,2014,IB 2013001931 W,2013-06-19,IB 2013001931 W,2013-06-19,DECENTRALIZED DISTRIBUTED COMPUTING SYSTEM,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include a unique identifier. If a node receives a task including its unique identifier, the node executes the task. Each node stores each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure. Tasks may be launched on nodes based on location data gained by using in-band access to metadata specifying a location of nodes storing data corresponding to the metadata. A task may include starting a virtual machine such that an IP address is encoded in a file configuring the virtual machine.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,,https://lens.org/127-116-730-770-753,Patent Application,yes,5,5,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50,,4,2,167-179-581-720-240;;106-208-063-391-333,10.1109/ccgrid.2012.71;;10.1109/iccci.2013.6466147,"EUGEN FELLER ET AL: ""Snooze: A Scalable and Autonomic Virtual Machine Management Framework for Private Clouds"", CLUSTER, CLOUD AND GRID COMPUTING (CCGRID), 2012 12TH IEEE/ACM INTERNATIONAL SYMPOSIUM ON, IEEE, 13 May 2012 (2012-05-13), pages 482 - 489, XP032186564, ISBN: 978-1-4673-1395-7, DOI: 10.1109/CCGRID.2012.71;;KE XU ET AL: ""A Cloud Computing Platform Based on P2P"", IT IN MEDICINE&EDUCATION, 2009. ITIME '09. IEEE INTERNATIONAL SYMPOSIUM ON, IEEE, PISCATAWAY, NJ, USA, 14 August 2009 (2009-08-14), pages 427 - 432, XP031528425, ISBN: 978-1-4244-3928-7;;CHANDRASEKAR S ET AL: ""A novel indexing scheme for efficient handling of small files in Hadoop Distributed File System"", COMPUTER COMMUNICATION AND INFORMATICS (ICCCI), 2013 INTERNATIONAL CONFERENCE ON, IEEE, 4 January 2013 (2013-01-04), pages 1 - 8, XP032333008, ISBN: 978-1-4673-2906-4, DOI: 10.1109/ICCCI.2013.6466147;;LESLIE LAMPORT, PAXOS MADE SIMPLE SIGACT NEWS, vol. 32, no. 4, December 2001 (2001-12-01), pages 51 - 58",PENDING
231,AU,A1,AU 2018/341446 A1,165-908-762-486-670,2020-05-14,2020,AU 2018/341446 A,2018-09-26,US 201762563148 P;;US 2018/0052839 W,2017-09-26,Compositions and methods for inhibiting ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,,https://lens.org/165-908-762-486-670,Patent Application,no,0,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61P25/28;;A61K31/498;;C07D241/44,,0,0,,,,PENDING
232,CN,A,CN 111629787 A,171-387-865-393-334,2020-09-04,2020,CN 201880074731 A,2018-09-26,US 201762563148 P;;US 2018/0052839 W,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,,https://lens.org/171-387-865-393-334,Patent Application,no,3,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61P25/28;;A61K31/498;;C07D241/44,,0,0,,,,PENDING
233,US,B2,US 9110719 B2,041-359-724-443-56X,2015-08-18,2015,US 201414535850 A,2014-11-07,IB 2013001931 W,2013-06-19,Decentralized distributed computing system,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique node identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include one or more node identifiers. If a node receives a task including its node identifier, the node executes the task. Each node may store each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/041-359-724-443-56X,Granted Patent,yes,53,2,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/46;;G06F9/48;;G06F9/50;;G06F15/16;;G06F15/173;;G06F17/30;;H04L12/18;;H04L12/24;;H04L29/08,,8,4,167-179-581-720-240;;106-208-063-391-333;;124-036-949-278-027;;024-944-096-656-425,10.1109/ccgrid.2012.71;;10.1109/iccci.2013.6466147;;10.1109/sc.2006.19;;10.1145/1281100.1281103,"L. Lamport et al., ""Paxos Made Simple"", SIGACT News, Dec. 2001, pp. 51-58, vol. 32, No. 4.;;Feller et al., ""Snooze: A Scalable and Automatic Virtual Machine Management Framework for Private Clouds"", 2012 12th IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing, May 13, 2012, pp. 482-489.;;Xu et al., ""A Cloud Computing Platform Based on P2P"", IT in Medicine & Education, 2009. ITIME '09. IEEE International Symposium on, Aug. 14, 2009, pp. 427-432.;;Chandrasekar et al., ""A Novel Indexing Scheme for Efficient Handling of Small Files in Hadoop Distributed File System"", 2013 International Conference on Computer Communication and Informatics, Jan. 4, 2013, pp. 1-8.;;International Search Report and Written Opinion, dated Jan. 29, 2015 for International Patent Application No. PCT/US2013/065623.;;International Search Report and Written Opinion, dated Apr. 29, 2014 for International Patent Application No. PCT/IB2013/001931.;;Weil; Scott A. Brandt; Ethan L. Miller; Carlos Maltzahn; , ""CRUSH: Controlled, Scalable, Decentralized Placement of Replicated Data,"" Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, Nov. 2006, 12 pages.;;Tushar Deepak Chandra, Robert Griesemer, and Joshua Redstone, ""Paxos Made Live-An Engineering Perspective (2006 Invited Talk)"", Proceedings of the 26th Annual ACM Symposium on Principles of Distributed Computing, ACM press (Jun. 2007) 16 pages.",ACTIVE
234,US,A1,US 2018/0293288 A1,050-476-782-780-651,2018-10-11,2018,US 201515577987 A,2015-06-04,US 2015/0034122 W,2015-06-04,METHOD AND SYSTEM FOR DYNAMICALLY EXTENDABLE DISCIPLINES IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The disclosed embodiments include methods, systems and computer readable media for dynamically extendable disciplines in a multidisciplinary engineering system. The multidisciplinary engineering system is extended by adding a new engineering application 307 and engineering data associated with the new engineering application 307. The new engineering application data is linked to other engineering applications 307 in the multidisciplinary engineering system. Workflows are provided for accomplishing engineering tasks using the new and existing engineering data across engineering disciplines in the multidisciplinary engineering system.",SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,NOETZELMANN OSWIN;;REUVENI RAMI;;LABAS ATTILA;;DUREL MARINE;;GLASS MICHAEL;;BARTH WILFRIED;;DYLLA ANDREW,SIEMENS AKTIENGESELLSCHAFT (2017-12-21);;SIEMENS CORPORATION (2018-01-01);;SIEMENS PRODUCT LIFECYCLE MANAGEMENT SOFTWARE INC (2018-01-03),https://lens.org/050-476-782-780-651,Patent Application,yes,0,1,4,4,0,G06Q10/0633;;G06Q10/103;;G06Q10/0633;;G06Q10/103;;G06F16/258;;G06F16/252;;G06F16/289;;G06F16/258;;G06F16/252;;G06F16/289;;G06Q10/0633;;G06Q10/103;;G06F9/465,G06F17/30;;G06F9/46;;G06Q10/06,,0,0,,,,DISCONTINUED
235,EP,A1,EP 2863308 A1,184-714-864-165-628,2015-04-22,2015,EP 14197207 A,2013-06-19,EP 14197207 A;;EP 13786749 A;;IB 2013001931 W,2013-06-19,Decentralized distributed computing system,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include a unique identifier. If a node receives a task including its unique identifier, the node executes the task. Each node stores each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure. Tasks may be launched on nodes based on location data gained by using in-band access to metadata specifying a location of nodes storing data corresponding to the metadata. A task may include starting a virtual machine such that an IP address is encoded in a file configuring the virtual machine.
",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,"HITACHI, LTD. (2016-11-02)",https://lens.org/184-714-864-165-628,Patent Application,yes,1,0,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50;;G06F9/48;;H04L12/18,,3,1,106-208-063-391-333,10.1109/iccci.2013.6466147,"CHANDRASEKAR S ET AL: ""A novel indexing scheme for efficient handling of small files in Hadoop Distributed File System"", COMPUTER COMMUNICATION AND INFORMATICS (ICCCI), 2013 INTERNATIONAL CONFERENCE ON, IEEE, 4 January 2013 (2013-01-04), pages 1 - 8, XP032333008, ISBN: 978-1-4673-2906-4, DOI: 10.1109/ICCCI.2013.6466147;;KE XU ET AL: ""A Cloud Computing Platform Based on P2P"", IT IN MEDICINE&EDUCATION, 2009. ITIME '09. IEEE INTERNATIONAL SYMPOSIUM ON, IEEE, PISCATAWAY, NJ, USA, 14 August 2009 (2009-08-14), pages 427 - 432, XP031528425, ISBN: 978-1-4244-3928-7;;LESLIE LAMPORT, PAXOS MADE SIMPLE SIGACT NEWS, vol. 32, no. 4, December 2001 (2001-12-01), pages 51 - 58",ACTIVE
236,WO,A1,WO 2016/195687 A1,043-655-965-874-247,2016-12-08,2016,US 2015/0034122 W,2015-06-04,US 2015/0034122 W,2015-06-04,METHOD AND SYSTEM FOR DYNAMICALLY EXTENDABLE DISCIPLINES IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The disclosed embodiments include methods, systems and computer readable media for dynamically extendable disciplines in a multidisciplinary engineering system. The multidisciplinary engineering system is extended by adding a new engineering application 307 and engineering data associated with the new engineering application 307. The new engineering application data is linked to other engineering applications 307 in the multidisciplinary engineering system. Workflows are provided for accomplishing engineering tasks using the new and existing engineering data across engineering disciplines in the multidisciplinary engineering system.",SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,BARTH WILFRIED;;DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN;;REUVENI RAMI,,https://lens.org/043-655-965-874-247,Patent Application,yes,6,0,4,4,0,G06Q10/0633;;G06Q10/103;;G06Q10/0633;;G06Q10/103;;G06F16/258;;G06F16/252;;G06F16/289;;G06F16/258;;G06F16/252;;G06F16/289;;G06Q10/0633;;G06Q10/103;;G06F9/465,G06F9/46;;G06Q10/00,,2,0,,,". ET AL: ""SIMATIC WinCC Process visualization with Plant Intelligence SIMATIC HMI Answers for industry"", 30 April 2012 (2012-04-30), XP055220903, Retrieved from the Internet <URL:https://www.automation.siemens.com/salesmaterial-as/brochure/en/brochure_simatic-wincc_en.pdf> [retrieved on 20151014];;31 December 2005 (2005-12-31), XP055220919, Retrieved from the Internet <URL:https://cache.industry.siemens.com/dl/files/430/21401430/att_36978/v1/CFC_For_S7_e.pdf> [retrieved on 20151014]",PENDING
237,US,A1,US 2006/0131665 A1,088-823-632-491-574,2006-06-22,2006,US 33616006 A,2006-01-20,US 33616006 A;;US 99386504 A,2004-11-18,Method for forming an integrated circuit,"A method is described for manufacturing an n-MOS semiconductor transistor. Recesses are formed in a semiconductor substrate adjacent a gate electrode structure. Silicon is embedded in the recesses via a selective epitaxial growth process. The epitaxial silicon is in-situ alloyed with substitutional carbon and in-situ doped with phosphorus. The silicon-carbon alloy generates a uniaxial tensile strain in the channel region between the source and drain, thereby increasing electron channel mobility and the transistor's drive current. The silicon-carbon alloy decreases external resistances by reducing contact resistance between source/drain and silicide regions and by reducing phosphorous diffusivity, thereby permitting closer placement of the transistor's source/drain and channel regions.",MURTHY ANAND S;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;GHANI TAHIR,MURTHY ANAND S;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;GHANI TAHIR,TAHOE RESEARCH LTD (2022-07-18),https://lens.org/088-823-632-491-574,Patent Application,yes,15,82,2,2,0,H01L29/7834;;H01L29/7834;;H01L29/665;;H01L29/665;;H01L29/66636;;H01L29/66636,H01L29/76,257/384,0,0,,,,ACTIVE
238,US,A1,US 2006/0148151 A1,039-647-508-563-81X,2006-07-06,2006,US 2974005 A,2005-01-04,US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03);;INTEL CORPORATION (2004-10-29),https://lens.org/039-647-508-563-81X,Patent Application,yes,5,319,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/8234,438/197,0,0,,,,INACTIVE
239,CN,A,CN 105531675 A,122-483-928-545-204,2016-04-27,2016,CN 201380078999 A,2013-06-19,IB 2013001931 W,2013-06-19,Decentralized distributed computing system,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include a unique identifier. If a node receives a task including its unique identifier, the node executes the task. Each node stores each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure. Tasks may be launched on nodes based on location data gained by using in-band access to metadata specifying a location of nodes storing data corresponding to the metadata. A task may include starting a virtual machine such that an IP address is encoded in a file configuring the virtual machine.",HITACHI DATA SYSTEMS ENG UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,,https://lens.org/122-483-928-545-204,Patent Application,no,6,11,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50,,0,0,,,,ACTIVE
240,EP,A1,EP 2863307 A1,105-603-559-049-13X,2015-04-22,2015,EP 14197198 A,2013-06-19,EP 14197198 A;;EP 13786749 A;;IB 2013001931 W,2013-06-19,Decentralized distributed computing system,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include a unique identifier. If a node receives a task including its unique identifier, the node executes the task. Each node stores each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure. Tasks may be launched on nodes based on location data gained by using in-band access to metadata specifying a location of nodes storing data corresponding to the metadata. A task may include starting a virtual machine such that an IP address is encoded in a file configuring the virtual machine.
",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,"HITACHI, LTD. (2016-11-02)",https://lens.org/105-603-559-049-13X,Patent Application,yes,0,0,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50;;G06F9/48;;H04L12/18,,3,2,167-179-581-720-240;;077-802-804-256-975,10.1109/ccgrid.2012.71;;10.1109/greencom-cpscom.2010.62,"EUGEN FELLER ET AL: ""Snooze: A Scalable and Autonomic Virtual Machine Management Framework for Private Clouds"", CLUSTER, CLOUD AND GRID COMPUTING (CCGRID), 2012 12TH IEEE/ACM INTERNATIONAL SYMPOSIUM ON, IEEE, 13 May 2012 (2012-05-13), pages 482 - 489, XP032186564, ISBN: 978-1-4673-1395-7, DOI: 10.1109/CCGRID.2012.71;;EUGEN FELLER ET AL: ""Snooze: A Scalable, Fault-Tolerant and Distributed Consolidation Manager for Large-Scale Clusters"", GREEN COMPUTING AND COMMUNICATIONS (GREENCOM), 2010 IEEE/ACM INT'L CONFERENCE ON&INT'L CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (CPSCOM), IEEE, 18 December 2010 (2010-12-18), pages 125 - 132, XP031923475, ISBN: 978-1-4244-9779-9, DOI: 10.1109/GREENCOM-CPSCOM.2010.62;;LESLIE LAMPORT, PAXOS MADE SIMPLE SIGACT NEWS, vol. 32, no. 4, December 2001 (2001-12-01), pages 51 - 58",DISCONTINUED
241,CA,A1,CA 3077191 A1,113-451-568-015-871,2019-04-04,2019,CA 3077191 A,2018-09-26,US 201762563148 P;;US 2018/0052839 W,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,,https://lens.org/113-451-568-015-871,Patent Application,no,0,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61K31/498;;A61P25/28;;C07D241/44,,0,0,,,,PENDING
242,US,A1,US 2015/0074168 A1,080-465-988-718-620,2015-03-12,2015,US 201414535850 A,2014-11-07,IB 2013001931 W,2013-06-19,DECENTRALIZED DISTRIBUTED COMPUTING SYSTEM,"A distributed system includes a plurality of nodes connected over a network. Each node has a unique node identifier which identifies the node in the distributed system. Tasks are launched from any node in the distributed system and include one or more node identifiers. If a node receives a task including its node identifier, the node executes the task. Each node may store each task in a log. If a node fails, after recovering from the failure, the node queries the distributed system for tasks which were not received and tasks which were not completed due to the failure.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/080-465-988-718-620,Patent Application,yes,11,21,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,H04L12/18;;G06F9/48,709/201,0,0,,,,ACTIVE
243,US,B2,US 7195985 B2,092-424-806-212-835,2007-03-27,2007,US 2974005 A,2005-01-04,US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",INTEL CORP,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03);;INTEL CORPORATION (2004-10-29),https://lens.org/092-424-806-212-835,Granted Patent,yes,9,95,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/331,438/341;;438/357;;438/413,4,4,064-219-662-969-477;;016-026-113-467-931;;088-935-428-975-009;;064-093-298-723-743,10.1109/.2005.1469197;;10.1016/j.apsusc.2003.08.030;;10.1109/iedm.2004.1419383;;10.1109/essder.2004.1356549,"Ueno, T. et al., ""Dramatically enhanced performance of recessed SiGe source-drain pmos by in-situ etch and regrowth technique (InSERT)"", VLSI Technology 2005, Digest of Technical Papers, 2005 Symposium on Kyoto, Japan, Jun. 14-16, 2005.;;Loo, R. et al., ""A new technique to fabricate ultra-shallow-junctions, combining in situ vapour HCI etching and in situ doped epitaxial SiGe re-growth"", Applied Surface Science, vol. 224., No. 1-4, Mar. 15, 2004, pp. 63-67.;;Kah Wee Ang et al., ""Enhanced performance in 50nm N-MOSFETS with silicon-carbon source/drain regions"", IEEE International Electron Devices Meeting, 2004. IEDM Technical Digest, San Francisco, CA, Dec. 13-15, 2004, pp. 1069-1071.;;Zhikuan Zhang et al., ""Self-aligned recessed source/drain ultra-thin body SOI MOSFET technology"", Proceeding of the 34th European Solid-State Device Research Conference, 2004. ESSDERC 2004, Leuven, Belgium, Sep. 21-23, 2004, pp. 301-304.",INACTIVE
244,US,B2,US 7402872 B2,097-209-264-189-756,2008-07-22,2008,US 33616006 A,2006-01-20,US 33616006 A;;US 99386504 A,2004-11-18,Method for forming an integrated circuit,"A method is described for manufacturing an n-MOS semiconductor transistor. Recesses are formed in a semiconductor substrate adjacent a gate electrode structure. Silicon is embedded in the recesses via a selective epitaxial growth process. The epitaxial silicon is in-situ alloyed with substitutional carbon and in-situ doped with phosphorus. The silicon-carbon alloy generates a uniaxial tensile strain in the channel region between the source and drain, thereby increasing electron channel mobility and the transistor's drive current. The silicon-carbon alloy decreases external resistances by reducing contact resistance between source/drain and silicide regions and by reducing phosphorous diffusivity, thereby permitting closer placement of the transistor's source/drain and channel regions.",INTEL CORP,MURTHY ANAND S;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;GHANI TAHIR,TAHOE RESEARCH LTD (2022-07-18),https://lens.org/097-209-264-189-756,Granted Patent,yes,15,70,2,2,0,H01L29/7834;;H01L29/7834;;H01L29/665;;H01L29/665;;H01L29/66636;;H01L29/66636,H01L29/76;;H01L29/94;;H01L31/062;;H01L31/113,257/382;;257/408;;257/412,5,1,166-121-823-688-506,10.1109/iedm.2003.1269442,"U.S. Appl. No. 11/039,197, filed Jan. 18, 2005, Doyle et al.;;Ghani, T. et al., ""A 90nm High Volume Manufacturing Logic Technology Featuring Novel 45nm Gate Length Strained Silicon CMOS Transistors"", 2003 International Electron Devices Meeting, 3 pages, Dec. 9, 2003.;;Thompson, S. et al, ""A 90 nm Logic Technology Featuring 50 nm Strained Silicon Channel Transistors, 7 layers of Cu Interconnects, Low k ILD, and 1 mum<SUP>2 </SUP>SRAM Cell"", 2002 International Electron Devices Meeting, pp. 61-64, Dec. 9, 2002.;;Lammers, D., ""Intel, TI 'Straining' to Improve 90-nm Silicon"", EE Times, 3 pages, Oct. 24, 2003.;;Moroz, Victor et al., ""Analyzing Strained-Silicon Options for Stress-Engineering Transistors,"" Solid State Technology, Jul. 2004, available at http://sst.pennnet.com/Articles/Article<SUB>-</SUB>Display.cfm?Section=ARTCL&ARTICLE<SUB>-</SUB>ID=208681&VERSION<SUB>-</SUB>NUM=1&p=5.",ACTIVE
245,TW,B,TW I307462 B,013-873-691-638-833,2009-03-11,2009,TW 93103519 A,2004-02-13,US 39607103 A,2003-03-25,Ibist apparatus and computer system,,INTEL CORP,NEJEDLO JAY J;;WIZNEROWICZ MIKE;;ELLIS DAVID;;GLASS RICHARD;;MARTWICK ANDREW W;;SCHOENBORN THEODORE,,https://lens.org/013-873-691-638-833,Granted Patent,no,0,0,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,EXPIRED
246,EP,A1,EP 3687628 A1,018-229-656-079-065,2020-08-05,2020,EP 18861237 A,2018-09-26,US 201762563148 P;;US 2018/0052839 W,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,,https://lens.org/018-229-656-079-065,Patent Application,yes,0,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61P25/28;;A61K31/498;;C07D241/44,,0,0,,,,PENDING
247,US,B2,US 9069784 B2,068-652-245-523-311,2015-06-30,2015,US 201414542756 A,2014-11-17,US 201414542756 A;;US 201414535850 A;;IB 2013001931 W,2013-06-19,Configuring a virtual machine,"In some examples, a node in a distributed system may receive one or more IP addresses for use with one or more virtual machines. For example, at least one of the received IP addresses may be encoded into a respective MAC address. Further, a hypervisor implemented on the node may configure a virtual machine on the node. For instance, configuring the virtual machine may include passing the encoded MAC address to the virtual machine through the hypervisor. The virtual machine may be configured to decode the IP address from the encoded MAC address, and the IP address is assigned to the virtual machine.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/068-652-245-523-311,Granted Patent,yes,53,3,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F15/177;;G06F9/455;;G06F9/48;;G06F9/50;;G06F17/30;;H04L12/18;;H04L12/24;;H04L29/08;;H04L29/12,,8,4,167-179-581-720-240;;106-208-063-391-333;;124-036-949-278-027;;024-944-096-656-425,10.1109/ccgrid.2012.71;;10.1109/iccci.2013.6466147;;10.1109/sc.2006.19;;10.1145/1281100.1281103,"L. Lamport et al., ""Paxos Made Simple"", SIGACT News, Dec. 2001, pp. 51-58, vol. 32, No. 4.;;Feller et al., ""Snooze: A Scalable and Automatic Virtual Machine Management Framework for Private Clouds"", 2012 12th IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing, May 13, 2012, pp. 482-489.;;Xu et al., ""A Cloud Computing Platform Based on P2P"", IT in Medicine & Education, 2009. ITIME '09. IEEE International Symposium on, Aug. 14, 2009, pp. 427-432.;;Chandrasekar et al., ""A Novel Indexing Scheme for Efficient Handling of Small Files in Hadoop Distributed File Systems"", 2013 International Conference on Computer Communication and Informatics, Jan. 4, 2013, pp. 1-8.;;International Search Report and Written Opinion, dated Jan. 29, 2015 for International Patent Application No. PCT/US2013/065623.;;International Search Report and Written Opinion, dated Apr. 29, 2014 for International Patent Application No. PCT/IB2013/001931.;;Weil; Scott A. Brandt; Ethan L. Miller; Carlos Maltzahn; , ""CRUSH: Controlled, Scalable, Decentralized Placement of Replicated Data,"" Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, Nov. 2006, 12 pages.;;Tushar Deepak Chandra, Robert Griesemer, and Joshua Redstone, ""Paxos Made Live-An Engineering Perspective (2006 Invited Talk)"", Proceedings of the 26th Annual ACM Symposium on Principles of Distributed Computing, ACM press (Jun. 2007) 16 pages.",ACTIVE
248,US,A1,US 2009/0039390 A1,040-293-170-700-409,2009-02-12,2009,US 25019108 A,2008-10-13,US 25019108 A;;US 64352306 A;;US 2974005 A,2005-01-04,CMOS TRANSISTOR JUNCTION REGIONS FORMED BY A CVD ETCHING AND DEPOSITION SEQUENCE,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03),https://lens.org/040-293-170-700-409,Patent Application,yes,9,21,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L29/778;;H01L21/336,257/190;;438/285;;X257E29246;;X257E21403,0,0,,,,ACTIVE
249,CN,A,CN 107667385 A,050-490-745-340-797,2018-02-06,2018,CN 201580080644 A,2015-06-04,US 2015/0034122 W,2015-06-04,METHOD AND SYSTEM FOR DYNAMICALLY EXTENDABLE DISCIPLINES IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,"The disclosed embodiments include methods, systems and computer readable media for dynamically extendable disciplines in a multidisciplinary engineering system. The multidisciplinary engineering system is extended by adding a new engineering application 307 and engineering data associated with the new engineering application 307. The new engineering application data is linked to other engineeringapplications 307 in the multidisciplinary engineering system. Workflows are provided for accomplishing engineering tasks using the new and existing engineering data across engineering disciplines in the multidisciplinary engineering system.",SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,BARTH WILFRIED;;DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN;;REUVENI RAMI,,https://lens.org/050-490-745-340-797,Patent Application,no,7,0,4,4,0,G06Q10/0633;;G06Q10/103;;G06Q10/0633;;G06Q10/103;;G06F16/258;;G06F16/252;;G06F16/289;;G06F16/258;;G06F16/252;;G06F16/289;;G06Q10/0633;;G06Q10/103;;G06F9/465,G06Q10/06;;G06Q10/10,,1,0,,,"SIEMENS: ""SIMATIC WinCC Process visualization with Plant Intelligence"", 《HTTPS://WWW.AUTOMATION.SIEMENS.COM/SALESMATERIAL-AS/BROCHURE/EN/BROCHURE_SIMATIC-WINCC_EN.PDF》",DISCONTINUED
250,US,A1,US 2015/0088882 A1,168-891-551-273-297,2015-03-26,2015,US 201414542760 A,2014-11-17,US 201414542760 A;;US 201414535850 A;;IB 2013001931 W,2013-06-19,LOCATING FILE DATA FROM A MAPPING FILE,"In some examples, a distributed system may include a plurality of nodes with a file stored in a file system across the plurality of nodes. One of the nodes may receive a request for location data corresponding to a part of the file. For instance, the location data may be included in a mapping file, and the request may specify an offset of the mapping file. The mapping file may include locations of nodes storing parts of the file in the file system across the plurality of nodes, and the mapping file may have a plurality of parts corresponding to the parts of the file. In response to the request, the node may access the mapping file and send location data corresponding to the offset of the mapping file. The location data may indicate at least one of the nodes storing the part of the file.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/168-891-551-273-297,Patent Application,yes,18,3,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F17/30;;H04L29/08,707/736,0,0,,,,ACTIVE
251,EP,A4,EP 3687628 A4,011-125-225-436-250,2021-09-22,2021,EP 18861237 A,2018-09-26,US 201762563148 P;;US 2018/0052839 W,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,,https://lens.org/011-125-225-436-250,Search Report,no,1,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,A61P25/28;;A61K31/4174;;A61K31/4184;;A61K31/498;;A61K31/5377;;C07D235/08;;C07D235/12;;C07D235/16;;C07D241/42;;C07D241/44;;C07D401/14;;C07D403/04;;C07D403/12;;C07D405/14;;C07D413/14,,0,0,,,,PENDING
252,EP,A1,EP 2847678 A1,060-203-725-315-752,2015-03-18,2015,EP 13786749 A,2013-06-19,IB 2013001931 W,2013-06-19,DECENTRALIZED DISTRIBUTED COMPUTING SYSTEM,,HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,"HITACHI, LTD., JP (2017-06-28);;HITACHI, LTD. (2016-11-02)",https://lens.org/060-203-725-315-752,Patent Application,yes,0,0,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50,,0,0,,,,ACTIVE
253,US,A1,US 2015/0089504 A1,106-841-473-358-943,2015-03-26,2015,US 201414542756 A,2014-11-17,US 201414542756 A;;US 201414535850 A;;IB 2013001931 W,2013-06-19,CONFIGURING A VIRTUAL MACHINE,"In some examples, a node in a distributed system may receive one or more IP addresses for use with one or more virtual machines. For example, at least one of the received IP addresses may be encoded into a respective MAC address. Further, a hypervisor implemented on the node may configure a virtual machine on the node. For instance, configuring the virtual machine may include passing the encoded MAC address to the virtual machine through the hypervisor. The virtual machine may be configured to decode the IP address from the encoded MAC address, and the IP address is assigned to the virtual machine.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/106-841-473-358-943,Patent Application,yes,5,6,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/455;;H04L12/24;;H04L29/12,718/1,0,0,,,,ACTIVE
254,US,A1,US 2007/0105331 A1,134-254-142-565-162,2007-05-10,2007,US 64352306 A,2006-12-21,US 64352306 A;;US 2974005 A,2005-01-04,CMOS transistor junction regions formed by a CVD etching and deposition sequence,"This invention adds to the art of replacement source-drain cMOS transistors. Processes may involve etching a recess in the substrate material using one equipment set, then performing deposition in another. Disclosed is a method to perform the etch and subsequent deposition in the same reactor without atmospheric exposure. In-situ etching of the source-drain recess for replacement source-drain applications provides several advantages over state of the art ex-situ etching. Transistor drive current is improved by: (1) Eliminating contamination of the silicon-epilayer interface when the as-etched surface is exposed to atmosphere and (2) Precise control over the shape of the etch recess. Deposition may be done by a variety of techniques including selective and non-selective methods. In the case of blanket deposition, a measure to avoid amorphous deposition in performance critical regions is also presented.",MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,MURTHY ANAND;;GLASS GLENN A;;WESTMEYER ANDREW N;;HATTENDORF MICHAEL L;;WANK JEFFREY R,DAEDALUS PRIME LLC (2022-06-03),https://lens.org/134-254-142-565-162,Patent Application,yes,9,27,26,26,0,H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/517;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L21/2053;;H01L21/8238;;H01L29/66628;;H01L29/7834;;H01L29/7848;;H01L29/517;;H01L21/02381;;H01L21/02532;;H01L21/0262;;H01L21/02639;;H01L29/7848;;H01L21/02381;;H01L29/7834;;H01L21/0262;;H01L21/02532;;H01L29/66628;;H01L29/517;;H01L21/02639,H01L21/331,438/341,0,0,,,,ACTIVE
255,US,A1,US 2020/0291005 A1,045-333-497-038-862,2020-09-17,2020,US 201816650901 A,2018-09-26,US 201816650901 A;;US 201762563148 P;;US 2018/0052839 W,2017-09-26,COMPOSITIONS AND METHODS FOR INHIBITING ACSS2,The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.,UNIV PENNSYLVANIA,MEWS PHILIPP;;BERGER SHELLEY L;;WINKLER JEFFREY D;;GLASS ANDREW;;BAUGH SIMON DAVID PETER,THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (2020-01-10),https://lens.org/045-333-497-038-862,Patent Application,yes,2,0,10,10,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;A61K31/498;;C07D235/08;;C07D235/12;;C07D235/16;;C07D403/04;;C07D241/42;;A61P25/28;;A61K31/4184;;A61K31/4174;;A61K31/5377;;A61P25/00;;C07D409/14,C07D409/14;;A61P25/00,,3,2,053-061-664-486-552;;126-904-001-744-791,pmc2646256;;10.1016/j.bbrc.2007.03.056;;17482143;;pmc3303926;;10.1016/j.bmc.2012.02.022;;22386982,"Crowe, A. et al.: High throughput screning for small molecule inhibitors of heparin-induced tau fibril formation. Biochem. & Biophys. Res. Commun., vol. 358, pages 1-6, 2007.;;Rajule, R. et al.: Perturbing pro-survival proteins using quinoxaline derivatives: A structure-activity relationship study. Biorganic & Med. Chem., vol. 20, pages 2227-2234, 2012.;;Compounds with RN 508185-73-7 and RN 709000-08-8.",PENDING
256,EP,B1,EP 2847678 B1,199-959-391-278-533,2016-06-08,2016,EP 13786749 A,2013-06-19,IB 2013001931 W,2013-06-19,DECENTRALIZED DISTRIBUTED COMPUTING SYSTEM,,HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,"HITACHI, LTD., JP (2017-06-28);;HITACHI, LTD. (2016-11-02)",https://lens.org/199-959-391-278-533,Granted Patent,yes,5,0,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/50,,3,0,,,"EUGEN FELLER ET AL: ""Snooze: A Scalable and Autonomic Virtual Machine Management Framework for Private Clouds"", CLUSTER, CLOUD AND GRID COMPUTING (CCGRID), 2012 12TH IEEE/ACM INTERNATIONAL SYMPOSIUM ON, IEEE, 13 May 2012 (2012-05-13), pages 482-489, XP032186564, DOI: 10.1109/CCGRID.2012.71 ISBN: 978-1-4673-1395-7;;KE XU ET AL: ""A Cloud Computing Platform Based on P2P"", IT IN MEDICINE&EDUCATION, 2009. ITIME '09. IEEE INTERNATIONAL SYMPOSIUM ON, IEEE, PISCATAWAY, NJ, USA, 14 August 2009 (2009-08-14), pages 427-432, XP031528425, ISBN: 978-1-4244-3928-7;;CHANDRASEKAR S ET AL: ""A novel indexing scheme for efficient handling of small files in Hadoop Distributed File System"", COMPUTER COMMUNICATION AND INFORMATICS (ICCCI), 2013 INTERNATIONAL CONFERENCE ON, IEEE, 4 January 2013 (2013-01-04), pages 1-8, XP032333008, DOI: 10.1109/ICCCI.2013.6466147 ISBN: 978-1-4673-2906-4",ACTIVE
257,US,B2,US 9304821 B2,193-363-934-872-833,2016-04-05,2016,US 201414542760 A,2014-11-17,US 201414542760 A;;US 201414535850 A;;IB 2013001931 W,2013-06-19,Locating file data from a mapping file,"In some examples, a distributed system may include a plurality of nodes with a file stored in a file system across the plurality of nodes. One of the nodes may receive a request for location data corresponding to a part of the file. For instance, the location data may be included in a mapping file, and the request may specify an offset of the mapping file. The mapping file may include locations of nodes storing parts of the file in the file system across the plurality of nodes, and the mapping file may have a plurality of parts corresponding to the parts of the file. In response to the request, the node may access the mapping file and send location data corresponding to the offset of the mapping file. The location data may indicate at least one of the nodes storing the part of the file.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/193-363-934-872-833,Granted Patent,yes,53,1,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F9/46;;G06F9/455;;G06F9/48;;G06F9/50;;G06F15/16;;G06F15/173;;G06F17/30;;H04L12/18;;H04L12/24;;H04L29/08;;H04L29/12,,8,4,167-179-581-720-240;;106-208-063-391-333;;124-036-949-278-027;;024-944-096-656-425,10.1109/ccgrid.2012.71;;10.1109/iccci.2013.6466147;;10.1109/sc.2006.19;;10.1145/1281100.1281103,"L. Lamport et al., ""Paxos Made Simple"", SIGACT News, Dec. 2001, pp. 51-58, vol. 32, No. 4.;;Feller et al., ""Snooze: A Scalable and Automatic Virtual Machine Management Framework for Private Clouds"", 2012 12th IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing, May 13, 2012, pp. 482-489.;;Xu et al., ""A Cloud Computing Platform Based on P2P"", IT in Medicine & Education, 2009. ITIME '09. IEEE International Symposium on, Aug. 14, 2009, pp. 427-432.;;Chandrasekar et al., ""A Novel Indexing Scheme for Efficient Handling of Small Files in Hadoop Distributed File System"", 2013 International Conference on Computer Communication and Informatics, Jan. 4, 2013, pp. 1-8.;;International Search Report and Written Opinion, dated Jan. 29, 2015 for International Patent Application No. PCT/US2013/065623.;;International Search Report and Written Opinion, dated Apr. 29, 2014 for International Patent Application No. PCT/IB2013/001931.;;Weil; Scott A. Brandt; Ethan L. Miller; Carlos Maltzahn; , ""Crush: Controlled, Scalable, Decentralized Placement of Replicated Data,"" Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, Nov. 2006, 12 pages.;;Tushar Deepak Chandra, Robert Griesemer, and Joshua Redstone, ""Paxos Made Live-An Engineering Perspective (2006 Invited Talk)"", Proceedings of the 26th Annual ACM Symposium on Principles of Distributed Computing, ACM press (Jun. 2007) 16 pages.",ACTIVE
258,TW,A,TW 200424843 A,090-454-785-068-84X,2004-11-16,2004,TW 93103519 A,2004-02-13,US 39607103 A,2003-03-25,A high performance serial bus testing methodology,"According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits.",INTEL CORP,NEJEDLO JAY J;;WIZNEROWICZ MIKE;;ELLIS DAVID;;GLASS RICHARD;;MARTWICK ANDREW W;;SCHOENBORN THEODORE,,https://lens.org/090-454-785-068-84X,Patent of Addition,no,0,1,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G06F11/26;;G01R31/317;;G01R31/3187;;G06F13/00;;G06F19/00;;H04L1/24,,0,0,,,,EXPIRED
259,EP,A1,EP 3304296 A1,105-867-726-459-881,2018-04-11,2018,EP 15731162 A,2015-06-04,US 2015/0034122 W,2015-06-04,METHOD AND SYSTEM FOR DYNAMICALLY EXTENDABLE DISCIPLINES IN A MULTIDISCIPLINARY ENGINEERING SYSTEM,,SIEMENS AG;;SIEMENS PRODUCT LIFECYCLE MAN SOFTWARE INC,BARTH WILFRIED;;DUREL MARINE;;DYLLA ANDREW;;GLASS MICHAEL;;LABAS ATTILA;;NOETZELMANN OSWIN;;REUVENI RAMI,SIEMENS AKTIENGESELLSCHAFT (2020-01-08);;SIEMENS INDUSTRY SOFTWARE INC. (2020-01-08),https://lens.org/105-867-726-459-881,Patent Application,yes,0,0,4,4,0,G06Q10/0633;;G06Q10/103;;G06Q10/0633;;G06Q10/103;;G06F16/258;;G06F16/252;;G06F16/289;;G06F16/258;;G06F16/252;;G06F16/289;;G06Q10/0633;;G06Q10/103;;G06F9/465,G06F9/46;;G06Q10/00,,0,0,,,,DISCONTINUED
260,US,A1,US 2016/0188628 A1,012-182-627-618-660,2016-06-30,2016,US 201615064862 A,2016-03-09,US 201615064862 A;;US 201414542760 A;;US 201414535850 A;;IB 2013001931 W,2013-06-19,DISTRIBUTED SYSTEM INCLUDING A NODE WHICH BROADCASTS A TASK MESSAGE AND MANAGES INFORMATION OF THE TASK MESSAGE UNTIL COMPLETION,"In some examples, a distributed system may include a plurality of nodes with a file stored in a file system across the plurality of nodes. One of the nodes may receive a request for location data corresponding to a part of the file. For instance, the location data may be included in a mapping file, and the request may specify an offset of the mapping file. The mapping file may include locations of nodes storing parts of the file in the file system across the plurality of nodes, and the mapping file may have a plurality of parts corresponding to the parts of the file. In response to the request, the node may access the mapping file and send location data corresponding to the offset of the mapping file. The location data may indicate at least one of the nodes storing the part of the file.",HITACHI DATA SYSTEMS ENGINEERING UK LTD,HARTMAN DAVID STEPHEN;;GLASS THOMAS ANDREW;;SINHA SHANTANU;;BERNHARD BEN;;KISELEV OLEG;;MATTLY JAMES,HITACHI LTD (2016-07-18);;HITACHI DATA SYSTEMS ENGINEERING UK LIMITED (2013-05-27),https://lens.org/012-182-627-618-660,Patent Application,yes,2,65,17,17,0,G06F9/5027;;H04L67/06;;H04L67/10;;G06F16/182;;G06F16/13;;G06F9/50;;G06F9/5005;;G06F9/5038;;G06F9/5072;;G06F16/182;;G06F16/13;;G06F9/5027;;H04L67/10;;H04L67/06;;H04L61/5007;;H04L65/40;;G06F9/4881;;H04L12/1881;;H04L67/1097;;H04L41/0803;;G06F9/45533,G06F17/30;;H04L29/08,,1,0,,,"Condor team, âCondor Version 7.0.0 Manualâ, University of Wisconsin-Madison, January 22, 2008, pages 1 â 856",DISCONTINUED
261,EC,A,EC SP003588 A,042-562-825-371-200,2001-05-23,2001,EC SP003588 A,2000-07-27,EC SP003588 A,2000-07-27,METODO Y SISTEMA DE INSPECCION DEL TAPON COMBINADOR,"Un sistema cilíndrico de filtro de cigarrillo que comprende una máquina combinadora de tapón que tiene un corte ubicado descendetemente de un sensor. El corte genera una señal en el pulsador que indica una Unidad de Inspección para ubicar un sistema de información del sensor, previamente almacenado, que corresponde a la sección cilíndrica que fue dividida por el corte. La Unidad de Inspección aplica umbrales al sistema de la información del sensor para determinar la ubicación de las uniones del segmento de filtro, y luego determina si los anillos de aire están presentes en la información. La Unidad de Inspección luego compara las medidas tomadas en el sistema de la información del sensor con una fórmula pre-almacenada que indica los valores esperados para el sistema. La información estadística es enviada a una HMI Unidad para su análisis y exhibición. El sistema realiza el rechazamiento de la sección cilíndrica de filtro y ordena el corte en base del análisis realizado por la Unidad de Inspección y la HMI.",,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,,https://lens.org/042-562-825-371-200,Patent Application,no,0,0,1,1,0,,A24C5/34,,0,0,,,,PENDING
262,GB,A,GB 2413938 A,132-836-052-963-316,2005-11-16,2005,GB 0517173 A,2004-03-25,US 2004/0009142 W;;US 45723103 P,2003-03-25,Modular security cabinet system for storing firearms or the like,"A storage cabinet assembly (60) for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests (160) for positioning in the bottom of the cabinet interior, as well as barrel rests (164) and pistol supports (166) that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/132-836-052-963-316,Patent Application,no,4,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,A4B B9B16         B9B+F;;A4B B9F9          B9B+F;;U1S S1191,0,0,,,,INACTIVE
263,EP,A1,EP 1218274 A1,107-064-742-501-14X,2002-07-03,2002,EP 00950413 A,2000-07-25,US 0019548 W;;US 36135899 A,1999-07-27,PLUG COMBINER INSPECTION SYSTEM AND METHOD,,PHILIP MORRIS PROD,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,,https://lens.org/107-064-742-501-14X,Patent Application,yes,0,0,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24C5/34;;A24D3/02;;A24D3/04,,0,0,,,,DISCONTINUED
264,US,B2,US 10191621 B2,168-009-384-143-514,2019-01-29,2019,US 201615142327 A,2016-04-29,US 201615142327 A,2016-04-29,Exposing populated lists of personalized strings,"Presenting a list of personalized strings to a user in response to the user's interaction with a single key of a keyboard. Interaction of a user with a single key of a keyboard is detected. Responsive to detecting the user interaction at the single keyboard key, a string type associated with the user interaction is identified. One or more personalized strings that are associated with the user and that are of the identified string type are also identified. A list of strings with the one or more personalized strings of the string type associated with the user interaction is then populated. The populated list of strings is then presented, wherein each string of the list of strings comprises a user-selectable element.",MICROSOFT TECHNOLOGY LICENSING LLC,RIDEOUT MARK RODGER;;ALBERTS ANA ISABEL A N RIBEIRO;;GLASS ANDREW STUART;;MARKIEWICZ JAN-KRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2016-04-27),https://lens.org/168-009-384-143-514,Granted Patent,yes,19,0,5,5,0,G06F3/04886;;G06F40/174;;G06F40/274;;G06F40/174;;G06F40/274;;G06F3/0482;;G06F3/04886,G06F3/0482;;G06F3/0488;;G06F17/24;;G06F17/27,,9,0,,,"“Using the HTML Help control to display contextual help—CodeProject”, Published Feb. 17, 2003, Available at http://www.codeproject.com/Articles/3679/Using-the_HTML-Help-control-to-display-contextual?display=Print, retrieved on Jul. 14, 2017, pp. 1-2.;;“International Search Report and the Written Opinion Issued in PCT Application No. PCT/US2017/029228”, dated Jul. 26, 2017.;;“MIT App Inventor”, Published on: Aug. 15, 2012 Available at: http://appinventor.mit.edu/explore/content/social.html#EmailPicker.;;Clitter, Sandra, “Your Tech Tamer”, Published on: Aug. 8, 2011 Available at: http://www.yourtechtamer.com/blog/2011/08/can-you-create-a-shortcut-to-auto-paste-your-email-address-onto-the-clipboard/.;;“Mozilla support: Thunderbird”, Published on: Sep. 2, 2014 Available at: https://support.mozilla.org/en-US/kb/addressing-email#thunderbird:win7;tb38.;;Broida, Rick, “PCWorld: Create a Keyboard Shortcut to Insert Your E-Mail Address”, Published on: Dec. 14, 2012 Available at: http://www.pcworld.com/article/238709/create_a_keyboard_shortcut_to_insert_your_e_mail_address.html.;;Horowitz, Paul, “OSXDaily: Create a Shortcut for Typing eMail Address Quickly in iOS”, Published on; Aug. 4, 2012 Available at: http://osxdaily.com/2012/08/04/create-shortcut-for-typing-email-address-ios/.;;Pearson, William, “OSXDaily: Set a Shortcut to Type an Email Address Instantly in Mac OS X with Text Expansion”, Published on: Aug. 15, 2012 Available at: http://osxdaily.com/2012/08/15/email-address-type-shortcut-mac-os-x-text-expansion/.;;Wyatt, Allen, “WordTIPS”, Published on: Apr. 19, 2011 Available at: http://word.tips.net/T006765_Inserting_Text_with_a_Shortcut_Key.html.",ACTIVE
265,US,A1,US 2008/0218040 A1,093-690-315-879-801,2008-09-11,2008,US 12230408 A,2008-05-16,US 12230408 A,2008-05-16,Modular security cabinet system for storing firearms or the like,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/093-690-315-879-801,Patent Application,yes,26,16,1,1,0,A47B47/02;;A47B81/005;;F41C33/06;;A47B81/005;;A47B47/02;;F41C33/06,A47B81/00,312/128;;312/326;;312/215;;312/263,0,0,,,,DISCONTINUED
266,WO,A2,WO 2005/016072 A2,095-033-242-824-684,2005-02-24,2005,US 2004/0009142 W,2004-03-25,US 45723103 P,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,"A storage cabinet assembly (60) for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests (160) for positioning in the bottom of the cabinet interior, as well as barrel rests (164) and pistol supports (166) that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP;;PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/095-033-242-824-684,Patent Application,yes,0,2,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,,0,0,,,,PENDING
267,WO,A1,WO 2001/007351 A1,109-043-834-140-417,2001-02-01,2001,US 0019548 W,2000-07-25,US 36135899 A,1999-07-27,PLUG COMBINER INSPECTION SYSTEM AND METHOD,"A cigarette filter rod system comprises a plug combiner machine having a knife (320) located downstream from a sensor. The knife generates a trigger signal which prompts an Inspection Unit (404) to locate a previously stored frame of sensor data corresponding the rod which was cut by the knife. The Inspection Unit (404) applies thresholds to the frame of sensor data to determine the location of filter segment boundaries, and then determines whether air rings are present in the data. The Inspection Unit then compares measurements made on the frame of sensor data with a pre-stored recipe indicating expected values for the frame. Statistical data is sent to a Human-Machine Interface Unit (406) for analysis and display. The system performs filter rod rejection and cut registration based on the analysis performed by the Inspection Unit and the Human-Machine Interface.",PHILIP MORRIS PROD,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,,https://lens.org/109-043-834-140-417,Patent Application,yes,7,5,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24C5/34;;A24D3/02;;A24D3/04,,1,0,,,See also references of EP 1218274A4,PENDING
268,CA,A1,CA 2514702 A1,125-315-674-955-241,2005-02-24,2005,CA 2514702 A,2004-03-25,US 45723103 P;;US 2004/0009142 W,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,,SPACESAVER CORP,GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C;;PUNZEL WILLIAM H,,https://lens.org/125-315-674-955-241,Patent Application,no,0,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,,0,0,,,,INACTIVE
269,US,B2,US 7524002 B2,034-880-502-008-718,2009-04-28,2009,US 58506906 A,2006-10-23,US 58506906 A;;US 54212904 A,2004-03-25,Locking door system for a storage cabinet,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/034-880-502-008-718,Granted Patent,yes,24,13,3,4,0,A47B81/005;;E05C9/043;;F41C33/06;;Y10T292/0839;;Y10T292/0839;;F41C33/06;;A47B81/005;;E05C9/043,A47B96/00;;E05C1/12,312/217;;312/215;;292/36,4,0,,,"International Search Report dated May 20, 2005.;;Written Opinion of The International Searching Authority dated May 20, 2005.;;International Preliminary Report On Patentability dated Oct. 1, 2005.;;""Multitrack Multiple Weapons Storage Rack"", U.S. Government, DSN 482-5860/5768, May 17, 2000, 18 pages.",INACTIVE
270,CA,C,CA 2514702 C,171-101-440-886-196,2007-12-11,2007,CA 2514702 A,2004-03-25,US 45723103 P;;US 2004/0009142 W,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,"A storage cabinet assembly (60) for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in openi ng and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests (160) for positioning in the bottom of the cabinet interior, as well a s barrel rests (164) and pistol supports (166) that are secured to amounting member which may be adjustably positioned within the storage cabinet interio r. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the stora ge cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;MUTH JAMES C;;DINGLE STEVEN S;;KOLMAN ANDREW J,,https://lens.org/171-101-440-886-196,Granted Patent,no,0,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,,0,0,,,,INACTIVE
271,US,A1,US 2009/0079308 A1,030-263-108-317-134,2009-03-26,2009,US 27333308 A,2008-11-18,US 27333308 A;;US 54212904 A;;US 2004/0009142 W;;US 45723103 P,2003-03-25,Modular Security Cabinet System For Storing Firearms Or The Like,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/030-263-108-317-134,Patent Application,yes,26,6,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,312/306;;312/351,0,0,,,,DISCONTINUED
272,MY,A,MY 125304 A,043-810-857-807-829,2006-07-31,2006,MY PI20003383 A,2000-07-25,US 36135899 A,1999-07-27,PLUG COMBINER INSPECTION SYSTEM AND METHOD,"A CIGARETTE FILTER ROD SYSTEM COMPRISE A PLUG COMBINER MACHINE (402) HAVING A KNIFE (410) LOCATED DOWNSTREAM FROM A SENSOR (412). THE KNIFE (410) GENERATES A TRIGGER SIGNAL WHICH PROMPTS AN INSPECTION UNIT (404) TO LOCATE A PREVIOUSLY STORED FRAME OF SENSOR DATA CORRESPONDING THE ROD WHICH WAS CUT BY THE KNIFE (410). THE INSPECTION UNIT (404) APPLIES THRESHOLDS THE FRAME OF SENSOR DATA TO DETERMINE THE LOCATION OF FILTER SEGMENT BOUNDARIES, AND THEN DETERMINES WHETHER AIR RINGS (900) ARE PRESENT IN THE DATA. THE INSPECTION UNIT (404) THEN COMPARES MEASUREMENTS MADE ON THE FRAME OF SENSOR DATA WITH PRE-STORED RECIPE INDICATING EXPECTED VALUES FOR THE FRAME. STATISTICAL DATA IS SENT TO A HUMAN-MACHINE INTERFACE UNIT (406) FOR ANALYSIS AND DISPLAY. THE SYSTEM PERFORMS FILTER ROD REJECTION AND CUT REGISTRATION BASED ON THE ANALYSIS PERFORMED BY THE INSPECTION UNIT (404) AND THE HUMAN-MACHINE INTERFACE (406).(FIG. 5)",PHILIP MORRIS PROD,BRUCE W KEEN;;JANET L THOMPSON;;MARC BELCASTRO;;ANDREW STRUCKHOFF;;LEE CRAMER;;GILBERT D GLASS,,https://lens.org/043-810-857-807-829,Granted Patent,no,0,0,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24D3/04;;A24C5/34;;A24D3/02,,0,0,,,,EXPIRED
273,EP,A4,EP 1218274 A4,066-745-668-346-118,2007-06-20,2007,EP 00950413 A,2000-07-25,US 0019548 W;;US 36135899 A,1999-07-27,PLUG COMBINER INSPECTION SYSTEM AND METHOD,,PHILIP MORRIS PROD,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,,https://lens.org/066-745-668-346-118,Search Report,no,4,0,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24C5/34;;A24D3/02;;A24D3/04,,1,0,,,See also references of WO 0107351A1,DISCONTINUED
274,AU,A,AU 2000/063522 A,060-405-639-784-806,2001-02-13,2001,AU 2000/063522 A,2000-07-25,US 36135899 A;;US 0019548 W,1999-07-27,Plug combiner inspection system and method,,PHILIP MORRIS PROD,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,,https://lens.org/060-405-639-784-806,Patent Application,no,0,0,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24D3/04;;A24C5/34;;A24D3/02,,0,0,,,,DISCONTINUED
275,DE,T5,DE 112004000493 T5,153-954-443-951-741,2006-06-14,2006,DE 112004000493 T,2004-03-25,US 2004/0009142 W,2004-03-25,Modulares Sicherheitsschranksystem zur Lagerung von Schusswaffen oder ähnlichem,,SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/153-954-443-951-741,Patent Application,no,0,0,1,1,0,,A47B81/00,,0,0,,,,DISCONTINUED
276,GB,A,GB 2427349 A,177-724-083-949-097,2006-12-27,2006,GB 0613852 A,2004-03-25,US 45723103 P;;GB 0517173 A,2003-03-25,Modular security cabinet system for storing firearms or the like,"A storage cabinet assembly 60 for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. A locking arrangement includes latch members and control members carried by each of the folding door sections. Each control member is interconnected with a latch member and movable between open and closed positions. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests 160 for positioning in the bottom of the cabinet interior, as well as barrel rests 164 and pistol supports 166 that are secured to a mounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/177-724-083-949-097,Patent Application,no,4,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,A4B B9B16         B9B+F;;A4B B9F9          B9B+F;;U1S S1191,0,0,,,,INACTIVE
277,GB,B,GB 2427349 B,057-172-766-465-231,2007-04-18,2007,GB 0613852 A,2004-03-25,US 45723103 P;;GB 0517173 A,2003-03-25,Modular security cabinet system for storing firearms or the like,,SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/057-172-766-465-231,Granted Patent,no,4,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,A4B B9B16         B9B+F;;A4B B9F9          B9B+F;;U1S S1191,0,0,,,,INACTIVE
278,CA,A1,CA 2594256 A1,120-268-750-527-097,2005-02-24,2005,CA 2594256 A,2004-03-25,US 45723103 P;;CA 2514702 A,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,"The present invention provides a storage cabinet assembly, comprising: a cabinet defining an interior; a folding door arrangement mounted to the cabinet, wherein the folding door arrangement includes a pair of folding door sections, each of which includes an inner door member and at least one outer door member, wherein th e folding door sections are movable between a closed position in which the folding door sections cooperate to prevent access to the cabinet interior, and an open position in which the folding door sections are positioned to provide access to the cabinet interior, wherein the inner door members of the folding door sections are located adjacent each other when the folding door sections are in the closed positio n; and a locking arrangement associated with the folding door arrangement, wherein th e locking arrangement includes a latch member carried by each of the folding door sections, wherein each latch member is movable between an engaged position a nd a release position, wherein each latch member in the engaged position maintain s its associated door section in the closed position and wherein each latch member in the release position enables movement of its associated door section between the closed position and the open position, and wherein the locking arrangement further includes a movable control member carried by each door section, wherein each control member is interconnected with one of the latch members and wherein each control member is movable between a first position in which the control member place s its associated latch member in the engaged position, and a second position in which the control member places its associated latch member in the release position, wherein the control members in the first position overlie the inner door members and are adapted to be secured together to maintain the door sections in the closed position.",SPACESAVER CORP,GLASS JANE E;;PUNZEL WILLIAM H;;MUTH JAMES C;;DINGLE STEVEN S;;KOLMAN ANDREW J,,https://lens.org/120-268-750-527-097,Patent Application,no,0,1,2,15,0,,A47B96/00;;A47B81/00,,0,0,,,,INACTIVE
279,WO,A1,WO 2017/189467 A1,134-524-576-478-290,2017-11-02,2017,US 2017/0029228 W,2017-04-25,US 201615142327 A,2016-04-29,TRIGGERING EXPOSURE OF AUTO-FILL LISTS WITH PERSONALIZED STRINGS,"Presenting a list of personalized strings to a user in response to the user's interaction with a single key of a keyboard. Interaction of a user with a single key of a keyboard is detected. Responsive to detecting the user interaction at the single keyboard key, a string type associated with the user interaction is identified. One or more personalized strings that are associated with the user and that are of the identified string type are also identified. A list of strings with the one or more personalized strings of the string type associated with the user interaction is then populated. The populated list of strings is then presented, wherein each string of the list of strings comprises a user-selectable element.",MICROSOFT TECHNOLOGY LICENSING LLC,RIDEOUT MARK RODGER;;ALBERTS ANA ISABEL A N RIBEIRO;;GLASS ANDREW STUART;;MARKIEWICZ JAN-KRISTIAN,,https://lens.org/134-524-576-478-290,Patent Application,yes,4,0,5,5,0,G06F3/04886;;G06F40/174;;G06F40/274;;G06F40/174;;G06F40/274;;G06F3/0482;;G06F3/04886,G06F17/24;;G06F3/048;;G06F17/27,,1,0,,,"ANONYMOUS: ""Using the HTML Help control to display contextual help - CodeProject"", 17 February 2003 (2003-02-17), XP055390967, Retrieved from the Internet <URL:https://www.codeproject.com/Articles/3679/Using-the-HTML-Help-control-to-display-contextual?display=Print> [retrieved on 20170714]",PENDING
280,US,B1,US 6264591 B1,171-203-402-911-407,2001-07-24,2001,US 36135899 A,1999-07-27,US 36135899 A,1999-07-27,Plug combiner inspection system and method,"A cigarette filter rod system comprises a plug combiner machine having a knife located downstream from a sensor. The knife generates a trigger signal which prompts an Inspection Unit to locate a previously stored frame of sensor data corresponding the rod which was cut by the knife. The Inspection Unit applies thresholds to the frame of sensor data to determine the location of filter segment boundaries, and then determines whether air rings are present in the data. The Inspection Unit then compares measurements made on the frame of sensor data with a pre-stored recipe indicating expected values for the frame. Statistical data is sent to a Human-Machine Interface Unit for analysis and display. The system performs filter rod rejection and cut registration based on the analysis performed by the Inspection Unit and the Human-Machine Interface.",PHILIP MORRIS INC,KEEN BRUCE W;;THOMPSON JANET L;;BELCASTRO MARC;;STRUCKHOFF ANDREW;;CRAMER LEE;;GLASS GILBERT D,PHILIP MORRIS INCORPORATED (1999-09-10),https://lens.org/171-203-402-911-407,Granted Patent,yes,11,37,8,8,0,A24C5/3412;;A24D3/0295;;A24C5/3412;;A24D3/0295,A24C5/34;;A24D3/04;;A24D3/02,493/4;;493/22;;250/559.04;;250/559.39,0,0,,,,EXPIRED
281,GB,B,GB 2413938 B,190-288-064-402-435,2006-12-06,2006,GB 0517173 A,2004-03-25,US 2004/0009142 W;;US 45723103 P,2003-03-25,Modular security cabinet system for storing firearms or the like,,SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/190-288-064-402-435,Granted Patent,no,8,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,A4B B9B16         B9B+F;;A4B B9F9          B9B+F;;U1S S1191,0,0,,,,INACTIVE
282,CN,A,CN 109074352 A,091-642-796-935-915,2018-12-21,2018,CN 201780025755 A,2017-04-25,US 201615142327 A;;US 2017/0029228 W,2016-04-29,TRIGGERING EXPOSURE OF AUTO-FILL LISTS WITH PERSONALIZED STRINGS,"The invention is to present a list of personalized strings to a user in response to the user's interaction with a single key of a keyboard. Interaction of a user with a single key of a keyboard is detected. Responsive to detecting the user interaction at the single keyboard key, a string type associated with the user interaction is identified. One or more personalized strings that are associated with the user and that are of the identified string type are also identified. A list of strings with the one or more personalized strings of the string type associated with the user interaction is thenpopulated. The populated list of strings is then presented, wherein each string of the list of strings comprises a user-selectable element.",MICROSOFT TECHNOLOGY LICENSING LLC,RIDEOUT MARK RODGER;;ALBERTS ANA ISABEL A N RIBEIRO;;GLASS ANDREW STUART;;MARKIEWICZ JAN-KRISTIAN,,https://lens.org/091-642-796-935-915,Patent Application,no,2,0,5,5,0,G06F3/04886;;G06F40/174;;G06F40/274;;G06F40/174;;G06F40/274;;G06F3/0482;;G06F3/04886,G06F17/24;;G06F3/0488;;G06F17/27,,1,0,,,"《从零开始学电脑》编委会编著: ""《从零开始学电脑》"", 31 May 2012",PENDING
283,EP,A1,EP 3449385 A1,132-308-004-984-981,2019-03-06,2019,EP 17721497 A,2017-04-25,US 201615142327 A;;US 2017/0029228 W,2016-04-29,TRIGGERING EXPOSURE OF AUTO-FILL LISTS WITH PERSONALIZED STRINGS,,MICROSOFT TECHNOLOGY LICENSING LLC,RIDEOUT MARK RODGER;;ALBERTS ANA ISABEL A N RIBEIRO;;GLASS ANDREW STUART;;MARKIEWICZ JAN-KRISTIAN,"MICROSOFT TECHNOLOGY LICENSING, LLC (2021-11-10)",https://lens.org/132-308-004-984-981,Patent Application,yes,0,0,5,5,0,G06F3/04886;;G06F40/174;;G06F40/274;;G06F40/174;;G06F40/274;;G06F3/0482;;G06F3/04886,G06F17/24;;G06F3/048;;G06F17/27,,0,0,,,,DISCONTINUED
284,US,A1,US 2007/0188058 A1,186-542-502-337-394,2007-08-16,2007,US 74143807 A,2007-04-27,US 74143807 A;;US 58506906 A;;US 54212904 A;;US 2004/0009142 W;;US 45723103 P,2003-03-25,Modular Security Cabinet System For Storing Firearms,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/186-542-502-337-394,Patent Application,yes,27,6,3,4,0,A47B81/005;;E05C9/043;;F41C33/06;;Y10T292/0839;;Y10T292/0839;;F41C33/06;;A47B81/005;;E05C9/043,E05C7/06,312/221,0,0,,,,DISCONTINUED
285,US,A1,US 2007/0089999 A1,047-122-420-859-200,2007-04-26,2007,US 58246906 A,2006-10-17,US 58246906 A;;US 72862105 P,2005-10-20,Debit or credit cardholder,There is provided a protective case for a plastic data card. This protective case includes a non-transparent housing having a first planar surface and a second planar surface both having a desired length and a desired height. The first planar surface and the second planar surface are joined together at a first end with a slit separating the first planar surface from the second planar surface. This slit extends inward from an opposing second end of said transparent housing. The slit terminates proximate the first end at a distance from the first end which is effective to position desired data on the plastic data card at an effective distance from the first end. A transparent window is formed in the first planar side and is effective to expose the desired data. The height of the second planar surface is effective to expose a magnetic stripe on the plastic data card.,HIGHER ONE INC,DECKER DAVID D;;GLASS SEAN P;;LASATER MILES H;;RAKACZKI ANDREW M;;VOLCHEK MARK T,HIGHER ONE INC (2006-10-08),https://lens.org/047-122-420-859-200,Patent Application,yes,12,4,1,1,0,A45C11/182;;A45C11/182;;A45C2200/10;;A45C2200/10,A45C11/18,206/39,0,0,,,,DISCONTINUED
286,US,B2,US 7478892 B2,070-819-741-524-173,2009-01-20,2009,US 54212904 A,2004-03-25,US 54212904 A;;US 45723103 P;;US 2004/0009142 W,2003-03-25,Modular security cabinet system for storing firearms or the like,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,SPACESAVER CORPORATION (2006-04-21),https://lens.org/070-819-741-524-173,Granted Patent,yes,28,34,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,312/322;;312/216;;312/351;;211/64;;49/395,4,0,,,"English translation of König, DE 197 00 330.;;International Search Report dated May 20, 2005.;;Written Opinion of The International Searching Authority dated May 20, 2005.;;International Preliminary Report On Patentability dated Oct. 1, 2005.",INACTIVE
287,US,A1,US 2006/0255699 A1,195-628-128-353-901,2006-11-16,2006,US 54212904 A,2004-03-25,US 54212904 A;;US 45723103 P;;US 2004/0009142 W,2003-03-25,Modular security cabinet system for storing firearms or the like,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,SPACESAVER CORPORATION (2006-04-21),https://lens.org/195-628-128-353-901,Patent Application,yes,24,30,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E05B65/46;;E06B3/50,312/217,0,0,,,,INACTIVE
288,CA,C,CA 2594256 C,091-275-869-839-78X,2009-01-13,2009,CA 2594256 A,2004-03-25,US 45723103 P;;CA 2514702 A,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,"The present invention provides a storage cabinet assembly, comprising: a cabinet defining an interior; a folding door arrangement mounted to the cabinet, wherein the folding door arrangement includes a pair of folding door sections, each of which includes an inner door member and at least one outer door member, wherein th e folding door sections are movable between a closed position in which the folding door sections cooperate to prevent access to the cabinet interior, and an open position in which the folding door sections are positioned to provide access to the cabinet interior, wherein the inner door members of the folding door sections are located adjacent each other when the folding door sections are in the closed positio n; and a locking arrangement associated with the folding door arrangement, wherein th e locking arrangement includes a latch member carried by each of the folding door sections, wherein each latch member is movable between an engaged position a nd a release position, wherein each latch member in the engaged position maintain s its associated door section in the closed position and wherein each latch member in the release position enables movement of its associated door section between the closed position and the open position, and wherein the locking arrangement further includes a movable control member carried by each door section, wherein each control member is interconnected with one of the latch members and wherein each control member is movable between a first position in which the control member place s its associated latch member in the engaged position, and a second position in which the control member places its associated latch member in the release position, wherein the control members in the first position overlie the inner door members and are adapted to be secured together to maintain the door sections in the closed position.",SPACESAVER CORP,MUTH JAMES C;;KOLMAN ANDREW J;;DINGLE STEVEN S;;GLASS JANE E;;PUNZEL WILLIAM H,,https://lens.org/091-275-869-839-78X,Granted Patent,no,0,0,2,15,0,,A47B96/00;;A47B81/00,,0,0,,,,INACTIVE
289,WO,A3,WO 2005/016072 A3,038-797-469-009-273,2005-07-21,2005,US 2004/0009142 W,2004-03-25,US 45723103 P,2003-03-25,MODULAR SECURITY CABINET SYSTEM FOR STORING FIREARMS OR THE LIKE,"A storage cabinet assembly (60) for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests (160) for positioning in the bottom of the cabinet interior, as well as barrel rests (164) and pistol supports (166) that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP;;PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/038-797-469-009-273,Search Report,yes,5,0,13,15,0,A47B81/005;;E05C9/043;;E06B3/5045;;F41C33/06;;E05Y2900/212;;E05D15/58;;A47B81/005;;F41C33/06;;A47B81/005;;E06B3/5045;;E05C9/043,A47B81/00;;E06B3/50,,0,0,,,,PENDING
290,US,A1,US 2007/0278912 A1,105-121-514-488-356,2007-12-06,2007,US 58506906 A,2006-10-23,US 58506906 A;;US 54212904 A,2004-03-25,Locking door system for a storage cabinet,"A storage cabinet assembly for use in storing firearms or the like includes a cabinet with a recessed bifold door arrangement, to facilitate access to items contained within the cabinet assembly. The door arrangement includes a single-point locking system, which provides a secure arrangement for maintaining the doors in a closed position while providing ease in opening and closing the doors. Various support and storage modules or components are adapted to be contained within the interior of the cabinet, including stock rests for positioning in the bottom of the cabinet interior, as well as barrel rests and pistol supports that are secured to amounting member which may be adjustably positioned within the storage cabinet interior. A bin or shelf arrangement may also be positioned within the storage cabinet interior. The various support and storage modules or components may be used in various combinations, and may be moved to various positions within the storage cabinet interior.",SPACESAVER CORP,PUNZEL WILLIAM H;;GLASS JANE E;;KOLMAN ANDREW J;;DINGLE STEVEN S;;MUTH JAMES C,,https://lens.org/105-121-514-488-356,Patent Application,yes,19,6,3,4,0,A47B81/005;;E05C9/043;;F41C33/06;;Y10T292/0839;;Y10T292/0839;;F41C33/06;;A47B81/005;;E05C9/043,E05B65/46,312/215,0,0,,,,INACTIVE
291,US,A1,US 2017/0315679 A1,159-463-686-120-709,2017-11-02,2017,US 201615142327 A,2016-04-29,US 201615142327 A,2016-04-29,EXPOSING POPULATED LISTS OF PERSONALIZED STRINGS,"Presenting a list of personalized strings to a user in response to the user's interaction with a single key of a keyboard. Interaction of a user with a single key of a keyboard is detected. Responsive to detecting the user interaction at the single keyboard key, a string type associated with the user interaction is identified. One or more personalized strings that are associated with the user and that are of the identified string type are also identified. A list of strings with the one or more personalized strings of the string type associated with the user interaction is then populated. The populated list of strings is then presented, wherein each string of the list of strings comprises a user-selectable element.",MICROSOFT TECHNOLOGY LICENSING LLC,RIDEOUT MARK RODGER;;ALBERTS ANA ISABEL A N RIBEIRO;;GLASS ANDREW STUART;;MARKIEWICZ JAN-KRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2016-04-27),https://lens.org/159-463-686-120-709,Patent Application,yes,0,1,5,5,0,G06F3/04886;;G06F40/174;;G06F40/274;;G06F40/174;;G06F40/274;;G06F3/0482;;G06F3/04886,G06F3/0482;;G06F3/0488;;G06F17/27,,0,0,,,,ACTIVE
292,US,B2,US 6733634 B2,101-679-290-271-744,2004-05-11,2004,US 96428001 A,2001-09-26,US 96428001 A,2001-09-26,"Apparatus, system and method for transferring a running web","
    An improved system, apparatus and method is disclosed for transferring a running web from a first carrier fabric to a second carrier fabric in the manufacture of webbed products, such as tissue, paper toweling, and the like. A multi-stage vacuum process applies a vacuum to the running web. One or more auxiliary units apply a vacuum to one or more edge portions of the running web. The apparatus provides for a reliable and efficient transfer of the running web among carrier fabrics, in which the carrier fabrics may include topographical features upon their surface. 
",KIMBERLY CLARK CO,VAN RENGEN EDWARD J;;KRAUSE ANDREW;;GLASS KEITH D;;WILHELM DAVID;;RINDY LENNIS W;;SPRANGERS DANIEL,FIRST QUALITY TISSUE SE LLC (2012-11-06);;KIMBERLY-CLARK WORLDWIDE INC (2001-12-10),https://lens.org/101-679-290-271-744,Granted Patent,yes,29,4,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21F2/00;;D21F11/14;;D21G9/00,162/363;;162/364;;162/370;;34/117;;226/91;;226/97.4,1,0,,,"PCT Search Report Nov. 14, 2002.",EXPIRED
293,MX,A,MX 2023001876 A,163-388-349-461-26X,2023-03-10,2023,MX 2023001876 A,2020-07-13,US 201762563312 P,2017-09-26,RAPAMYCIN DERIVATIVES.,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;BONAZZI SIMONE;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/163-388-349-461-26X,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,PENDING
294,US,A1,US 2022/0242878 A1,009-425-718-379-971,2022-08-04,2022,US 202117499433 A,2021-10-12,US 202117499433 A;;US 202017004434 A;;US 201816141856 A;;US 201762563312 P,2017-09-26,RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,NOVARTIS AG (2018-02-16);;NOVARTIS PHARMA AG (2018-09-17);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2018-01-16),https://lens.org/009-425-718-379-971,Patent Application,yes,0,0,28,28,2,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,A61P1/16;;C07D498/18;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/6561,,0,0,,,,PENDING
295,LT,T,LT 3687999 T,150-820-701-256-037,2024-02-26,2024,LT IB2018057422 T,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/150-820-701-256-037,Unknown,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P1/16;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32;;C07F9/6561,,0,0,,,,PENDING
296,US,A1,US 2019/0092788 A1,179-292-874-665-257,2019-03-28,2019,US 201816141856 A,2018-09-25,US 201816141856 A;;US 201762563312 P,2017-09-26,NOVEL RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,NOVARTIS AG (2018-02-16);;NOVARTIS PHARMA AG (2018-09-17);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2018-09-17),https://lens.org/179-292-874-665-257,Patent Application,yes,0,3,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00,,0,0,,,,ACTIVE
297,US,A1,US 2020/0392159 A1,112-574-196-060-316,2020-12-17,2020,US 202017004434 A,2020-08-27,US 202017004434 A;;US 201816141856 A;;US 201762563312 P,2017-09-26,NOVEL RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/112-574-196-060-316,Patent Application,yes,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61P1/16;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/6561,,0,0,,,,DISCONTINUED
298,AU,A1,AU 2018/342784 A1,143-892-302-560-495,2020-02-06,2020,AU 2018/342784 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,Rapamycin derivatives,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/143-892-302-560-495,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,ACTIVE
299,EP,B1,EP 3687999 B1,197-209-433-824-526,2024-01-03,2024,EP 18786408 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/197-209-433-824-526,Granted Patent,yes,3,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,ACTIVE
300,KR,A,KR 20200059219 A,080-182-830-506-804,2020-05-28,2020,KR 20207007749 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,라파마이신 유도체,"본 개시내용은 화학식 I의 화합물 및 이의 약제학적으로 허용 가능한 염, 및 조성물에 관한 것이며, 치환기는 본 명세서에 정의한 바와 같다. 또한 화학식 I의 화합물의 제조 방법, 및 본 명세서에 기재된 장애 및 질환을 치료하기 위한 화합물 또는 조성물을 수반하는 방법이 제공된다.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/080-182-830-506-804,Patent Application,no,0,0,28,28,6,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P13/12;;A61P29/00;;A61P35/00;;A61P43/00;;C07F9/6561,,0,0,,,,DISCONTINUED
301,MX,A,MX 2020007265 A,119-663-989-646-703,2020-09-18,2020,MX 2020007265 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES.,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;BONAZZI SIMONE;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/119-663-989-646-703,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07D498/18;;C07F9/32,,0,0,,,,PENDING
302,UY,A,UY 37900 A,116-543-574-639-979,2019-04-30,2019,UY 37900 A,2018-09-24,US 201762563312 P,2017-09-26,NUEVOS DERIVADOS DE RAPAMICINA,"La divulgación se refiere a compuestos de la fórmula (I) y sales farmacéuticamente aceptables, y composiciones de los mismos, en donde los sustituyentes son como se definen en la presente. También se proporcionan métodos para preparar compuestos de la fórmula (I) y métodos que implican los compuestos o composiciones para tratar trastornos y enfermedades descritos en este documento.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;DAVID JONATHAN GLASS;;ANDREW W PATTERSON;;ROGGO SILVIO;;SHAVLAKADZE TEA;;MIHALIC MANUEL,,https://lens.org/116-543-574-639-979,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,A61K31/397;;A61P35/00;;A61K31/425;;A61K31/436;;A61P37/00;;C07D498/16,,0,0,,,,DISCONTINUED
303,AU,B2,AU 2018/342784 B2,161-925-699-116-683,2021-01-28,2021,AU 2018/342784 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,Rapamycin derivatives,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/161-925-699-116-683,Granted Patent,no,3,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,ACTIVE
304,DK,T3,DK 3687999 T3,148-504-841-122-667,2024-02-12,2024,DK 18786408 T,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCINDERIVATER,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/148-504-841-122-667,Granted Patent,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,ACTIVE
305,WO,A1,WO 2019/064182 A1,064-450-089-085-098,2019-04-04,2019,IB 2018057422 W,2018-09-25,US 201762563312 P,2017-09-26,RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/064-450-089-085-098,Patent Application,yes,28,15,28,28,3,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,A61K31/436;;C07D498/18;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,54,40,012-781-922-366-608;;018-027-023-098-56X;;040-692-130-168-76X;;084-509-210-795-657;;183-143-678-156-514;;091-762-167-328-721;;028-386-403-141-053;;101-936-623-204-924;;002-719-485-917-319;;005-910-694-042-592;;048-760-044-102-310;;013-768-941-640-967;;020-549-996-912-556;;002-527-106-889-404;;094-752-256-212-560;;083-542-814-498-686;;144-974-850-827-790;;021-896-708-499-094;;104-600-895-368-447;;036-954-321-835-118;;095-500-995-610-437;;119-089-342-392-18X;;007-364-858-655-289;;132-131-112-947-407;;052-775-030-455-023;;128-753-285-752-087;;060-221-367-896-647;;009-432-951-795-221;;035-899-612-116-37X;;026-469-333-215-440;;003-955-466-158-960;;034-862-500-527-435;;069-150-416-650-646;;183-143-678-156-514;;047-308-646-101-537;;054-418-959-978-111;;050-133-270-638-85X;;082-151-267-963-934;;018-027-023-098-56X;;034-391-483-835-138,pmc3331679;;22500797;;10.1016/j.cell.2012.03.017;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;10.1016/j.ekir.2017.07.016;;29340326;;pmc5762943;;10.7164/antibiotics.44.688;;1712766;;10.1021/ja00019a057;;10.1126/science.1115535;;16293764;;pmc2754830;;15186745;;10.1016/j.cub.2004.03.059;;pmc4954603;;19797661;;10.1126/science.1177221;;10.1038/426620b;;14668850;;14668851;;10.1038/426620a;;10.1038/nature08221;;pmc2786175;;19587680;;10.1126/scitranslmed.3009892;;25540326;;22015915;;10.1016/j.expneurol.2011.10.002;;pmc3265661;;pmc3403799;;10.12659/pjr.882968;;22844307;;12150915;;10.1016/s1097-2765(02)00568-3;;10.1038/ng1494;;15624019;;10.1111/j.1528-1167.2007.01035.x;;17386056;;pmc2664098;;10.1038/nm1788;;18568033;;18495876;;10.1523/jneurosci.0955-08.2008;;pmc2633923;;18389497;;10.1002/ana.21331;;pmc3937593;;pmc2707106;;19470613;;10.1242/dmm.002386;;pmc3904448;;10.1523/jneurosci.5685-08.2009;;19211884;;pmc2727061;;10.1523/jneurosci.0066-09.2009;;19474323;;10.1002/jps.2600660104;;833720;;10.1016/b978-0-12-442702-0.50021-2;;10.1016/j.jacc.2009.08.031;;20082935;;10.4161/auto.6.2.11135;;20104016;;25453134;;10.1111/liv.12416;;10.15252/emmm.201505079;;pmc4693502;;26612854;;26951622;;pmc4818752;;10.15252/emmm.201506131;;10.1016/j.gde.2016.03.005;;pmc5055853;;27065468;;26840489;;10.1038/nature16932;;pmc4845101;;10.1016/b978-0-08-052349-1.00168-2;;10.1002/hlca.19910740513;;10.1021/ja00019a057;;20124692;;pmc2815665;;10.1107/s0907444909047337;;10.1107/s0907444994003112;;15299374;;pmc3069751;;10.1107/s0907444911001314;;21460454;;20383002;;pmc2852313;;10.1107/s0907444910007493;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;16968213;;10.1146/annurev.pharmtox.47.120505.105359,"LAPLANTE M. ET AL., CELL, vol. 149, no. 2, 2012, pages 274 - 93;;MARZ A.M. ET AL., MOL CELL BIOL., vol. 33, no. 7, 2013, pages 1357 - 1367;;ROYCE M.E. ET AL., BREAST CANCER (AUCKL, vol. 9, 2015, pages 73 - 79;;PLENICEANU O., KIDNEY INT REP, vol. 3, no. 1, 2018, pages 155 - 159;;MCALPINE, J.B. ET AL., J. ANTIBIOTICS, vol. 44, 1991, pages 688;;SCHREIBER, S.L. ET AL., J. AM. CHEM. SOC., vol. 113, 1991, pages 7433;;KAEBERLEIN ET AL., SCIENCE, vol. 310, 2005, pages 1193 - 1196;;KAPAHI ET AL., CURR BIOL, vol. 14, 2004, pages 885 - 890;;SELMAN ET AL., SCIENCE, vol. 326, 2009, pages 140 - 144;;VELLAI ET AL., NATURE, vol. 426, 2003, pages 620;;HARRISON ET AL., NATURE, vol. 460, no. 7253, 2009, pages 392 - 395;;M. LESLIE, SCIENCE, 2013, pages 342;;J. MANNICK ET AL., SCI TRANSL MED., vol. 6, no. 268, 2014, pages 268ra179;;WONG ET AL., EXPERIMENTAL NEUROLOGY, vol. 244, 2013, pages 22 - 26;;KABAT J ET AL., POL J. RADIOLOGY, vol. 77, no. 2, 2012, pages 35 - 43;;MANNING: ""Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway"", MOL. CELL, vol. 10, 2002, pages 151 - 162;;INOKI ET AL.: ""Dysregulation of the TSC-mTOR pathway in human Disease"", NAT. GENET, vol. 37, 2005, pages 19 - 24, XP002484968, DOI: doi:10.1038/ng1494;;HOLMES; STAFSTROM: ""Tuberous sclerosis complex and epilepsy: recent developments and future Challenges"", EPILEPSIA, vol. 48, 2007, pages 617 - 630;;EHNINGER: ""Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis"", NAT. MED., 2008, pages 843 - 848, XP009142437, DOI: doi:10.1038/nm1788;;MEIKLE ET AL.: ""Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin, mTOR inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function"", J. NEUROSCIENCE., vol. 28, 2008, pages 5422 - 5432, XP009142421;;ZENG ET AL.: ""Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex"", ANN. NEUROL., vol. 63, 2008, pages 444 - 453, XP055490101, DOI: doi:10.1002/ana.21331;;LJUNGBERG ET AL., RAPAMYCIN SUPPRESSES SEIZURES AND NEURONAL HYPERTROPHY IN A MOUSE MODEL OF CORTICAL DYSPLASIA, 2009, pages 389 - 398;;ZHOU ET AL.: ""Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice"", J. NEUROSCI., vol. 29, 2009, pages 1773 - 1783;;ZENG ET AL.: ""The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy"", J. NEUROSCI., 2009, pages 6964 - 6972;;CELL METABOLISM, vol. 26, 1 August 2017 (2017-08-01), pages 419 - 428;;""Handbook of Chemistry and Physics"";;THOMAS SORRELL: ""Organic Chemistry"", 1999, UNIVERSITY SCIENCE BOOKS;;SMITH; MARCH: ""March's Advanced Organic Chemistry"", 2001, JOHN WILEY & SONS, INC.;;LAROCK: ""Comprehensive Organic Transformations"", 1989, VCH PUBLISHERS, INC.;;CARRUTHERS: ""Some Modern Methods of Organic Synthesis"", 1987, CAMBRIDGE UNIVERSITY PRESS;;J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19;;""Remington The Science and Practice of Pharmacy"", 2013, PHARMACEUTICAL PRESS, pages: 1049 - 1070;;TL, vol. 43, 1995, pages 7823;;TL, vol. 37, 1994, pages 6835;;JOC, vol. 59, 1994, pages 6512;;M. H. SCHREIER; R. TEES: ""Immunological Methods"", vol. II, 1981, ACADEMIC PRESS, pages: 263 - 275;;BUSS, S.J. ET AL.: ""Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction"", J AM COLL CARDIOL., vol. 54, no. 25, 2009, pages 2435 - 46, XP026807861;;BUSS, S.J. ET AL.: ""Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters"", AUTOPHAGY, vol. 6, no. 2, 2010, pages 304 - 6;;VILLAMIL, F.G. ET AL.: ""Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomized study of everolimus vs. calcineurin inhibitors"", LIVER INT., vol. 34, no. 10, 2014, pages 1513 - 21;;CHINNERY, P.F., EMBO MOL. MED., vol. 7, 2015, pages 1503 - 1512;;KOOPMAN, W.J. ET AL., EMBO MOL. MED., vol. 8, 2016, pages 311 - 327;;YOUNG, M.J.; YOUND; COPELAND, W.C., CURR. OPIN. GENET. DEV., vol. 38, 2016, pages 52 - 62;;BAKER, D. J. ET AL., NATURE, vol. 530, no. 7589, 2016, pages 184 - 9;;GREENE: ""Protecting Groups in Organic Synthesis"", 1991, WILEY;;THE JOURNAL OF ANTIBIOTICS (TOKYO, vol. 44, no. 6, 1991, pages 688 - 90;;TETRAHEDRON LETTERS, vol. 33, no. 33, 1992, pages 4139 - 4142;;MIERKE, D. F.; SCHMIEDER, P.; KARUSO, P.; KESSLER, H.: ""Conformational Analysis of the cis- and trans-Isomers of FK506 by NMR and Molecular Dynamics"", HELVETICA CHIMICA ACTA, vol. 74, 1991, pages 1027 - 1047;;STUART L. SCHRIEBER; JON CLARDY ET AL.: ""Atomic Structure of the Rapamycin Humano Immunophilin FKBP-12 Complex"", J. AM. CHEM. SOC., vol. 113, 1991, pages 7433 - 7434;;KABSCH, W., XDS. ACTA CRYST. D, vol. 66, 2010, pages 125 - 132;;""Collaborative Computational Project"", ACTA CRYST., vol. D50, 1994, pages 760 - 763;;MURSHUDOV GN; SKUBAK P; LEBEDEV AA ET AL.: ""REFMAC5 for the refinement of macromolecular crystal structures"", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, vol. 67, 2011, pages 355 - 367;;EMSLEY P; LOHKAMP B; SCOTT WG; COWTAN K: ""Features and development of Coot"", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 486 - 501;;MOL. CELL BIOL., vol. 33, 2013, pages 1357 - 1367;;LEE, C. H.; INOKI, K.; GUAN, K. L.: ""mTOR pathway as a target in tissue hypertrophy"", ANNU. REV. PHARMACOL. TOXICOL., vol. 47, 2007, pages 443 - 467",PENDING
306,TW,A,TW 201920189 A,092-879-233-721-798,2019-06-01,2019,TW 107133541 A,2018-09-25,US 201762563312 P,2017-09-26,Novel RAPAMYCIN derivatives,"The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/092-879-233-721-798,Patent of Addition,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D491/16;;A61K31/436,,0,0,,,,PENDING
307,BR,A2,BR 112020005898 A2,013-536-559-497-95X,2020-11-17,2020,BR 112020005898 A,2018-09-25,IB 2018057422 W;;US 201762563312 P,2017-09-26,derivados de rapamicina,"a presente invenção refere-se a compostos da fórmula (i) (i), e sais farmaceuticamente aceitáveis, e composições dos mesmos, em que os substituintes são como definidos no presente documento. também são fornecidos métodos de preparação de compostos da fórmula (i) e métodos envolvendo os compostos ou composições para o tratamento de distúrbios e doenças descritos no presente documento.",NOVARTIS AG,ANDREW WILLIAM PATTERSON;;DAVID JONATHAN GLASS;;MANUEL MIHALIC;;MICHAEL CONNOLLY;;SILVIO ROGGO;;SIMONE BONAZZI;;TEA SHAVLAKADZE,,https://lens.org/013-536-559-497-95X,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P31/10;;A61P35/00;;A61P37/00,,0,0,,,,PENDING
308,FI,T3,FI 3687999 T3,003-378-386-020-606,2024-02-14,2024,FI 18786408 T,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/003-378-386-020-606,Unknown,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,A61K31/436;;C07D498/18;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,PENDING
309,CA,A1,CA 3078191 A1,071-285-321-118-673,2019-04-04,2019,CA 3078191 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/071-285-321-118-673,Patent Application,no,0,0,28,28,3,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,PENDING
310,US,B2,US 10800793 B2,079-267-360-454-209,2020-10-13,2020,US 201816141856 A,2018-09-25,US 201816141856 A;;US 201762563312 P,2017-09-26,Rapamycin derivatives,"The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,NOVARTIS AG (2018-02-16);;NOVARTIS PHARMA AG (2018-09-17);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2018-09-17),https://lens.org/079-267-360-454-209,Granted Patent,yes,24,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61P1/16;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/6561,,37,36,003-955-466-158-960;;052-775-030-455-023;;128-753-285-752-087;;009-432-951-795-221;;051-035-066-702-786;;144-974-850-827-790;;005-910-694-042-592;;083-542-814-498-686;;043-112-679-656-416;;094-752-256-212-560;;020-549-996-912-556;;091-762-167-328-721;;028-386-403-141-053;;059-163-625-080-635;;035-899-612-116-37X;;012-781-922-366-608;;034-391-483-835-138;;028-237-981-802-053;;036-954-321-835-118;;048-760-044-102-310;;002-527-106-889-404;;018-027-023-098-56X;;084-509-210-795-657;;021-896-708-499-094;;069-150-416-650-646;;040-692-130-168-76X;;085-518-082-774-691;;183-143-678-156-514;;101-936-623-204-924;;002-719-485-917-319;;060-221-367-896-647;;013-768-941-640-967;;026-469-333-215-440;;104-600-895-368-447;;119-089-342-392-18X;;095-500-995-610-437,26840489;;10.1038/nature16932;;pmc4845101;;10.1016/j.jacc.2009.08.031;;20082935;;10.4161/auto.6.2.11135;;20104016;;10.15252/emmm.201505079;;pmc4693502;;26612854;;17372361;;10.1107/s0907444907007652;;pmc2664098;;10.1038/nm1788;;18568033;;10.1038/nature08221;;pmc2786175;;19587680;;10.1111/j.1528-1167.2007.01035.x;;17386056;;10.1016/s0040-4039(00)61273-x;;10.1038/ng1494;;15624019;;pmc3403799;;10.12659/pjr.882968;;22844307;;10.1126/science.1115535;;16293764;;pmc2754830;;15186745;;10.1016/j.cub.2004.03.059;;28768179;;10.1016/j.cmet.2017.07.007;;26951622;;pmc4818752;;10.15252/emmm.201506131;;pmc3331679;;22500797;;10.1016/j.cell.2012.03.017;;16968213;;10.1146/annurev.pharmtox.47.120505.105359;;24233701;;10.1126/science.342.6160.789;;pmc2707106;;19470613;;10.1242/dmm.002386;;10.1126/scitranslmed.3009892;;25540326;;12150915;;10.1016/s1097-2765(02)00568-3;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;10.7164/antibiotics.44.688;;1712766;;18495876;;10.1523/jneurosci.0955-08.2008;;pmc2633923;;10.1002/hlca.19910740513;;10.1016/j.ekir.2017.07.016;;29340326;;pmc5762943;;10.4137/bcbcr.s29268;;pmc4571987;;26417203;;10.1021/ja00019a057;;pmc4954603;;19797661;;10.1126/science.1177221;;10.1038/426620b;;14668850;;14668851;;10.1038/426620a;;25453134;;10.1111/liv.12416;;22015915;;10.1016/j.expneurol.2011.10.002;;pmc3265661;;10.1016/j.gde.2016.03.005;;pmc5055853;;27065468;;18389497;;10.1002/ana.21331;;pmc3937593;;pmc2727061;;10.1523/jneurosci.0066-09.2009;;19474323;;pmc3904448;;10.1523/jneurosci.5685-08.2009;;19211884,"Baker, Darren J. et al.: “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan”, Nature, (2016), vol. 530, pp. 184-203.;;Buss, Sebestian J. et al: “Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction”, Journal of American College of Cardiology, (2009), vol. 54, No. 25, pp. 2435-2446.;;Buss, Sebastian J. et al: “Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters”, Autophagy, (2010), vol. 6, Issue 2, pp. 304-306.;;Chinnery, Patrick F.: “Mitochondrial disease in adults: what's old and what's new”, EMBO Molecular Medicine, (2015), vol. 7, No. 2, pp. 1503-1512.;;D'Arcy, Allan D. et al: “An automated microseed matrix-screening method for protein crystallization”, Acta Cyst. (2007), D63, pp. 550-554.;;Ehninger, D. et al.: “Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis”, Nature Medicine, Aug. 2008, vol. 14, No. 8, pp. 843-848.;;Harrison, David E. et al.: “Rapamycin fed late in life extends lifespan in genetically heterogeneous mice”, Nature, (2009), vol. 460, pp. 392-396.;;Holmes, Gregory L.: “Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challanges”, Epilepsia, (2007) vol. 48, No. 4, pp. 617-630.;;Hughes, Philip et al.:“The Isolation, Synthesis and characterization of an Isomeric Form of Rapamycin”, Tetrahedron Letters, (1992), vol. 33, No. 33, pp. 4739-4742.;;Inoki, Ken et al.: “Dysregulation of the TSC-mTOR pathway in human disease”, Nature Genetics, Jan. 2005, vol. 37, No. 7, pp. 19-24.;;Kabat et al.: “Focal cortical dysplasia—review”, Pol. J. Radial., 2012; 77(2): 35-43.;;Kaeberlein, Malt et al.: “Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients”, Science, (2005), vol. 310, pp. 1193-1196.;;Kapahi, Pankaj et al.:“Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling Pathway,” Current Biology, 2004, vol. 14, pp. 885-890.;;Khan, Nahid A. et al.: “mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progession”, Cell Metabolism, (2017) vol. 26, pp. 419-428.;;Koopman, Werner JH et al.:“Mitochondrial disorders in children: toward development of small-molecule treatment strategies”, EMBO Molecular Medicine, vol. 8, No. 4, (2016), pp. 311-327.;;Laplante, Mathieu et al.: “mTOR Signaling in Growth Control and Disease”, Cell (2012), 149, pp. 274-293.;;Lee, Chung-Han Lee, “mTOR Pathway as a Target in Tissue Hypertrophy”, Ann. Rev. Pharmacol. Toxicol., 2007, vol. 47, pp. 443-467.;;Leslie, M.: “A Putative Antiaging Drug Takes a Step From Mice to Men”, Science, (2015) vol. 342.;;Ljungberg, Cecilia M. et al.: “Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia”, Dis Model Mech., Jul.-Aug. 2009, vol. 2, No. 7-8, pp. 389-398.;;Mannick, Joan B. et al.: “mTOR inhibition improves immune function in the elderly”, Science Translational Medicine, Dec. 24, 2014, vol. 268, pp. 1.;;Manning, Brendan et al.:“Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway”, Molecular Cell, (2002), vol. 10, pp. 151-162.;;Marz, Andreas et al.: “Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin”, Molecular and Cellular Biology, (2013), vol. 33, No. 7, pp. 1357-1367.;;McApline, James B. et al.: “Revised NMR Assignments for Rapamycin”, The Journal of Antibiotics, Jun. 1991, vol. 14, No. 6, pp. 688-690.;;Meikle, Lynsey et al.: “Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function”, The Journal of Neuroscience, May 2008, vol. 28, No. 21, pp. 5422-5432.;;Mierke, Dale F. et al.:“97. Conformational Analysis of the cis- and trans-Isomers of FK506 by NMR and Molecular Dynamics”, Helvetica Chimica Acta, vol. 74 (1991), pp. 1027-1045.;;Pleniceanu, Oren et al.: “mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma”, Kidney International Reports, (2018), vol. 3, pp. 155-159.;;Royce et al.: “Everolimus in the Treatment of Metastatic Breast Cancer”, Breast Cancer: Basic and Clinical Research 2015, vol. 9, pp. 73-79.;;Schreiber et al.: “Atomic Structure of the Rapamycin Human Immunophilin FKBP-12 Complex”, J. Am. Chem. Soc., 1991, vol. 113, pp. 7433-7434.;;Selman, Colin et al.: “Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span”, Science, (2009), vol. 326, pp. 140-144.;;Vellai, Tibor et al.: “Influence of TOR kinase on lifespan in C. elegans”, Nature, (2003), vol. 426, p. 620.;;Villamil, Federico G. et al.: “Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitors”, Liver, (2014), pp. 1513-1521.;;Wong, Michael: “Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal vortical malformations”, Experimental Neurology, (2013), vol. 244, pp. 22-26.;;Young, Matthew J. et al.: “Human mitochondrial DNA replication machinery and disease”, Current Opinion in Genetics & Development, 2016, vol. 38, pp. 52-62.;;Zeng, Ling-Hui et al.:“Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex”, Ann. Neuorol., 2008, vol. 63, pp. 444-453.;;Zeng, Ling-Hui et al.:“The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy”, The Journal of Neuroscience, (2009), vol. 29, No. 21, pp. 6964-6972.;;Zhou, Jing et al.: “Pharmacological Inhibition of mTORCC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice”, The Journal of Neuroscience, (2009). vol. 29, No. 6, pp. 1773-1781.;;Notification of Transmittal of The International Search Report and Written Opinion of the International Searching Authority, or the Declaration, dated Jan. 3, 2019, issued in Int'l Appl. No. PCT/IB2018/057422, Int'l Filing Date: Sep. 25, 2018, 14 pages.",ACTIVE
311,US,A1,US 2003/0056926 A1,184-573-438-369-605,2003-03-27,2003,US 96428001 A,2001-09-26,US 96428001 A,2001-09-26,"Apparatus, system and method for transferring a running web","
   An improved system, apparatus and method is disclosed for transferring a running web from a first carrier fabric to a second carrier fabric in the manufacture of webbed products, such as tissue, paper toweling, and the like. A multi-stage vacuum process applies a vacuum to the running web. One or more auxiliary units apply a vacuum to one or more edge portions of the running web. The apparatus provides for a reliable and efficient transfer of the running web among carrier fabrics, in which the carrier fabrics may include topographical features upon their surface. 
",RENGEN EDWARD J. VAN;;KRAUSE ANDREW;;GLASS KEITH D.;;WILHELM DAVID;;RINDY LENNIS W.;;SPRANGERS DANIEL,RENGEN EDWARD J VAN;;KRAUSE ANDREW;;GLASS KEITH D;;WILHELM DAVID;;RINDY LENNIS W;;SPRANGERS DANIEL,FIRST QUALITY TISSUE SE LLC (2012-11-06);;KIMBERLY-CLARK WORLDWIDE INC (2001-12-10),https://lens.org/184-573-438-369-605,Patent Application,yes,13,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21F2/00;;D21F11/14;;D21G9/00,162/363;;162/364;;162/193;;34/117;;226/97.4,0,0,,,,EXPIRED
312,JP,A,JP 2023106500 A,190-570-135-482-284,2023-08-01,2023,JP 2023081938 A,2023-05-18,JP 2020516599 A;;US 201762563312 P,2017-09-26,NOVEL RAPAMYCIN DERIVATIVES,"To provide rapamycin derivatives for treating a disorder or disease mediated by the mTOR pathway such as liver fibrosis.SOLUTION: For example, (R)-C16-(1,1-dioxidoisothiazolidin-2-yl)-C32-deoxo-rapamycin of the formula in the figure is presented.SELECTED DRAWING: Figure 2-1",NOVARTIS AG,SIMONE BONAZZI;;MICHAEL CONNOLLY;;DAVID JONATHAN GLASS;;MANUEL MIHALIC;;ANDREW WILLIAM PATTERSON;;SILVIO ROGGO;;TEA SHAVLAKADZE,,https://lens.org/190-570-135-482-284,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61K45/00;;A61P1/16;;A61P3/00;;A61P3/04;;A61P9/04;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P15/00;;A61P15/10;;A61P17/00;;A61P17/08;;A61P19/02;;A61P19/04;;A61P21/00;;A61P25/00;;A61P25/02;;A61P25/16;;A61P25/28;;A61P27/02;;A61P27/06;;A61P27/12;;A61P27/16;;A61P29/00;;A61P31/00;;A61P35/00;;A61P35/02;;A61P37/04;;A61P43/00,,0,0,,,,PENDING
313,CN,A,CN 111094299 A,135-161-603-857-410,2020-05-01,2020,CN 201880057805 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,"The disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of makingcompounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/135-161-603-857-410,Patent Application,no,6,2,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,1,0,,,"林辰初 等: ""雷帕霉素靶蛋白信号通路与靶向雷帕霉素靶蛋白抗肿瘤药物研究进展"", 《中国新药杂志》",ACTIVE
314,EP,A1,EP 3687999 A1,153-630-082-345-074,2020-08-05,2020,EP 18786408 A,2018-09-25,US 201762563312 P;;IB 2018057422 W,2017-09-26,RAPAMYCIN DERIVATIVES,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW WILLIAM;;ROGGO SILVIO;;SHAVLAKADZE TEA,,https://lens.org/153-630-082-345-074,Patent Application,yes,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/436;;A61P3/04;;A61P3/10;;A61P9/10;;A61P9/12;;A61P11/00;;A61P13/12;;A61P19/00;;A61P19/02;;A61P19/10;;A61P25/02;;A61P25/16;;A61P25/28;;A61P29/00;;A61P31/10;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,ACTIVE
315,AR,A1,AR 112834 A1,062-714-319-843-653,2019-12-18,2019,AR P180102741 A,2018-09-24,US 201762563312 P,2017-09-26,DERIVADOS DE RAPAMICINA,"La divulgación se refiere a compuestos y sales farmacéuticamente aceptables, y composiciones de los mismos. También se proporcionan métodos para preparar los compuestos y métodos que implican los compuestos o composiciones para tratar trastornos y enfermedades descritos en este documento. Reivindicación 1: Un compuesto de la fórmula (1), o una sal farmacéuticamente aceptable del mismo, en donde: R¹ se selecciona a partir del grupo que consta de hidroxilo, o un compuesto del grupo de fórmulas (2); y R² se selecciona del grupo que consiste en los compuestos del grupo de fórmulas (3) en donde m es 0, 1, 2 ó 3; n es 1, 2 ó 3; o es 1, 2, 3, 4, 5 ó 6; p es 1, 2, 3, 4 ó 5; q es 1, 2, 3, 4 ó 5, en donde la suma de p y q es 2, 3, 4, 5 ó 6; r es 2, 3 ó 4; s es 2, 3 ó 4, en donde la suma de r y s es 4, 5 ó 6; X es O, S, NR⁶ o SO₂; R³ es hidrógeno, alquilo C₁₋₄, hidroxialquilo C₁₋₈, cicloalquilo C₃₋₈alquilo C₀₋₆ o fenilalquilo C₀₋₆; R⁴ es hidrógeno; R⁵ es hidrógeno, hidroxi o ciano; o R⁴ y R⁵ juntos forman =O; y R⁶ es hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₈alquilo C₀₋₆, fenilalquilo C₀₋₆, alquilo C₁₋₆-CO-, cicloalquilo C₃₋₈alquilo C₀₋₆-CO-, alquilo C₁₋₆-SO₂- o cicloalquilo C₃₋₈alquilo C₀₋₆-SO₂-.",NOVARTIS AG,SHAVLAKADZE TEA;;ROGGO SILVIO;;PATTERSON ANDREW W;;MIHALIC MANUEL;;GLASS DAVID JONATHAN;;CONNOLLY MICHAEL;;BONAZZI SIMONE,,https://lens.org/062-714-319-843-653,Patent Application,no,0,0,28,28,0,C07F9/6561;;A61P19/00;;A61P3/04;;A61P31/10;;A61P9/10;;A61P11/00;;A61P25/16;;A61P25/28;;A61P29/00;;A61P19/10;;A61P37/00;;A61P25/02;;A61P19/02;;A61P9/12;;A61P3/10;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;C07D498/18;;A61K31/436;;A61K31/439;;A61P1/16;;A61P43/00;;A61P29/00;;A61P13/12;;A61P35/00;;C07F9/6561;;C07D498/18;;A61P1/16;;A61P13/12;;A61P35/00;;A61P25/16;;A61P37/00;;A61P9/10;;A61P19/10;;A61P19/00;;A61P29/00;;A61P31/10;;A61P19/02;;A61P25/28;;A61P3/10;;A61P9/12;;A61P11/00;;A61P3/04;;C07F9/6561;;A61P25/02,C07D498/18;;A61K31/435;;A61P35/00;;A61P37/00;;C07F9/32,,0,0,,,,PENDING
316,EP,A4,EP 0590101 A4,020-378-942-146-24X,1994-07-13,1994,EP 93900772 A,1992-12-03,US 9210380 W;;US 80187791 A,1991-12-03,INTERACTIVE VIDEO TESTING AND TRAINING SYSTEM,,FRENCH SPORTECH CORP,FRENCH BARRY JAMES;;FERGUSON KEVIN R;;MCDONALD HALLEY A III;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREGORY,,https://lens.org/020-378-942-146-24X,Search Report,no,0,0,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,1,0,,,No further relevant documents disclosed,EXPIRED
317,US,A,US 5469740 A,003-727-368-581-402,1995-11-28,1995,US 98433792 A,1992-12-02,US 98433792 A;;US 38015789 A;;US 80187791 A,1989-07-14,Interactive video testing and training system,"A testing and training system for measuring and assessing leg reaction movement sequence of a subject includes a test field having a plurality of load sensing target positions defining vectored movement paths for the subject, the field and target positions being replicated on a video screen positioned frontally with respect to the subject with visual cues presented on the screen directing movement between positions with hardware and software processing the cues and signals from the target positions to determine time intervals associated with changes in loading during the movement and determining reaction movement sequence parameters based thereon.",IMPULSE TECHNOLOGY INC,FRENCH BARRY J;;FERGUSON KEVIN R;;MCDONALD III HALLEY A;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREGORY,IMPULSE TECHNOLOGY INC (1994-02-25);;CYBEX INTERNATIONAL INC (2007-12-31);;FRENCH SPORTECH CORPORATION (1992-12-01),https://lens.org/003-727-368-581-402,Granted Patent,yes,7,578,1,14,0,A61B5/1036;;A61B5/1102;;A61B5/113;;A61B2562/0219;;A63B69/00;;A63B69/0053;;A63B2220/53;;A63K3/023;;G01L1/16;;A61B2503/10;;Y10S482/901;;Y10S482/902;;A61B2562/0247;;A61B2562/046;;A61B5/4023;;G01L1/16;;A63B2220/53;;A63B69/00;;A61B5/113;;A63B69/0053;;A61B5/1036;;A63K3/023;;A61B5/1102;;A61B2562/0219;;A61B2503/10;;Y10S482/901;;A61B2562/0247;;Y10S482/902;;A61B2562/046;;A61B5/4023,A61B5/103;;A61B5/11;;A61B5/113;;A63B24/00;;A63B69/00;;A63K3/02;;G01L1/16,73/379.04;;273/445;;482/901;;482/902,0,0,,,,EXPIRED
318,US,A1,US 2004/0204912 A1,154-304-180-717-727,2004-10-14,2004,US 39607103 A,2003-03-25,US 39607103 A,2003-03-25,High performance serial bus testing methodology,"
   According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits. 
",NEJEDLO JAY J.;;WIZNEROWICZ MIKE;;ELLIS DAVID G.;;GLASS RICHARD J.;;MARTWICK ANDREW W.;;SCHOENBORN THEODORE Z.,NEJEDLO JAY J;;WIZNEROWICZ MIKE;;ELLIS DAVID G;;GLASS RICHARD J;;MARTWICK ANDREW W;;SCHOENBORN THEODORE Z,INTEL CORPORATION (2003-07-10),https://lens.org/154-304-180-717-727,Patent Application,yes,25,39,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/317;;G01R31/3187;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,702/188,0,0,,,,EXPIRED
319,WO,A1,WO 1993/010708 A1,090-143-953-981-198,1993-06-10,1993,US 9210380 W,1992-12-03,US 80187791 A,1991-12-03,INTERACTIVE VIDEO TESTING AND TRAINING SYSTEM,"A testing and training system for measuring and assessing leg reaction movement sequence of a subject includes a test field (14) having a plurality of load sensing target positions (20) defining vectored movement paths for the subject, the field and target positions being replicated on a video screen (12) positioned frontally with respect to the subject with visual cues presented on the screen directing movement between positions with hardware and software processing the cues and signals from the target positions to determine time intervals associated with changes in loading during the movement and determining reaction movement sequence parameters based thereon.",FRENCH SPORTECH CORP,FRENCH BARRY JAMES;;FERGUSON KEVIN R;;MCDONALD HALLEY A III;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREORY,,https://lens.org/090-143-953-981-198,Patent Application,yes,3,76,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A63B69/00;;A63K3/02;;A61B5/11,,1,0,,,See also references of EP 0590101A4,PATENTED
320,EP,B1,EP 0590101 B1,170-933-525-863-482,1999-06-23,1999,EP 93900772 A,1992-12-03,US 9210380 W;;US 80187791 A,1991-12-03,INTERACTIVE VIDEO TESTING AND TRAINING SYSTEM,,FRENCH SPORTECH CORP,FRENCH BARRY JAMES;;FERGUSON KEVIN R;;MCDONALD HALLEY A III;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREGORY,,https://lens.org/170-933-525-863-482,Granted Patent,yes,3,0,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,0,0,,,,EXPIRED
321,US,B2,US 7464307 B2,186-444-393-162-273,2008-12-09,2008,US 39607103 A,2003-03-25,US 39607103 A,2003-03-25,High performance serial bus testing methodology,"According to one embodiment, a built-in self test (IBIST) architecture/methodology is disclosed. The IBIST provides for testing the functionality of an interconnect (such as a bus) between a transmitter and a receiver component. The IBIST architecture includes a pattern generator and a pattern checker. The pattern checker operates to compare a received plurality of bits (for the pattern generator) with a previously stored plurality of bits.",INTEL CORP,NEJEDLO JAY J;;WIZNEROWICZ MIKE;;ELLIS DAVID G;;GLASS RICHARD J;;MARTWICK ANDREW W;;SCHOENBORN THEODORE Z,INTEL CORPORATION (2003-07-10),https://lens.org/186-444-393-162-273,Granted Patent,yes,25,25,11,11,0,G01R31/31717;;G01R31/3187;;H04L1/242;;G06F11/26;;G06F13/00;;G01R31/3187;;G01R31/31717;;H04L1/242,G01R31/28;;G01R31/317;;G01R31/3187;;G06F11/00;;G06F11/26;;G06F13/00;;G06F19/00;;H04L1/24,714/712;;714/738,1,0,,,"PCT Searh Report, PCT/US2004/004219, mailed Nov. 5, 2004.",INACTIVE
322,CA,A1,CA 2101633 A1,020-899-796-289-712,1993-06-04,1993,CA 2101633 A,1992-12-03,US 80187791 A,1991-12-03,INTERACTIVE VIDEO TESTING AND TRAINING SYSTEM,"2101633 9310708 PCTABS00022 A testing and training system for measuring and assessing leg reaction movement sequence of a subject includes a test field (14) having a plurality of load sensing target positions (20) defining vectored movement paths for the subject, the field and target positions being replicated on a video screen (12) positioned frontally with respect to the subject with visual cues presented on the screen directing movement between positions with hardware and software processing the cues and signals from the target positions to determine time intervals associated with changes in loading during the movement and determining reaction movement sequence parameters based thereon.",FRENCH SPORTECH CORP,FRENCH BARRY J;;FERGUSON KEVIN R;;MCDONALD HALLEY A III;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREORY,,https://lens.org/020-899-796-289-712,Patent Application,no,0,0,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,0,0,,,,DISCONTINUED
323,EP,A1,EP 0590101 A1,154-418-536-408-112,1994-04-06,1994,EP 93900772 A,1992-12-03,US 9210380 W;;US 80187791 A,1991-12-03,INTERACTIVE VIDEO TESTING AND TRAINING SYSTEM.,"L'invention se rapporte à un système pour tester et entraîner les capacités physiques d'un sujet, qui permet de mesurer et d'établir une séquence de mouvements de réaction des jambes du sujet. Ce système comprend un terrain de test (14) ayant une pluralité de positions cibles de détection de charge (20) définissant des trajectoires de mouvements vectorisées pour le sujet, le terrain et les positions cibles étant reproduits sur un écran vidéo (12) placé en face du sujet, avec présentation d'ordres visuels sur l'écran dirigeant le mouvement entre les différentes positions, un matériel et un logiciel informatiques étant prévus pour traiter les ordres et les signaux provenant des positions cibles, afin de déterminer les intervalles de temps associés aux changements d'application de charge pendant les mouvements et déterminant des paramètres de séquences de mouvements de réaction basés sur ces changements.",FRENCH SPORTECH CORP,FRENCH BARRY JAMES;;FERGUSON KEVIN R;;MCDONALD HALLEY A III;;GLASS ANDREW B;;MOHANSINGH TIMOTHY;;BORGES GREGORY,,https://lens.org/154-418-536-408-112,Patent Application,yes,0,1,8,14,0,A61B2562/0219;;A63B69/0053;;A63K3/023;;A63B69/0053,A61B5/11;;A63B69/00;;A63K3/02,,0,0,,,,EXPIRED
324,CN,A,CN 113260619 A,091-292-179-416-768,2021-08-13,2021,CN 201980087363 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,RAPAMYCIN DERIVATIVES,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGE SVEN;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/091-292-179-416-768,Patent Application,no,3,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P35/00;;A61P37/00,,3,3,003-428-163-281-182;;044-547-914-938-931;;012-204-010-525-397,10.1016/j.chembiol.2005.10.017;;16426976;;10888319;;10.1016/s0960-894x(00)00184-0;;9383449;;10.1016/1074-5521(95)90264-3,"J. HENRI BAYLE ET AL.: ""Rapamycin Analogs with Differential Binding Specificity Permit Orthogonal Control of Protein Activity"", 《CHEMISTRY & BIOLOGY》, vol. 13, pages 99 - 107, XP055469985, DOI: 10.1016/j.chembiol.2005.10.017;;DICKMAN, D. A. ET AL: ""Antifungal Rapamycin Analogues with ReducedImmunosuppressive Activity"", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 10, no. 13, pages 1405 - 1408;;JUAN I LUENGO ET AL.: ""Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBPI2-FRAP interface"", 《CHEMISTRY & BIOLOGY》, vol. 2, no. 7, pages 1074 - 5521",PENDING
325,CA,A1,CA 2453334 A1,127-814-936-802-077,2003-04-03,2003,CA 2453334 A,2002-08-01,US 96428001 A;;US 0224683 W,2001-09-26,"APPARATUS, SYSTEM AND METHOD FOR TRANSFERRING A RUNNING WEB","An improved system, apparatus and method is disclosed for transferring a running web (30) from a first carrier fabric (14) to a second carrier fabric (17) in the manufacture of webbed products, such as tissue, paper toweling, and the like. A multi-stage vacuum process applies a vacuum to the running web. One or more auxiliary units (36) apply a vacuum to one or more edge portions of the running web. The apparatus provides for a reliable and efficient transfer of the running web among carrier fabrics, in which the carrier fabrics may include topographical features upon their surface.</SDOA B>",KIMBERLY CLARK CO,GLASS KEITH D;;WILHELM DAVID K;;KRAUSE ANDREW M;;RINDY LENNIS W;;VAN RENGEN EDWARD J;;SPRANGERS DANIEL,,https://lens.org/127-814-936-802-077,Patent Application,no,0,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21F2/00;;D21F11/14;;D21G9/00,,0,0,,,,DISCONTINUED
326,US,B2,US 8380130 B2,058-000-760-890-910,2013-02-19,2013,US 201113229608 A,2011-09-09,US 201113229608 A;;US 42323506 A;;US 45306603 A,2003-06-03,Capacitive bonding of devices,"Various embodiments relate to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices.",MICROSOFT CORP;;GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/058-000-760-890-910,Granted Patent,yes,44,1,6,6,0,H04W40/24;;H04W40/24,H04B7/00;;H04L12/28;;H04L12/56,455/41.2;;455/41.1;;455/95;;455/100;;340/5.64;;340/72;;340/825;;713/186;;382/115;;382/123;;382/124,25,4,022-472-647-779-312;;028-721-911-690-054;;004-814-878-410-365;;022-564-808-245-652,10.1145/570645.570647;;10.1109/risp.1993.287643;;10.1145/238168.238177;;10.1147/sj.353.0609,"""Advisory Action"", U.S. Appl. No. 10/453,066, (Jan. 8, 2007),3 pages.;;""Advisory Action"", U.S. Appl. No. 10/453,066, (Oct. 25, 2007),6 pages.;;""BIO-ANALOGICS: Body Composition Techniques"", retrieved from on Jun. 19, 2003,7 pages.;;""BIO-ANALOGICS: Technology Resources"", retrieved from on Jun. 19, 2003,2 pages.;;""Core"", Specification of the Bluetooth System: Wireless Connections Made Easy, vol. 1, Version 1.1, retrieved from on Jun. 19, 2003,(Feb. 22, 2001), 1084 pages.;;""European Search Report"", European Application No. 05112925.2, (Jul. 6, 2006),13 pages.;;""Examiner's Answer to Appeal Brief"", U. S. Appl. No. 10/453,066, (Jun. 2, 2008),17 pages.;;""Final Office Action"", U.S. Appl. No. 10/453,066, (Oct. 23, 2006),10 pages.;;""Final Office Action"", U.S. Appl. No. 10/453,066, (Aug. 14, 2007),13 pages.;;""IEEE Standard for Information Technology-Telecommunications and Information Exchange between Systems-Local and Metropolitan Area Networks-Specific Requirements"", ISO/IEC 8802-11, ANSI/IEEE Std 802.11, First Edition 1999-00-00, (1999),pp. 34-58.;;""Non Final Office Action"", U.S. Appl. No. 10/453,066, (Mar. 12, 2007),12 pages.;;""Non Final Office Action"", U.S. Appl. No. 10/453,066, (May 16, 2006),12 pages.;;""Non Final Office Action"", U.S. Appl. No. 11/159,605, (Aug. 25, 2008),18 pages.;;""Non Final Office Action"", U.S. Appl. No. 11/423,235, (Nov. 17, 2009),9 pages.;;""Non Final Office Action"", U.S. Appl. No. 11/423,235, (Nov. 18, 2010),9 pages.;;""Notice of Allowance"", U.S. Appl. No. 10/453,066, (Jan. 26, 2010),9 pages.;;""Notice of Allowance"", U.S. Appl. No. 11/423,235, (Jun. 6, 2011),6 pages.;;""Restriction Requirement"", U.S. Appl. No. 11/423,235, (Apr. 19, 2011),5 pages.;;""Restriction Requirement"", U.S. Appl. No. 11/423,235, (May 5, 2010),6 pages.;;""Restriction Requirement"", U.S. Appl. No. 11/423,235, (Aug. 24, 2010),6 pages.;;Corner, Mark D., et al., ""Zero-Interaction Authentication"", Proceedings of the 8th Annual International Conference on Mobile Computing and Networking, Sep. 23-38, 2002, Atlanta, GA, (Sep. 23, 2002),11 pages.;;Molva, Refik et al., ""Authentication Method with Impersonal Token Cards"", Proceedings of 1993 IEEE Symposium on Research in Security and Privacy, (1993),pp. 1-10.;;Samar, Vipin ""Unified Login with Pluggable Authentication Modules (PAM)"", Proceedings of the 3rd ACM Conference on Computer and Communications Security, New Delhi, India, (1996),pp.1-10.;;Zimmerman, T. G., ""Personal Area Networks: Near-Field Intrabody Communication"", IBM Systems Journal, vol. 35, Nos. 3 & 4, retrieved from on Sep. 19, 2011,(1996),pp. 609-617.;;Lutz, Martin ""The Determination of the Immunity to Electrostatic Discharge (ESD) with Transient 1000 Generator"", Seminar, 1999, EMC Partner, (1999), 35 pages.",EXPIRED
327,EP,A1,EP 1436460 A1,110-904-121-921-894,2004-07-14,2004,EP 02752682 A,2002-08-01,US 0224683 W;;US 96428001 A,2001-09-26,"APPARATUS, SYSTEM AND METHOD FOR TRANSFERRING A RUNNING WEB",,KIMBERLY CLARK CO,VAN RENGEN EDWARD J;;KRAUSE ANDREW M;;GLASS KEITH D;;WILHELM DAVID K;;RINDY LENNIS W;;SPRANGERS DANIEL,"KIMBERLY-CLARK WORLDWIDE, INC. (2010-01-13)",https://lens.org/110-904-121-921-894,Patent Application,yes,0,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21F2/00;;D21F11/14;;D21G9/00,,0,0,,,,DISCONTINUED
328,WO,A1,WO 2003/027389 A1,191-333-680-960-867,2003-04-03,2003,US 0224683 W,2002-08-01,US 96428001 A,2001-09-26,"APPARATUS, SYSTEM AND METHOD FOR TRANSFERRING A RUNNING WEB","An improved system, apparatus and method is disclosed for transferring a running web (30) from a first carrier fabric (14) to a second carrier fabric (17) in the manufacture of webbed products, such as tissue, paper toweling, and the like. A multi-stage vacuum process applies a vacuum to the running web. One or more auxiliary units (36) apply a vacuum to one or more edge portions of the running web. The apparatus provides for a reliable and efficient transfer of the running web among carrier fabrics, in which the carrier fabrics may include topographical features upon their surface.",KIMBERLY CLARK CO,VAN RENGEN EDWARD J;;KRAUSE ANDREW M;;GLASS KEITH D;;WILHELM DAVID K;;RINDY LENNIS W;;SPRANGERS DANIEL,,https://lens.org/191-333-680-960-867,Patent Application,yes,3,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21F2/00;;D21F11/14;;D21G9/00,,0,0,,,,PENDING
329,KR,A,KR 20210105397 A,098-822-156-038-514,2021-08-26,2021,KR 20217022532 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,라파마이신 유도체,"본 개시내용은 하기 화학식 I의 32-데옥소-라파마이신 유도체 또는 이의 약제학적으로 허용 가능한 염, 화학식 I의 화합물을 포함하는 약제학적 조성물 및 약제학적 조합물, 및 이의 제조 방법을 제공한다. 또한 본 명세서에 기재된 질환 및 장애를 치료하기 위해 화학식 I의 화합물 또는 이의 약제학적으로 허용 가능한 염을 이용하는 방법이 본 명세서에 제공된다. [화학식 I] JPEGpct00102.jpg5859",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/098-822-156-038-514,Patent Application,no,0,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/439;;A61P1/16;;A61P13/12;;A61P35/00;;A61P43/00,,0,0,,,,PENDING
330,US,A1,US 2004/0248513 A1,066-183-381-643-164,2004-12-09,2004,US 45306603 A,2003-06-03,US 45306603 A,2003-06-03,Capacitive bonding of devices,"
   The present invention relates to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices. Although configurations and/or other communications can be conducted through a medium such as the human body, the present invention can employ an initial touch to identify respective devices whereby other electronic configuration sequences commence without further device contact. Other aspects include chain touching between users and/or devices to facilitate contact between the devices. Location detection components can also be provided to identify when users are present near a device, the detected presence to commence further automated procedures, and/or the location detection components can enable devices to identify other devices in a crowded wireless environment. 
",GLASS ANDREW C.;;DREHER CHRISTOPHER M.;;SUNG ELLICK H.;;AULL RANDALL E.;;HOLAN DORON J.;;RANTA CRAIG S.,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-06-02),https://lens.org/066-183-381-643-164,Patent Application,yes,19,51,6,6,0,H04W40/24;;H04W40/24,H04L12/28;;H04L12/56,455/41.1;;455/411,0,0,,,,EXPIRED
331,EP,A1,EP 3898637 A1,054-682-947-006-844,2021-10-27,2021,EP 19836546 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,RAPAMYCIN DERIVATIVES,,NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/054-682-947-006-844,Patent Application,yes,0,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P35/00;;A61P37/00,,0,0,,,,PENDING
332,AU,B2,AU 2019/409366 B2,146-799-707-639-559,2022-10-27,2022,AU 2019/409366 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,Rapamycin derivatives,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/146-799-707-639-559,Granted Patent,no,1,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P35/00;;A61P37/00,,3,3,044-547-914-938-931;;003-428-163-281-182;;012-204-010-525-397,10888319;;10.1016/s0960-894x(00)00184-0;;10.1016/j.chembiol.2005.10.017;;16426976;;9383449;;10.1016/1074-5521(95)90264-3,"DICKMAN, D. A. et al., ""Antifungal rapamycin analogues with reduced immunosuppressive activity"", Bioorg. Med. Chem. Lett., 2000, vol. 10, no. 13, pages 1405-1408;;BAYLE, J. H. et al., ""Rapamycin Analogs with Differential Binding Specificity Permit Orthogonal Control of Protein Activity"", Chem. Biol., 2006, vol. 13, no. 1, pages 99-107;;LUENGO, J. I. et al., ""Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface"", Chem. Biol., 1995, vol. 2, no. 7, pages 471-481",ACTIVE
333,AU,C1,AU 2002/362554 C1,091-720-206-392-270,2008-07-03,2008,AU 2002/362554 A,2002-08-01,US 96428001 A;;US 0224683 W,2001-09-26,"Apparatus, system and method for transferring a running web",,KIMBERLY CLARK CO,SPRANGERS DANIEL;;KRAUSE ANDREW M;;WILHELM DAVID K;;RENGEN EDWARD J VAN;;RINDY LENNIS W;;GLASS KEITH D,,https://lens.org/091-720-206-392-270,Amended Patent,no,3,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21G9/00;;D21F2/00;;D21F11/14,,0,0,,,,EXPIRED
334,US,A1,US 2022/0064185 A1,057-086-291-717-632,2022-03-03,2022,US 201917414696 A,2019-12-17,US 201917414696 A;;US 201862781242 P;;IB 2019060957 W,2018-12-18,RAPAMYCIN DERIVATIVES,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID JONATHAN;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,NOVARTIS AG (2019-09-19);;NOVARTIS PHARMA AG SWITZERLAND (2019-09-12);;NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC (2019-08-27),https://lens.org/057-086-291-717-632,Patent Application,yes,0,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61K45/06,,0,0,,,,PENDING
335,US,B2,US 8036595 B2,072-838-710-964-762,2011-10-11,2011,US 42323506 A,2006-06-09,US 42323506 A;;US 45306603 A,2003-06-03,Capacitive bonding of devices,"The present invention relates to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices. Although configurations and/or other communications can be conducted through a medium such as the human body, the present invention can employ an initial touch to identify respective devices whereby other electronic configuration sequences commence without further device contact. Other aspects include chain touching between users and/or devices to facilitate contact between the devices. Location detection components can also be provided to identify when users are present near a device, the detected presence to commence further automated procedures, and/or the location detection components can enable devices to identify other devices in a crowded wireless environment.",MICROSOFT CORP,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-06-02),https://lens.org/072-838-710-964-762,Granted Patent,yes,40,8,6,6,0,H04W40/24;;H04W40/24,H04B5/00;;H04L12/28;;H04L12/56,455/41.1;;455/40;;455/95;;455/100;;340/5.64;;340/825.72;;340/565;;713/186,11,4,022-564-808-245-652;;069-844-149-338-135;;028-721-911-690-054;;004-814-878-410-365,10.1147/sj.353.0609;;10.1109/ieeestd.2015.7226767;;10.1109/risp.1993.287643;;10.1145/238168.238177,"""Bio|analogics Technology Resources""; downloaded from: http://www.bioanalogics.com/technology.htm on Jun. 19, 2003, 2 pages.;;""Bio|analogics Technology-Body Composition Techniques""; downloaded from: http://www.bioanalogics.com/techniques.htm on Jun. 19, 2003, 7 pages.;;""Wireless connections made easy""; Specification of the Bluetooth System, Specification vol. 1, Core, v. 1.1, Feb. 22, 2001, pp. 1-32; and Revision History, Feb. 22, 2001, pp. 896-897.;;""Personal Area Networks: Near-field intrabody communication""; IBM Systems Journal, vol. 35, No. 3&4, 1996-MIT Media Lab, 11 pages.;;Martin Lutz, ""The Determination of the Immunity to Electrostatic Discharge ""ESD"" With Transient 1000 Generator"", Seminar 1999, EMC Partner.;;ISO/IEC 8802-11. ""IEEE Standard for Information Technology-Telecommunications and Information Exchange Between Systems-Local and Metropolitan Area Networks-Specific Requirement Part 11: Wireless LAN Medium Access Control (MAC) and Physical Layer (PHY) Specification"" 1999. pp. 1, 34-58.;;Mark D. Corner et al. Zero-interaction Authentication, Proceedings of the 8th Annual International Conference on Mobile Computing and Networking. Sep. 23-28, 2002, pp. 1-11, Atlanta, Georgia.;;Refik Molva et al., Authentication Method with Impersonal Token Cards, IEEE Computer Society Symposium on Research in Security and Privacy, 1993, pp. 1-10.;;Vipin Samar, Unified Login with Pluggable Authentication Modules (PAM), Proceedings of the 3rd ACM Conference on Computer and Communications Security, 1996, pp. 1-10, New Delhi, India.;;Office Action dated Aug. 25, 2008 for U.S. Appl. No. 11/159,605, 18 pages.;;European Search Report dated Jun. 7, 2006, mailed Jul. 7, 2006 for European Patent Application No. 05112925, 9 pages.",INACTIVE
336,US,A1,US 2011/0319019 A1,149-909-456-335-748,2011-12-29,2011,US 201113229608 A,2011-09-09,US 201113229608 A;;US 42323506 A;;US 45306603 A,2003-06-03,CAPACITIVE BONDING OF DEVICES,"Various embodiments relate to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices.",GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S;;MICROSOFT CORP,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/149-909-456-335-748,Patent Application,yes,2,1,6,6,0,H04W40/24;;H04W40/24,H04B5/00;;H04L12/28;;H04L12/56,455/41.1,0,0,,,,EXPIRED
337,WO,A1,WO 2022/245925 A1,036-608-853-043-267,2022-11-24,2022,US 2022/0029807 W,2022-05-18,US 202163190162 P,2021-05-18,SYSTEMS AND METHODS FOR MACHINE LEARNING (ML) MODEL DIAGNOSTIC ASSESSMENTS BASED ON DIGITAL PATHOLOGY DATA,"Techniques for performing diagnostic assessments based on digital pathology data are disclosed. In one particular embodiment, the techniques may be realized as a method for performing a diagnostic assessment based on digital pathology data comprising obtaining first digital pathology data comprising intensity information, the first digital pathology data being associated with a plurality of regions of interest in a biological sample; applying first machine learning models to the first digital pathology data, the first machine learning models identifying first regions of interest among the plurality of regions of interest based on the intensity information; applying second machine learning models to the first digital pathology data, the second machine learning models identifying at least one pattern associated with at least one of the first regions of interest; generating a diagnostic assessment based on the first regions of interest and the at least one pattern.",PATHAI INC,GLASS BENJAMIN;;CHAVALI SURYA;;JAVED SYED;;WEAVER SHAMIRA;;RESNICK MURRAY;;WAPINSKI ILAN;;MONTALTO MICHAEL;;BECK ANDREW;;KHOSLA ADITYA,,https://lens.org/036-608-853-043-267,Patent Application,yes,6,0,3,3,0,G06T7/0012;;G06T2207/20084;;G06T2207/10056;;G06T2207/30024;;G06V10/25;;G06V20/695;;G06V20/698;;G16H50/70;;G16H20/10;;G16H50/30;;G16H30/20;;G16H10/20;;G06N3/0464;;G06N3/09;;G06N3/0464;;G06T7/0012;;G06T2207/10056;;G06T2207/20084;;G06T2207/30024;;G06T2207/30096;;G16H10/20;;G16H20/10;;G16H30/20;;G16H50/20;;G16H50/30;;G16H50/70;;G16H70/60;;G06V10/25;;G06V20/695;;G06V20/698;;G06N3/09;;G16H50/20;;G16H70/60;;G06T2207/30096;;G06T7/0012;;G06V10/25,G16H50/30;;G06K9/62;;G06N3/08;;G16H50/20,,0,0,,,,PENDING
338,MX,A,MX 2021007247 A,155-464-462-804-764,2021-07-15,2021,MX 2021007247 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,RAPAMYCIN DERIVATIVES.,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,CONNOLLY MICHAEL;;BONAZZI SIMONE;;MIHALIC MANUEL;;ROGGO SILVIO;;SHAVLAKADZE TEA;;GLASS DAVID J;;PATTERSON ANDREW W;;ZUEGER PATRIK,,https://lens.org/155-464-462-804-764,Patent Application,no,0,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,A61P35/00;;A61K31/436;;A61P37/00;;C07D498/18,,0,0,,,,PENDING
339,AU,B2,AU 2002/362554 B2,165-491-165-329-393,2008-01-17,2008,AU 2002/362554 A,2002-08-01,US 96428001 A;;US 0224683 W,2001-09-26,"Apparatus, system and method for transferring a running web",,KIMBERLY CLARK CO,SPRANGERS DANIEL;;KRAUSE ANDREW M;;WILHELM DAVID K;;RENGEN EDWARD J VAN;;RINDY LENNIS W;;GLASS KEITH D,,https://lens.org/165-491-165-329-393,Granted Patent,no,3,0,8,8,0,D21F2/00;;D21F11/14;;D21G9/0063;;D21F11/14;;D21G9/0063;;D21F2/00,D21G9/00;;D21F2/00;;D21F11/14,,0,0,,,,EXPIRED
340,US,A1,US 2006/0217064 A1,189-963-811-599-472,2006-09-28,2006,US 42323506 A,2006-06-09,US 42323506 A;;US 45306603 A,2003-06-03,CAPACITIVE BONDING OF DEVICES,"The present invention relates to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices. Although configurations and/or other communications can be conducted through a medium such as the human body, the present invention can employ an initial touch to identify respective devices whereby other electronic configuration sequences commence without further device contact. Other aspects include chain touching between users and/or devices to facilitate contact between the devices. Location detection components can also be provided to identify when users are present near a device, the detected presence to commence further automated procedures, and/or the location detection components can enable devices to identify other devices in a crowded wireless environment.",MICROSOFT CORP,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-06-02),https://lens.org/189-963-811-599-472,Patent Application,yes,27,15,6,6,0,H04W40/24;;H04W40/24,H04B5/00;;H04L12/28;;H04L12/56,455/41.1,0,0,,,,EXPIRED
341,CA,A1,CA 3122922 A1,036-089-217-161-05X,2020-06-25,2020,CA 3122922 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,RAPAMYCIN DERIVATIVES,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/036-089-217-161-05X,Patent Application,no,0,0,10,10,7,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P35/00;;A61P37/00,,0,0,,,,PENDING
342,AU,A1,AU 2019/409366 A1,062-012-561-577-633,2021-06-10,2021,AU 2019/409366 A,2019-12-17,US 201862781242 P;;IB 2019060957 W,2018-12-18,Rapamycin derivatives,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/062-012-561-577-633,Patent Application,no,0,0,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,C07D498/18;;A61K31/436;;A61P35/00;;A61P37/00,,0,0,,,,ACTIVE
343,WO,A1,WO 2020/128861 A1,117-636-955-207-968,2020-06-25,2020,IB 2019060957 W,2019-12-17,US 201862781242 P,2018-12-18,RAPAMYCIN DERIVATIVES,"The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a compound of Formula (I), and methods of making same. Also provided herein are methods of using a compound of Formula (I) or a pharmaceutically acceptable salt thereof for treating the diseases and disorders described herein.",NOVARTIS AG,BONAZZI SIMONE;;CONNOLLY MICHAEL;;GLASS DAVID J;;MIHALIC MANUEL;;PATTERSON ANDREW W;;ROGGO SILVIO;;SHAVLAKADZE TEA;;ZUEGER PATRIK,,https://lens.org/117-636-955-207-968,Patent Application,yes,7,6,10,10,0,C07D498/18;;C07D498/18;;A61K31/439;;A61P1/16;;A61P43/00;;A61P13/12;;A61P35/00;;A61K31/436;;A61K45/06;;C07D498/18,A61K31/436;;C07D498/18;;A61P35/00;;A61P37/00,,43,30,044-547-914-938-931;;003-428-163-281-182;;012-204-010-525-397;;012-781-922-366-608;;018-027-023-098-56X;;040-692-130-168-76X;;084-509-210-795-657;;183-143-678-156-514;;091-762-167-328-721;;028-386-403-141-053;;101-936-623-204-924;;002-719-485-917-319;;005-910-694-042-592;;028-237-981-802-053;;119-089-342-392-18X;;060-221-367-896-647;;089-958-577-650-361;;052-775-030-455-023;;128-753-285-752-087;;009-432-951-795-221;;035-899-612-116-37X;;026-469-333-215-440;;069-150-416-650-646;;051-035-066-702-786;;047-308-646-101-537;;050-133-270-638-85X;;082-151-267-963-934;;018-027-023-098-56X;;108-561-861-242-105;;034-391-483-835-138,10888319;;10.1016/s0960-894x(00)00184-0;;10.1016/j.chembiol.2005.10.017;;16426976;;9383449;;10.1016/1074-5521(95)90264-3;;pmc3331679;;22500797;;10.1016/j.cell.2012.03.017;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;10.1016/j.ekir.2017.07.016;;29340326;;pmc5762943;;10.7164/antibiotics.44.688;;1712766;;10.1021/ja00019a057;;10.1126/science.1115535;;16293764;;pmc2754830;;15186745;;10.1016/j.cub.2004.03.059;;pmc4954603;;19797661;;10.1126/science.1177221;;10.1038/426620b;;14668850;;14668851;;10.1038/426620a;;10.1038/nature08221;;pmc2786175;;19587680;;24233701;;10.1126/science.342.6160.789;;pmc2727061;;10.1523/jneurosci.0066-09.2009;;19474323;;25453134;;10.1111/liv.12416;;10.1016/0040-4020(77)80264-0;;10.1016/j.jacc.2009.08.031;;20082935;;10.4161/auto.6.2.11135;;20104016;;10.15252/emmm.201505079;;pmc4693502;;26612854;;26951622;;pmc4818752;;10.15252/emmm.201506131;;10.1016/j.gde.2016.03.005;;pmc5055853;;27065468;;10.1002/hlca.19910740513;;17372361;;10.1107/s0907444907007652;;20124692;;pmc2815665;;10.1107/s0907444909047337;;pmc3069751;;10.1107/s0907444911001314;;21460454;;20383002;;pmc2852313;;10.1107/s0907444910007493;;23358420;;10.1128/mcb.00678-12;;pmc3624267;;10.1093/gerona/glx249;;29304191;;pmc6001891;;16968213;;10.1146/annurev.pharmtox.47.120505.105359,"DICKMAN D A ET AL: ""Antifungal rapamycin analogues with reduced immunosuppressive activity"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 10, no. 13, 3 July 2000 (2000-07-03), pages 1405 - 1408, XP004222117, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(00)00184-0;;J. HENRI BAYLE ET AL: ""Rapamycin Analogs with Differential Binding Specificity Permit Orthogonal Control of Protein Activity"", CHEMISTRY AND BIOLOGY., vol. 13, no. 1, 1 January 2006 (2006-01-01), GB, pages 99 - 107, XP055469985, ISSN: 1074-5521, DOI: 10.1016/j.chembiol.2005.10.017;;LUENGO J I ET AL: ""STRUCTURE-ACTIVITY STUDIES OF RAPAMYCIN ANALOGS: EVIDENCE THAT THE C-7 METHOXY GROUP IS PART OF THE EFFECTOR DOMAIN AND POSITIONED AT THE FKBP12-FRAP INTERFACE"", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 2, no. 7, 1 January 1995 (1995-01-01), pages 471 - 481, XP002045681, ISSN: 1074-5521, DOI: 10.1016/1074-5521(95)90264-3;;LAPLANTE M. ET AL., CELL, vol. 149, no. 2, 2012, pages 274 - 93;;MARZ A.M. ET AL., MOL CELL BIOL., vol. 33, no. 7, 2013, pages 1357 - 1367;;ROYCE M.E. ET AL., BREAST CANCER (AUCKL, vol. 9, 2015, pages 73 - 79;;PLENICEANU O. ET AL., KIDNEY INT REP., vol. 3, no. 1, 2018, pages 155 - 159;;MCALPINE, J.B. ET AL., J. ANTIBIOTICS, vol. 44, 1991, pages 688;;STUART L. SCHRIEBERJON CLARDY ET AL.: ""Atomic Structure of the Rapamycin Humano Immunophilin FKBP-12 Complex"", J. AM. CHEM. SOC., vol. 113, 1991, pages 7433 - 7434;;KAEBERLEIN ET AL., SCIENCE, vol. 310, 2005, pages 1193 - 1196;;KAPAHI ET AL., CURR BIOL, vol. 14, 2004, pages 885 - 890;;SELMAN ET AL., SCIENCE, vol. 326, 2009, pages 140 - 144;;VELLAI ET AL., NATURE, vol. 426, 2003, pages 620;;HARRISON ET AL., NATURE, vol. 460, no. 7253, 2009, pages 392 - 395;;M. LESLIE, SCIENCE, vol. 342, 2013;;J. MANNICK ET AL., SCI TRANSL MED., vol. 6, no. 268, 2014, pages 268ral79;;ZENG ET AL.: ""The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy"", J. NEUROSCI., 2009, pages 6964 - 6972;;VILLAMIL, F.G. ET AL.: ""Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomized study of RAD001 vs. calcineurin inhibitors"", LIVER INT., vol. 34, no. 10, 2014, pages 1513 - 21;;CELL METABOLISM, vol. 26, 1 August 2017 (2017-08-01), pages 419 - 428;;THOMAS SORRELL: ""Organic Chemistry"", 1999, UNIVERSITY SCIENCE BOOKS;;SMITHMARCH: ""March's Advanced Organic Chemistry"", 2001, JOHN WILEY & SONS, INC.;;LAROCK: ""Comprehensive Organic Transformations"", 1989, VCH PUBLISHERS, INC.;;CARRUTHERS: ""Some Modern Methods of Organic Synthesis"", 1987, CAMBRIDGE UNIVERSITY PRESS;;JACQUES ET AL.: ""Enantiomers, Racemates and Resolutions"", 1981, WILEY INTERSCIENCE;;WILEN ET AL.: ""Tetrahedron"", vol. 33, 1977, pages: 2725;;ELIEL, E.L.: ""Stereochemistry of Carbon Compounds"", 1962, MCGRAW-HILL;;WILEN, S.H.: ""Tables of Resolving Agents and Optical Resolutions"", 1972, UNIV. OF NOTRE DAME PRESS, pages: 268;;BUSS, S.J. ET AL.: ""Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction"", J AM COLL CARDIOL., vol. 54, no. 25, 2009, pages 2435 - 46, XP026807861;;BUSS, S.J. ET AL.: ""Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters"", AUTOPHAGY, vol. 6, no. 2, 2010, pages 304 - 6;;CHINNERY, P.F., EMBO MOL. MED., vol. 7, 2015, pages 1503 - 1512;;KOOPMAN, W.J. ET AL., EMBO MOL. MED., vol. 8, 2016, pages 311 - 327;;YOUNG, M.J.YOUND, COPELAND, W.C., 2016;;CURR. OPIN. GENET. DEV., vol. 38, pages 52 - 62;;THE JOURNAL OF ANTIBIOTICS (TOKYO, vol. 44, no. 6, 1991, pages 688 - 90;;TETRAHEDRON LETTERS, vol. 33, no. 33, 1992, pages 4139 - 4142;;MIERKE, D. F.SCHMIEDER, P.KARUSO, P.KESSLER, H.: ""Conformational Analysis of the cis- and trans-Isomers of FK506 by NMR and Molecular Dynamics"", HELVETICA CHIMICA ACTA, vol. 74, 1991, pages 1027 - 1047;;ALLAN D'ARCY ET AL.: ""An automated microseed matrix-screening method for protein crystallization"", ACTA CRYST., vol. D63, 2007, pages 550 - 554;;KABSCH, W., XDS. ACTA CRYST. D, vol. 66, 2010, pages 125 - 132;;MURSHUDOV GNSKUBAK PLEBEDEV AA ET AL.: ""REFMAC5 for the refinement of macromolecular crystal structures"", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY., vol. 67, 2011, pages 355 - 367;;EMSLEY PLOHKAMP BSCOTT WGCOWTAN K: ""Features and development of Coot"", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 486 - 501;;MOL. CELL BIOL., vol. 33, 2013, pages 1357 - 1367;;SHAVLAKADZE ET AL., J GERONTOL A BIOL SCI MED SCI., vol. 73, no. 7, 2018, pages 845 - 852;;LEE, C. H.INOKI, K.GUAN, K. L.: ""mTOR pathway as a target in tissue hypertrophy"", ANNU. REV. PHARMACOL. TOXICOL., vol. 47, 2007, pages 443 - 467",PENDING
344,US,B2,US 7684754 B2,175-993-266-184-19X,2010-03-23,2010,US 45306603 A,2003-06-03,US 45306603 A,2003-06-03,Capacitive bonding of devices,"The present invention relates to systems and methods that facilitate wireless device communications and configuration. A detection component identifies N devices that are coupled together via a biological medium, N being an integer, wherein the medium includes direct or indirect touching to a device or devices. After biological contact, a configuration component initiates a configuration between a subset of the devices. Although configurations and/or other communications can be conducted through a medium such as the human body, the present invention can employ an initial touch to identify respective devices whereby other electronic configuration sequences commence without further device contact. Other aspects include chain touching between users and/or devices to facilitate contact between the devices. Location detection components can also be provided to identify when users are present near a device, the detected presence to commence further automated procedures, and/or the location detection components can enable devices to identify other devices in a crowded wireless environment.",MICROSOFT CORP,GLASS ANDREW C;;DREHER CHRISTOPHER M;;SUNG ELLICK H;;AULL RANDALL E;;HOLAN DORON J;;RANTA CRAIG S,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2003-06-02),https://lens.org/175-993-266-184-19X,Granted Patent,yes,20,13,6,6,0,H04W40/24;;H04W40/24,H04B7/00;;H04L12/28;;H04L12/56,455/41.2;;455/40;;455/41.1;;340/5.52;;340/5.53;;340/5.8;;382/115;;382/123;;382/124,5,1,022-564-808-245-652,10.1147/sj.353.0609,"""Bio|Analogics Technology Resources""; downloaded from: http://www.bioanalogics.com/technology.htm on Jun. 19, 2003, 2 pages.;;""Bio|Analogics Technology-Body Composition Techniques""; downloaded from: http://www.bioanalogics.com/techniques.htm on Jun. 19, 2003, 7 pages.;;""Wireless connections made easy""; Specification of the Bluetooth System, Specification vol. 1, Core, v. 1.1, Feb. 22, 2001, pp. 1-32; and Revision History, Feb. 22, 2001, pp. 896-897.;;""Personal Area Networks: Near-field intrabody communication""; IBM Systems Journal, vol. 35, No. 3&4, 1996-MIT Media Lab, 11 pages.;;Martin Lutz, ""The Determination of the Immunity to Electrostatic Discharge ""ESD"" With Transient 1000 Generator"", Seminar 1999, EMC Partner.",INACTIVE
345,US,A1,US 2013/0326347 A1,146-894-058-631-455,2013-12-05,2013,US 201213485829 A,2012-05-31,US 201213485829 A,2012-05-31,APPLICATION LANGUAGE LIBRARIES FOR MANAGING COMPUTING ENVIRONMENT LANGUAGES,"Language selection and application within a computing environment are often distributed over and differently applied by the operating system and various applications, leading to additional administration, inconsistencies in the user experience based on different language feature implementations among different applications; and increased cost and redundancy in developing language features for different applications. Presented herein are techniques for configuring a device with an application language library that centralizes the selection of languages by the user, and that provides a wide variety of language features (e.g., text translation, user interface adaptation, and data formats) to the applications and operating system. The application language library may also enable a multilingual user to select multiple languages; may apply a selection logic to choose a suitable language for each invocation of the application language library; and may enable the user to configure the selection among the languages for various types and instances of invocations.",ALBRIGHT ERIC SCOTT;;BEAL NICHOLAS A;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON;;MICROSOFT CORP,ALBRIGHT ERIC SCOTT;;BEAL NICHOLAS A;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-27),https://lens.org/146-894-058-631-455,Patent Application,yes,21,21,3,3,0,G06F9/454;;G06F9/454,G06F17/00,715/265,0,0,,,,DISCONTINUED
346,CN,A,CN 103399847 A,167-552-323-974-590,2013-11-20,2013,CN 201310212039 A,2013-05-31,US 201213485829 A,2012-05-31,Application language library for managing computing environment language,"Language selection and application within a computing environment are often distributed over and differently applied by the operating system and various applications, leading to additional administration, inconsistencies in the user experience based on different language feature implementations among different applications; and increased cost and redundancy in developing language features for different applications. Presented herein are techniques for configuring a device with an application language library that centralizes the selection of languages by the user, and that provides a wide variety of language features (e.g., text translation, user interface adaptation, and data formats) to the applications and operating system. The application language library may also enable a multilingual user to select multiple languages; may apply a selection logic to choose a suitable language for each invocation of the application language library; and may enable the user to configure the selection among the languages for various types and instances of invocations.",MICROSOFT CORP,ALBRIGHT ERIC SCOTT;;BEAL NICHOLAS A;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON,MICROSOFT TECHNOLOGY LICENSING LLC (2015-07-02),https://lens.org/167-552-323-974-590,Patent Application,no,6,3,3,3,0,G06F9/454;;G06F9/454,G06F17/30,,5,0,,,"张尧: ""权重信息不完全的不确定语言多属性群决策方法"", 《东北大学学报》;;马艳: ""基于不同粒度语言评价且属性权重未知的群决策方法"", 《合肥工业大学学报》;;王万军: ""基于模糊语言的多属性联系数决策方法"", 《教学的实践与认识》;;张亦驰: ""考虑权重信息的二元语义多属性群决策方法"", 《武汉理工大学学报》;;肖艳: ""基于不确定语言环境的绩效考评模型"", 《重庆高教研究》",INACTIVE
347,US,B1,US 10904639 B1,089-294-295-193-036,2021-01-26,2021,US 201715494914 A,2017-04-24,US 201715494914 A,2017-04-24,Server-side fragment insertion and delivery,"Techniques are described for server-side fragment insertion and delivery of media content. After receiving a request to play back media content, a manifest is generated that includes fragments associated with the requested media content and fragments associated with different media content. A client device requests fragments from a media server according to the manifest, and the media server provides the correct fragment in response to the request.",AMAZON TECH INC,BENSON NICHOLAS JAMES;;GLASS ANDREW;;KOTAGIRI SRIKANTH KIRAN;;LI LEI;;RICHTER STEFAN CHRISTIAN;;TANGIRALA RAKESH;;WINSTON AMARSINGH BUCKTHASINGH;;WU YONGJUN,AMAZON TECHNOLOGIES INC (2017-04-18),https://lens.org/089-294-295-193-036,Granted Patent,yes,6,13,1,1,0,H04N21/2393;;H04N21/812;;H04N21/23106;;H04N21/23106;;H04N21/2393;;H04N21/26258;;H04N21/2665;;H04N21/2665;;H04N21/812;;H04N21/8456;;H04N21/8456,H04L29/06;;H04L29/08;;H04N21/2187;;H04N21/231;;H04N21/234;;H04N21/239;;H04N21/262;;H04N21/2665;;H04N21/472;;H04N21/482;;H04N21/81;;H04N21/845;;H04N21/8547,,0,0,,,,ACTIVE
348,IL,A,IL 308449 A,079-828-332-421-423,2024-01-01,2024,IL 30844923 A,2023-11-09,US 202163190162 P;;US 2022/0029807 W,2021-05-18,Systems and methods for machine learning (ml) model diagnostic assessments based on digital pathology data,,PATHAI INC;;GLASS BENJAMIN;;CHAVALI SURYA TEJA;;JAVED SYED ASHAR;;WEAVER SHAMIRA SRIDHARAN;;RESNICK MURRAY;;WAPINSKI ILAN;;MONTALTO MICHAEL;;BECK ANDREW HANNO;;KHOSLA ADITYA,GLASS BENJAMIN;;CHAVALI SURYA TEJA;;JAVED SYED ASHAR;;WEAVER SHAMIRA SRIDHARAN;;RESNICK MURRAY;;WAPINSKI ILAN;;MONTALTO MICHAEL;;BECK ANDREW HANNO;;KHOSLA ADITYA,,https://lens.org/079-828-332-421-423,Patent Application,no,0,0,3,3,0,G06T7/0012;;G06T2207/20084;;G06T2207/10056;;G06T2207/30024;;G06V10/25;;G06V20/695;;G06V20/698;;G16H50/70;;G16H20/10;;G16H50/30;;G16H30/20;;G16H10/20;;G06N3/0464;;G06N3/09;;G06N3/0464;;G06T7/0012;;G06T2207/10056;;G06T2207/20084;;G06T2207/30024;;G06T2207/30096;;G16H10/20;;G16H20/10;;G16H30/20;;G16H50/20;;G16H50/30;;G16H50/70;;G16H70/60;;G06V10/25;;G06V20/695;;G06V20/698;;G06N3/09;;G16H50/20;;G16H70/60;;G06T2207/30096;;G06T7/0012;;G06V10/25,G06V10/25;;G06V20/69;;G16H10/20;;G16H20/10;;G16H30/20;;G16H50/20;;G16H50/30;;G16H50/70;;G16H70/60,,0,0,,,,PENDING
349,US,A1,US 2022/0375606 A1,115-815-389-300-295,2022-11-24,2022,US 202217747536 A,2022-05-18,US 202217747536 A;;US 202163190162 P,2021-05-18,SYSTEMS AND METHODS FOR MACHINE LEARNING (ML) MODEL DIAGNOSTIC ASSESSMENTS BASED ON DIGITAL PATHOLOGY DATA,"Techniques for performing diagnostic assessments based on digital pathology data are disclosed. In one particular embodiment, the techniques may be realized as a method for performing a diagnostic assessment based on digital pathology data comprising obtaining first digital pathology data comprising intensity information, the first digital pathology data being associated with a plurality of regions of interest in a biological sample; applying first machine learning models to the first digital pathology data, the first machine learning models identifying first regions of interest among the plurality of regions of interest based on the intensity information; applying second machine learning models to the first digital pathology data, the second machine learning models identifying at least one pattern associated with at least one of the first regions of interest; generating a diagnostic assessment based on the first regions of interest and the at least one pattern.",PATHAI INC,GLASS BENJAMIN;;CHAVALI SURYA TEJA;;JAVED SYED ASHAR;;WEAVER SHAMIRA SRIDHARAN;;RESNICK MURRAY;;WAPINSKI ILAN;;MONTALTO MICHAEL;;BECK ANDREW HANNO;;KHOSLA ADITYA,,https://lens.org/115-815-389-300-295,Patent Application,yes,0,1,3,3,0,G06T7/0012;;G06T2207/20084;;G06T2207/10056;;G06T2207/30024;;G06V10/25;;G06V20/695;;G06V20/698;;G16H50/70;;G16H20/10;;G16H50/30;;G16H30/20;;G16H10/20;;G06N3/0464;;G06N3/09;;G06N3/0464;;G06T7/0012;;G06T2207/10056;;G06T2207/20084;;G06T2207/30024;;G06T2207/30096;;G16H10/20;;G16H20/10;;G16H30/20;;G16H50/20;;G16H50/30;;G16H50/70;;G16H70/60;;G06V10/25;;G06V20/695;;G06V20/698;;G06N3/09;;G16H50/20;;G16H70/60;;G06T2207/30096;;G06T7/0012;;G06V10/25,G16H50/20;;G06T7/00;;G06V10/25;;G16H70/60,,0,0,,,,PENDING
350,US,A1,US 2019/0066240 A1,149-222-064-348-266,2019-02-28,2019,US 201715832222 A,2017-12-05,US 201715832222 A;;US 201762550306 P,2017-08-25,USER DETECTION BASED ON LOCATOR-EMBEDDED IDENTIFIER,"A server machine is configured to map an identifier of a user to an account of the user within a database. The server machine also embeds the identifier within a uniform resource locator (URL) that, when operated by a browser of the user, causes the browser to interact with a supplier server machine. The server machine later receives interaction result data from the supplier server machine, and the interaction result data includes the identifier of the user and an interaction detail resultant from the interaction initiated by the browser with the supplier server machine. A machine then detects that the interaction detail corresponds to the account of the user based on the identifier being both received in the interaction result data and mapped to the account of the user. Accordingly, the server machine causes inclusion of the interaction detail within an information entry that corresponds to the user.",HIPMUNK INC,GOLDSTEIN ADAM JULIAN;;GLASS WILLIAM ROBERT;;SKEVINGTON MELISSA ANNE;;DAWSON ANDREW JOSEPH;;CLARKE STEVEN;;HANG HA TU;;GENIN THOMAS PIERRE ROBERT;;LAL NAVIN,HIPMUNK INC (2017-11-27),https://lens.org/149-222-064-348-266,Patent Application,yes,3,2,3,3,0,G06Q50/14;;G06Q50/14;;G06F16/9535;;G06Q10/02;;G06Q10/02;;G06Q40/12;;G06Q40/12,G06Q50/14;;G06Q10/02;;G06Q40/00,,0,0,,,,ACTIVE
351,US,B2,US 6515023 B2,043-697-655-875-768,2003-02-04,2003,US 77235301 A,2001-01-30,US 77235301 A;;US 17918400 P,2000-01-31,Thrombin receptor antagonists,"
    A thrombin receptor antagonist having the formula 

    useful for inhibiting the aggregation of blood platelets. The compounds can be used in a method of acting upon a thrombin receptor which comprises administering a therapeutically effective but non-toxic amount of such compound to a mammal, preferably a human. 
",MERCK & CO INC,BARROW JAMES C;;NANTERMET PHILIPPE G;;SELNICK HAROLD G;;HUTCHINSON JOHN H;;BRESLIN MICHAEL J;;GLASS KRISTEN L;;CONNOLLY THOMAS M;;STERN ANDREW,MERCK & CO. INC (2001-01-04),https://lens.org/043-697-655-875-768,Granted Patent,yes,10,6,2,2,0,C07B2200/07;;C07C275/40;;C07D207/16;;C07D213/81;;C07D213/82;;C07D233/90;;C07D235/06;;C07D333/24;;C07D333/38;;C07D471/04;;C07C2601/02;;C07C2601/04;;C07D213/81;;C07D207/16;;C07D471/04;;C07D213/82;;C07D333/24;;C07D233/90;;C07B2200/07;;C07D333/38;;C07D235/06;;C07C275/40;;C07C2601/02;;C07C2601/04,C07C275/40;;C07D207/16;;C07D213/81;;C07D213/82;;C07D233/90;;C07D235/06;;C07D333/24;;C07D333/38;;C07D471/04,514/597;;514/303;;514/350;;514/423;;514/438;;514/552;;546/118;;546/318;;546/323;;548/537;;549/77;;558/417;;560/27;;564/49;;564/51,3,2,047-442-737-034-103;;077-827-054-702-876,8960546;;10.1021/jm960455s;;9871500;;10.1007/bf01318860,"Tiers, Chem. Abst. 110:66645 (1989).*;;Bernatowicz, Michael, S. et al., ""Development of Potent Thrombin Receptor Antagonict Peptides"", J. Med. Chem., pp. 4879-4887; 39: 1996.;;Alexopoulos, K. et al., ""A comparative SAR study of thrombin receptor derived non peptied mimetics: Importance of phenyl/guanidino proximity for activity"", Amino Acids, pp. 211-220; 15: 1998.",EXPIRED
352,US,B2,US 11049200 B2,046-851-951-820-763,2021-06-29,2021,US 201715832222 A,2017-12-05,US 201715832222 A;;US 201762550306 P,2017-08-25,User detection based on locator-embedded identifier,"A server machine is configured to map an identifier of a user to an account of the user within a database. The server machine also embeds the identifier within a uniform resource locator (URL) that, when operated by a browser of the user, causes the browser to interact with a supplier server machine. The server machine later receives interaction result data from the supplier server machine, and the interaction result data includes the identifier of the user and an interaction detail resultant from the interaction initiated by the browser with the supplier server machine. A machine then detects that the interaction detail corresponds to the account of the user based on the identifier being both received in the interaction result data and mapped to the account of the user. Accordingly, the server machine causes inclusion of the interaction detail within an information entry that corresponds to the user.",HIPMUNK INC,GOLDSTEIN ADAM JULIAN;;GLASS WILLIAM ROBERT;;SKEVINGTON MELISSA ANNE;;DAWSON ANDREW JOSEPH;;CLARKE STEVEN;;HANG HA TU;;GENIN THOMAS PIERRE ROBERT;;LAL NAVIN,HIPMUNK INC (2017-11-27),https://lens.org/046-851-951-820-763,Granted Patent,yes,10,0,3,3,0,G06Q50/14;;G06Q50/14;;G06F16/9535;;G06Q10/02;;G06Q10/02;;G06Q40/12;;G06Q40/12,G06Q10/02;;G06F16/9535;;G06Q40/00;;G06Q50/14,,6,4,145-405-973-571-509;;091-507-815-651-407;;177-522-918-138-925;;000-707-128-273-497,10.2139/ssrn.2978281;;10.1109/jproc.2016.2637878;;10.1007/978-3-319-30505-9_3;;10.1109/sp.2012.47,"Wang, Yunsen, and Alexander Kogan. “Designing privacy-preserving blockchain based accounting information systems.” SSRN Electronic Journal (2017). (Year: 2017).;;“European Application Serial No. 18186504.9, Office Action dated Oct. 5, 2018”, 10 pgs.;;Bujlow, Tomasz, et al., “A Survey on Web Tracking—Mechanisms, Implications, and Defenses”, Proceedings of the IEEE. vol. 105, No. 8, (Aug. 2017), 1476-1510.;;Falahrastegar, Marjan, et al., “Tracking Personal Identifiers Across the Web”, MICCAI Lecture Notes in Computer Science, pp. 31-34, (2016), 30-41.;;Mayer, Jonathan, et al., “How Verizon's Advertising Header Works”, [Online]. Retrieved from the Internet: <URL: http://webpolicy.org/2014/10/24/how-verizons-advertising-header-works/>, (2014), 3 pgs.;;Mayer, Jonathan, et al., “Third-Party Web Tracking—Policy and Technology”, IEEE Symposium on Security and Privacy, (2012), 413-427.",ACTIVE
353,US,A1,US 2013/0325435 A1,037-396-526-276-674,2013-12-05,2013,US 201213485917 A,2012-05-31,US 201213485917 A,2012-05-31,LANGUAGE LISTS FOR RESOURCE SELECTION,"A device may be configured to enable a user to select a language, and may fulfill resource requests from applications by selecting, from among resources respectively associated with a language, a resource associated with the selected language of the user. However, this resource selection process may be inadequate if the user selects multiple languages; if a resource associated with the selected language of the user is unavailable, but resources associated with related languages are available; or if the user and/or the application specifies an ordering for the selection among the languages. Presented herein are techniques for performing the resource selection by, for respective languages selected by the user, calculating a weight representing a suitability of the language for the resource request; generating a selection order of the selected languages according to the weights; and selecting a resource based on the position of the associated language in the selection order.",HAWKINS RYLAN MICHAEL;;ALBRIGHT ERIC SCOTT;;BEAL NICHOLAS A;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON;;MICROSOFT CORP,HAWKINS RYLAN MICHAEL;;ALBRIGHT ERIC SCOTT;;BEAL NICHOLAS A;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-27),https://lens.org/037-396-526-276-674,Patent Application,yes,5,10,4,4,0,G06F9/454;;G06F9/454;;G06F16/3337;;G06F16/955;;G06F40/40;;G06F40/58,G06F40/00,704/8,0,0,,,,ACTIVE
354,US,A1,US 2002/0007045 A1,166-717-279-169-012,2002-01-17,2002,US 77235301 A,2001-01-30,US 77235301 A;;US 17918400 P,2000-01-31,Thrombin receptor antagonists,"
    A thrombin receptor antagonist having the formula 

   useful for inhibiting the aggregation of blood platelets. The compounds can be used in a method of acting upon a thrombin receptor which comprises administering a therapeutically effective but non-toxic amount of such compound to a mammal, preferably a human. 
",BARROW JAMES C.;;NANTERMET PHILIPPE G.;;SELNICK HAROLD G.;;HUTCHINSON JOHN H.;;BRESLIN MICHAEL J.;;GLASS KRISTEN L.;;CONNOLLY THOMAS M.;;STERN ANDREW,BARROW JAMES C;;NANTERMET PHILIPPE G;;SELNICK HAROLD G;;HUTCHINSON JOHN H;;BRESLIN MICHAEL J;;GLASS KRISTEN L;;CONNOLLY THOMAS M;;STERN ANDREW,MERCK & CO. INC (2001-01-04),https://lens.org/166-717-279-169-012,Patent Application,yes,0,6,2,2,0,C07B2200/07;;C07C275/40;;C07D207/16;;C07D213/81;;C07D213/82;;C07D233/90;;C07D235/06;;C07D333/24;;C07D333/38;;C07D471/04;;C07C2601/02;;C07C2601/04;;C07D213/81;;C07D207/16;;C07D471/04;;C07D213/82;;C07D333/24;;C07D233/90;;C07B2200/07;;C07D333/38;;C07D235/06;;C07C275/40;;C07C2601/02;;C07C2601/04,C07C275/40;;C07D207/16;;C07D213/81;;C07D213/82;;C07D233/90;;C07D235/06;;C07D333/24;;C07D333/38;;C07D471/04,530/331;;546/118;;564/47,0,0,,,,EXPIRED
355,EP,A1,EP 3447693 A1,013-043-774-719-994,2019-02-27,2019,EP 18186504 A,2018-07-31,US 201762550306 P;;US 201715832222 A,2017-08-25,USER DETECTION BASED ON LOCATOR-EMBEDDED IDENTIFIER,"A server machine is configured to map an identifier of a user to an account of the user within a database. The server machine also embeds the identifier within a uniform resource locator (URL) that, when operated by a browser of the user, causes the browser to interact with a supplier server machine. The server machine later receives interaction result data from the supplier server machine, and the interaction result data includes the identifier of the user and an interaction detail resultant from the interaction initiated by the browser with the supplier server machine. A machine then detects that the interaction detail corresponds to the account of the user based on the identifier being both received in the interaction result data and mapped to the account of the user. Accordingly, the server machine causes inclusion of the interaction detail within an information entry that corresponds to the user.
",HIPMUNK INC,GOLDSTEIN ADAM JULIAN;;GLASS WILLIAM ROBERT;;SKEVINGTON MELISSA ANNE;;DAWSON ANDREW JOSEPH;;CLARKE STEVEN;;HANG HA TU;;GENIN THOMAS PIERRE ROBERT;;LAL NAVIN,,https://lens.org/013-043-774-719-994,Patent Application,yes,0,0,3,3,0,G06Q10/02;;G06Q50/14;;G06Q40/12;;G06Q10/02;;G06Q50/14;;G06Q40/12;;G06F16/9535,G06Q50/14;;G06Q10/02,,4,2,091-507-815-651-407;;000-707-128-273-497,10.1109/jproc.2016.2637878;;10.1109/sp.2012.47,"BUJLOW TOMASZ ET AL: ""A Survey on Web Tracking: Mechanisms, Implications, and Defenses"", PROCEEDINGS OF THE IEEE, IEEE. NEW YORK, US, vol. 105, no. 8, 8 August 2017 (2017-08-08), pages 1476 - 1510, XP011656907, ISSN: 0018-9219, [retrieved on 20170717], DOI: 10.1109/JPROC.2016.2637878;;JONATHAN R MAYER ET AL: ""Third-Party Web Tracking: Policy and Technology"", SECURITY AND PRIVACY (SP), 2012 IEEE SYMPOSIUM ON, IEEE, 20 May 2012 (2012-05-20), pages 413 - 427, XP032456301, ISBN: 978-1-4673-1244-8, DOI: 10.1109/SP.2012.47;;FALAHRASTEGAR MARJAN ET AL: ""Tracking Personal Identifiers Across the Web"", 24 March 2016, MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2015 : 18TH INTERNATIONAL CONFERENCE, MUNICH, GERMANY, OCTOBER 5-9, 2015; PROCEEDINGS; [LECTURE NOTES IN COMPUTER SCIENCE; LECT.NOTES COMPUTER], SPRINGER INTERNATIONAL PUBLISHING, CH, ISBN: 978-3-540-70543-7, ISSN: 0302-9743, XP047344796;;JONATHAN MAYER: ""How Verizon's Advertising Header Works | Web Policy"", 24 October 2014 (2014-10-24), XP055507015, Retrieved from the Internet <URL:http://webpolicy.org/2014/10/24/how-verizons-advertising-header-works/> [retrieved on 20180913]",DISCONTINUED
356,US,B2,US 10949230 B2,068-149-452-083-023,2021-03-16,2021,US 201213485917 A,2012-05-31,US 201213485917 A,2012-05-31,Language lists for resource selection based on language text direction,"A device may be configured to enable a user to select a language, and may fulfill resource requests from applications by selecting, from among resources respectively associated with a language, a resource associated with the selected language of the user. However, this resource selection process may be inadequate if the user selects multiple languages; if a resource associated with the selected language of the user is unavailable, but resources associated with related languages are available; or if the user and/or the application specifies an ordering for the selection among the languages. Presented herein are techniques for performing the resource selection by, for respective languages selected by the user, calculating a weight representing a suitability of the language for the resource request; generating a selection order of the selected languages according to the weights; and selecting a resource based on the position of the associated language in the selection order.",HAWKINS RYLAN MICHAEL;;ALBRIGHT ERIC SCOTT;;BEAL NICK;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON;;TECH LICENSING MICROSOFT;;MICROSOFT TECHNOLOGY LICENSING LLC,HAWKINS RYLAN MICHAEL;;ALBRIGHT ERIC SCOTT;;BEAL NICK;;CONSTABLE PETER GEOFFREY;;CURTISS WADE H;;FORTUNE ERIK;;GLASS ANDREW STUART;;BEARD SAMUEL AARON;;TECHNOLOGY LICENSING MICROSOFT,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-27),https://lens.org/068-149-452-083-023,Granted Patent,yes,37,0,4,4,0,G06F9/454;;G06F9/454;;G06F16/3337;;G06F16/955;;G06F40/40;;G06F40/58,G06F16/33;;G06F9/451;;G06F16/955;;G06F40/00;;G06F40/40;;G06F40/58,,12,0,,,"“First Office Action Issued in Chinese Patent Application No. 201310211732.0”, dated Oct. 26, 2015, 17 Pages.;;“Third Office Action Issued in Chinese Application No. 201310211732.0”, dated Aug. 30, 2016, 7 Pages.;;“Second Office Action and Search Report Issued in Chinese Patent Application No. 201310211732.0”, dated Jun. 1, 2016, 21 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Apr. 16, 2014, 11 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Aug. 7, 2014, 10 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Dec. 19, 2014, 11 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Apr. 1, 2015, 11 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Oct. 30, 2015, 18 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/485,683”, dated Feb. 26, 2016, 12 Pages.;;“First Office Action and Search Report Issued in Chinese Patent Application No. 201310213093.1”, dated Sep. 1, 2015, 13 Pages.;;“Second Office Action Issued in Chinese Patent Application No. 201310213093.1”, dated Jun. 1, 2016, 8 Pages.;;“Third Office Action Issued in Chinese Patent Application No. 201310213093.1”, dated Oct. 28, 2016, 13 Pages.",ACTIVE
357,US,B1,US 11915823 B1,160-283-471-084-98X,2024-02-27,2024,US 202217984866 A,2022-11-10,US 202217984866 A;;US 202017019142 A;;US 201962900387 P,2019-09-13,Systems and methods for frame-based validation,"In some aspects, the described systems and methods provide for validating performance of a model trained on a plurality of annotated pathology images. A pathology image is accessed. Frames are generated using the pathology image. Each frame in the set includes a distinct portion of the pathology image. Reference annotations are received from one or more users. The reference annotations describe at least one of a plurality of tissue or cellular characteristic categories for one or more frames in the set. Each frame in the set is processed using the trained model to generate model predictions. The model predictions describe at least one of the tissue or cellular characteristic categories for the processed frame. Performance of the trained model is validated based on determining a degree of association between the reference annotations and the model predictions for each frame and/or across all frames in the set of frames.",PATHAI INC,POKKALLA HARSHA VARDHAN;;WANG DAYONG;;ELLIOTT HUNTER L;;GLASS BENJAMIN P;;WAPINSKI ILAN N;;KERNER JENNIFER K;;BECK ANDREW H;;KHOSLA ADITYA;;GULLAPALLY SAI CHOWDARY;;SRINIVASAN RAMPRAKASH,PATHAI INC (2018-09-05),https://lens.org/160-283-471-084-98X,Granted Patent,yes,7,0,2,2,0,G06F18/23;;G16H30/40;;G16H50/20;;G16H50/70;;G06N3/0464;;G06N3/0985;;G06N3/09;;G06N3/048;;G06N3/082;;G16H30/40;;G16H30/20;;G06N3/08;;G16H50/20;;G06F18/23,G06F18/23;;G06N3/08;;G16H30/20;;G16H30/40;;G16H50/20,,0,0,,,,ACTIVE
358,US,B1,US 11527319 B1,061-381-502-708-063,2022-12-13,2022,US 202017019142 A,2020-09-11,US 202017019142 A;;US 201962900387 P,2019-09-13,Systems and methods for frame-based validation,"In some aspects, the described systems and methods provide for validating performance of a model trained on a plurality of annotated pathology images. A pathology image is accessed. Frames are generated using the pathology image. Each frame in the set includes a distinct portion of the pathology image. Reference annotations are received from one or more users. The reference annotations describe at least one of a plurality of tissue or cellular characteristic categories for one or more frames in the set. Each frame in the set is processed using the trained model to generate model predictions. The model predictions describe at least one of the tissue or cellular characteristic categories for the processed frame. Performance of the trained model is validated based on determining a degree of association between the reference annotations and the model predictions for each frame and/or across all frames in the set of frames.",PATHAI INC,POKKALLA HARSHA VARDHAN;;ELLIOTT HUNTER L;;WANG DAYONG;;GLASS BENJAMIN P;;WAPINSKI ILAN N;;KERNER JENNIFER K;;BECK ANDREW H;;KHOSLA ADITYA;;GULLAPALLY SAI CHOWDARY;;SRINIVASAN RAMPRAKASH,PATHAI INC (2018-09-05),https://lens.org/061-381-502-708-063,Granted Patent,yes,5,1,2,2,0,G06F18/23;;G16H30/40;;G16H50/20;;G16H50/70;;G06N3/0464;;G06N3/0985;;G06N3/09;;G06N3/048;;G06N3/082;;G16H30/40;;G16H30/20;;G06N3/08;;G16H50/20;;G06F18/23,G06K9/00;;G06K9/62;;G06N3/08;;G16H30/20;;G16H30/40;;G16H50/20,,0,0,,,,ACTIVE
359,US,B2,US 7436300 B2,076-704-499-709-353,2008-10-14,2008,US 98798004 A,2004-11-12,US 98798004 A,2004-11-12,Wireless device support for electronic devices,"Disclosed are a unique system and method that facilitate establishing and maintaining a secure connection between at least one wireless input component and a host (e.g., PC). The system and method involve the wireless input component broadcasting a message that can be “heard” by any potential host located within a given distance from the wireless input component. The message can indicate that the input component is available for use or pairing with a PC. PCs in the area can respond to the message by notifying the user that a wireless input component is available and by generating a random PIN. The PIN can be displayed to the user on the respective PC. The user can be prompted to enter the PIN using the wireless device. When a match between the user's response and the corresponding PC is determined, the two can be securely linked. In addition the invention provides support of wireless input devices at boot or start up.",MICROSOFT CORP,GLASS ANDREW C;;THOMPSON BERNARD J;;FOSDICK BRADLEY L;;WEN CHIH JEN;;DREHER CHRISTOPHER M;;HOLAN DORON J;;BHESANIA FIRDOSH K;;RENSBERGER GARY M;;HAUSER PETER E H;;AULL RANDALL E,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2004-11-11),https://lens.org/076-704-499-709-353,Granted Patent,yes,6,86,2,2,0,G06F21/31;;G06F21/35;;G06F21/83;;H04L63/0853;;H04W12/06;;H04W12/06;;G06F21/31;;G06F21/35;;G06F21/83;;H04L63/0853,G08B13/14;;H04B5/00;;H04M3/00,340/568.1;;455/41.1;;455/418;;455/412.1;;370/310;;370/313,0,0,,,,ACTIVE
360,US,A1,US 2006/0105712 A1,131-444-472-279-239,2006-05-18,2006,US 98798004 A,2004-11-12,US 98798004 A,2004-11-12,Wireless device support for electronic devices,"Disclosed are a unique system and method that facilitate establishing and maintaining a secure connection between at least one wireless input component and a host (e.g., PC). The system and method involve the wireless input component broadcasting a message that can be “heard” by any potential host located within a given distance from the wireless input component. The message can indicate that the input component is available for use or pairing with a PC. PCs in the area can respond to the message by notifying the user that a wireless input component is available and by generating a random PIN. The PIN can be displayed to the user on the respective PC. The user can be prompted to enter the PIN using the wireless device. When a match between the user's response and the corresponding PC is determined, the two can be securely linked. In addition the invention provides support of wireless input devices at boot or start up.",MICROSOFT CORP,GLASS ANDREW C;;THOMPSON BERNARD J;;FOSDICK BRADLEY L;;WEN CHIH J;;DREHER CHRISTOPHER M;;HOLAN DORON J;;BHESANIA FIRDOSH K;;RENSBERGER GARY M;;HAUSER PETER E H;;AULL RANDALL E,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2004-11-11),https://lens.org/131-444-472-279-239,Patent Application,yes,6,186,2,2,0,G06F21/31;;G06F21/35;;G06F21/83;;H04L63/0853;;H04W12/06;;H04W12/06;;G06F21/31;;G06F21/35;;G06F21/83;;H04L63/0853,H04B7/00,455/41.2,0,0,,,,ACTIVE
361,US,B2,US 9438959 B2,050-829-756-239-651,2016-09-06,2016,US 201213523515 A,2012-06-14,US 201213523515 A,2012-06-14,Method and system for watching content and playing games on a mobile communication device,"A method and system for watching video and playing games in a mobile communication device are described in which video content is received from a network television channel and, based on the orientation of the mobile communication device and the device type, the video content and/or a game may be displayed. When in a portrait orientation, the operating mode may be such that the video content and/or the game may be displayed. For a tablet device in a portrait orientation, for example, both the video content and the game may be displayed. When the mobile communication device is changed to a landscape orientation, the operating mode may be different and only one of the video content and the game may be displayed based on whether the mobile communication device was rotated clockwise or counter-clockwise. A rewards program may combine the video-watching and game-playing activities of the user.",BAUGUS CARRIE;;GLASS SHERRI;;WALDRON CHRISTOPHER;;WENTZEL JAMES;;MOORE ALAN;;VEITH CHRISTINE;;TEAGUE BEAU;;CANNON JACLYN;;COSTON RANDALL;;PIEDRA MARIO;;CONDOLORA PAUL;;NUNES JASON;;KAHL FREDERICK;;PRATT ANDREW;;ELLLINGTON KRISTIN;;FULLER CHAD;;BUNCH KENNETH;;TURNER BROADCASTING SYS INC,BAUGUS CARRIE;;GLASS SHERRI;;WALDRON CHRISTOPHER;;WENTZEL JAMES;;MOORE ALAN;;VEITH CHRISTINE;;TEAGUE BEAU;;CANNON JACLYN;;COSTON RANDALL;;PIEDRA MARIO;;CONDOLORA PAUL;;NUNES JASON;;KAHL FREDERICK;;PRATT ANDREW;;ELLLINGTON KRISTIN;;FULLER CHAD;;BUNCH KENNETH,TURNER BROADCASTING SYSTEM INC (2012-06-06),https://lens.org/050-829-756-239-651,Granted Patent,yes,4,0,2,2,0,A63F13/21;;A63F13/211;;A63F13/211;;A63F13/2145;;A63F13/2145;;A63F13/338;;A63F13/52;;A63F13/92;;A63F13/92;;G06T3/60;;H04N21/4781;;H04N21/4781,G09G5/10;;A63F13/211;;A63F13/2145;;A63F13/92;;H04N21/478,,0,0,,,,ACTIVE
362,US,A1,US 2013/0337917 A1,170-909-584-763-30X,2013-12-19,2013,US 201213523515 A,2012-06-14,US 201213523515 A,2012-06-14,METHOD AND SYSTEM FOR WATCHING CONTENT AND PLAYING GAMES ON A MOBILE COMMUNICATION DEVICE,"A method and system for watching video and playing games in a mobile communication device are described in which video content is received from a network television channel and, based on the orientation of the mobile communication device and the device type, the video content and/or a game may be displayed. When in a portrait orientation, the operating mode may be such that the video content and/or the game may be displayed. For a tablet device in a portrait orientation, for example, both the video content and the game may be displayed. When the mobile communication device is changed to a landscape orientation, the operating mode may be different and only one of the video content and the game may be displayed based on whether the mobile communication device was rotated clockwise or counter-clockwise. A rewards program may combine the video-watching and game-playing activities of the user.",BAUGUS CARRIE;;GLASS SHERRI;;WALDRON CHRISTOPHER;;WENTZEL JAMES;;MOORE ALAN;;VEITH CHRISTINE;;TEAGUE BEAU;;CANNON JACLYN;;COSTON RANDALL;;PIEDRA MARIO;;CONDOLORA PAUL;;NUNES JASON;;KAHL FREDERICK;;PRATT ANDREW;;ELLLINGTON KRISTIN;;FULLER CHAD;;BUNCH KENNETH,BAUGUS CARRIE;;GLASS SHERRI;;WALDRON CHRISTOPHER;;WENTZEL JAMES;;MOORE ALAN;;VEITH CHRISTINE;;TEAGUE BEAU;;CANNON JACLYN;;COSTON RANDALL;;PIEDRA MARIO;;CONDOLORA PAUL;;NUNES JASON;;KAHL FREDERICK;;PRATT ANDREW;;ELLLINGTON KRISTIN;;FULLER CHAD;;BUNCH KENNETH,TURNER BROADCASTING SYSTEM INC (2012-06-06),https://lens.org/170-909-584-763-30X,Patent Application,yes,4,4,2,2,0,A63F13/21;;A63F13/211;;A63F13/211;;A63F13/2145;;A63F13/2145;;A63F13/338;;A63F13/52;;A63F13/92;;A63F13/92;;G06T3/60;;H04N21/4781;;H04N21/4781,A63F13/00;;G06F19/00,463/40;;463/43,0,0,,,,ACTIVE
